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Introduction Head injury is a rare but possible etiology of cerebral 
thrombophlebitis. The diagnosis should be considered especially in 
front of open head injuries extended to venous sinuses. The MR angi-
ography is the gold standard for early diagnosis.
Patients and methods This is a descriptive prospective study of all 
trauma patients hospitalized in the intensive care unit of the Univer-
sity Hospital Habib Bourguiba Sfax over a period of 6  years between 
January 2010 and June 2016 and in whom the diagnosis of cerebral 
venous thrombophlebitis has been confirmed by angiography CT or MR 
angiography.
Results During the period study, 15 patients were included. The 
median age of patients was 29 [17–49] years. All patients were male, 
victims of poly trauma following an accident of traffic. In admission, 
SAPSII was 31 [24–52] and SOFA was 4 [2–8]. We have noted the pres-
ence of a serious head injury in 15 patients, extended open skull frac-
tures of the venous sinus in 9 patients. A related chest trauma was 
present in 12 patients and abdominal trauma in 4 patients, trauma 
of the pelvis and/or members were present in 7 patients. All patients 
underwent mechanical ventilation. The diagnosis of cerebral venous 
thrombosis was confirmed by cerebral angiography CT in 9 patients 
and cerebral MR angiography in 6 patients. 7 patients have presented 
secondary pulmonary embolism. All patients did not show a contrain-
dication against anticoagulation at diagnosis of thrombophlebitis. The 
thrombophilia (antithrombin III, protein C and S, homocysteine, and 
antiphospholipid, gene mutation factors II and V) as well as for anti-
neutrophil cytoplasmic antibodies were negative in all patients. The 
outcome was favorable in 13 patients. Two patients were died due to a 
state of refractory septic shock.
Discussion Post traumatic cerebral thrombophlebitis is a rare 
thrombotic vascular disease. It must be mentioned especially 
with presence of extensive skull fractures in open sinuses. Venous 
MR angiography is the gold standard. The treatment is based on 
anticoagulation curative dose. Its prescription can be complicated in 
these cases associated with traumatic intracranial hemorrhage.
Conclusion Head injury is a rare but possible etiology of cerebral 
thrombophlebitis. Other prospective studies are needed to better 
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Introduction Pain is highly prevalent in critically ill trauma patients 
especially those with a traumatic brain injury (TBI). Behavioral 
pain tools such as the Behavioral pain scale (BPS), and critical 
care pain observation tool (CPOT) are recommended for sedated 
non-communicative patients. The analgesia nociception index 
(ANI) assesses the relative parasympathetic tone as a surrogate 
for antinociception/nociception balance in sedated patients. The 
primary aim is to evaluate the effectiveness of ANI in detecting pain 
in TBI patients. The secondary aim was to evaluate the impact of 
Norepinephrine use on ANI effectiveness, and to determine the 
correlation between ANI and BPS.
Patients and methods We performed a prospective observational 
study in 21 deeply sedated TBI patients. Exclusion criteria were non-
sinus cardiac rhythm; presence of pacemaker; atropine or isoprenaline 
treatment; neuromuscular blocking agents and major cognitive 
impairment. HR, blood pressure and ANI were continuously recorded 
using the Physiodoloris® device at rest (T1), during (T2) and after the 
end (T3) of the painful stimulus (tracheal suctioning).
Results In total, 100 observations were scored. Patients’ characteristics 
were resumed in Fig. 1. ANI was significantly lower at T2 (Med (min–max) 
54.5 (22–100)) compared with T1 (90.5 (50–100), p < 0.0001) and T3 (82 
(36–100), p  <  0.0001). Similar results were found in the subgroups of 
patients with (65 measurements) or without (35) Norepinephrine. Dur-
ing procedure, A negative linear relationship was observed between ANI 
and BPS (r2 = −0.469, p < 0.001). At the threshold of 50, the sensitivity 
and specificity of ANI to detect patients with BPS ≥ 5 were 73 and 62%, 
respectively with a negative predictive value of 86%.
Discussion
Conclusion ANI is effective in detecting pain in deeply sedated 
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Introduction The aim of our study was to assess the prognostic factors 
of cervical spine trauma in elderly subjects admitted in the surgical 
intensive care unit.
Patients and methods We conducted a retrospective, and single-
center study over 16 years (January 2000–January 2016) in Ibn Rochd 
hospital, we included all patients aged over 65  years with isolated 
cervical spine trauma, operated and non-operated, admitted in 
surgical intensive care, the death risk factors were searched by uni and 
multivariate analysis.
Results 198 patients were collected, the average age was 
69.4 ±  3.9  years, with a male predominance 70.2%, the main causes 
were road accidents (50.5%) and fall (34.3%), 68.2% had a complete 
form (Frankel A), 75.7% were operated. The death rate in our study was 
55%. The prognostic factors in univariate analysis were: hypertension, 
heart disease, fall injury, surgical delay >10 h; independent factors of 
death in multivariate analysis: heart disease and fall injury.
Conclusion The cervical spine trauma in elderly patients hospitalized 
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Introduction Legionnaire’s disease is a rare but severe acute 
pneumonia with a difficult definitive diagnosis. Legionella’s urine 
antigen testing is a quick, sensitive and specific test, widely prescribed 
in the case of an acute and severe community-acquired pneumonia. 
However, its overall contribution to the diagnosis of atypical 
pneumonia remains unknown in daily practice. The aims of this study 
were to evaluate the usefulness of this test in a “real life” utilization and 
to identify potential clinical markers of legionnaire’s disease in order 
to optimize its prescription. Legionnaire’s disease is a rare but severe 
acute pneumonia with a difficult definitive diagnosis. Legionella’s 
urine antigen testing is a quick, sensitive and specific test, widely 
prescribed in the case of an acute and severe community-acquired 
pneumonia. However, its overall contribution to the diagnosis of 
atypical pneumonia remains unknown in daily practice. The aims of 
this study were to evaluate the usefulness of this test in a “real life” 
utilization and to identify potential clinical markers of legionnaire’s 
disease in order to optimize its prescription.
Patients and methods We conducted a retrospective, monocentric 
and observational study. All the prescriptions of the urine antigen 
testing where monitored in the intensive care department and the 
emergency room admitting severe patients, in our University Teaching 
Hospital, from January 1st 2013 to December 31st 2015. Qualitative 
variables were compared by a Fischer’s exact test, and quantitative 
variables by a Mann–Whitney test. All tests were bilateral, and p ≤ 0.05 
was considered as significant. ROC curves were determined for the 
variables of interest.
Results During the period of the survey, 1142 urinary tests were 
performed in 1002 patients. Three tests were positive for 0.26% of 
patients. Only 569 patients suffered from an actual pneumonia. 
Other patients suffered mostly from acute bronchitis (137 cases), 
and exacerbation of chronic obstructive pulmonary disease 
(123 cases). The characteristics of the 3 patients suffering from 
legionnaire’s disease differed significantly compared to the other 
kinds of acute pneumonia for: the need for invasive mechanical 
ventilation (100 vs 34.96% of patients; p  =  0.043), PaO2/FiO2 
ratio (107.5 vs 274.5; p = 0.0107), duration of mechanical ventilation 
(27.5 vs 2.5  days; p  =  0.0062), natremia (129.5 vs 138  mmol/l; 
p  =  0.0125), Creatine Phospho-Kinase level (16,125 vs 106UI; 
p  =  0.0225) and Serum Glutamat Oxalacetat Transaminase (251 vs 
35UI; p = 0.0157). We determined ROC curves for these last biological 
variables. Natremia: better threshold  =  131, Se/Sp  =  100/84.2%, 
AUC  =  0.92. SGOT: better threshold  =  191, Se/Sp  =  100/89.6%, 
AUC = 0.9. CPK: better threshold 195, Se/Sp = 100/66.5, AUC = 0.88.
Discussion Urine antigen testing for Legionnaire’s disease appears to 
be over-prescribed in many cases with a very poor level of positivity 
in our cohort. However, it could be limited to patients exhibiting a 
pneumonia, and among them to patients with the classical biological 
perturbations described in this disease, which have excellent 
diagnostic performance. This targeted strategy would present an 
important benefit in term of costs.
Conclusion Our results show that a better selection in the patients 
who could benefit of this test is mandatory. Simples markers in routine 





Staphylococcal community‑acquired urinary tract infection in the 
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Fig. 1 Baseline demographic and clinical characteristics. Values 
are expressed as mean ± standard deviation (SD); n (%) or median 
[interquartile range]. EDH extradural haemorrhage SDH subdural 
haemorrhage, SAH subarachnoid hemorrhage
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Introduction Urinary tract infection is a frequent cause of admission 
at the Emergency Department (ED). Most prevalent bacteria are 
usually gram-negative bacilli and Staphylococcus aureus (Sa) is rarely 
evidenced (2.5%) except in hospital-acquired infections due to urinary 
catheter [1]. Bacteriuria can be observed in Sa infective endocarditis 
(IE) because of the metastatic properties of Sa. We hypothesized 
that presence of Sa in the urine could be related to Staphylococcal 
bacteremia associated with unsuspected IE and not only the 
expression of a “usual” urinary tract infection.
Patients and methods This is a descriptive single-center study 
conducted over a 10 year-period in the Teaching Hospital of Limoges. 
All patients admitted to the ED with Sa (both MSSA and MRSA) isolated 
from their urine cultures were retrospectively analyzed. Data were 
collected from the database of the microbiology department and the 
patient medical charts. We secondarily searched if a Sa IE had been 
documented in patients with Sa isolated from their blood cultures in 
order to establish a link between IE and presence of Sa in the urine. We 
used modified Dukes criteria as diagnostic criteria of IE [2].
Results Between 2005 and 2015, 420,000 patients were admitted 
in the ED. Out of the 204 records analyzed, 174 patients whose urine 
culture grew Sa were excluded because they had a urinary catheter 
(n  =  75) or sterile blood cultures (n  =  99). Finally, 30 patients were 
studied (17 men; median age: 73 years; diabetes: n = 7; mitral valvular 
disease: n  =  2, aortic valvular disease: n  =  2) (Table  1). Reasons for 
admission were markedly heterogeneous and fever accounted for 14 
cases. Echocardiography was performed in 25 patients with a median 
delay of 6.5  days (range: 0–23  days) and IE was confirmed in 21 of 
them. Only three cases of IE have been diagnosed in the ED because 
of a fever and valvular murmur (n = 2) but no patient was admitted 
to the ED for IE suspicion. Other initially suspected diagnoses were 
prostatitis, pneumonia or appendicitis and not related to any type 
of infection in 26% of the cases. The origin of Sa bacteremia was 
cutaneous in 67% of the cases. During the hospital stay, 70% of the 
patients presented secondary sites of Sa infection in addition to the 
urinary tract (arthritis, splenic abcess, cerebral hematoma). Among 21 
patients presenting with an IE, 8 died within 7 days, and total hospital 
mortality reached 50%.
Conclusion This case series suggests that IE should be ruled out when 
Sa bacteriuria is evidenced, irrespective of the clinical presentation. 
This could question the reality of isolated community-acquired urinary 
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Introduction Since the outbreak scourge of intravenous drug 
addiction in Tunisia, we are witnessing the emergence of cases of 
infectious tricuspid endocarditis (ITE). This pathology should be 
studied because it requires specific medical and surgical management. 
The aim of the study was to describe the clinical features, management 
and outcome of ITE in intensive care unit.
Patients and methods This was a retrospective study from January 
2009 to December 2014. We enrolled patients who were hospitalized 
in intensive care unit and had ITE. We recorded baseline characteristics, 
management and outcome.
Results During the study period, we collected 10 cases of ITE making 
an incidence rate of 3 cases for 1000 patient admissions. They were 
divided into 8 men and 2 women. The median age was of 37.5 years. 
The main reasons of ICU admission was acute respiratory failure (80%), 
among them 5 required mechanical ventilation. Hemodynamic failure 
was present in 3 cases.
The median SAPS II was of 33 [19–90]. The median APACHE II was of 
17 [7–53]. Different contributing factors were identified: intravenous 
drug abuse (6 patients), a central venous catheter (1 patient) and a 
pacemaker (1 patient).
All patients underwent transesophageal echocardiography showing 
one or several vegetations on native tricuspid valve. No associated left 
endocarditis was found.
Blood cultures were positive in 8 cases of which 5 contained 2 
different micro-organisms. The identified micro-organisms were: 
Meticillin Resistant Staphylococcus aureus (n  =  6), Meticillin Sensitive 
Staphylococcus aureus (n  =  3), coagulase-negative staphylococcus 
(n  =  2), Enterobacter cloacae (n  =  1), and candida famata (n  =  1). 
Occurring complications were hospital-acquired infections (n  =  5), 
septic pulmonary embolism (n =  4), withdrawal syndrome (5 cases), 
acute renal failure (n = 2) and atrioventricular block (n = 2).
Medical treatment consisted of a double antibiotic treatment. Surgical 
treatment was required in 7 patients: tricuspid valve replacement by 
bioprosthesis (6 cases) and valvuloplasty (1 case).
The average length of stay was of 31.3 days [2–56]. ITE had recurred on 
bioprotheses in two patients after intravenous drug resumption; they 
underwent surgery again and one of them died.
Table 1 Patients characteristics
Characteristics n (%)
Median age (year) 63
Heart murmur 5 (24)
Congenital heart valve defect 19 (90)
Mitral localization 19 (90)
Abuse (drug, alcohol…) 4 (19)
Microbiology
 MSSA 20 (95)
 MRSA 1 (5)
Origin
 Skin 14 (67)
 Unknown 7 (33)
Complications
 Central nervous system 9 (43)
 Visceral abscesses 2 (9.5)
 Septic arthritis 9 (43)
 Skin and eye petechiae 9 (43)
Death 8 (38)
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In hospital mortality was of 30%. The outcome was favorable in 7 
patients.
Conclusion The ITE in ICU is a severe disease with frequent complica-
tions and in hospital mortality reaches 30%. The most frequent incrim-
inated micro-organism is Meticillin Resistant Staphylococcus aureus. 
It often requires medical and surgical treatment. Intravenous drug 
addiction remains the most common cause and worsens the progno-
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Introduction French guidelines for community-acquired IAI underline 
the importance of establishing antibiotherapy protocols based 
on regular analysis of microbiological data; and of systematic site 
infection cultures to determine microbial sensitivity to antibiotics. 
Our study describes microbial population involved in our community-
acquired IAI and defines an annual follow-up indicator of probabilistic 
antibiotherapy inadequacy to microbial sensitivity.
Materials and methods We conducted a retrospective, monocentric, 
observational study from January the 1st 2014 to December the 31st 
2015. All community-acquired IAI in adults were included. Exclusion 
criteria were: cirrhosis and peritoneal dialysis. Initial probabilistic 
antibiotherapy and total antibiotherapy duration were left to the 
discretion of the physician in charge. Results of intra-abdominal 
cultures (IAC) were analyzed. Three microbial groups were defined: 
(A) A-group: wild-type bacteria strains treated with adequat 
antibiotherapy; (B) B-group: antibiotic resistant bacteria treated with 
adequat antibiotherapy; (C) C-group: multi-drug resistant bacteria 
treated with inadequat antibiotherapy. A Chi square analysis was 
performed on SPSS software (IBM).
Results 98 community-acquired IAI were included: 54 (55%) had 
positive IAC with 133 bacteria; 34 (35%) didn’t have intra-abdominal 
swab; 10 (10%) had sterile cultures. Predominant strains were Gram-
negative bacteria (76/133 (57%)). More represented bacteria were 
Escherichia Coli (50/133 (38%)) and Bacteroïdes fragilis (16/133 (12%)). 
127/133 (95%) bacteria belong to A- and B-groups. B-group importance 
increased significantly between 2015 and 2016. C-group characteristics 
were comparable over the 2 years. Initial antibiotherapy was inadequate 
with French guidelines in 38/98 (39%) cases and with microbial 
antibiotic susceptibility in 6/133 (4.5%) cases (C-group). Average 
antibiotherapy duration was 11.3  days. Antibiotic treatment duration 
was too long according to French guidelines for 65/98 (67%) patients.
Discussion Our microbial population in community-acquired IAI is 
similar to national studies with a lowest resistance rate (C-group under 
10%). Probabilistic antibiotherapy proposed by French guidelines is 
appropriated to our microbial ecology. Antibiotherapy duration is 
unconformed with guidelines in 67% cases. Peroperative swabs are 
frequently missing (35%). Non-compliance with French guidelines 
highlights the importance to formalize our local procedure. This 
formalization at any stage (surgical, medical and biological cares) 
seems essential to improve our standard of care. C-group rate could be 
used as a real-time feedback to adapt our protocol continuously.
Conclusion The goal of our study is to improve local standard of care 
by offering a formalization of community-acquired IAI management 
procedure. C-group rate seems to be a good follow-up indicator of 
probabilistic antibiotherapy inadequacy to microbial sensitivity, allow-
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Introduction The resumption of peritonitis is a serious complication of 
abdominal and pelvic surgery. It’s a medical and surgical emergency, 
the prognosis depends on the speed, the quality of the care, and the 
underlying terrain and etiology.
Patients and methods We conducted a descriptive analytic 
retrospective study over a period of 5 years (January 2011–June 2016) 
60 cases of peritonitis hospitalized in surgical intensive care unit.
Results The average age of our patients was 44.36  years with a sex 
ratio of 1.5 (36H/24F). The most frequent risk factors were: factors 
relating to the ground, and factors related to the initial peritonitis.
Clinical signs were dominated by fever (75%), abdominal pain (52%). 
The period of the average recovery was 8.2 days. The decision of the 
surgical revision was based on a clinical, biological and radiological 
criteria.
40 patients in our series, 67% of cases were taken on clinical and bio-
logical criteria while 15 patients 25% were taken on radiological crite-
ria. In 8% of the remaining cases, the potential severity of the clinical 
and biological state in association with an inconclusive ultrasound, led 
to reoperation.
The therapeutic treatment was based on a perioperative resuscitation, 
treatment of organ failure, empirical antibiotic therapy and by midline 
laparotomy surgery. Bacteriological samples performed intraopera-
tively allowed to have the following bacteriological profile: predomi-
nance of BGN (79%) dominated by E. coli (28%) followed by Klebsiella 
pneumoniae (21%), Acinetobacter and Enterococcus baumanii (12%). 
The multimicrobien character was found in 55%. The E. coli–Klebsiella 
pneumoniae association was the most frequent (37%).
The anastomotic dehiscence was the direct cause of the most common 
surgical revision found intraoperative (62%). The average hospital stay 
was 8 days. The mortality rate was 61%. The main prognostic factors in 
our study emerged in the univariate analysis were: kidney failure, the 
number of organ failure, a TP <50% the needs of ventilation and the 
use of catecholamines.
Discussion Mortality is variable depending on the studies, between 
25 and 60%.
Conclusion The diagnosis often difficult. Only effective and early 
therapeutic management reduces mortality remains high in recent 
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Introduction Intra- abdominal sepsis represents a life threatening 
condition. Its manifestations are non specific and can quickly lead 
to multi organ failure if not treated correctly. Patient’s assessment 
is essential in order to adjust the therapy. The aim of our study is to 
highlight the prognostic factors in this situation.
Patients and methods It’s a prospective observational study 
performed during 6 months (02/2016–08/2016) in visceral emergency 
operating rooms.
Inclusion criteria: adults admitted with intra-abdominal infectious 
disease diagnosed with biological and radiological means.
Studied parameters: demographic data, co morbidities, number 
of organ failure, type of anesthesia, intraoperative incidents and 
evolution. Results were analyzed using SPSS software, prognostic 
factors were extracted with univariate then multivariate analysis. 
Significant results were noted.
Results During this period, we admitted 302 patients, the mean age: 
41.14 ± 17 years. Male predominance was noticed in our population: 
69.9%. The mortality rate was: 13.2%.
The main prognostic factors were reported in the attached Table 2.
Discussion Many significant prognostic factors were identified: 
Age, existence of hemodynamic failure with renal involvement, long 
operative time and the use of vasoactive drugs.
A high hemoglobin level at the admission was a protective factor.
The presence of respiratory distress, the sex and the presence of yeasts 
were not significant factors in our study.
Conclusion Intra abdominal sepsis is causing quickly a multi organ 
dysfunction syndrome leading to death. Therefore, our priority is to 
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Introduction Intra abdominal sepsis is a dangerous condition causing 
a high mortality rate even with surgery and post operative care 
improvement.
The aim of the study is to assess the bacteriological and 
epidemiological profile of this population.
Patients and methods It’s a prospective observational study 
performed during 6 months (02/2016–08/2016) in visceral emergency 
operating rooms.
Inclusion criteria: adults admitted with intra-abdominal infectious 
disease diagnosed with biological and radiological means.
Exclusion criteria: post operative peritonitis and deceased patients 
before their admittance.
Studied parameters: demographic data (gender, age…), the time 
management, co morbidities, number of organ failure, intraoperative 
incidents and postoperative evolution.
Results During this period, we admitted 302 patients, the mean age: 
41.14 ± 17 years. Male predominance was noticed in our population: 
69.9%.
Main emergencies are reported in the attached Table  3. Concerning 
the bacteriological profile: we had 121 positive samplings. 
Enterobacterias were the most frequent strain. E coli was predominant: 
43%, Enterococcus faecalis: 25%, Streptococcus (viridians and 
acidominimus): 14%, we had 1 case of Acinetobacter baumanii resistant 
to imipenem. 6 cases of yeasts were found (Candida albicans).
Antibiotic use was: Ampicilline: 44%, Ceftriaxone 41%, metronidazole: 
76% and tazocilline: 4%.
Discussion In our context, community acquired intra abdominal sep-
sis leads to a high death rate. We noticed relevant parameters: a late 
time management, high gravity scores, some surgical procedures not 
directed by supervisors. Therefore, we have to establish therapeutic 
protocols tailored to each disease in order to improve patients’ man-
agement and help to reduce the mortality rate.
Conclusion Early diagnosis and care for intra abdominal sepsis rep-
resent a major way to prevent complications. Bacteriological proof is 
necessary to adjust post operative antibiotherapy.
Competing interests
None.
Table 2 Main prognostic factors in intra abdominal sepsis
Variable Hazard ratio 
unadjusted
p Hazard ratio 
adjusted
p
Age 1.047 0.001 1.032 0.009
Sex 3.25 0.001 0.068 0.47
High hemoglobin 0.68 0.01 0.33 0.52
creatinine 1.11 0.001 1.16 0.001
Pesence of clammy skin 14.74 0.001 77 0.05
Urea 37.34 0.01 37 0.25
Hemodynamic instability 26 0.001 1.27 0.834
Use of vasoactive drugs 29 0.001 34 0.001
Operating time 1.018 0.0001 1.014 0.001
Table 3 Main emergencies with epidemiological profile
Disease Number  
(n)












Peptic perforation peritonitis 48 47 42.5 1.54 1 10 1
Appendicitis 100 1.43 31.7 2.95 0 7 0
intestinal perforation peritonitis 18 0.63 36 5.6 3 19 6
Biliary peritonitis 10 0.43 62.2 7.2 2 16 4
Post traumatic peritonitis 6 6 25 3.1 3 15 2
Necrotizing fasciitis 28 13 55.9 20 0 12 0
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Introduction The development of bacterial resistance is a major 
public health problem due to unreasonable use of antibiotics. The 
introduction of appropriate antibiotic therapy has a positive impact 
on patient survival and a significant economic impact. The objective 
of this study is to evaluate the compliance of antibiotics prescribed in 
emergencies.
Patients and methods Prospective study conducted on 1  year 
(01/01/2015–31/12/2015). We have included patients admitted to 
the emergency with hyperthermia (>38°), hypothermia (<36°) or two 
criteria of systemic inflammatory response syndrome. Were collected 
in the emergency department: history, presence of prior antibiotic 
therapy, demographic and clinical characteristics at admission, 
prescription of antibiotics in emergencies and its modalities and 
the discharge diagnosis. During hospitalization were collected: the 
introduction, modification or discontinuation of the antibiotic, the 
reasons for this change and certainty diagnosis. The compliance 
analysis of antibiotic therapy was performed by an expert group 
(two infectiologists, a bacteriologist and an emergency doctor) with 
regard to the current recommendations. Two groups were defined and 
compared: group of patients receiving complies antibiotic therapy and 
group with antibiotics considered improper. The criteria associated 
with non-compliance were sought.
Results Four hundred and twenty-two patients were enrolled. The 
final diagnosis retained an infectious etiology in 356 patients (84%). 
The mean age was 62.4 ± 18 years. Blood cultures were taken in 370 
cases (87.7%). Infectious sites were most often lung (52%) and urine 
(32%). Severe sepsis was diagnosed in 14 patients (3.3%). A complies 
prescription was found in 335 patients (79.4%). Antibiotic therapy 
was started in 302 patients (71.5%) at the emergency and classified 
complies with 234 (55.4%). Among the 68 patients (16.1%) with an 
illegal antibiotic, it was continued in 24 (35.3%) during hospitalization. 
Among 120 patients (28.4%) did not receive antibiotics, this attitude 
was classified complies in 115 patients (95.8%). Non-compliance was 
related to the presence of antibiotics in the last 3  months and the 
presence of renal failure.
Conclusion Particular attention should be paid to the antibiotic 
prescription in patients subject to prior exposure to these. Dose 
adjustments should be respected in cases of renal failure. Regular 
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Introduction The study of the bacterial cartography in thoracic 
surgery is extremely important for the treatment of post-operative 
infections due to the severity of the underlying pathology, the fragility 
of patients after surgery in addition to the choice of the empiric 
antibiotic therapy.
Materials and methods We led a prospective study following all the 
patients who underwent a pulmonary resection surgery for a period 
of 7 months from January to July 2016, jointly with the microbiology 
department, CHU Ibn Rochd, Casablanca. The bronchial secretions 
were collected by a protected distal bronchial sample using a 
(Combicath) after the intubation.
Results During the period of the study, 92 patients underwent a 
pulmonary resection, 65% for a neoplastic pathology.
The medium age was 43  years ±8 and 58% of our sample were 
male. 48% of our patients had smoking habits and 16 of them had 
pulmonary tuberculosis, 12 had repeated respiratory infections. 
The antibiotics used in pre-operative: 58% of beta-lactams; 22% of 
fluoroquinolones; 5% of macrolides.
Moreover, 60% of our patients were classified ASA1.
Of the 92 obtained samples, 22 were positive (23.9%). The most 
frequently observed germs were the Acinetobacter baumannii (8.7%), 
Pseudomonas aeruginosa (6.5%), Klebsiella pneumoniae (4.3%), 
Staphylococcus aureus (4.3%). The Acinetobacter baumannii was the 
most resistant germ (60% sensibility to carbapenem).
These patients were followed until their D30 after surgery, 12 of them 
developed a post-operative pneumonitis with 4 cases of multi-resist-
ant Acinetobacter Baumanii, 2 of which deceased.
Conclusion Pneumonitis after pulmonary resection are common and 
severe that’s why it is necessary to establish a global prevention strat-
egy mainly based on general patricians and pneumologists’ awareness 
concerning the choice of the prescribed antibiotics, in order to avoid 
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Introduction Infection is a major cause of morbidity and mortality 
in burned. The bacterial ecology varies among centers. Despite the 
progress in the management of severe burned, mortality remains very 
high. The aim of this study is to establish the pathogenic profile of AB 
in this population.
Materials and methods Single-center retrospective study of 
7  months, including any serious burned hospitalized for more than 
48 h in intensive care, and who benefited from bacteriological samples 
during his stay.
Infectivity was retained on a range of clinical and biological arguments 
(CDC criteria) changed). They excluded all burned died for non-
infectious causes, and patients with isolated settlement.
Results Sixty-two (72) patients were infected by the AB during 
our study period. The sex ratio (M/F) was 1.7 and the mean age was 
39 ± 23 years. Nosocomial pneumonia was present in 61.11% of cases. 
Urinary tract infection was present in 18.05% of cases. Bacteremia was 
present in 12.5% of cases. Skin infection was present 8.33% of cases. 
The resistance profile was marked by 100% of cases of resistance to 
third-generation cephalosporins (C3G), 88% of cases of resistance to 
fluoro-quinolones (FQ), 74% of cases of resistance to imipenem and 
64, 28% of cases of resistance to tigecycline.
Conclusion The incidence of infection with Acinetobacter baumannii 
in our unit remains high compared to that of intensive care units. 
Colonization and infection by the AB are significantly associated 
with increased length of stay, and mortality, and given the gravity of 
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Introduction ESBL are enzymes mostly found in Enterobacteriaceae 
and confer resistance to all beta lactams antibiotics except cefoxitin 
and carbapenems. Recently, a significant increase in the rate of ESBL-
related infections in ICU makes difficult the choice of empiric antibiotic 
therapy, especially in patients colonized by extended-spectrum 
β-lactamase producing Enterobacteriaceae (ESBLe) [1]. Notably, 
very few data are currently available regarding the role of ESBLe 
colonization on further pneumonia involving the same bacteria [2]. 
The aim of our study was to describe the incidence of ESBLe infections 
among ESBLe-colonized ICU patients.
Patients and methods This study was conducted retrospectively from 
January 1st 2011 to May 1st 2016, in our intensive care department. All 
admitted ESBLe-colonized patients who develop an infection during their 
ICU stay have been included in the study. The only exclusion criterion was 
an antibiotic treatment for an ESBLe infection at ICU admission.
Results During the period of the study, 386 stays were associated with 
an ESBLe colonization in 384 patients. 148 infections were diagnosed in 
patients colonized by ESBLe, among which 78 pneumonias. In 18 cases 
(23%) the ESBLe was involved in the pulmonary infection (PN-ESBLe+) 
and was the only responsible bacterium in 66% of cases. The ESBLe 
was the same in screening and pneumonia in 15 cases (83%). The 
PN-ESBLe+ was associated with septic shock in 9 (50%) cases, acute 
respiratory distress syndrome in 2 (11%) cases and neurologic failure 
in 7 (39%) cases. Episodes were ventilator-associated pneumonia in 
56% (10 cases) of PN-ESBLe+ and 52% (31 cases) of PN-ESLBe-. The 
most common pathogens involved were Escherichia coli, Klebsiella 
pneumoniae, and Enterobacter cloacae in both groups. Comparing 
groups (PN-ESBLe+ or PN-ESLBe−), only the notion of prior antibiotic 
therapy within 30 days (OR 3.9 [1.07–18.3]; p = 0.03) and colonization 
by ESBL Klebsiella pneumoniae (OR 4.04 [1.02–16.1]; p  =  0.04) were 
more frequent in PN-ESBLe+. At least one empiric antibiotic was 
effective on the ESBLe in 83% of cases. In vitro antibiotic susceptibility 
tests demonstrate 100% efficiency of the association of piperacillin/
tazobactam and amikacin on ESBLe involved in pneumonia.
Mortality at day 28 was 24% for PN-ESBLe+ and 44% for PN-ESBLe−. 
Hospital mortality was 53 and 38% respectively (p = NS).
Among 70 extra-pulmonary infections, ESLBe take part in 30 (43%) 
cases. The involvement of ESBLe was significantly lower in pneumonia 
than in other infections (p = 0.01).
Discussion Due to the single center character of our study, results can-
not be extrapolated to the whole ICU population. Nevertheless, the 
observed incidence of colonizing ESBLe in our study is close enough 
from others studies. This point consolidates reflection about ICU pneu-
monia empiric treatment.
Conclusion The involvement of colonizing-ESBLe in ICU pneumonia is 
rare in our population and significantly lower than in other infections. 
Identified risk factors for PN-ESBLe  +  are a prior antibiotic therapy 
within 30  days and colonization with K. pneumoniae. Alternative 
associations to carbapenem remain efficient in all cases of pneumonia 
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Introduction Immediate adequate treatment of ICU-acquired Gram 
negative bacilli (GNB) bloodstream infections (BSI) improves patients’ 
prognosis. Risk factors of resistance of GNB-BSIs should be better 
assessed.
Materials and methods Data from a large French national ICU 
network were explored during a 10-year period (2005–2014). Patients 
with a GNB-BSI were included and were divided into two groups 
according to the resistance (R) profile (BSI due to a R isolate or not). 
The following three groups were considered: (1) all GNB-BSI including 
Pseudomonas spp., Acinetobacter spp., Stenotrophomonas spp. and 
Enterobacteriacae (Eb) for which the following R were considered: 
ticarcillin (Pseudomonas spp., Acinetobacter spp., Stenotrophomonas 
spp.); ceftazidime (cefta) (P. aeruginosa (PA), Acinetobacter spp., 
Stenotrophomonas spp.), third generation cephalosporin (3GC) (Eb) 
and imipenem (all GNB, during the period 2011–2014 only), (2) PA 
cefta R from 2005 to 2014 and (3) Eb species resistant to 3GC from 
2005 to 2014. Univariable hierarchical logistic models with two levels 
(random center and region effects) were used to select variables 
associated with resistance using a p value threshold of 0.2. Selected 
variables were further introduced in multivariable analyses using a 
hierarchical model with two random effects.
Results From 265,035 patients admitted in an annual median of 158 
French ICUs, 9553 experienced an ICU-acquired (>48  h.) BSI, 5062 
(53%) BSI due to GNB, including 1764 (35%) BSI due to R isolates. 
PA was identified in 1167 (23%) BSIs (480 (41%) R) and Eb in 3298 
(65%) BSIs (1226 (34%) R). The median annual incidences of R GNB 
BSIs/10,000 ICU patients were: 68 for all R GNB BSI, 41 for Eb 3GC-R BSIs 
and 9.2 for PA cefta-R BSI. There was a significant increase of annual 
incidence for all GNB R and Eb 3GC-R BSI.
Independent factors associated with all R GNB BSI were: 1) ICU vari-
ables: percentage of patients with an immunosuppression other 
than neutropenia (7.9–14%: OR 1.23; 95% CI, [1.04–1.46]; >14%: 1.31 
[1.09–1.57]); percentage of resistant GNB the previous year (55–66%: 
1.87 [1.59–2.2]; >66%: 2.93 [2.43–3.53]) and 2) patient-variables: anti-
microbial therapy at ICU admission (1.79 [1.55–2.08]); presence of an 
invasive device (CVC or intubation) (1.99 [1.25–3.16]) before infection; 
and one protective factor: trauma at ICU admission (0.76 [0.65–0.89]). 
The year effect was significant both for all R GNB and 3GC-R Eb but 
not for R PA. This effect was more pronounced for 3GC-R Eb, with an 
increase in the risk of R from 2005 to 2014 (Fig. 2). The duration from 
ICU admission to infection was the main risk factor of R for all BGN 
and sub-groups (Eb and PA): the probability of having a BSI due to a 
R strain increased with the time in ICU before infection (Fig.  3). ICU-
based random effect remains significant indicating major impact of 
local epidemiology.
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Limitation The absence of information about antibiotic consumption 
may partly explain the remaining significant center random effect in 
the final models.
Conclusion The duration from ICU admission to BSI was a main risk 
factor for a resistant isolate in GNB BSI. Resistance rates increased 
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Introduction Prevalence of Extended-spectrum beta-lactamase-
producing Enterobacteriaceae (ESBL-PE) carriers dramatically increases 
all over the world with a spread to the community. The increasing 
prevalence of ESBL-PE carriage at Intensive Care Unit (ICU) admission 
raises important questions on empiric therapy strategies in patients 
presenting with infection, which may include the use of a carbapenem 
as first-line therapy. Data on ESBL-PE sepsis at ICU admission among 
colonized patients are lacking.
Patients and methods We prospectively assessed between 2009 
and 2015 the prevalence, risk factors and prognosis of ESBL-PE 
sepsis among ESBL-PE carriers at ICU admission. The following data 
were collected: demographic characteristics, which included sex, 
age, simplified acute physiology score (SAPS II), location before ICU 
admission, antibiotic exposure, surgery during the previous year, 
presence of underlying disease, Charlson comorbidity index, presence 
of indwelling devices and outcomes.
Results A total of 597 patients had ESBL-PE carriage detected at 
admission, corresponding to 9.5% of admitted patients. Among these 
patients, 325 patients had sepsis at ICU admission. Fifty patients 
(15.4%) had ESBL-PE related sepsis at ICU admission. ESBL-PE infection 
included 23 (46%) urinary tract infections, 14 (28%) pulmonary 
infections, 9 (18%) abdominal infections and 4 (8%) other infections. 
All but two ESBL-PE pneumonia cases were hospital-acquired (86%) 
while community-acquired ESBL-PE urinary tract infection was not 
uncommon (12/36 = 33%).
By multivariable analysis, prior urinary tract disease [OR 3.0 (1.1–8.0)], 
hospital-acquired sepsis at admission [OR 2.9 (1.4–5.7)], treatment 
with fluoroquinolone within the past 3  months [OR 2.8 (1.2–6.4)] 
past ESBL-PE infection [OR 2.8 (1.2–6.5)] were independent predictive 
factors for ESBL-PE sepsis at admission, whereas a pulmonary source 
of sepsis [OR 0.30 (0.15–0.61)] was protective. The final model showed 
a good calibration (chi2 = 3.7, p = 0.45) and discrimination (area under 
the curve = 0.85). Patients with ESBL-PE related sepsis had more often 
septic shock and bacteraemia at admission. ESBL-PE related sepsis was 
also more often associated with more frequent inadequate empirical 
therapy (68 vs 87%, p  <  0.001). However, mortality did not differ 
significantly between patients with ESBL-PE infection and others (20 
vs 22%).
Conclusion At ICU admission, ESBL-PE related sepsis was relatively 
infrequent among colonized patients. Our predictive factors for 
ESBL-PE may help choosing empiric therapy for sepsis among ESBL-PE 
carriers at ICU admission. The study did not show a significant 
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Introduction Carbapenemase-producing Enterobacteriaceae (CPEc) 
are increasingly reported worldwide and constitutes a real challenge 
antibiotic for clinicians to preserve the bacterial ecology. Its incidence 
has remarkably increased in our intensive care unit during the last 
5 years.
Fig. 2 Evolution of the risk to have a BSI due to a resistant strain 
according to the year of ICU admission
Fig. 3 Days from ICU admission to infection
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This work aims to focus on the impact of CPEc increasing in our 
intensive care unit.
Patients and methods A retrospective and descriptive study 
conducted in a Tunisian intensive care unit, including all hospitalized 
patients infected by an Enterobacteriaceae. We have determined 
annual incidence of CPEc from January 2008 to December 2015.
Results One thousand two hundred and three episodes of 
Enterobacteriaceae infections were eligible in 748 patients (324 
male/424 female) aged between 14 and 88 years.
The global prevalence of CPEc across study period was 4.48% 
(54/1203).The prevalence of CPEc in each site was respectively of 
23% in hemocultures, 18% in coproculture, 12% in catheters, 3.3% in 
respiratory tract, and 3% in urinary tract.
The overall incidence of (CPEc) increased from 0.69% (1/144) in 2008 
to 7.77% (15/193) in 2015 (Fig. 4).
Conclusion
Our study confirms the rapid spread of CPEc in Tunisian hospital 
and the urgent need for a well-structured and coordinated national 
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Introduction The ESBL spread has a major consequence in term 
of antibiotic choices. Carbapenem antibiotic are regarded as the 
most effective treatment. However numbers of authors suggest 
that alternatives antibiotics (i.e. noncarbapenems) could be used in 
ESBL-PE infections. There are some conflicting data regarding the use 
of alternatives in case of ESBL-PE infections. Moreover as far as we 
know, there are no data in ICU.
Objectives the aim of this study was to describe ESBL-PE infections in 
ICU and therapeutic options chosen in these specific situations.
Patients and methods Prospective multicentric observational 
cohort study conducted in volunteers ICU. All consecutive patients 
hospitalized in ICU with ESBL-PE infection according to CDC definitions 
were included. Severity of illness was defines according to bone 
criteria, SAPS II and SOFA. Demographic datas, empirical and definitive 
antibiotic therapy (ET and DT), clinical evolution, and outcome were 
recorded. In  vitro antimicrobial susceptibility testing was performed 
by the disk diffusion method or the Vitek 2 system according to the 
guidelines of the Antibiogram Committee of the French Microbiologic 
society.
Results During the study period 146 patients with ESBL-PE infection 
met eligibility criteria with respectively a median age and SAPS II score 
of 63 (51–74) and 50 (38–70). The median SOFA Score at first day of 
antibiotic therapy and ICU admission were 7 (4–11) and 7 (5–11) 
respectively. The most frequent site of infection were respiratory tract 
(45%), urinary tract (20%) and abdominal (17%). The most frequent 
isolated species were: Escherichia coli (43%), Klebsiella sp (37%) and 
Enterobacter sp (18%). Respectively 50, 23 and 27% patients had 
septic shock, severe sepsis and sepsis according to Bone criteria.
Among ESBL-PE, 98.6% were carbapenem and 46.5 were BLBI 
sensitive. Among the whole population, 47 (48%) patients received a 
carbapenems as ET. 66 (68%) received a DT with carbapenems and 31 
(32%) patients received an alternative DT. The most frequent reasons 
for maintaining carbapenems as DT were: Antibiotic susceptibility 
tests (38% of cases), severity level (33% of cases) immunosuppression 
(8% of cases). The Median length of ICU stay after infection was 
respectively 12 (6–27) and 11 (7–16) days for carbapenems and 
alternatives DT (p = 0.1). The D28 mortality was 24% for patients with 
carbapenems DT and 24% for patients with alternatives DT (p = 0.02).
Surprisingly, there were no differences between the 2 groups 
(carbapenems vs alternatives) in term of severity.
Conclusion Alternatives are frequently used for ESBL-PE infections in 
ICU. In our cohort 31 (32%) patients received antibiotics other than 
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Introduction Multidrug micro-organisms are responsible for longer 
hospitalisations and poorer outcomes in intensive care unit (ICU). 
The transmission of extended-spectrum beta-lactamase producing 
enterobacteriaceae (ESBL-PE) is prevented by the application of 
additional contact precautions, mainly relying on isolation in a 
private room and hand hygiene with waterless alcohol-based 
solution. Contact isolation cannot be achieved in our 12-bed ICU only 
composed of two twin bedrooms. We aimed at reporting the ESBL-PE 
acquisition in this peculiar architectural form of ICU and at studying 
the impact of twin bedrooms on ESBL-PE cross-transmission.
Patients and methods An observational and non-interventional study 
was prospectively conducted in the 12-bed ICU of a university hospital 
Ambroise Paré (Boulogne-Billancourt, France). Inclusion criteria were: 
(1) adult patients and (2) a period of hospitalisation allowing the 
patient to be nursed by at least two paramedical teams. Characteristics 
of patients at admission (age, sex, SAPSII) and clinical data during 
hospital stay (duration of mechanical ventilation, duration of ICU 
stay, outcome) were prospectively collected. Microbiological data 
Fig. 4 CPEc increasing from 2011 to 2015
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concerning ESBL-PE imported and acquired carriage were monitored 
by rectal swabs collected at admission and once weekly every Monday 
for the whole duration of the ICU stay. ESBL imported carriage was 
defined as a first screening positive for ESBL whereas ESBL acquired 
carriage as a negative first screening at admission followed by at least 
one positive rectal swan. Mechanistic of a potential cross-transmission 
was studied following a three-step process consisting in (1) identifying 
patients considered as possible ESBL sources (index patients) for 
transmission, (2) classifying each ESBL strain according to the CTXm 1 
and 9 groups and (3) diagnosing potential cross-transmission by gene 
sequencing of remaining cases of possible transmission.
Results From June 2014 to April 2015, 550 patients were admitted 
in the ICU, among which 470 followed the inclusion criteria. The rate 
of ESBL colonization at admission was 13.2% (n  =  62), mainly with 
Escherichia coli. Two hundred and twenty-one non-colonized patients 
were screened at least twice. The incidence of ESBL acquisition was 
4.1% (9 patients on 221), also mainly with Escherichia coli. Mortality 
did not differ between ESBL carriers and non-carriers. In univariate 
analysis, ESBL acquisition was associated with the Injury Global 
Score II (IGSII) and the Sequential Organ Failure Assessment (SOFA) 
at admission, the need for catecholamine and the ICU length of 
stay (LOS). In multivariate analysis, ICU LOS and IGSII at admission 
were the strongest risk factor for ESBL acquisition. The nine ESBL-
acquired carriers had one to three index patients defined as a patient 
hospitalized who shared at least 1  day hospitalization. The CTXm 
grouping of the ESBL strains excluded a cross-transmission for 4 
patients. The gene sequencing did it for 3 others and confirmed a 
cross-transmission in only two patients (0.8%). The cross-transmission 
emanated from the same source of a CTXm 1 ESBL-producing E. coli. 
This patient shared 1  day in a different unit with the first acquired 
carrier and 2  days in the same unit with the other. No case of cross-
transmission in the same room was observed.
Conclusion The rate of 13.2% of ESBL carriage on admission was 
comparable to other rates in French ICUs (15%). Despite the absence 
of contact isolation, the incidence of ESBL acquisition was 4.1% which 
is actually lower than transmission rates previously published in other 
ICUs. A cross-transmission concerned two ESBL-acquired carriers 
only and resulted from the same index patient during short shared 
hospitalizations of 1 day in a different unit and 2 days in the same unit. 
Our results question whether the contact isolation in private rooms 
plays a major role for the prevention of ESBL cross-transmission in ICU, 
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Introduction Bacterial resistance to antibiotics is a common problem 
worldwide. In South America, this prevalence is reported to be the 
highest in the world. However, in French Guyana, there is no data on 
the epidemiology of colonization and infection caused by extended 
spectrum B-lactamase producing enterobacteriaceae (ESBL-PE). We 
conducted this study to investigate the prevalence of colonization 
with ESBL-PE and subsequent ICU acquired infection in French Guiana.
Materials and methods A 24  months (January 2014 to December 
2015) observational study in a 14 beds ICU in a general hospital. Our 
unit, is the sole and the referral one of all French Guiana department.
Results Over the study period, 670 patients were admitted to ICU 
and 603 of them (90%) were hospitalized more than 48  h. The mean 
occupancy rate was 82.5  ±  20.6% and the mean colonization index 
(with ESBL-PE) was de 37 ± 18.1%. The mean age was 43.4 ± 21.1 years. 
The sex-Ratio (M/F) was 1.3. The mean IGS II calculated at admission 
to ICU was 44.6 ± 24.2. The most recorded organ failures at admission 
to ICU were respiratory and hemodynamic ones (56.7 and 37.2% 
respectively). At admission to ICU, 44.2% of patients presented active 
infection and 57.3% received antibiotics. Multidrug resistant (MDR) 
bacteria carriage was found in 88 patients (13.4%) at ICU admission and 
was acquired in ICU in 89 other patients (13.4%). The most isolated MDR 
bacteria at admission were ESBL producing E coli and K. pneumoniae. 
However, the most isolated MDR bacteria during ICU stay were ESBL 
producing K. pneumoniae and E cloacae. During the ICU stay, 98 
patients (14.6%) had presented 147 episodes of ICU acquired infections 
(ICU-AI). Over the 177 patients carrying MDR bacteria, 159 (89.8%) 
carried ESBL-PE and 66 developed ICU-AI. ESBL-PE caused 21.2, 37.5, 
20, and 66.7% of 1st, 2nd, 3rd and 4th ICU-AI episodes respectively. 
Statistical analysis didn’t show any link between ESBL-PE carriage and a 
first episode of ICU-AI caused by ESBL-PE.
Conclusion Our study show a high prevalence of ESBL-PE bacteria 
carriage at admission in our ICU. ESBL-PE carriage was not associated 
to higher prevalence of ICU-AI caused by the same microorganism. 
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Introduction The implementation of hemofiltration (HF) as a renal 
replacement therapy in septic shock patients requires the supply 
of large quantities of replacement solutions. These solutions are 
either industrially prepared in autoclaved expensive plastic bags 
(conventional hemofiltration, CHF) or continuously provided 
in unlimited amounts at the dialysis machine directly from the 
water treatment plant to form the replacing solutions (on-line 
hemofiltration, OLHF).The aim of our study was to evaluate the safety 
and effectiveness of on-line hemofiltration compared to conventional 
hemofiltration in septic shock patients.
Patients and methods The investigative protocol was approved 
by the Institutional Ethics Authorities and all patients or their legally 
authorized representatives provided written informed consent. 
It was a prospective, randomized, clinical study, including septic 
shock patients with acute renal failure. Patients were randomized 
to receive either on-line hemofiltration (n  =  8) or conventional 
hemofiltration (n = 25) for renal replacement therapy during 4 days. 
Hemodynamic monitoring was conducted by conventional devises, 
including: electrocardiogram and a radial arterial catheter for invasive 
arterial pressure every 6  h during period study. We collected serum 
samples also every 6 h (urea, potassium and sodium levels, troponin, 
hemoglobin, platelets, C-reactive protein and lactates).
Results The evolution of heart rate (HR), mean arterial pressure 
(MAP), biological markers were comparable between the two groups 
over time except a significant decrease in MAP in the OLHF group 
compared to CHF group only at H6 (P =  0.008) and H12 (P =  0.015) 
and a significant decrease in C-reactive protein level in the OLHF 
group at H48 (P = 0.02).
Conclusion On-line hemofiltration seems to be a safe and reliable 
method of renal replacement therapy in septic shock patients. It may 
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Introduction Clinical and biological monitoring of efficacy and safety 
of RRT sessions is thought useful and in many ICUs biological testing 
at mid RRT session and at its end is routinely performed. The aim of the 
present study is to evaluate the impact of laboratory tests performed 
during RRT session on clinical decision making and treatment alteration.
Patients and methods Retrospective study including all consecutive 
patients hospitalized in the medical ICU of the University Hospital 
Monastir, Tunisia between January 2015 and September 2016, 
requiring intermittent hemodialysis performed in the ICU. For each 
patient we collected demographic characteristics (age, sex, SAPS III, 
diagnosis, comorbidities), indication of the RRT, clinical and biological 
parameters before, during and at the end of RRT session. Based on 
the patient monitoring records during each RRT session we identified 
therapeutic interventions started before the end of the RRT session in 
the light of the results of laboratory tests performed during the session 
(usually in the middle the session): infusion of glucose, potassium, 
transfusion, extension of the session.
Results During the study period, 370 patients were admitted to the 
ICU. Of these 24 patients required acute hemodialysis. The median age 
of these patients were 54 years (IQR = 31), 53% of them were female. 
The main comorbidities were hypertension, diabetes, chronic renal 
failure (CRF) with preserved diuresis, respectively in 55, 38 and 36%. 
¾ of the patients included were in septic shock and had median SAPS 
III score of 92 (IQR =  34). Anuria, pulmonary oedema, hyperkalemia, 
and acidosis indicated RRT sessions respectively in 47.1, 24.5, 8.8, 9.8 
and 9.8%. Results of laboratory tests performed during RRT sessions 
prompted a specific attitude in the following rates: infusion of glucose 
in 35.7%, addition of potassium in 22%, and extension of the session 
duration 15.2%.
Conclusion The practice of laboratory tests during the RRT sessions 
seems useful since it could impact clinical decision making in more 
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Introduction Therapeutic plasma exchange (TPE) is crucial for 
the management of auto-immune diseases like thrombotic 
thrombocytopenic purpura or myasthenia gravis. TPE is performed 
either by centrifugation, with specific machines which are not 
routinely available in ICUs, or by using specific plasma separation 
membranes with widely spread in ICUs hemofiltration machines. 
Regional citrate anticoagulation for TPE is well established with 
centrifugation but has been seldom described for membrane TPE. We 
are reporting the experience of our ICU in this field.
Patients and methods Retrospective study including all patients 
who received TPE with citrate regional anticoagulation between 2013 
and 2016 in an 18-bed ICU. TPE is performed solely in the ICU in our 
institution.
Results 26 patients were included. TPE was required for thrombotic 
microangiopathy (13 patients), vasculitis (6 patients), hyperviscosity 
syndrome (2 patients), Guillain–Barré syndrome (2 cases) and others 
(3 patients). Mean SAPS2score was 32 [standard deviation (SD) 16.6]. 
281 TPE were performed, with a mean number of 10.5 (SD 11.5; range 
2–57) TPE per patients. Coagulation of the circuit of TPE occurred in 10 
(38%) patients. Coagulation of the circuit occurred in 10.3% (29/281) of 
the TPE. Minor adverse events have been reported in two patients: one 
had a rash during the first TPE (no recurrence during the 56 next TPEs) 
and the other had paresthesia during the first two TPEs (the calcium 
infusion was increased and there had been no recurrence during 
the 25 next TPEs). No serious adverse events related to citrate were 
observed.
Conclusion Regional anticoagulation with citrate allowed us to 
perform TPE in 26 patients, without significant adverse events. The 
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Introduction A reduced incidence of membrane thrombosis after 
injection of Anti-thrombin (AT) has been reported in septic patients 
with acquired deficit in AT undergoing continuous hemofiltration. 
As this strategy was routinely performed in our unit until 2012, we 
investigated its cost-effectiveness.
Patients and methods Data about the use of hemofiltration, 
the consumption of AT and hemofiltration devices during 2011 
(period with routine use of AT) and 2012 (period with use of AT 
only if a membrane thrombosis occurred) were extracted from the 
administrative database of the institution. A decisional tree was built 
to modelize the impact of AT on the consumption of hemofiltration 
devices and blood products. The decisional tree took into account 
the probability of membrane thrombosis with and without AT and 
the probability of transfusion after membrane thrombosis. Costs were 
obtained from the pharmacy of the institution (AT, hemofiltration 
devices) and from the literature (blood products).
Results During 2011, 77  days of hemofiltration were performed, 
with the use of 45 doses of AT (23,202€) and 76 hemofiltration 
devices (11,632€). During 2012, 76 (−1%) days of hemofiltration 
were performed, with the use of 5 (−89%) doses of AT (2578€) and 85 
(+10%) hemofiltration devices (13,443€). The mean cost of 1  day of 
hemofiltration decreased from 449€ to 211€ with the diminution of 
the use of AT.
According to the decisional tree, AT was almost never cost-effective. 
The only circumstances associated with a benefit for the use of AT was 
the association of a probability of thrombosis with AT inferior to 0.1, 
of a probability of thrombosis without AT equal 1, of a probability of 
transfusion after thrombosis equal 1 and a cost of transfusion of 424€. 
In these extremely favorable circumstances, AT could decrease the 
daily cost of hemofiltration of 2.22–19.30€.
Discussion The model has several limits: the losses of utility related 
to transfusion and to interruption of hemofiltration due to thrombo-
sis were not taken into account; the cost of AT measurement was not 
estimated; the work load of changing a membrane and of transfusion 
after membrane thrombosis was not analyzed.
Conclusion Our results suggest that anti-thrombin is not cost-
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Introduction Several temporary venous catheterizations are 
sometimes required for acute renal replacement therapy (RRT) in the 
intensive care unit (ICU). This study compares catheterizations in the 
femoral and jugular veins in terms of patient safety.
Materials and methods This was a descriptive retrospective review of 
dialysis sessions (DS) records monitoring performed in patients older 
than 17 years hospitalized in medical intensive care unit between April 
2011 and December 2015.
A study of dialysis catheter, was conducted in critically ill adults 
requiring RRT was performed.
Catheter insertion site, catheter age and urea reduction ratio (URR) 
were analyzed.
Results URRs were analyzed from 330 dialysis sessions (n  =  64 
patients). The mean rate of URRs was 52.8  ±  12.4. Only 31.4% of 
dialysis sessions (DS) were efficient with URR ≥ 60.
This study analyzed 64 patients who underwent two different sites of 
catheterization: the femoral and jugular site.
The mean age of cathéters was 1.613 days.
No significant difference (P  =  0.18) in the efficiency of (DS) was 
detected between sessions performed through femoral (n = 225; 68%) 
and jugular (n = 105; 32%) dialysis catheters.
Conclusion Femoral and internal jugular acute vascular access sites 
are both acceptable for RRT therapy in the ICU. The effectiveness of 
(DS) in the ICU is low (31.4%). An analysis of predictive factors of inef-
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Introduction In Intensive Care Unit (ICU), some patients suffering from 
acute kidney injury need renal replacement therapy (RRT). It requires 
the circuit anticoagulation, this could be done by a regional citrate 
method. Today, this is a recommended approach for the everyday care, 
even if the technique isn’t widespread yet [1]. The ionized calcemia 
dosing through the filter (“post-filter” ionized-calcemia) is used to 
monitor the technique efficacy, with a target of 0.25–0.35  mmol/L 
showing a good filter anticoagulation.
The objective of our study was the assessment of efficacy and safety 
of our regional citrate anticoagulation protocol, with a less restrictive 
post-filter ionized calcemia target (0.3–0.6 mmol/L). The main goal was 
the analysis of the circuit lifespan, considering a lifespan above 24 h, as 
well as the search of some clinical and biological factors affecting the 
technique efficacy. Moreover, we analyzed the side effects incidence 
of the protocol (hypernatremia, metabolic alcalosis), and their 
consequences. The study received the scientific ethical agreement 
of University Hospital of Toulouse, and is registered with number 
18-0214.
Patients and methods 57 patients, admitted to one of the two 
University Hospital ICUs of Toulouse, needing a continuous RRT 
method, without any need for systemic heparin anticoagulation, and 
without severe hepatocellular failure, were included in the study. 103 
filters included over a 1-year period were analyzed.
Results Results show a mean filter lifespan of 48  h, with a lifespan 
above 24  h for 85.4% of all filters. Coagulation was the cessation 
reason for 29.1% of filters, most of them before 24 h of the filter use. 
A value of post-filter ionized calcemia at day 1 below 0.54  mmol/L 
was the main factor influencing a filter lifespan above 24  h. An age 
older than 51 and a SAPS II severity score below 80 were other factors 
conditioning a filter lifespan of more than 24 h. Side effects of citrate 
were rare and didn’t have any clinical impact among our patients.
Discussion These results suggest that citrate used for anticoagulation 
in RRT could have an additional anti inflammatory effect through 
the induced hypocalcemia, as well as an energetic gain which could 
lead to a renal protection against ischemia–reperfusion mechanism 
[2]. Moreover, these results call into question the need of post-filter 
ionized calcemia dosing for the monitoring of citrate anticoagulation 
efficacy, since the method safety is monitored by the total-to-ionized 
calcium ratio.
Conclusion During continuous RRT in ICU, a regional citrate 
anticoagulation protocol with a non-restrictive post-filter ionized 
calcemia target seems to be efficient and could reduce side effects. 




1. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney 
international Supplements, 2012.
2. Oudemans‑van Straaten, HM et al. Citrate anticoagulation for continuous 
venovenous hemofiltration. Crit Care Med, 2009;37(2):545–52.
P171 
Impact of the use of an oXiris filter versus an AN69ST filter on the 
duration of hemofiltration in intensive care
Charlotte Kelway1, Valery Blasco1, Cyril Nafati1, Karim Harti1, Laurent 
Reydellet1, Jacques Albanese1 
1RPPF, Hopital de la Timone, Marseille, France
Correspondence: Charlotte Kelway ‑ chakel@hotmail.com
Annals of Intensive Care 2017, 7(Suppl 1):P171
Introduction Continuous veno-venous haemofiltration (CVVH) is 
used to treat acute kidney injury in critically ill patients. To optimize 
its efficiency, CVVH requires effective anticoagulation. Systemic 
anticoagulation with standard heparin, the most used, can lead to 
major bleeding complications. Hemofilters that are able to adsorb 
heparin molecules on their surface such as AN69ST and oXiris 
membranes represent an alternative. The objective of this study was 
to compare these two types of filters in terms of duration, efficiency, 
dysfunctions and cost.
Materials and methods From October 2012 to May 2014, we 
conducted a retrospective, observational, and non-interventional 
study. All patients admitted in the intensive care unit needing CVVH 
were included. The primary endpoint was the filter lifespan: AN69ST 
versus oXiris. The secondary endpoint was the filter efficiency 
(urea reduction ratio: URR). The main analysis did not consider the 
anticoagulation type. We conducted a subgroup analysis taking into 
account the use or not of an anticoagulation.
Results 181 sessions in 93 patients were carried out using 386 filters 
representing 10,706  h of treatment. The mean AN69ST filter lifespan 
was 27 ±  20  h and 28 ±  22  h for oXiris filters (p  >  0.05). There is no 
significant difference in terms of duration between the two filters. 
The subgroup analysis taking into consideration the use or not of 
anticoagulation did not show any difference either. The mean URR 
was 48 ± 23% in the AN69ST group and 44 ± 25% in the oXiris group 
(p  >  0.05). Concerning the dysfunctions, there were no significant 
difference between the two filters. One hundred and seventy-six 
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AN69ST filters were used for a total cost of 24,288 euros. Two hundred 
and ten oXiris filters were used for a total cost of 39,060 euros.
Conclusion The AN69ST and oXiris lifespans are not significantly 
different. They were as efficient in terms of blood epuration and had 
as many dysfunctions. The use of an oXiris filter rather than an AN69ST 
to extend the circuit’s lifespan in the same clinical conditions is not 
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Introduction Because oliguria is a poor prognostic sign in patients 
with acute renal failure (ARF), diuretics are often used to increase urine 
output in patients with or at risk of ARF. From a pathophysiological 
point of view there are several reasons to expect that loop diuretics 
could have a beneficial effect on renal function. However, a review 
of literature shows that the use of loop diuretics in patients with ARF 
has been associated with inconclusive results despite the theoretical 
benefits [1].
To assess the adjunctive effect of diuretics, to alter the progression to 
kidney injury or failure, in patients at risk for acute renal failure.
Patients and methods This is a retrospective chart review of 
consecutive patients who developed ARF with oliguria in the intensive 
care unit. Chart abstractors were well trained residents. Two chart 
reviewers (senior intensivists) studied all the charts. An explicit 
protocol was used to precise all needed definitions. Uniform handling 
of data was ensured especially for conflicting, missing or unknown 
data. Oliguria was defined as urine output lower than 0.5 ml/kg/h for 
at least 3 h.
RIFLE score was assessed before and after urinary output normalisa-
tion. Therapeutic intervention to optimize pre-renal perfusion was 
described. Mean arterial blood pressure (MBP) before and after thera-
peutic initiation, oliguria duration, delay from oliguria onset to diuretic 
administration, delay from diuretic administration to urinary output 
normalisation were measured.
Results 23 patients were studied over a 2 years period. They were 63 
[24, 87] median (IQR) aged, with diabetes mellitus, 22%; hypertension, 
47.8%; cardiac failure, 32% and chronic respiratory failure, 43%. 
Chronic and obstructive kidney diseases were excluded. Median SAPS 
II was 37 [23, 75]. 80% were on mechanical ventilation.
RIFLE score before diuretics administration was assessed at oliguria 
onset as (patients without risk, zero; R, 69%; I, 17%; F, 10%; L, 4%; E, 
zero). Fluid resuscitation after oliguria onset was administered in 77% 
and vasopressors in 80%. Median (IQR) delay from oliguria onset to 
diuretic administration was 5 [0.5, 22] h while optimization of pre-
renal hemodynamic disturbances was already achieved.
The median (IQR) MBP before and after therapeutic intervention was 
respectively, 74 [46, 100] and 95 [69, 110] mmHg. Median (IQR) delay 
from initiation of therapeutic intervention and MBP improvement was 
1.5 [0, 3] h. The delay from diuretic administration to urinary output 
normalization was 3 [0.5, 27] h.
After resumption of diuresis, RIFLE score was assessed as (patients 
without risk, 74%; R, 17%; I, 8%; F, 1% L, zero; E, zero) (Fig. 5). Increased 
serum creatinine level, above 1.5 fold normal range, was observed 
only in 6 (26%) patients.
Conclusion Rapid optimization of pre-renal hemodynamic 
disturbances associated with short delay administration of diuretics 
could significantly alter the progression to kidney injury or failure in at 
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Introduction The ventilator associated pneumonia (VAP) is a common 
and severe complication of assisted ventilation. It’s the leading cause 
of nosocomial infections in intensive care unit and remain responsible 
for a high morbidity and mortality because of the emergence of multi-
drug resistant (MDR) bacterial agent such us Acinetobacter baumannii 
(AB). The aim of this study was to determine the incidence, risk factors 
and prognosis of AB VAP.
Patients and methods Retrospective study extending over a 5  year 
period (January 2010–January 2016) that included all patients over 
Fig. 5 Progression of RIFLE score classes respectively from baseline to 
after therapeutic intervention
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18  years and ventilated more than 48  h and developing AB VAP. 
Patients were divided into two groups: one consisting of patients 
who developed VAP to AB and the second developed VAP to another 
bacterial pathogen.
Results One hundred and forty patients developed VAP. The incidence 
rate of AB VAP was 15.3% with a density of incidence of 20.3 per 1000 
ventilator days. Age, male gender, the time between hospitalization 
and mechanical ventilation and the medical pathology were risk 
factors for developing AB VAP. AB was resistant to ceftazidime in 
100%, to imipenem in 65%, tobramycin in 70% and netilmycin in 
35.3%, rifampin in 85% with a sensitivity to colistin in 100% of cases. 
The resistance of this germ to imipenem increased from 35% in 2010 
to 88.5% in 2016. The evolution of patients with AB VAP developed 
frequently septic shock compared to other patients (44 vs 19.3%; 
p = 0.038). The AB VAP mortality was higher (50 vs 33%; p = 0.03).
Conclusion The increasing incidence of multi-drug resistant AB VAP is 
responsible for a high morbidity and mortality. So we need to identify 
risk factors and to strengthen the means of prevention of hand 
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Introduction Central line associated bloodstream infections (CLABSI) 
are among the serious hospital-acquired infections. The aim of this 
study is to determine the incidence of CLABSI, the pathogens and the 
risk factors that play a role in the development of BSI among patients 
followed in a Tunisian medical intensive care unit.
Patients and methods All patients admitted for more than 48  h 
were included in the study over a 1-year period in an 8-bed medical 
ICU. The enrollment was based on clinical and laboratory diagnosis 
of BSI. Blood samples were collected from catheter hub of all patients 
for culture, followed by identification and antibiotic sensitivity 
testing of the isolates. For all subjects, age, sex, underlying diseases, 
SAPS II score, ICU length of stay, invasive procedures and their 
durations (mechanical ventilation, central catheterization, urinary 
catheterization) were recorded. Risk factors were evaluated by a 
multivariate logistic regression model.
Results Among a total of 237 admissions from September 15th 
2015 to September 15th 2016, 163 (68.7) patients were eligible. One 
hundred twenty-five (76) patients had a central line. A total of 27 
episodes of CLABSI were assessed in 23 (18.4) patients. The mean 
SPASII of patients with CLABSI was 33 ± 15.4. Their mean CHARLSON 
index was 1.8 ±  1.7, median duration of catheterization was 4 [1.5–
7] days and 8 (34.8) had more than one catheterization attempt. The 
rate of CLABSI was 19.2/1000 catheter.days. Gram positive bacteremia 
was determined in 13% of BSI patients. Of these isolates, 3 were 
Staphylococci. Gram negative bacteremia was determined in 35% 
of these isolates, 4 were Acinetobacter baumannii, 3 were Klebsiella 
pneumonia and 1 was Proteus mirabilis and in 56% of cases BSI 
was diagnoses clinically. A univariate analysis identified ventilator-
associated pneumonia, sedation, and longer interval between onset of 
CLABSIs and the duration of catheterization as risk factors of CLABSIs. 
In multivariate analysis, the independent factors of CLABSI which 
are the duration of catheterization (OR, 1.06; 95% CI, [1.003–1.139]; 
p  =  0.042) and catheterization attempt number (OR, 1.99; 95% CI, 
[1.18–3.37]; p = 0.01). Thirteen (56.5) patients developed septic shock 
and they all died.
Discussion The rate of CLABSI in our ICU (19.2/1000  catheter.days) 
was higher compared with the mean rate of CLABSI in ICU reported by 
the NNIS system surveillance for 2004, which is 3.9/1000 catheter.days 
[1]. Duration of catheterization, frequent manipulation of catheter, 
catheter location, catheter type, underlying diseases, suppression of 
immune system, and types of fluids administered through the catheter 
are significant risk factors in development of BSIs [2]. In our study both 
duration of catheterization and number of attempts are independent 
factors for CLABSI.
Conclusion In a monocenter cohort, CLABSI had a moderate density 
rate but are associated with poor outcome. Identifying the risk factors 




1. National Nosocomial Infections Surveillance (NNIS) system report, data 
summary from January 1992 through June 2004, issued October 2004. 
Am J Infect Control 2004;32:470–85.
2. Öztürk F, Gündeş S, Işık C. Prospective evaluation of the risk factors, 
etiology and the antimicrobial susceptibilities of the isolates in 
nosocomial bacteriemic patients. Mikrobiyol Bul.2008;42:17–27.
P175 
Is prehospital endobronchial intubation a risk factor 
for subsequent ventilator associated pneumonia?
Timothée Trampont1, Thomas Lafon2, Thomas Daix3, Vincent Legarçon1, 
Paul Claverie1, Henri Hani Karam1, Nicolas Pichon3, Philippe Vignon3, 
Bruno François3 
1Service urgences adultes/samu‑smur, C.H.U de Limoges, Limoges, 
France; 2Services urgences adultes/samu‑smur/inserm cic1435, C.H.U de 
Limoges, Limoges, France; 3Inserm cic 1435/réanimation polyvalente, 
C.H.U de Limoges, Limoges, France
Correspondence: Timothée Trampont ‑ timothee.trampont@orange.fr
Annals of Intensive Care 2017, 7(Suppl 1):P175
Introduction According to some studies, field-intubated patients 
have 1.5–3 times greater risk of ventilator associated pneumonia 
(VAP). Endobronchial intubation (EI) can be unrecognized by the 
physicians and may result in complications such as atelectasis which in 
turn could increase the risk of VAP. The aim of our study was to confirm 
this hypothesis.
Patients and methods This monocentric retrospective study included 
all consecutive patients >18 years who underwent an out-of-hospital 
tracheal intubation before their admission to the intensive care unit 
(ICU) between January 2012 and December 2015. Exclusion criteria 
were suspected aspiration or pneumonia on admission, patients who 
died within the first 5  days of ICU stay, extubation in less than 48  h 
and underlying disease making radiological interpretation difficult 
for VAP diagnosis. VAP were divided into early onset (<7  days) and 
late onset (≥7  days) events and were independently diagnosed by 
two experienced intensivists who had no access to the initial chest 
X-ray performed to check the position of the tracheal tube, based on 
the Clinical Pulmonary Infection Score. Onset of ventilator associated 
tracheobronchitis (VAT) was also noted. Inadvertent endobronchial 
intubation was determined by another independent physician based 
on the interpretation of admission chest X-ray.
Results 397 patients were intubated out-of-hospital. Of the 284 
patients excluded, 104 had an extubation in less than 48 h, 114 were 
died within the first 5 days, 22 had a suspicion of pneumonia, 28 a sus-
picion of aspiration and 8 an underlying disease making radiological 
interpretation difficult. Of the 121 patients included, 28 (23.1%) had an 
EI upon admission. No significant difference was observed between 
the EI and non-EI group for gender, age, SAPS2, comorbidities and 
diagnostic category (cardiorespiratory arrest, trauma, coma and cardi-
orespiratory failure). Early-onset VAP were diagnosed in 43% in the EI 
group and in 29% of non-EI patients (p = 0.085). Adding early onset 
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VAT, the respiratory infection rate was 61% in the EI group and 44% in 
the non-EI group (p =  0.061) (Fig.  6). Late-onset VAP were observed 
in 8.6% in the non-EI group and 7.1% in the EI group, without differ-
ence between groups (p = 0.403). There was no inter-group difference 
in the duration of ventilation, duration of ICU stay and ICU mortality. 
Staphyloccocus aureus was the most prevalent pathogen in patients 
with early-onset VAP (23.1%, only one strain was methicillin-resistant).
Conclusion This study found a high rate of inadvertent prehospital 
endobronchial intubation with a higher incidence of early-onset VAP. 
These results support the implementation of specific procedures to 
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Introduction Ventilator-associated pneumonia (VAP) is associated 
with increased hospital stay and high morbidity and mortality in 
critically ill patients. The classic dichotomy between early and late 
onset VAP is no longer helpful available. The aims of this study were to 
determine the incidence of multidrug-resistant pathogens in the first 
episodes of VAP and to assess potential differences in bacterial profiles 
of subjects with early-onset versus late-onset VAP.
Patients and methods Retrospective cohort study over a period 
of 18  months including all patients who had a first episode of VAP 
confirmed by positive culture. Subjects were distributed into 2 groups 
according to the number of intubation days: early-onset VAP (<5 days) 
or late-onset VAP (≥5  days).The primary endpoint was the nature of 
causative pathogens and their resistance profiles.
Results Sixty patients were included, 29 men and 31 women. The 
average age was 38 ± 16 years. The IGS 2 at admission was 40.5 [32; 44] 
APACHE 19 [15; 22]. Monomicrobial infections were diagnosed in of 46 
patients (77%).Two different bacteria were isolated in 14 cases (13%). 
A. baumannii was the most frequently isolated in 53% (n  =  32) of 
patients; followed by P. aeruginosa in 37% (n = 22), Enterobacteriaceae 
in 28% (n = 17) and S. aureus in 5% (n = 3). The isolated bacteria were 
multidrug-resistant in most cases (58/60). The VAP group comprised 36 
episodes (60%) of early-onset VAP and 24 episodes (40%) of late-onset 
VAP. A. baumannii was isolated in 47% of early VAP (n = 17) versus 62% 
of late VAP (n = 15) (p = NS), P. aeruginosa in 36% of early VAP (n = 13) 
versus 37% of late VAP (n = 9) (p = NS) and Enterobacteriaceae in 30% 
of early VAP (n = 11) versus 25% of late VAP (n = 6) (p = NS). For the 
resistance profile of the different pathogens isolated, there was no 
difference between early and late onset VAP.
Conclusion According to new data from the literature, there were no 
microbiological differences in the prevalence of potential multidrug-
resistant pathogens or in their resistance profiles associated with 
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Introduction The bacterial nosocomial infection is a major cause of 
morbidity and mortality in burned. The bacterial ecology in an ICU has 
a major impact in terms of morbidity and mortality, particularly in the 
center of burned or length of stay of patients is increased compared to 
a general intensive care.
Materials and methods We conducted an observational study spread 
over 7  months in ICU for severe burned burnt including any who 
have spent more than 48 h with nosocomial infection (modified CDC 
criteria), and in which all biological and bacteriological samples were 
taken. The different types of infections studied were: skin, urinary, 
lung and bloodstream infections. They excluded all patients belatedly 
supported or having stayed in other healthcare facilities.
Results One hundred twenty (120) patients showed nosocomial 
infection during this period. The sex ratio (M/F) was 1.7 and the mean 
age was 39  ±  23  years. Bacteremia was present in 44.84% of cases, 
followed by the urinary tract infection that was present in 21.21% of 
cases, followed by the cutaneous infection in 10.30% of cases, and 
last pulmonary infection in 9% of cases. Infection was polymicrobial 
in 14.5% of cases. The main bacteria identified were: Acinetobacter 
baumanii (43.45%) of which 74% is resistant to imipenem, 
Enterobacteriaceae (31.5%), Pseudomonas aeruginosa (24%) of which 
83.25% is resistant to ceftazidime and 68.2% is resistant to imipenem, 
Enterococcus (16%) and Staphylococcus Aureus (14.29%).
Conclusion The incidence of nosocomial infection is very high 
compared to literature. The rate of resistance to common antibiotics 
is very high. A drastic management of antibiotics in our context, the 
selection of patients and the frequent use in the operating room for 
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Fig. 6 Rate of early‑onset VAP + VAT depending of the position of 
the tube
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Introduction The management of ventilator acquired pneumonia 
is a diagnostic and therapeutic challenge. Antibiotic therapy is a key 
link. The objective of this work is to study the epidemiological, clinical 
patients who developed VAP during their stay in the Medical Intensive 
Care Unit of the CHU Ibn Rushd in Casablanca and are features of the 
bacterial ecology of VAP during the 2015.
Patients and methods It is a retrospective descriptive study and 
analytical spread over 1  year, from January 2015 to December 2015. 
Were included all patients with pneumonia Ventilator, with or without 
bacteraemia, after hospitalization for more than 48 h. Were collected 
clinical, biological, radiological, bacteriological and scalable patients 
included.
Results The average age of the patients was 42.19  years with a sex 
ratio (M/F) 1.47 APACHE II score average was 16.4, the average SAPSII 
was 31.12 and the average was 2.39 SOFA. 86.5% of patients were 
intubated on admission in intensive care. 3.5% were intubated within 
less than 5 days notice after admission and the average time to onset 
of VAP was 3.76 days. The VAP were early in 68.4% of cases. The average 
hospital stay of patients being 19.63 days. 73.68% in the sample used 
in our patients was bronchial aspiration. The most offending germs are 
27.2% Acinetobacter baumannii, Pseudomonas aeruginosa 16.3%. 100% 
of patients received empirical antibiotic therapy chosen according to 
the ecology of the service. 77.4% died. 43.8% of deaths were directly 
related to VAP.
Conclusion Ventilator acquired pneumonia is main problem in our 
ICU. The bacteriological ecology must be usually known. In our unit 
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Introduction Acinetobacter baumannii (AB) ventilator-associated 
pneumonia (VAP) is common in critically ill patients. The aims of 
this study were to describing the epidemiological characteristics of 
AB-VAP, to identify risk factors for acquisition and factors predictive of 
a poor outcome.
Materials and methods A retrospective-prospective study was 
conducted at the Medical Intensive Care Unit of the University 
Hospital Ibn Sina, Rabat-Morocco from January 2013 to December 
2015. They were included in the study that all patients developed VAP 
with identified germ. For identification of risk factors of acquisition of 
AB VAP, two groups of patients were compared: patients with AB VAP 
versus patients with VAP caused by other germs. To identify factors 
associated with mortality, two other groups were compared: Survivors 
versus died.
Results 122 patients presented VAP among which 60 were caused 
by Acinetobacter baumannii. Among isolates of AB, 8.3% were drug 
susceptible, and 16.7% were multidrug-resistant while 75% were 
extensively drug-resistant. They were Independent risk factors for 
acquisition of AB VAP in multivariate analysis: the presence of a central 
venous catheter before the occurrence of VAP, duration of prior hospi-
talization ≥4 days and ICU duration of stay ≥5 days. The mortality rate 
of AB VAP was 85%. The independent risk factors for poor outcome in 
multivariate analysis were: duration of antibiotic treatment >7  days, 
the reintubation and the presence of a previous hospitalization.
Discussion Our data were similar to those of the literature with a high 
incidence of VAP due to the AB (49%) and a high rate of resistance to 
this bacterium particularly to carbapenems. However, and compared 
to the literature, the VAP AB were responsible for a death rate much 
higher (85%).
Conclusion Our data were similar to those of the literature with a high 
incidence of VAP due to the AB (49%) and a high rate of resistance to 
this bacterium particularly to carbapenems. However, and compared 
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Introduction Ventilator-associated pneumonia (VAP) is common in 
critically-ill patients. In fact, 10–20% of patients requiring invasive 
mechanical ventilation develop this complication. The onset of VAP 
has been reported to be associated with increased mortality. However, 
data related to critically-ill elderly patients are scarce. The aim of this 
study is to assess the prognostic impact of VAP in critically-ill elderly 
patients.
Patients and methods Mono-center, retrospective study conducted 
from 01/012014 to 30/09/2015. All old patients (age ≥65  years) 
requiring mechanical ventilation were included. Two groups were 
compared: Patients who developed VAP (VAP (+) group) and those 
who did not develop VAP (VAP (−) group).
Results During the study period, 86 patients were included. The 
causes of admission in the intensive care unit (ICU) were shock 
(n  =  30), acute respiratory failure (n  =  41) and disturbed level of 
consciousness (n =  15). Diabetes mellitus, hypertension and chronic 
obstructive pulmonary disease were the most common comorbidities 
(44.2, 32.6 and 40.7% respectively). Mean age was 73.3  ±  6.5  years. 
Sex-ratio (M/F) was 1.8. Mean APACHE(II) score was 24 ± 9. The mean 
duration of mechanical ventilation was 10 ±  15  days. Thirty patients 
(34.9%) developed VAP. ICU-mortality was significantly higher in the 
VAP (+) group (90 vs 55.4%; p = 0.001). Multivariate analysis identified 
two independent factors predicting ICU mortality: Shock on admission 
(OR = 22.7, CI 95% [5.1–101.2], p < 0.001) and VAP (OR = 5.7, CI 95% 
[1.2–28.1], p = 0.033).
Conclusion VAP is common in critically-ill elderly patients and is 
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Introduction Ventilator associated pneumonia (VAP) is the most fre-
quent nosocomial infection in critically ill patients. It is associated with 
high mortality, prolonged mechanical ventilation, length of stay, and 
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increased health-care costs. Among pathogens responsible of VAP, Aci-
netobacter baumannii which is characterized by its ability to spread in 
the hospital environment and to acquire resistance leading sometimes 
to therapeutic impasses is associated with a particularly high mortality 
reaching 30–75%.
Objective To describe the epidemiological characteristics of A. 
baumannii VAP, to determine their prognosis and identify factors 
associated with mortality.
Patients and methods It is a monocentric observational study 
conducted over a period of 13 years in a Tunisian intensive care unit 
(ICU) including mechanical ventilated patients for more than 48 h with 
confirmed A. baumannii VAP.
Results One hundred and twenty-three patients were included 
in the study. A. baumannii was responsible for 31% of VAP in our 
ICU. The VAP were late in 59% of cases. More than 90% of isolates 
pathogens were resistant to ticarcillin, piperacillin, piperacillin–
tazobactam, ceftazidime and ciprofloxacin. Sixty percent of germs 
were sensitive to imipenem. Resistance to imipenem has increased 
consistently from 0% at the beginning of the study to 88% in 2015. 
All pathogens were susceptible to colistin. A. baumannii VAP was 
complicated by septic shock in 63% of cases. The median duration 
of mechanical ventilation and of ICU stay were 17 (IQR: 11–25) and 
25  days (IQR: 17–41) respectively. The use of parenteral nutrition 
was the only factor associated with the occurrence of A. bauman-
nii VAP resistant to imipenem (odds ratio 2.27, 95% CI [1.07–4.80], 
p = 0.033). ICU mortality was 45%. It was higher in patients with A. 
baumannii VAP resistant to imipenem (55 vs 39%, p  >  0.05). In the 
multivariate analysis, the age, the use of renal replacement therapy 
and the occurrence of VAP relapse have been identified as factors 
associated with mortality.
Conclusion A. baumannii resistance to imipenem became threaten-
ing. The use of parenteral nutrition was the only factor associated with 
the occurrence of A. baumannii VAP resistant to imipenem. The choice 
of empiric antimicrobial for VAP caused by this pathogen must take in 
consideration the epidemiologic data of each country and each ICU. 
A. baumannii VAP was associated with high mortality. The age, the use 
of renal replacement therapy and the occurrence of VAP relapse have 
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Introduction Adverse drug events (ADE) remain a serious public 
health problem. They represent between 0.16 and 15.7% of hospital 
admissions and between 0.37 and 27.4% of intensive care unit (ICU) 
admissions. They are defined as any injury related to a drug, and 
include both adverse drug reactions, expected or not, but also under-
use, overuse and misuse, unintended or undesired, preventable or not. 
Indeed, mortality from iatrogenic event would rise between 2.0 and 
28.1%, whereas these ADE that resulted in ICU hospitalization could be 
prevented in 17.5–85.7% of cases. These unplanned admissions over-
load ICU, limit access to health care for other patients and have serious 
economic consequences for the health system. It is therefore neces-
sary to study these ADE to know their main causes and attempt to find 
a solution to avoid them.
The main objectives of our study were to clinically and pharmaceutically 
analyze and stratify the different ADE leading to hospitalization in our ICU.
Patients and methods This is a monocentric prospective study, 
between June 2014 to January 2016, in medico-surgery ICU. From 
all admissions, we had included patients admitted in our hospital for 
involuntary ADE (plausible, likely and very likely causal). We had col-
lected clinical aspects (Failure mode, IGSII score, mortality in ICU) and 
pharmaceutical aspect (number of drug, offending drugs) at daily 
medical staff meeting.
Results On 1545 admissions, 154 patients were hospitalized for 
unintended ADE. The average age was 70  years old [26; 95], with a 
men/women ratio equal to 1.8. The clinical severity IGSII score found 
was 51 [13; 120]. Average length of stay in ICU was 5.5 days [1; 28] on 
average in this unit. The main reasons of admission were: hematologic 
failure (in particular hemorrhagic) (29.9%), metabolic failure (19.5%), 
renal failure (11.0%), neurological failure (11.0%) and sepsis (10.4%). 
Respiratory, hepatic, hemodynamic failures and hypersensitivity 
reactions represented respectively less than 10% of cases. 34 patients 
(22%) included died during their stays in ICU. On average, 7.6 drugs 
were found in the usual treatment of the patient. 32.5% of this 
population had a known cognitive disorder and 62% of them self-
management of their treatment. The main drugs involved were: 
furosemide (16.9%), metformin (13.0%), perindopril (9.1%), lysine 
acetylsalicylate (8.4%), warfarin (8.4%) and fluindione (7.8%). The most 
common drug families involved were: drugs of the cardiovascular 
system (33.8% of cases), anticoagulants and antiplatelet agents 
(31.8%), antidiabetics (16.9%) and psychotropic (13.6%).
Conclusion Hospitalizations in ICU for ADE are still too common 
despite their preventability for most cases. Many patients with known 
cognitive disorder manage their treatment themselves and this is 
probably one of the reasons of iatrogenic events. Anticoagulants 
and antiplatelet agents, by side effects, misuse, underuse or overuse 
are very often involved. The onset of kidney failure from dehydration 
and the continuation of nephrotoxic and antidiabetic treatment also 
remain one of the most common causes. Consequently, it is necessary 
to continue and develop primary, secondary and tertiary prevention 
strategies to prevent their appearance, to limit their consequences 
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Introduction Intensive care unit (ICU) is usually identified as a 
place of acute care, concentrated over a short period. For many 
reasons, a prolonged stay in the ICU has a pejorative connotation 
for the intensivist physician. The aim of our study is to describe the 
epidemiological, clinical, paraclinical profile of patients hospitalized for 
a long time in ICU (over 15 days) and to identify the main prognostic 
factors and those that can predict the duration of stay in ICU.
Patients and methods We conducted a retrospective study, over a 
period of 5 years and 6 months (January 2010 to June 2015), enrolling 
patients whose length of stay was greater than or equal to 15 days in 
medical ICU of the UH Ibn Rochd of Casablanca. Statistical analysis was 
performed using SPSS 21.0.
Results We enrolled 151 patients witch correspond to 8.2% 
of all admissions. The sex ratio was 1.6, the average age was 
(43.2  ±  18.5  years). The majority of patients (75%) were transferred 
from the emergency department. Medical pathology was the main 
motive of admission (82.1% of cases). Means of severity scores were 
calculated as follows: APACHE III (56.2 ±  22.9), IGS III (40 ±  9.6), OSF 
(0.6  ±  0.7). The average length of stay was (42.2  ±  59.7  days). The 
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incidence of nosocomial infection was 82.8%, the average day of 
onset was 9.34  ±  8.7  days. Pneumonia, bacteremia and vascular 
catheter infections were the main sites, Gram-Negative Bacilli 
were the most frequently identified, dominated by Acinetobacter 
baumanii (27.9%). Mechanical ventilation (91.4%) and vascular 
catheterization (84.1%) are the most used invasive devices. Antibiotics 
(92.1%), sedation (91.4%) and vasopressors (60.9%) were the main 
administrated treatments. The outcome was favorable in 37.7% of 
cases. Hemodynamic instability (64.2%) and respiratory complications 
(61.6%) were the complications most frequently observed, septic 
shock occurred in 49% of cases. Mortality rate was 55%. In univariate 
analysis, the variables that have emerged as risk factors of mortality 
were: sex, length of hospitalization, severity scores (APACHE III, IGS 
III, OSF), the Charlson comorbidity score adjusted to age, traumatic 
pathology, the occurrence of nosocomial infection, septic shock, 
hemodynamic instability, neurological worsening, use of vasopressors, 
and tracheostomy. In multivariate analysis: nosocomial infection 
(p =  0.04), hemodynamic worsening (p =  0.03), use of vasopressors 
(p  <  0.01) and antibiotics (p  <  0.01) appeared to be risk factors of 
mortality.
Conclusion Although patients hospitalized in ICU for more than 
15  days are few, they represent a serious problem of care and an 
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Introduction Despite an improvement in prognosis of patients 
with hematologic malignancies for the last decade, mortality of 
such patients admitted to the intensive care unit (ICU) remains high. 
Yet, it seems that a first ICU stay does not modify prognosis of the 
malignancy. Until now, there is no data on readmission in the ICU of 
such patients and its effect on short and long term prognosis impact.
Patients and methods This retrospective, single-center study 
conducted on a 5 years period in the medical ICU from our university 
hospital included 265 patients with hematological malignancies 
admitted for a first stay. Objectives were to evaluate the ICU, day 28 
and 6 months mortality, to identify prognostic factors associated with 
mortality within uni- and multivariate analysis, to evaluate readmission 
rate within the 60 days after discharge, to indentify the admission risk 
factors associated with ICU readmission and the prognosis factors 
associated with mortality during the second ICU stay.
Results The mean age was 58.6  ±  14.8  years, with a male–female 
ratio of 1.55. The most represented malignancies were acute 
leukemia (40.8%) and non-Hodgkin lymphomas (26.8%); 16.2% 
were hematopoietic stem cell transplant recipients. 54% of patients 
had newly diagnosed malignancy, 20.8% were in complete 
remission (CR), 11.7% had stable disease or partial remission and 
13.6% had progressive disease. 46.4% of patients presented with 
severe neutropenia at the time of ICU admission. The main life-
threatening complications precipitating ICU admission were acute 
respiratory failure for 43.8%, sepsis for 51.7%, acute kidney injury 
for 14%, neurological disturbance for 18.1% and preventing tumor 
lysis syndrome for 15.8%. 11.3% presented with hemophagocytic 
lymphohistiocytosis (HLH). 34.3% of patients received non-invasive 
ventilation, 46.8% mechanical ventilation (MV), 54.3% needed 
vasoactive drugs administration and 40.8% had renal replacement 
therapy. ICU, day 28 and 6  months mortality were 39.8, 46.4 and 
63.4% respectively. By multivariate analysis poor performance status, 
IGS II, HLH, MV and anti-fungal administration were associated 
with increased ICU mortality, infections with Pseudomonas were 
associated with higher day 28 mortality. Catheter related infections 
were associated with better ICU survival and CR was associated with 
lower day 28 mortality. 38 of 132 (28.9%) candidate patients for ICU 
readmission after a first stay were readmitted within the 60  days 
following discharge. Median overall survival was lower in readmitted 
versus non readmitted patients. 6  months mortality was 73.8% for 
readmitted versus 13.8% for no readmitted patients (p  <  0.0001). 
The second ICU stay mortality was 60.5% and 6  month mortality 
was 78.9%. By multivariate analysis, only MV was associated with 
prognosis. The 6  months mortality rate of patients who survived to 
the second ICU stay was significantly higher than the patients who 
survived to the first admission but were not readmitted (46.7 vs 13.8%, 
p = 0.0007).
Conclusion Main features, short and long term mortality and 
prognostic factors associated with ICU admission are in lines with 
previous studies. Early readmission rate was high with a negative 
impact on survival. Despite admission in the ICU of patients with 
hematologic malignancies seems not to affect long term prognosis, 
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Introduction Lung cancer is among all types of cancer, the most 
common solid tumour admitted in intensive care [1]. Recent studies 
showed that the prognosis of patients with lung cancer during 
intensive care unit (ICU) stay has improved [2]. The aim of our study 
was to determine the causes of ICU admission of lung cancer patients, 
their prognosis and to identify factors predicting hospital mortality 
and survival after hospital discharge.
Patients and methods We conducted a retrospective study including 
all patients with lung cancer admitted for a medical or surgical 
complication in the intensive care unit of a cancer hospital between 
September 1, 2008 and December 31, 2013. mbol’  >  [1]. Recent 
studies showed that the prognosis of patients with lung cancer during 
intensive care unit (ICU) stay has improved [2]. The aim of our study 
was to determine the causes of ICU admission of lung cancer patients, 
their prognosis and to identify factors predicting hospital mortality 
and survival after hospital discharge.
Results During this period, 212 ICU admissions occurred in 180 
patients with lung cancer. The majority of them were men (64%), 
had non small cell lung cancer (80%) and metastases at the time of 
admission (81%). 54% received an antineoplastic therapy during the 
month preceding the ICU admission. 47 patients (26%) died during 
hospitalisation with 36 deaths in the intensive care unit and 11 in 
the hospital ward after ICU discharge. The three main reasons of 
admissions were: cardiovascular problems (32%), respiratory failure 
(29%) and neurological (16%) complications. The SAPS II score (OR 
1.07; 95% CI 1.04–1.11) as continuous covariate and the presence 
of respiratory complications (OR 4.00; 95% CI 1.76–9.07) were the 
2 factors independently affecting hospital mortality in multivariate 
analysis. Median overall survival since ICU admission was 3.7 months 
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(95% CI, 2.8–4.4). Median overall survival for patients discharged 
alive from ICU was 4.8 months (95% CI, 3.9–5.6 months). Considering 
patients discharged alive from the hospital, only the presence of 
metastases was a statistically independent prognostic factor in 
multivariate analysis (HR 2.3; 95% CI 1.44–3.65).
Discussion The prognosis of patients with lung cancer admitted in ICU 
improved probably due to a better selection of these patients eligible 
for intensive care. As already observed in general cancer patients’ 
population, prognosis factors for hospital mortality are related to the 
acute complications but survival after hospital discharge is dependent 
from the cancer stage.
Conclusion Lung cancer patients are admitted in critical care in over 
half of the cases for cardiovascular and respiratory complications. The 
hospital mortality rate of these patients admitted in ICU was 26%. 
However survival after hospital discharge remains low and dependent 
of the cancer metastatic status. ICU admission should be considered 
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Introduction Admission of cancer patients with poor prognosis 
in intensive care units (ICU), like acute myeloid leukemia (AML) 
resistant to the first course of induction chemotherapy, continue 
to be controversial. The ICU trial may be an alternative in this case 
to ICU refusal. The ICU trial is a full-code ICU admission followed by 
reappraisal of the level of care. The objective of this study was to find 
variables available at ICU admission and at day 3 in order to predict 
prognosis of critically ill medical patients with relapsed acute myeloid 
leukemia.
Patients and methods Retrospective monocentric study of 
consecutive patients with a relapsed AML admitted to the 30 beds 
medical ICU of an academic hospital. We evaluated hematological 
treatments, organs supports and mortality in ICU.
Results Between 2002 and 2014, 24 patients with relapsed AML were 
admitted in the ICU. At admission, patients were 54  years old, IGS 2: 
64 ± 24, Lactates: 4.9 mmol/L (±4.7). Eight patients underwent bone 
marrow transplant (BMT). Five patients had graft-versus-host disease 
(GVHD). 12 patients were admitted for septic shock, 7 patients for acute 
respiratory failure, 2 for cardiac arrests, 1 for coma, 1 for acute kidney 
injury and 1 for hemorrhagic shock. BMT was significantly associated 
with higher mortality [Odds ratio (0R) 13.0 (95% confidence interval 
(95% CI) 1.7–99, 43)—p: 0.02]. 7 BMT patients died in ICU. Neutropenia 
[OR 0.33 (95% CI 0.05–1.87)—p: 0.4] and GVHD (OR 2.0 [95% CI 0.07–
51.6)—p: 1.0] were not able to predict mortality in ICU. The first day 
in ICU: 15 patients were under mechanical ventilation, 17 patients 
need vasopressor perfusion and 3 patients dialysis. Mortality in ICU 
was 37%. 4 patients died from acute illness before day 3. Among the 
24 patients admitted in ICU, none of the life-sustaining interventions 
at admission were associated with mortality: invasive mechanical 
ventilation [OR 9.14 (95% CI 0.9–92.4) - p: 0.08], vasopressor perfusion 
[OR 6.2 (95% CI 0.6–62.2)—p: 0.18] and renal replacement therapy 
[OR 4.8 (95% CI 0.3–65.8)—p: 0.27]. On day 3, life supports were not 
associated with higher mortality: invasive mechanical ventilation [OR 
3.7 (95% CI 0.32–41.1)—p: 0.35], vasopressor perfusion [OR 2.0 (95% 
CI 0.27–14.7)—p: 0.64] and renal replacement therapy [OR 1.2 (95% CI 
0.08–16.45)—p: 1.0].
Conclusion Mortality in ICU was 37% in patients with relapsed AML. In 
fact, temporary full-code ICU management in patients with relapsed 
AML seems to be appropriate. None of the life-sustaining interventions 
at admission and on day 3 were able to predict survival. An ICU trial of 
3 days might not be enough to appraise precisely the outcome. Bone 
marrow transplant was associated with a high mortality in our study. 
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Introduction The growing population of chronically critically-ill 
patients has a poor prognosis despite all the resources mobilised [1]. 
Our primary objective was to analyse the prognostic value of different 
definitions used to describe them. Our secondary objective was to 
look for early clinical and biological factors that could be associated 
with the in-hospital mortality.
Patients and methods We conducted an epidemiological prospective 
study in 3 intensive care units (neurosurgical, cardiosurgical and 
medical) of a large French teaching hospital (Henri Mondor, Créteil). 
We included all the patients hospitalized for at least 7 days. We tested 
5 definitions: the prolonged mechanical ventilation, the definition 
taken up by Kahn et al. [2], the prolonged length of stay, the persistent 
critical illness and the persistent inflammation-immunosuppression 
and catabolism syndrome. Two biological examinations were 
performed: upon entering the study and 1  week later. The study 
endpoint was the in-hospital mortality.
Results Thirty patients were included between April and July 
2016. Among them, only 40% matched the definition of prolonged 
mechanical ventilation, which is still the most used in the literature. 
Further, it was not associated with the mortality, but the prolonged 
length of stay was, with 59% of these patients, that did not survive to 
their hospital stay. Other parameters that were significantly different 
between the patients who died and those who survived were an 
advanced age, an elevated IGS II score at hospital admission, an 
elevated SOFA score at study entry, a late healthcare-associated 
infection and several biological variables: a high C reactive protein, low 
albumin and prealbumin and a poor percent of monocytes expressing 
HLA-DR, all measured at day 7.
Conclusion The in-hospital mortality of chronically critically-ill is still 
high. A prolonged length of stay is the only definition who may be 
helpful to identify the patients with the poorest outcome. Among the 
early factors associated with mortality, we found a late healthcare-
associated infection and a low percent of monocytes expressing HLA-
DR, pointing to the value of studying the immune system of these 
patients.
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Introduction As a result of demographic transition, the proportion of 
«very elderly» (≥90 years) patients is increasing worldwide and more 
of these patients are nowadays admitted to intensive care units (ICU). 
Among physicians the discussion about appropriateness of these ICU 
admissions still remains controversial mostly due to questionable 
outcome, limited resources and costs. The aim of the study was to 
determine and evaluate the clinical characteristics and outcome in a 
very old population admitted to a medical ICU in an urban teaching 
hospital.
Patients and methods We present here a monocentric, retrospective 
and observational study. We reviewed the charts of all patients 
(≥90  years) admitted to a medical ICU between 2000 and 2015 
(16  years). We collected epidemiological, clinical and biological 
parameters and all therapeutic measures during the ICU stay. A long-
term survival follow-up was also performed. Two hundred eighty-four 
patients were included for statistical analysis. Multivariate Cox regression 
was also performed to identify risk factors for 28-day outcome.
Results A total of 284 patients were included, which represented 
1.8% of admissions to the ICU during the period of the study. The 
mean age was 92.6 ± 2.1 years, the sex ratio was 0.41. Most of patients 
(41%) were admitted from the Emergency Department. 20% of these 
admitted patients suffered of previous dementia. The mean Charlson 
comorbidity score was 7.7  ±  1.7 and the mean McCabe score was 
1.33 ± 0.5. The admission diagnosis in the ICU was mainly respiratory 
distress (51%), septic shock (11%), cardiac arrest (10%) and coma (8%). 
The mean SAPS-II score within 24 h of ICU admission was 55.9 ± 21.7. 
Half of these patients required support by mechanical ventilation 
(mean duration 7.3  days) and vasoactive drugs and 6% of patients 
received renal replacement. ICU and in-hospital mortality rates were 
38 and 44% respectively. Overall survival at 6  months after hospital 
discharge was 33%. Multivariate regression revealed necessity of 
catecholamines and mechanical ventilation as independent risk 
factors and urinary sepsis as protective factor for 28-day outcome. 
In fine, for 34% of these patients, a limitation of active treatment was 
decided (on average after 2 days of stay). For all others there was no 
justification for limiting care because of a well-established treatment 
plan (with family, GP, ICU team).
Conclusion The proportion of elderly patients remains low, but they 
are increasingly being treated in intensive care units. Nevertheless, the 
in-hospital mortality is high compared to the average mortality in our 
ICU over the same period (20%). The prognosis is often not as poor as 
initially perceived by physicians. The indication for ICU treatment in 
our study was mostly justified; in the setting of consistent patient care 
and good clinical practice. It remains therefore appropriate to discuss 
every single ICU admission of elderly patients without any restric-
tion related to age. Thus, the ongoing cluster-randomized trial of ICU 
admissions for the elderly patients (ICE-CUB 2 study) is deeply awaited 
to confirm or not these results [1].
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Introduction Regardless of the route of delivery, the postpartum 
hemorrhage (PPH) is defined as blood loss ≥500  ml after childbirth, 
and severe PPH as blood loss ≥1000  ml. PPH is the leading cause of 
maternal mortality in Africa. The aim of this prospective study was to 
assess the quality of the initial management of PPH in Algeria in Oran 
EHU and to determine the factors of care with the severity of this 
complication.
Patients and methods We conducted a prospective cohort study 
between April 2014 and September 2014 at the EHU ORAN. All 
women who delivered vaginally and showed HPP including the 
suspected cause was uterine atony were included. The severe PPH 
was defined as bleeding that required invasive surgical treatment 
(hysterectomy, arterial ligation), a transfusion, a transfer to an 
intensive care unit or death of the patient. The quality of care was 
evaluated using objective criteria defined by a delay of diagnosis and 
care and mortality.
Results Among the 466 women who delivered vaginally during 
the study period, 23 had a PPH, link with uterine atony alleged at 
diagnosis, 18 of which presented signs of severity. In 41% of cases, 
the delay in diagnosis of PPH was less than 30 min; 70% of women 
received oxytocin within 10  min after diagnosis. The tranexanique 
acid was used in 1 case. The examination of the cervix, uterine 
exploration and uterine massage was performed in 67, 99 and 
97%, respectively. The failure of first line treatment involved 24% 
of patients. Among them, the time between the diagnosis of PPH 
and administration of blood derivatives was greater than 1  h in a 
third of cases. The administration of oxytocin delay exceeds 10 min 
multiplied by 2.5 the risk of severe PPH. However we had 2 deaths in 
our series.
Discussion In our study the optimal period of care was not adequate, 
obtaining blood derivatives in our institution remains among the 
factors aggravating Among the main risk factors for PPH, uterine 
atony was the main source of complication. Bleeding postpartum 
aggravated in our two patients has led to the deaths from late 
diagnosis and care that was not optimal. These hemorrhages PP is 
the leading cause of mortality: 21% of obstetric deaths (25% in the 
confidential survey 1996–1997) [1].
A hysterectomy was indicated after failure to conservative treatment. 
The death rate is estimated at 8% following a disorder complicated 
hemostasis of disseminated intravascular coagulation (DIC). In some 
series, the mortality rate is estimated between 2 and 4% [2].
Conclusion The management of PPH in obstetrics gynecology service 
The EHU Oran was not optimal. The issue of timing of diagnosis and 
initial treatment is crucial. Solutions must be sought locally to ensure 
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the administration of essential medicines in time, especially the injec-
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Introduction Chronic obstructive pulmonary disease (COPD) is a 
common pathology that would represent the third cause of death 
worldwide by 2020. Its evolution is interspersed with episodes of acute 
exacerbations (AECOPD) that may indicate an admission in intensive 
care unit in the most.
Objective To study the evolution of management modalities of 
patients admitted in our intensive care unit for AECOPD, to determine 
their prognosis and to identify factors associated with mortality.
Patients and methods It is a retrospective, monocentric study, per-
formed in a Tunisian intensive care unit (ICU) over a period of 10 years. 
We including all patients admitted in ICU for AECOPD. Parameters col-
lected were demographic features, comorbidities, regular treatment, 
dyspnea assessed by the MRC scale, initial clinical severity reflected by 
SAPS II and APACHE II scores, modalities and ICU admission deadlines, 
initial arterial blood gas analysis, management of patients in the ICU 
(ventilation modalities, prescription of antibiotics, use of vasoactive 
drugs) and their outcomes (incidence of nosocomial infections and 
their sites, length of stay and ICU mortality).
Results A total of 512 patients, which represents 17.5% of all 
hospitalizations, with mean age of 72  years (IQR: 66–77) were 
admitted for AECOPD during the study period. The mean SAPS II and 
APACHE II were respectively 32 (IQR: 24–45) and 18 (IQR: 14–24). Of 
these, 60% were ventilated with NIV whose overall failure rate was 
48% with a significant decrease between the beginning and the end of 
the study (94 vs 31% p = 0.001). Sixty-four percent of patients received 
antibiotics at admission. The prescription rate of antibiotics has 
decreased significantly over the years from 82 to 36%. The incidence 
of nosocomial infections was 18%. It remained steady between 11 and 
27%. Their sites were pulmonary in 83% of cases. ICU mortality was 
16%. In multivariate analysis, ICU admission deadlines, NIV failure and 
the use of vasoactive drugs were identified as factors associated with 
mortality.
Conclusion Our study showed the importance of AECOPD in the 
activity of our ICU. The management of these patients has evolved 
over the years, which was reflected by the significant decrease in the 
prescription of antibiotics and the enhancement of NIV success rate. 
This result could be attributed to the combination of several factors: 
precocious management of patients, experience of the healthcare 
team and the use of efficient ventilators. ICU admission deadlines, 
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Introduction Aim. Investigate the effect of music therapy on the 
tolerance of non-invasive ventilation (NIV) during its introduction.
Patients and methods Type of study Prospective, randomized, single 
blind, monocentric.
Thirty patients who needed NIV introduction were included.
They were divided into two groups (15 with music and 15 without 
music) and randomized by block of 4.
The patients were all equipped with headphones and half of them 
received a 60  min session of music therapy of their choice, and the 
other half had to keep the headphones on without music.
The main outcome measure was the number of non-programmed 
interventions by the caregivers during the hour.
Patient’s and caregiver’s feeling were evaluated at the end of the ses-
sion by a semi-quantitative scale:
+2 very difficult; +1 difficult; 0 normal; −1 easy; −2 very easy
Pulse rate, systolic and diastolic blood pressure, respiratory rate, pain, 
peripheral oxygen saturation, arterial blood gas parameters, Glasgow 
Coma score and Richmond scale were reported before and after the 
session.
Results Music therapy allowed a significant reduction of the number 
of non-programmed interventions during the hour (0.6 ± 0.74 against 
1.73 ± 1.62; p < 0.05).
The patient’s and the caregiver’s feeling of the session was better 
under music therapy (−1.07  ±  0.88 and −1.07  ±  1.03 against 
0.13 ± 0.83 and 0.07 ± 1.03; p < 0.05).
The other parameters were not statistically significant.
Discussion Our study showed that music therapy allows a better 
tolerance of the NIV’s introduction in a quantitative and a qualitative 
way.
Conclusion Music therapy allows a 65.3% reduction in the number 
of non-programmed interventions by the caregivers, during the first 
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Introduction Although NIV is effective in acute hypercapnic COPD-
related respiratory failure, its efficacy in AE/OHS has been less 
demonstrated.
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The aim of the study was to evaluate efficacy of NIV in AE/OHS and 
to identify factors associated with poor prognosis in non-invasive-
ventilated AE/OHS patients.
Patients and methods A retrospective analysis of all consecutive 
patients admitted to ICU for AE/OHS. Clinical, ABG’s and outcome 
characteristics were collected. Factors associated with poor prognosis 
were identified.
Results One hundred patients were included over a 13  years 
period. 44 patients underwent NIV. They were 66.6  ±  12.6  years 
aged; BMI, 40.6 ±  7.7  kg/m2; SAPSII, 29 ±  13; pH, 7.33 ±  0.08; pCO2, 
69 ± 22 mmHg. They were scored with grade II encephalopathy score 
on admission. Mean duration of NIV was 5.1  ±  4.4  days. 14 (32%) 
patients failed NIV and were intubated with a delay of 85.6 ± 156.7 h. 
11 (25%) died and length of stay was 10.7 ± 9.5 days. Four factors were 
significantly associated with mortality, mMRC, (47 vs 14%; p =  0.02); 
encephalopathy score, (60 vs 15%; p = 0.008); NIV failure, (64 vs 7%; 
p = 0.0001); inotropic agents, (58 vs 12.5%; p = 0.004).
Conclusion NIV in AE/OHS demonstrates rather efficient. However 
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Introduction Oxygen therapy is an essential issue for the French 
Military Health Service (FMHS). Wounded soldiers are severe trauma 
patients often burnt and suffering from haemorrhagic shock. They need 
all along their management oxygen therapy. The theatres of external 
operations are isolated with limited resources. Their supply is difficult. 
Currently, 50% of the trauma are intubated. Thirty-three percent of the 
patient admitted in intensive care suffers from acute respiratory distress 
syndrome (ARDS). The FMHS chose oxygen concentrator as oxygen 
source in addition to oxygen pressurized bottles. Their supply can be 
uncertain in conflict areas. Insufficient data are available concerning the 
use of oxygen concentrator in intensive care unit.
The primary endpoint was to determine over the total duration of 
oxygen therapy, the number of days on which the use of pressurized 
oxygen was needed for patients oxygenated by oxygen concentrator. 
The secondary endpoints were to identify when pressurized oxygen 
was needed, describe the characteristics of the population with 
oxygen therapy and estimate the oxygen quantity economised thanks 
to the use of oxygen concentrator.
Materials and methods The study took place in the forward surgical 
unit of Bouffard. It’s a French role 3 located in Djibouti Republic in 
Africa. All patients over 15 admitted in the intensive care and needing 
oxygen therapy were included. All the patients were oxygenated 
with an oxygen concentrator. The oxygen concentrators used 
were Sequaltm Integra 10 OM, that could deliver up to 10  l/min of 
normobaric oxygen. The ventilator used were Pulmonetictm LTV 1000 
and 1200.
Results Thirty-six patients were included over the 6  months’ study 
period. Sixty percent of the patients were men with an average age 
of 38 (15–90). Sixty percent of them were medical admissions, 22.9% 
were trauma and 17.1% were surgical admissions. Eight persons 
died which represented 22.9% of the patients. The mean SAPS II was 
38.8. The mean length of stay in intensive care was 9  days (0–44). 
The mean time of mechanical ventilation was 6 (1–35)  days. Among 
the patients, 76.5% were intubated. Eight patients (22.8%) needed 
noninvasive ventilation, for six (17%) of them it was after extubation. 
Two hundred and fifty-one days represents the total number of 
days of oxygen therapy divided into 142 days of invasive ventilation, 
15  days of noninvasive ventilation and 94  days of oxygen mask. The 
use of pressurized oxygen was necessary 19 times over the 251 days of 
oxygen therapy which represents 7.5% of the total time. The causes of 
its use were in ten cases (52.6%) criteria of severe ARDS, in six cases an 
emergency intubation and in three cases a transfer. One dysfunction 
of an oxygen concentrator happened during our study. The oxygen 
concentrator produced 1024 m3 of oxygen over the study period, 
which represents 104 oxygen pressurized bottles of 50 litres. This 
enabled an economy of 10,000 euros.
Conclusion It is safe to use oxygen concentrator to take care of critically 
ill patients in limited resources environment. The use of pressurized 
oxygen is still compulsory in two situations: in case of electricity 
failure and in case of high FiO2 (above 60%). Oxygen concentrators are 
sufficient in 92.5% of the time. They enable to deliver oxygen any time 
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Introduction Oxygen therapy is the main supportive treatment 
of hypoxia. Nasal cannula (NC) and nasal oxygen catheter (NOC) 
were used to administer oxygen therapy in hypoxia. Few studies 
have examined the difference in fractional delivered oxygen (FDO2) 
between these two systems. The aim of our study was to compare the 
difference of FDO2between NC and NOC.
Materials and methods On a bench study, a two-compartment 
model of adult lung (Dual Test Lung DTL, Michigan Instrument) was 
connected to a Servo i® Ventilator. The ventilator was set in volume-
controlled mode. Three minute ventilation (MV: 6/9/12  l/min at Ti/
Ttot  =  0.33) and two oxygen flow rate (OFR: 2 and 4  l/min) were 
analyzed. OFR was analyzed with a thermal mass flow meter Vogtlyn™ 
Red Y. The compliance of the artificial lung was set to 70 ml/cmH2O and 
the resistance set to 5 cmH2O/l s
−1. The FDO2 and MV measurements 
were made using an iWorx® acquisition system (GA207gas analyzer 
and analog/digital IX/228  s) and LabScribe II® software. To simulate 
the anatomic dead space of the nasopharynx (±50  ml for an adult) 
we have used a 15 cm length corrugated tubing ISO 22 mm (CT22) at 
the level of inflow of DTL. NC was introduced at the entry of the CT22 
while the NOC was introduced totally into the CT22. Statistical: ANOVA 
on ranks followed by Student–Newman–Keuls.
Results
Conclusion In oxygen therapy, with NC or NOC, for a Ti/Ttot =  0.33, 
FDO2 is influenced by MV, OFR and oxygen system delivery. For the 
same level of OFR and system delivery, when MV increases, FDO2 
decreases (see Table 4). For the same MV and level of OFR, FDO2 was 
Table 4 FDO2 comparison between NC and NOC at different 
OFR and MV
ANOVA on ranks: p < 0.05, except between: NOC2 (VE 9 L/min) and NOC4 (VE12 
L/min)/NC2 (VE 9 L/min) and NOC2 (VE12 L/min)/NOC2 (VE12 L/min) and NC4 






NC 4 L/min NOC4 
L/min
6 31% (0.5) 37% (0.5) 38% (0.6) 43% (0.5)
9 29% (0.7) 34% (0.6) 34% (0.5) 39% (0.7)
12 26% (0.6) 30% (0.6) 30% (0.7) 34% (0.5)
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more efficient with NOC than NC. The differences of FDO2 between 
NOC and NC decrease with increasing MV. The FDO2 fluctuations 
according to the value of the MV are greater with the NOC to 4 L/min.
In clinical situation, NOC is less used than the NC. Compared to the NC, 
NOC is an alternative to increase the FDO2 with the same OFR. NOC 
is more efficient than NC because during expiratory time, anatomical 
dead space it fills with O2, which increases the FDO2. However, if the 
respiratory frequency increases then expiratory time decreases, filling 
with O2 decreases which reduces FDO2. Note that NOC may become 
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Introduction Nasal Cannula (NC) is an option to deliver oxygen 
therapy. According to American Thoracic Society (ATS), standard NC 
delivers a fractional delivered oxygen (FDO2) of 24–40% at supply 
oxygen flows ranging from 1 to 5  L/min. An equation was proposed 
by ATS to predict oxygen delivery: FDO2  =  20%  +  (4  *  O2  L/min). 
Moreover, for ATS, FDO2 is also influenced by respiratory frequency 
(Rf ), tidal volume (Vt) and ratio Ti/Ttot. However, the equation of ATS 
does not take into account these parameters. Our hypothesis is that 
these parameters can significantly affect the FDO2. The aim of this 
study was to determine the effect of Rf, Vt and Ti/Ttot on FDO2.
Materials and methods The study was conducted on bench with 
NC connected to a two compartment adult lung model (Dual Test 
Lung®) (DTL) controlled by a Maquet Servo I® ventilator. One oxygen 
flow rate (OFR) (5  L/min) and 3  min ventilation (MV: 6/9/12  L/min) 
with two Ti/Ttot (0.33 and 0.25) were investigated. All settings of MV 
were generated by modifying Rf (10–40 CPM) and Vt (0.3 and 0.6 L). 
Inspiratory flows rate (IFR) obtained with settings range from 18 to 
48 L/min. OFR was analyzed by a thermal mass flow meter Vogtlyn™ 
Red Y. FDO2 and MV measurements were made using a iWorx® 
acquisition system (GA207 gas analyzer) and LabScribe II® software. 
Compliance of DTL was set to: 0.07  L/cmH2O and resistance to: 
5  cmH2O/L  s
−1. Statistical: ANOVA repeated measures followed by 
Newman Keuls method.
Results FDO2comparisons between: Ti/Ttot 0.33 and 0.25 and three 
MV: 6–9–12 L/min at OFR: 5 L/min.
Conclusion IFR and OFR are the main determinants of FDO2. Equation 
of ATS is correct when IFR is equal to 18 L/min.
When IFR is different of this value, Equation of ATS is not appropriate.
In our experiment, with an OFR of 5L/min, when IFR  =  18  L/min 
(MV =  6  L/min and Ti/Ttot =  0.33), the FDO2 is equal to 41% (±1%) 
(see Table 5). To this value of IFR, the FDO2 is in accordance with the 
formula of ATS, but when IFR increase beyond 18  L/min, the FDO2 
decrease and the formula is not in accordance with ATS. This can 
be explain because during inspiratory phase, air room (Fractional 
oxygen  =  0.21) entry in airway mixes with OFR (FO2  =  1), which 
modifies the FDO2. In this case, when IFR increase then FDO2 decrease 
and vice versa. Medical and paramedical staff must be aware that with 
patients who receive OFR by nasal cannula, any change of OFR and/or 
inspiratory flow changes the FDO2. In this case, for maintain the same 
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Introduction The actual FiO2delivered under oxygen mask in patients 
with acute respiratory failure and the factors that may influence 
the FiO2 are poorly known. In clinical practice, different methods 
including formula or conversion tables based on oxygen flow can be 
used to estimate delivered FiO2. We aimed to assess first the factors 
influencing measured values of FiO2, and second the best method to 
estimate FiO2 in patients breathing under oxygen mask.
Patients and methods We included ICU patients admitted for acute 
hypoxemic respiratory failure from a previous prospective trial [1] 
in whom FiO2 was measured under oxygen mask using a portable 
oxygen analyzer. We collected demographic variables and respiratory 
parameters that may influence measured FiO2. Low FiO2 was defined 
according to the median measured FiO2.
For each patient, measured FiO2 was compared to “Calc + 3%” formula 
(FiO2 = oxygen flow in liters per minute × 0.03 + 0.21) to “Calc + 4%” 
formula (FiO2 = oxygen flow in liters per minute × 0.04 + 0.21), and to 
a conversion table [2]. A ± 10% limit of agreement for each estimation 
method was arbitrarily considered acceptable.
Results Among the 265 patients included, median measured FiO2 
was 65% [60–73]. After adjustment on oxygen flow, the three 
variables independently associated with low measured FiO2 
using multivariate analysis were patient’s height, a low PaCO2, and a 
respiratory rate greater than 30 breaths/min.
Using paired analysis, each estimation methods differed significantly 
from measured FiO2 (p  <  0.0001 for each). Values outside the limits 
Table 5 FDO2 comparisons between diffferent TI/Ttot and MV at OFR 5 L/min
Rf respiratory frequency (in CPM), Vt tidal volume (in Liter)
ANOVA RM results: p < 0.05. No statistical difference are found between: (a–d)/(b–e)/(c–f )/(g–j)/(h–k)/(i–l)/(b–j)/(b–g)/(f–k)/(c–k)/(f–h)/(f–l)/(f–i)/(c–i)/(c–l)/(e–g)
MV (L/min) Ti/Ttot = 0.33 Ti/Ttot = 0.25
RfxVt FDO2 RfxVt FDO2 RfxVt FDO2 RfxVt FDO2
6 10 × 0.6 41% (a) 20 × 0.3 42% (d) 10 × 0.6 36% (g) 20 × 0.3 37% (j)
9 15 × 0.6 36% (b) 30 × 0.3 35% (e) 15 × 0.6 32% (h) 30 × 0.3 32% (k)
12 20 × 0.6 31% (c) 40 × 0.3 30% (f ) 20 × 0.6 30% (i) 40 × 0.3 29% (l)
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of agreement accounted for 55% of cases for the Calc + 3% formula, 
69% for the Calc  +  4% formula, and 94% for the conversion table 
(p < 0.0001).
Conclusion Independently from oxygen flow, the 3 major physiologic 
variables associated with low FiO2 delivered under mask were tallness, 
high respiratory rate and low PaCO2. None of the tested methods 
estimated accurately measured FiO2 in patients with acute respiratory 
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Introduction Acute hyperglycemia is common in intensive care. It was 
associated with poor prognosis and increased mortality.
The purpose of our study is to investigate the frequency of 
hyperglycemia in our ICU, to determine the main causes of high blood 
sugar and to analyze the impact of this hyperglycemia.
Patients and methods Our study is prospective during 3  months. It 
was conducted in the intensive care unit of the University Hospital 
Habib Bourguiba Sfax-Tunisia. Were included in our study all patients 
admitted to the service during the period of the study. For each 
patient included were collected from the ICU admission, clinical and 
biological data.
Results During the study period, 194 patients were hospitalized in our 
ICU and the diagnosis of hyperglycemia (>8 mmol/l) was admitted in 
93 patients (48%). The comparison between patients who developed 
hyperglycemia and those free hyperglycemia group showed that, 
the patients of the first group were significantly older (p  <  0.001). 
Additionally, hyperglycemic patients had more medical history 
including history of diabetes (p < 0.001), a higher SAPS II (p < 0.05), a 
more significant frequency of active infections (p  <  0.05). Moreover, 
the presence of hyperglycemia was associated with shock (p  <  0.05) 
and respiratory distress (p < 0.05).
Their evolution was marked by the significantly higher frequency of 
infectious complications (p  <  0.05), thromboembolic complications 
(p  <  0.05) and acute renal failure (p  <  0.05). The average duration of 
mechanical ventilation and the length of stay were also significantly 
prolonged in hyperglycemia group patients (p < 0.05 for both).
Finally, the presence of hyperglycemia was significantly associated 
with a higher mortality rate.
Conclusion We concluded that hyperglycemia is correlated with 
poor prognosis of morbidity and mortality. But strict glycemic control 
remain controversial. Thus, further studies on this subject will be rec-
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Introduction Acute kidney injury (AKI) is a common complication 
after orthotopic liver transplantation that can increase morbidity and 
mortality rates. Identification of AKI risk factors is important to prevent 
renal failure. The composition of preservation solution for organ 
transplants limiting ischemia and reperfusion injuries, may play an 
important role in the development of AKI and has never been studied 
before. The aim of this study was first to evaluate the impact of four 
preservation solutions (SCOT, Solutions de Conservations des Organes 
et Tissus; UW, University of Wisconsin; Celsior; IGL-1) on the occurrence 
of early AKI after liver transplant, second to identify perioperative risk 
factors transplant, and third to determine urine biochemical profiles.
Materials and methods In this prospective observational study, 
we analysed clinical and laboratory data, during the preoperative, 
intraoperative and postoperative periods, from 168 liver transplant 
recipients, between February 2009 and June 2012. AKI was defined by 
KDIGO criteria [1].
Results AKI was reported in 86 patients (51.2%) in the 7  days after 
orthotopic liver transplant. In univariate analysis, SCOT was a risk fac-
tor for development of AKI. There was no difference with the other 
preservation solutions. The other risk factors for AKI occurrence were: 
MELD score, female gender, Body Mass Index (BMI) and preopera-
tive serum total bilirubin. After fitting a forward stepwise regression 
model, the type of preservation solution was not anymore an inde-
pendent risk factor for development of AKI, unlike MELD score, female 
gender and BMI (p ≤ 0.05). The 1-year mortality, duration of mechani-
cal ventilation, intensive care unit (ICU) and hospital length of stays 
were significantly increased among patients who developed AKI. 
Urine biochemistry profiles, although disturbed by the use of diuretics, 
could highlight an early inadequate renal perfusion after liver trans-
plantation. See Fig. 7.
Discussion In this study, a high incidence of post-liver transplant AKI 
in ICU during the first week after surgery was noted and risk factors 
of AKI were identified. However, this study failed to demonstrate 
an impact of preservation solution on AKI occurrence after liver 
transplant. Risk-factors (MELD, female gender and BMI) are only related 
to the patient characteristics. Our results should be interpreted with 
caution given the small sample size, and the monocentric character of 
the study.
Conclusion Solution for organ preservation has no impact on AKI 
occurrence in ICU within 7 days following orthotopic liver transplant. 
Because of many factors that can influence AKI, a new study with 
largest sample size is necessary to demonstrate or eliminate a possible 
impact of preservation solution.
Fig. 7 See text for description
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Introduction Despite the advances made in recent years in the 
definition and classification of acute renal failure (ARF), epidemiological 
data remain varied and imprecise. These data basically vary with the 
population studied and the pathologies that are responsible of the 
ARF can be particularly complex and intricated especially in emergency 
and intensive care units (ICU).The aim of our study was to describe the 
clinical, etiologic, and therapeutic and outcome of ARF, to apply the 
RIFLE classification (Bellomo and col, Crit Care 2004) to our population 
of kidney failure patients admitted to intensive care, and assess its 
relevance in terms of hospital mortality risk.
Materials and methods We conducted a retrospective analysis over 
a period of 48 months (January 2011–December 2014), of records of 
patients who experienced ARF. The ARF is defined according to the 
RIFLE classification. We picked up all the clinical and laboratory data, 
the need for renal replacement therapy, the complications and the 
disease progression.
Results During this study period, 82 out of 1269 patients admitted 
to our ICU were hospitalized for ARF. They were classified into RIFLE 
R (30 patients or 37%); RIFLE I (15 patients or 18%) and RIFLE F (37 
patients or 45%). The initial reason for visiting the emergency was 
asthenia (41%), followed by disorders of consciousness and dyspnea. 
The average age of our patients was 67 ± 13 years with a sex ratio of 
2.9. Most found risk factors were hypertension (50%), diabetes (39%) 
and heart disease (35%). The ARF was essentially functional (56%). 
The main origin was septic (28%) followed by hypovolemia. Renal 
replacement therapy was required by 34 patients (41%).
Overall mortality in our population was 45%. Most RIFLE F patients 
died (62%). Among the risk factors associated with a severe prognosis, 
we definitely include the RIFLE classification (OR 4.2; CI 95% [2.66–
6.65]). The other factors associated with mortality were SAPS II score 
(OR 6.45; CI 95% [2.77–7.32]) and use of vasopressor agents (OR 3.34; 
CI 95% [2.07–5.41]).
Conclusion ARF is a serious pathology burdened with a heavy 
morbidity and mortality. It is essentially functional and its main causes 
are sepsis and hypovolemia. RIFLE classification can predict morality in 
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Introduction Acute renal failure (ARF/IRA) is a frequent complication 
in intensive care unit. Despite of many technical innovations, mortality 
remains important.
Our study’s aim is to establish the different mortality risk factors ARF/
IRA in intensive care.
Materials and methods It is a descriptive cross-sectional study 
interesting 76 patients admitted at the ICU of the 20 August UHC Ibn 
Rochd, who showed out (ARF/IRA) according to RIFLE classification, on 
admission or have developed it during hospitalization. The study was 
made over a period of 18 months.
It excluded all patients with chronic or pre-terminal renal failure.
Statistical analysis used the epi-info test with significance level 
P < 0.05.
Results During the study period, 423 patients were enrolled, 76 of 
which have completed our inclusion criteria, that is an incidence of 
17.96%. Patients average age was 54.57  ±  19.78  years with a male 
predominance. Antecedents most found are diabetes (43.4%) and 
high blood pressure (28.94%). Most of the cases were in class F (65.6% 
of the cases). Classes I and R are 21.9 and 12.5% respectively. Death 
rate was 64.47%, septic shock was death’s cause in 22.36% of them.
Mortality risk factors selected were age, the disease’s medical 
background, diabetes or pre-renal failure history, presence of 
hemodynamic failure, RIFLE stage F and organic nature of the acute 
renal failure.
Conclusion Acute renal failure occurrence in intensive care is a 
critical step with a very derogatory prognosis significance. A better 
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Introduction Tumor lysis syndrome (TLS) occur with tumor 
breakdown usually by response to chemotherapy. It may also occur 
spontaneously. The rapid destruction of malignant cells release 
intracellular content into the extracellular compartment, inducing 
metabolic and electrolytic imbalances, which result in acute kidney 
injury. Early prophylactic therapy is essential to ovoid the occurence of 
TLS and prevent life threatening complications.
The aim of this study was to prove the value of the early management 
and monitoring of patients with high risk of TLS in intensive care units 
(ICU).
Patients and methods This was a mono-centric, descriptive and 
retrospective study. During a 3  year period, from January 2013 
to June 2016, case notes of fifteen patients with hematologic 
malignancies were reviewed. They were admitted in intensive care 
unit for chemotherapy induction for patients with high risk of TLS, or 
for established TLS. We collected informations regarding clinical and 
biological presentation, treatment and outcome.
Results Fifteen patients were included. The median age was 65 
[45–73]  years, with IGS II score at the admission 40 [31–51]. Mainly 
male (87%). The major part had acute myeloid leukemia and 
highly aggressive lymphoma. Twelve patients were admitted in 
ICU for chemotherapy induction. Four patients had spontaneous 
TLS and three patients had TLS after chemotherapy started in 
oncology department. Concerning patients who had acute myeloid 
leukemia the median rate of white blood cells count was 84,000 
[15,000–166,000] white blood cells per microliter. Seven patients 
had tumoral renal infiltration. The median CKD-epi score was 77 
[23.9–95.6] mL/min/1.73  m2. According to KDICO score, five patients 
were in stage G1, five were in stage G4, four were in stage G2 
and one in stage G3a. At the time of admission, seven patients had 
hyperphosphatemia, nine had hypocalcemia, five had hyperuricemia, 
and only one had hyperkalemia. Chemotherapy was started in ICU 
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for twelve patients. The median hydration amount was 2.5 [1–3]  l the 
first 48 h. The aggressive IV hydration was monitored with daily heart 
ultrasound examination and urine output. Recombinant urate oxidase 
(rasburicase) was given to all patients, the number of doses depended 
on urecemia levels. Six patients needed only one dose of rasburicase. 
Seven patients had renal replacement therapy (RRT) and it lasted 
48 [48–72]  h. The RRT was prophylactic in four cases started when 
phophatemia was more than 2  mmol/L, and therapeutic for renal 
failure and established TLS in three cases. The median duration stay in 
ICU was 5 [4–7] j. Thirteen patients left the ICU without major metabolic 
dysfunction. Two patients deceased due to infectious complications.
Discussion Monitoring of electrolytes was done on average, three 
times a day which is hard to do in onco-hematology unit. The early use 
of rasburicase and the aggressive IV hydration helped to prevent TLS 
for seven patients. The aggressive IV hydration was made according 
to echocardiography data and close monitoring of vital signs and 
urine output which has allowed to avoid volume overload and acute 
pulmonary edema. The early prophylactic RRT prevented renal failure 
and metabolic complications.
Conclusion Early management of TLS in ICU can prevent TLS and most 
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Introduction Plasma and urinary NGAL concentrations have been 
proposed for the early diagnosis of acute kidney injury (AKI). However, 
the added value of these parameters on simple usual clinical data (such 
as baseline serum creatinine and/or diuresis) has been questioned [1].
Patients and methods We measured both urinary and plasma NGAL 
concentration (Bioporto, Gentofte, Denmark on Roche Cobas 6000) 
in 98 patients admitted to the medical ICU of an Academic Hospital. 
The measurement was done in the first 24 h after ICU admission. Renal 
transplanted and dialysis patients were excluded. AKI was defined 
according to serum creatinine criteria of the KDIGO guidelines (1.5–1.9 
times baseline or ≥0.3 mg/dL increase).
Results Three patients were excluded from the analysis because of 
early (in the first 24  h) death. For the 95 patients, median [IQR] age 
was 64 years [20], mean (SD) SAPSII score was 46 (17), 39% were septic, 
median baseline (=at admission in ICU) serum creatinine was 9.7 [8.4] 
mg/dL, and median first 24 h diuresis was 1432 [1340] mL. ICU mortality 
was 14.7%. Prevalence of AKI stage 1 was 21%. Both urinary (expressed 
as the ratio of NGAL on urinary creatinine) and plasma NGAL were 
predictive of AKI Stage 1. Predictive value of plasmatic measurements 
was higher than the urinary one (AUC of 0.627 and 0.758, respectively, 
p = 0.0273 between AUC), but not higher than either baseline serum 
creatinine (AUC = 0.737) or 24 h diuresis (AUC = 0.735). Backward mul-
tivariate regression showed that plasma NGAL concentration was asso-
ciated with serum creatinine, CRP and albumin, whereas urinary NGAL 
was associated with leucocyturia and baseline creatinine.
Discussion Previous positive studies with NGAL did not compare 
the performance of this costly biomarker with simple usual clinical 
parameters to predict AKI. Moreover, several parameters were 
associated with NGAL concentrations with a high risk of collinearity 
(CRP) and/or false positive results (leucocyturia).
Conclusion Our data do not support any added value of NGAL 
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Introduction Acute renal failure (ARF) is a common entity in intensive 
care, concern that the heavy morbidity and mortality it is associated [1].
Early diagnosis of this entity remains difficult, neither diuresis and 
creatinine are early parameters in the diagnosis of ARF. The kidney is 
an organ that suffers long to become faulty, the priority is to recognize 
renal aggression and to achieve a therapeutic allowing reversibility of 
the infringement.
A number of markers have been developed for the diagnosis of 
the IRA but costs remain high not allowing their routine use. The 
measurement of resistance index with the renal Doppler could be a 
solution for the diagnosis of aggression and also of the etiology.
Patients and methods Performed prospective study in the intensive 
care unit of emergency room from January 2016 to June 2016. 
Bringing together ninety-two patients.
The material used, PHILIPS brand with cardiac ultrasound probe of 
3.5 MHz.
Three patient groups are made selon their renal resistive index, 
group A with IR < 0.75, group B, 0.75 < IR < 0.90, and Group C with IR3 
to 0.90.
Results Patients in group A number of 33 patients showed no 
impairment of renal function. Patients in group B at number 41 which 
are supported effectively do not progress to the group C.
Five patients progressed to group C.
Patients in group C at number eighteen, lives with a higher resistance 
index of 0.90 or required an extra renal purification.
Patients in group C are classified as risk or failure check the RIFLE clas-
sification, eleven have a persistent hyper hydration seven with persis-
tent hypovolemia.
The elevation of creatinine was seen later within 48 h after the IR >90.
Discussion In our series the resistance index has a value of early 
diagnosis of renal prognosis aggression in the occurrence and 
development of renal failure. Renal doppler associated with a 
strictly applied standardized protocol achieves the two goals of 
monitoring who aid in the diagnosis and guide treatment. Although 
the recommendations of experts to this tool provides that it should 
probably not use the resistance index measured by renal doppler 
to diagnose or treat an IRA (Grade 2) [2]. Identifying the cause of 
kidney aggression is a prerequisite before any therapeutic action. 
Hypovolemia and soda hydro overload are the causes principales. 
Excess filling hyper intra thoracic pressure and hypoxia are the main 
causes of kidney congestion.
Conclusion Doppler is an early renal medium in the diagnosis of renal 
aggression. A larger series could assert this observation.
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Introduction Peri-partum thrombotic microangiopathic syndrome 
(PP-TMA) is a frequent situation in intensive care unit, mainly with 
HELLP syndrome. Other syndromes as Thrombotic Thrombocytopenic 
Syndrome (PTT) and atypical Hemolytic and Uremic Syndrome (aHUS), 
need specific treatments. When PP-TMA is diagnosed there are no clear 
guidelines about the right treatment to start after foetal extraction. 
Plasma exchange (PE) should be used to treat PTT. The prognosis of 
patients is improved when this technique is started early in the course 
of the disease but several days are necessary to obtain results of 
diagnosis tests. The aim of our study was to evaluate characteristics of 
the patients with PP-TMA who were treated by PE in ICU and to define 
the characteristics associated with the beginning of PE.
Patients and methods We conducted a retrospective analysis of all 
the women with PP-TMA admitted in ICU between 2012 and 2016, in a 
hospital with a level 3 maternity with about 5000 deliveries a year and 
the possibility to perform plasmatic exchanges. We have differentiated 
2 groups, with PE and without PE.
Results 38 patients were admitted in our unit with PP-TMA. 33 were 
treated without PE and 5 with PE. 32/33 patients in the no PE group had a 
diagnosis of HELLP and 4/5 in the other group. PE group had a greater IGS2 
score (21.62 [8–84] vs 34 [13–52]), had significantly more pre-eclampsia, 
4/5 (80%) versus 7/33 (21%) p =  0.0187. PE were started at an average 
of 1.6  days after foetal extraction, and with an average of 5 sessions. 
Patients of the PE group had significantly lower nadir of hemoglobin but 
also lower hemoglobin level at day 2 and day 5. Nadir of platelets count 
was also lower and level remain lower at days 1, 2, 3 and 5. Acute kidney 
injury (using Kdigo classification) was more frequent with a higher rate 
of dialysis in ICU, in the PE group (4/5 (80%) vs 3/33 (9%) p  =  0.0022) 
with a more frequent need for dialysis at the exit of ICU. Proteinuria was 
significantly higher in the PE group (862.8 mg/mmol vs 308.41 mg/mmol, 
p = 0.0134). ADAMTS13 dosage was done only in patients with PE. We find 
a diminution of ADAMTS13 activity (before PE) with an average of 53% 
[40–70] in this group. There was no death, and adverse effects were not 
significantly different.
Discussion This study shows that PE was used when diagnosis was 
uncertain in the most severe form of PP-TMA. Low hemoglobin, low 
platelets, acute kidney injury and high level of proteinuria are the 
main factors associated with the decision to begin PE. This technique 
was safe and not associated with major adverse events. Several studies 
show that there are physiopathological crossovers between diseases 
associated with PP-TMA, for example low ADAMTS13 activity in HELLP 
or mutation in alternative complement pathway which induced HELLP. 
Moreover, studies and case reports show a benefit of PE in HELLP 
syndrome. Our study did not find significant difference in adverse 
events (maybe due to a lack of power), but this is another argument 
to discuss PE in the management of PP-TMA in severe patients. The 
main limits of our study are that none of the patients who had a 
plasmatic exchange had a diagnosis of PTT and that diagnosis tests 
were not performed in all patients with PP-TMA (complements level, 
ADAMTS13…).
Conclusion PP-TMA treated with PE has lower hemoglobin, lower 
platelets, higher rate of kidney injury and proteinuria than those 
treated without PE. No difference were found for adverse events. 
Begining of PE should be discussed for management of a PP-TMA 
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Introduction Diffuse alveolar damage (DAD) is the typical histological 
feature of acute respiratory distress syndrome (ARDS). However, in a 
previous study including 356 patients with criteria for ARDS, we found 
that only 45% of them had DAD at autopsy exanimation [1]. It has 
been shown that patients with ARDS and DAD on open lung biopsy 
had higher mortality than those without DAD [2]. Thus, we aimed to 
identify markers associated with DAD in patients with ARDS.
Patients and methods We included the 356 patients who met criteria 
for ARDS at time of death in our large database of clinical autopsies 
[1]. We assessed the proportion of DAD according to the severity 
of ARDS including the degree of hypoxemia and the 4 ancillary 
variables from the Berlin definition: use of high levels of positive end-
expiratory pressure (PEEP at least 10  cmH2O), radiographic severity 
(3 or 4 quadrants on chest radiograph), altered respiratory system 
compliance (≤40  mL/cmH2O), and large dead space defined as a 
corrected expired volume per minute (≥10 L/min).
Results DAD was associated with all the severity markers above-
mentioned using univariate analysis. After multivariable logistic 
regression, the three markers independently associated with presence 
of DAD were the gender with an odds ratio (OR) of 1.76 [1.08–2.86] for 
females (p =  0.02), the degree of hypoxemia with an OR of 3.88 [1.51–
9.94] for moderate and 7.22 [2.83–18.3] for severe ARDS (p < 0.01 for both), 
and the radiographic severity with an OR of 3.56 [1.88–6.72] (p < 0.01) for 
patients with diffuse opacities involving the 4 quadrants. DAD was found 
in 67% of patients with PaO2/FiO2 ≤ 100 mmHg and diffuse opacities.
Conclusion DAD was significantly more frequent in females. In 
addition to the severity of hypoxemia, diffuse infiltrates involving the 
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Introduction Ventilation Induced Lung Injury (VILI) is responsible 
for an increased mortality in ARDS [1]. Mechanical ventilation may 
trigger an inflammatory response, comprising alveolar macrophage 
activation and recruitment, which may be specifically, repeatedly and 
spatially assessed by functional imaging techniques such as Positron 
Emission Tomography combined with Computerized Tomography 
(PET/CT) [2]. 11C-PK11195 is a PET radiotracer with potential to 
quantify macrophage inflammation. We aim to assess its performance 
to detect lung macrophage recruitment in an experimental high-
volume VILI model.
Materials and methods VILI was performed in 5 anesthetized pigs 
under neuromuscular blockade by rapidly increasing the tidal volume 
(Vt) to obtain a transpulmonary pressure (TPP) between 35 and 
40  cmH2O under zero end-expiratory pressure. PET/CT acquisitions 
were performed before (T1) and after 4 h of high-volume ventilation 
(T2), and image-derived measurements were realized on the whole 
lungs, and regionally on 6 distinct lung regions (divided along the 
anteroposterior and the cephalocaudal axes). 11C-PK11195lung 
uptake was estimated using the Standardized Uptake Value (SUV), 
normalized to the CT-derived tissue fraction in the region of interest 
(ROI). Mechanical lung aggression was estimated by CT-derived 
dynamic and static strains, and tidal alveolar hyperinflation (expressed 
as a fraction of the tidal variation in the ROI volume). After euthanasia, 
alveolar damage and macrophage recruitment were assessed in the 6 
lung regions, using semi-quantitative scores.
Results Between T1and T2, VT and TPP significantly increased from 
6.0  ±  0.1 to 49.4  ±  2.9  ml/kg and 8.6  ±  1.5 to 37.8  ±  4.4  cmH2O, 
respectively. SUV on the whole lung significantly increased from 
1.8  ±  0.6 to 3.0  ±  0.5 between T1and T2 and dynamic strain from 
0.36 ± 0 to 2.1 ± 0.2, whereas static strain did not significantly vary. 
Tidal alveolar hyperinflation significantly increased from 18  ±  4 to 
68 ± 3% on the whole lung between T1 and T2. Regionally, dynamic 
strain, and tidal alveolar hyperinflation significantly differed between 
regions, as well as between T1 and T2. Regional SUV differed between 
T1 and T2 but not between regions. Regional static strain did not differ 
between regions, nor between T1 and T2. In multivariate analysis, 
regional SUV was independently and significantly associated with 
dynamic strain and tidal alveolar hyperinflation. Histologic analysis 
showed significant regional differences in alveolar damage but not 
in macrophage recruitment. SUV was positively associated with 
macrophage recruitment but not with alveolar damage.
Discussion In this experimental VILI model, 11C-PK11195 SUV was 
significantly increased after 4  h of injurious ventilation, and was 
significantly and positively associated with high-volume CT-derived 
mechanical parameters, such as dynamic strain and tidal alveolar 
hyperinflation. The radiotracer’s specificity for macrophages is 
confirmed by the SUV significant association with macrophage 
recruitment and the lack of association with alveolar inflammatory 
edema.
Conclusion 11C-PK11195is a macrophage-specific PET radiotracer, 
with potential to dynamically and specifically assess alveolar 
macrophage inflammation induced by high-volume ventilation.
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Introduction The reverse triggering (RT) is the term used to name 
the contractions reflexes of the muscle diaphragmatic provoked 
(“triggered”) by the periodic insufflations, delivered by the ventilator, at 
sedated patients under mechanical ventilation [1]. The RT constitutes a 
new form of patient–ventilator interaction clinically difficult to detect 
and little known. The RT could have potential implications during the 
management of acute respiratory distress syndrome (ARDS). At present, 
the management of severe ARDS consists among others, on the use of 
an early and systematic perfusion of neuromuscular blockade agents 
(NMBA) during a 48  h’ period, continuation to the ACURASYS essay 
which showed a reduction of the mortality in the group of the severe 
ARDS patient receiving NMBA. The reason of the beneficial effect of 
curare is not perfectly known. It is possible that the phenomenon of 
RT is a mechanism implied in the deleterious role of the mechanical 
ventilation during ARDS. The abolition of this phenomenon by NMBA 
could explain the beneficial effect of NMBA in ARDS [2]. The objective 
was to look for the phenomenon of RT in two groups of ARDS patients: 
a group receiving NMBA and a group not receiving NMBA.
Patients and methods Physiological observational and comparative 
study in intensive care units. We record continuous signals of airflow, 
airway pressure, and esophageal pressure during 24 h of consecutives 
patients with ARDS criteria and PaO2/FiO2 ratio ≤150 at a positive 
end-expiratory pressure (PEEP) of 5 cmH2O evolving for less than 48 h 
under mechanical ventilation.
Results Recording of esophageal pressure of 21 consecutives mod-
erate to severe ARDS patients were blinded analyzed (group NMBA 
n  =  11; group unless NMBA n  =  10). Any phenomenon of RT was 
observed in the group of mild ARDS patients receiving NMBA (Fig. 8a). 
We confirmed the existence of RT on 3 patients of 10 in the group of 
mild ARDS who not receiving NMBA (p = 0.05) (Fig 8b).
Discussion One of the main limits was the quality of the collection 
of the signal of esophageal pressure. The monitoring of esophageal 
pressure is technically difficult, and can d influence the quality of the 
signal and the reliability of the results.
Conclusion This study confirms the existence of the phenomenon 
of reverse triggering among deeply sedated patients not receiving 
NMBA with a 30% incidence. More research is needed to determine if 
the reverse triggering is a risk factor independent from VILI, associated 
with the bad prognosis of severe SDRA patients and, if a strategy of 
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Fig. 8 Recording of continuous signals of airflow, airway pressure, 
esophageal pressure, transpulmonary pressure and tidal volume. a 
NMBA group; b unless NMBA group
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Introduction In acute respiratory distress syndrome (ARDS), airway 
driving pressure (ΔPAW  =  Plateau pressure (PPLAT) minus total 
PEEP) reflects the strain applied to the respiratory system. ΔPAW 
below 15  cmH2O is associated with increased survival [1]. However, 
transpulmonary driving pressure (ΔPTP) is a better assessment of the 
strain applied to the lung. Treatment strategy leading to ΔPTP below 
8 cmH2O seems associated with increased survival [2]. INTELLiVENT-ASV is 
a fully closed loop ventilation mode that adjusts minute volume according 
to PETCO2 and select tidal volume according to respiratory mechanics. 
This prospective physiological study aimed to verify if the combination 
of an optimal recruitment strategy and a closed loop ventilation mode, 
namely INTELLiVENT-ASV could achieve a lung protective ventilation. 
Thus ΔPAW and ΔPTP selected by INTELLiVENT-ASV after recruitment 
were measured in moderate and severe ARDS patients.
Patients and methods The study was conducted in the general 
ICU of Hopital Sainte Musse, Toulon, France. Eligible participants 
were adults aged 18 or over, with early onset moderate or severe 
ARDS, invasively ventilated for less than 24 h at the time of inclusion. 
Exclusion criteria were contraindication to insert nasogastric tube, 
bronchopleural fistula, emphysema, pneumothorax, increased 
intracranial pressure, acute corpulmonale, hemodynamic instability, 
pregnancy. Patients were sedated and ventilated in controlled mode. 
An esophageal balloon was inserted and position was controlled by 
an occlusion test. A 10  s sustained inflation recruitment maneuver 
was performed targeting a transpulmonary pressure at 27  cmH20 
during the maneuver. Then a decremental PEEP trial was performed 
to determine the level of PEEP associated with end-expiratory 
transpulmonary pressure (PTP TE) at 1–2 cmH2O. At this level, airway 
and esophageal pressure (PESO) were measured at end-inspiration 
and end-expiration using 5  s end-inspiratory and end-expiratory 
occlusions, respectively. Transpulmonary pressure was calculated 
as airway minus esophageal pressure at end-inspiration and end-
expiration. ΔPTP was calculated as the difference between PTP TI and 
PTP TE.
Results Fourteen patients were included between February 2016 and 
August 2016, 8 moderate and 6 severe ARDS, 13 were paralyzed. Sex 
ratio = 11/3, Age = 59 ± 18 years, SAPS II = 56 ± 22, BMI = 26 ± 5.
For the total respiratory system: PEEP TOT  =  17  ±  4  cmH2O, P 
PLAT =  26 ±  5  cmH2O, ΔPAW =  9 ±  1  cmH2O, VT =  6.0 ±  1.0  mL/
KgPBW, P PEAK = 29 ± 5 cmH2O, CRS = 48 ± 15 ml/cmH2O.
For the chest wall: PESO TI = 18 ± 5 cmH2O, PESO TE = 15 ± 5 cmH2O.
For the lungs: PTP TI  =  8  ±  3  cmH2O, PTP TE=  2  ±  2  cmH2O, 
ΔPTP = 6 ± 2 cmH2O, CL = 81 ± 39 ml/cmH2O.
Conclusion After a recruitment maneuver and a PEEP set to achieve 
positive PTP TE, INTELLiVENT-ASV selected low and safe ΔPAW and 
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Introduction Because gas exchanges under ECMO are partially 
controlled independently of mechanical ventilation (MV), opposite 
strategies can be considered from fully controlled MV to early 
spontaneous ventilation (SV). To limit the risks associated with fully 
controlled ventilation, we changed our MV strategy by choosing 
a mode facilitating SV: BiPAP-APRV. This study in severe patients 
compared two consecutive strategies with or without early SV under 
ECMO.
Patients and methods Fully controlled MV used pressure assist 
control ventilation (PAC) without SV whereas SV was promoted with 
BiPAP-APRV using the same settings of controlled ventilation plus 40% 
of SV. In both group high inspiratory pressure was 24cmH20, PEEP was 
around 12  cmH2O with a driving pressure strickly below 14cmH20 
and respiratory frequency was 12 cycles/min.
Results 14 similar patients were analysed, 7 in each group. 
Patients in BIPAP-APRV spent 78% (40–88) of their time with SV 
under ECMO, this time was inversely correlated with weaning 
time under pressure support ventilation after ECMO removal, R2 
0.54, p = 0.04. Duration of sedation was similar in both groups. At SV 
initiation with APRV Sedation Agitation Scale was 1 (1–2). In the 500 
cycles recorded, controlled and spontaneous VT were 1.6 (1.3–2.7) and 
1.2 (1.1–1.5)  ml  kg−1 PBW respectively (p  <  0.0001) and the % of SV 
was 39 (30–48) %. Patients spent the same time under ECMO in both 
groups but the weaning time under pressure support ventilation (PSV) 
after ECMO removal had a significant median reduction of 3  days in 
the BIPAP-APRV group, p = 0.03 (Fig. 9).
Discussion
We reported the feasibility of a protocol based on BIPAP-APRV 
aiming at resuming SV as soon as possible in ARDS patients under 
ECMO. The occurrence of spontaneous inspiratory efforts in ARDS 
patients can major variability of transpulmonary pressure and 
as result jeopardise VT and driving pressure control. This might 
be an issue if protective ventilation is not guaranteed anymore. 
VT with BiPAP-APRV remains within safe range when the ratio 
Fig. 9 Circles are PAC group, rhombus are APRV group. MV mechani‑
cal ventilation, PSV pressure support ventilation. Data are presented 
as median (IQR), Comparison between the 2 groups at each time 
Mann–Whithney Test, *p < 0.05
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of spontaneous minute ventilation to total minute ventilation is 
between 30 and 40% [1].
BiPAP-APRV is more efficient than PSV to increase lung aeration in 
patients with ARDS [1]. Recruitment of dependent region is more 
likely to achieve if SV is not supported by synchronized positive airway 
pressure as during BiPAP-APRV [2]. Our strategy targeting a percentage 
of SV between 30 and 40% with high PEEP could be viewed as a 
compromise in order to promote SV and protective ventilation at the 
same time.
Conclusion Protective ventilation combined with SV under ECMO by 
using a specific protocol based on BiPAP-APRV is feasible and safe. It 
may facilitate weaning and thus reduce the time under MV after ECMO. 
To what extend this beneficial effect is directly due to the presence of 
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Introduction Since the first transplant from a patient in a state of 
brain death conducted in 2010 at the University Teaching Hospital 
IBN RUSHD of Casablanca, the number of transplants has increased. 
However, it is still inadequate meet the growing needs of organs. The 
refusal of families remains the main obstacle to the developpement of 
organ transplantation in Morocco. The aim of our study is to monitor 
and analyse the evolution of family refusal to organ donation in a 
brain dead patient.
Patients and methods This is a retrospective and comparative study 
from August until December 2014.The data were collected from 
records of brain dead patients candidates for organ donation at the 
7 intensive care units on IBN RUSHED Hospital. The coordination 
registers were also studied. A questionnaire was distributed to families 
who refused organ donation to investigate the causes of the refusal.
Results During this period, 79 patients with brain death have been 
identified and 78 families had been approached. 61 families (78%) 
refused organ donation. The main causes of refusal were: fear of body 
mutilation (35%), lack of will (24%) and religious causes in 28% of 
cases.
The refusal rate for families decreased from 85% in 2010 to 
50% in 2014. Only 2 patients experienced cardiac arrest before 
transplantation. During this period, 22 cornea transplants from brain-
dead patient were conducted with 20 kidney transplants and two liver 
transplants.
Discussion The evolution of the refusal of families saw a decline 
through awareness and communication campaigns for organ 
donation.
Conclusion Improvements to our health care system must be pro-
posed including strengthening detection of potential donors and rela-
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Introduction In the ICU, three major actors are involved in the caring 
relationship: patient, relatives and caregivers. Acting as spontaneous 
testimonials of the lived experience, thank-you letters from relatives 
may be considered by ICU teams as a source of original information 
which could help in improving care for critically ill patients and 
families. This study aimed to investigate the qualitative content of 
thank-you letters from relatives of patients who stayed in the ICU. 
Specifically, our research questions were, with regards to the letters’ 
content, (1) how is the caring relationship tackled and characterized 
by relatives? (2) to what extent does this relationship impact their 
experience of ICU?
Materials and methods The study took place in a 16-beds ICU during 
a 6-month period. The research team consisted in a care assistant, a 
nurse (also clinical research associate), a psychologist (not working 
in the ICU) and an intensivist. The corpus consisted in twenty thank-
you letters received in the ICU. We conducted a qualitative study 
according to the thematic inductive approach. The process of coding 
was intended to create established meaningful patterns.
Results Two main themes emerged as specific determinants of the 
caring relationship: (1) the temporality, comprising the time dedicated 
to the patients and their family, the time spent with the ICU team, the 
striking time corresponding to significant events for relatives needed 
to be shared with the staff, the extension of the link with caregivers 
by evocating a new life after ICU stay, the writing time as a counter-
gift to the caregivers; (2) the caregivers behaviour, including human 
skills detailed in many core values (kindness, availability, devotion, 
attention, goodwill, sensitivity) psychological support, emotional 
sharing, capabilities to give informations. Relatives feel to be “at the 
center of all attention” in the same way as their loved ones.
Through the narration of ICU experience, the caring relationship is 
characterized as follows: (1) the caregiver becomes a close person with 
an equal relationship (feelings of friendship, emotional closeness); 
(2) the ICU team becomes a new family (contrasting with the poor 
living environment of ICUs); (3) the relative becomes a caregiver (with 
appropriation of medical terms or speaking of his loved one as a patient); 
(4) the caregiver is seen as a “super-hero” through an asymmetrical 
relationship with an overstatement of personal dedication and 
investment of the staff members (abnegation, vocation, involvement).
The caring relationship impacts relatives’ experience of intensive care 
in several ways: (1) relatives are deeply touched by caregivers’ human 
behavior, emotional support being a source of solace and resilience 
in particular for bereaved families; (2) relatives express the idea that 
taking care of humans is not a valued and rewarded task and the 
emerging awareness of hospital realities and difficulties of work in 
the ICU; (3) the most striking transformational change in relatives is 
the perception of their own vulnerability and humanity, leading them 
to exhibit an outward-looking attitude (for example filling out their 
organ-donation card), and encouraging the ICU caregivers to continue 
their missions for the others.
Conclusion Thank-you letters provide both encouraging and informative 
messages for ICU teams about relational care for patients and families 
notably the indivisibility of the families and their critically ill loved ones. 
The relatives’ experience of the ICU appears strongly influenced by the 
caring relationship in the way they express an authentic revelation of 
their own humanity and altruistic thoughts. The thematic content of 
thank-you letters questions determinants and fundamental values at 
stake in the patient–relatives–caregivers relationship.
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Introduction Far from medical paternalism, the doctor-patient 
relationship has now evolved to respect “the autonomy and patients’ 
rights”. Changing behavior has been gradual, while the law offered 
the patient the freedom to consent to care and then of expressing 
their wishes regarding the therapeutic intensity they would benefit, 
in critical situations where consent would not be possible, through 
advance directives (AD) [1]. Their use is of paramount interest for 
intensivist in many critical situations. Unfortunately, the use of AD 
remains marginal because of the unfamiliarity of patients with their 
use and an appropriation default by clinicians [2]. The aim of our study 
was to investigate the perspective of the coming family physician 
generation on advances directives.
Patients and methods Population of interest was general 
practitioner fellow (GPF) from class of 2012 to 2014. We built an 
online questionnaire survey about knowledge and the place they 
want to give to AD in their forthcoming daily clinical activity. This 
questionnaire was sent to GPF emails obtained by universities, unions 
and via the official mailing lists of different regionals classes provided 
by the first contacted.
Descriptive analysis of quantitative data was expressed as mean and 
standard deviation, qualitative data in number and percentage. The 
comparison of continuous variables was performed by the Student 
t-test and the comparison of categorical variables by a Chi2 test. 
Analyzes were conducted on BiostaTGV website and Microsoft Excel®.
Results 2310 GPF answered the survey, mainly from Ile de France 
(n = 218), Toulouse (n = 199) and Lille (n = 169). For GPF the majority 
of patients do not know the AD (81.6%) and 54% think that those who 
know do not know how to use it.
88.4% of GPF think writing AD by patients requires better information. 
According to them, the information should concern the support offered 
in the ICU (77.1%), the use of mechanical ventilation (58.7%), dialysis 
(48.2%) and the evolution of patients after hospitalization in ICU (50.6%). 
Nevertheless information on the prognosis of chronic diseases or organ 
failure seems interesting for only 37 and 20.7% of them respectively.
89.8% of GPF wish to propose the drafting of AD to their patients. 
However, only 60.1% of them are willing to suggest AD to patients 
with cancer or hematologic malignancies, 56.2% to patients with 
neurological and/or degenerative disorders, 20.5% to elderly patients.
Discussion Despite the low proportion of the population we think 
these observations to be of interest because we probably selected the 
GPF the most interested in AD as the participation was not mandatory.
Conclusion A large majority of young of future general practitioner is 
willing to be involved in the implementation of AD with their patients, 
however the target population remains very limited, considering that 
half of them do not want to discuss AD with patients suffering from 
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Introduction Substantial variability exists between countries, 
institutions, and physicians in the decision to withhold or withdraw 
(WhWd) life-sustaining treatment in critically ill patients. Moreover 
practices and skills may co-evolve over time. This epidemiological 
study aims to compare the procedural features of foregoing 
treatments between two separate periods at a 4-year interval (2012 vs 
2016).
Patients and methods For each of the two periods considered, 
the characteristics and outcome of patients qualified for a WhWd 
procedure were collected in a single 16-bed ICU.
Results A total of 199 patients (70 ± 13 years, SAPS II 67 ± 22, sex ratio 
M/F 2.2) were qualified for a WhWd procedure in the past (84 patients) 
and current (115 patients) periods of the study. Differences (CI 95%) 
or Odds ratio (CI 95%) are given in Table 6 only in case of significant 
difference observed.
Discussion At a 4-year interval, the proportion of patients dying in 
the ICU with a previous instruction “not to resuscitate” substantially 
increases, such as that of patients discharged alive after a formal 
WhWd decision (p  <  0.0001). Correlatively, the rate of unexpected 
deaths declines. The overall death rate remains unchanged. The 
decrease in average length of stay is not statistically significant 
(p = 0.22).
Conclusion By anticipating unavoidable deaths, our efforts to with-
hold or withdraw hopeless treatments in critically ill patients have 
resulted in a lower rate of failed resuscitations without any change in 
global mortality.
Table 6 characteristics and  outcome of  patients admitted 
over the study periods (2012 vs 2016)
SAPS Simplified Acute Physiology Score, LOS length of stay, WhWd withholding 
or withdrawal
a Unexpected death: i.e. without previous do-not-resuscitate order






Odds ratio  
(CI 95%)
Length of the period (months) 12 8
Mean Age (yrs.) 65 65
Mean SAPS II 54 53
Mean LOS (days) 10.5 9.5
Mortality rate (%) 28 29
Sex ratio M/F 1.6 1.8
Rate of patients qualified for a 
withholding or withdrawal 
(WhWd) procedure (%)
14 29 2.4 (1.8–3.3)
Brain deceased patients (N) 25 19
Circulatory deceased patients 
(N)
143 97
Rate of WhWd patients 
among circulatory deceased 
patients (%)
53 87 5.7 (2.9–11.1)
Rate of WhWd patients 
ultimately discharged alive 
from the ICU (%)
10 27 3.5 (1.5–8.1)
Rate of unexpected deathsa 
among circulatory deceased 
patients (%)
47 13 0.18 (0.09–0.34)
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Introduction Many studies have ever been conducted on the stress 
factors in health care settings. These studies have led to the develop-
ment of stress scales intended for physicians and nurses (Bonneterre, 
2008). However, the serious pathological and unpredictable states of 
patients in ICU require specific work and confront ICU professionals 
with specific stress factors. In this context, the question is to know if 
ICUs need a specific tool to identified stress factors.
Patients and methods This study aims to identify stress factors to the 
ICU and compare with the stress factors of the scale used in the inter-
national studies (Nursing Stress Scale (NSS), Nursing Work Index and 
Derivates, Karasek’s Questionnaire, Effort-Reward Imbalance Question-
naire, Job stress scale, The Source of Occupational Stress Scale, Health 
Professions Stress Inventory…).
This study was conducted in adult intensive care units in public or pri-
vate hospitals in four countries: Canada, France, Italy, Spain. In each 
country, 40 health care professionals were solicited for an exploratory 
interview about the sources of stress in the work environment: 10 sen-
ior physicians, 10 residents, 10 experienced nurses (with more than 
2 years of experience in the service) and 10 inexperienced nurses (with 
less than 2 years of experience in the service). All the interview tran-
scripts were analysed using an inductive coding approach.
Results One hundred and sixty professionals (80 physicians and 80 
nurses) were included in the study. Eight themes emerged from the anal-
ysis, and they concerned the stress linked to (1) patient (2) care, (3) team, 
(4) family, (5) institutional context, (6) environment, (7) organizational 
context, (8) individual dimensions. In each theme, sub-themes have been 
identified and determine more precisely the difficulties at work.
Discussion Our findings emphasize the complexity of work in ICUs 
and show the specifics factors not taken into account in the generic 
stress scales such as stress in relation with family relationships, the end 
of life decisions and inequity of health care.
Conclusion The specific stress scale should allow to better identified 
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Introduction Intensive care units (ICU) is a place where caregivers 
face many constraints that can affect their physical and mental health 
due to the use of specific care and strong emotional charge related to 
patient death and pain of the families. The aim of the present study is 
to detect anxiety disorders and/or depression among staff working in 
ICUs.
Materials and methods On September 2016, a questionnaire was dis-
tributed to staff (medical and paramedical) operating in 5 ICUs in the 
university hospital Fattouma Bourguiba Monastir, Tunisia (1 medical 
ICU, 1 surgical ICU, 2 cardiologic CCUs and 1 nephrologic intermedi-
ate care unit). This questionnaire included demographic data of par-
ticipants (age, sex, marital status, length of service, psychiatric history, 
consumption of anxiolytic and/or antidepressant) and the Hospital 
Anxiety and Depression Scale (HAD: scale composed by 14 items to 
screen the anxiety (A) and/or depression (D) among hospital staff).
Results During the study period, 106 participants completed the 
questionnaire (82%), 58% of them were women, the median age was 
32  years  ±  8.4. Forty-nine participants were doctors (the majority 
of them residents: 41/49). 12.3% of participants (all paramedics) 
worked on night shift, seniority of more than a year in the ICU was 
found in 59% of participants. 53.8% of staff interviewed were 
married and only 14.2% of them reported consumption of anxiolytics 
and/or antidepressants. 65.9 and 63.2% of the participants had 
respectively symptoms suggesting anxiety and depression. The 
median HAD score was 19 (IQR  =  8); The medical function seems 
to be significantly associated with the occurrence of symptoms of 
anxiety and depression compared to paramedics, however the type 
of ICU (medical/surgical ICUs vs cordiologic/nephrologic ICUs) does 
not appear to be related to the occurrence of symptoms of anxiety or 
depression (Table 7).
Conclusion Anxiety and depression are common symptoms among 
caregivers in ICUs. Improved conditions of work in these units should 
be a target to avoid Burn Out Syndrome.
Competing interests
None.
Table 7 Relationship between  the type of  ICU, the func‑
tion and the occurrence of symptoms of anxiety or depres‑
sion in ICUs




36  (70%) versus 36 
(65.4%); p = 0.54
40 (78%) versus 37 
(67.2%); p = 0.13
Medical versus Para‑
médical
47  (83.9%) versus 25 
(51%); p = 0.001
46 (82%) versus 20 
(41%); p < 0.001
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Introduction The 3, 4-methylenedioxy-methamphetamine (called 
MDMA) is a widely consumed recreational amphetamine derivate. 
The objectives of our study were to describe the features of life-threat-
ening MDMA poisonings admitted to the intensive care unit (ICU) 
and to investigate the prognosticators on admission including the 
plasma concentrations of MDMA and its main active metabolite, the 3, 
4-methyldioxyamphétamine (MDA).
Patients and methods We conducted a retrospective single centre 
observational study including all MDMA-poisoned patients admitted 
to the ICU from 2007 to 2016. Plasma MDMA and MDA concentrations 
were determined using high-performance liquid chromatography 
coupled to mass spectrometry. Comparisons were performed using 
Chi-2 and Mann–Whitney tests. Pharmacokinetics was modeled using 
PKsolver® software and the usual parameters calculated.
Results Twenty patients (16M/4F; age: 25  years [21; 36] (median [25; 
75 percentiles]; poly-intoxications: 80%) were included. On admission, 
patients presented marked consciousness impairment (Glasgow Score: 
3 [3; 14]), hyperthermia (45%; 37.6  °C [37.3; 39.4].), serotonin syndrome 
(35%) and seizures (25%). Three patients (15%) experienced pre-hospital 
cardiac arrest. Management mainly consisted in the administration of 
adequate supportive care: massive fluid repletion (60%), mechanical ven-
tilation (55%; duration: 1 day [1; 4]), sedative drugs (50%), external cooling 
(40%), catecholamines (35%), defibrillation (20%), massive transfusions 
(20%) and arterio-venous ECMO (20%). Cyproheptadine, the antidote of 
the serotonin syndrome, was administered to 20% of the patients. During 
the ICU stay, the following complications were observed including aspi-
ration pneumonia (40%), cardiovascular failure (30%), disseminated intra-
vascular coagulation (30%), acute renal failure (30%), liver failure (30%), 
rhabdomyolysis (25%), hemorrhages (20%), ventilator-acquired pneumo-
nia (20%) and nerve/vessel compressions (10%). Five patients (25%) died 
in the ICU and among the survivors, one patient developed significant 
neurological sequellae. Based on a univariate analysis, pre-hospital cardiac 
arrest onset (p = 0.009), massive hyperlactatemia (p = 0.01) and marked 
coagulation disturbances (p = 0.004) on ICU admission were associated 
to death. Plasma MDMA (638 ng/mL [167; 989]) and MDA concentrations 
(25  ng/mL [17; 39]) on admission did not significantly differ according 
to the final outcome. The pharmacokinetic analysis showed that all the 
patients were in the elimination phase when admitted to the ICU, with 
prolonged MDMA and MDA half-lives in relation to the liver and renal fail-
ures and possibly to the elevated ingested doses of MDMA too.
Conclusion MDMA poisoning may be life-threatening and even fatal 
despite optimal ICU management. Strengthening the information 
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Introduction Carbon monoxide (CO) poisoning is one of the common 
causes of poisoning specially in the cold season, which leads to a 
significant morbidity and mortality.
Patients and methods We retrospectively reviewed the medical data 
of patients who presented to the toxicology emergency department 
with CO poisoning during January 2015 to March 2016. We analyzed 
patients’ characteristics, management, and outcomes.
Results A total of six hundred and sixty-six patients (523 female 
and 143 male), aged of 34  ±  14  years, were included; poisoning 
occurred between December and February in 75% of cases, sec-
ondary to an indoor heating system exposure in the majority of 
cases (89%). The estimated duration of exposure was 2.5  ±  2  h 
[0.5–13  h], with a mean carboxyhaemoglobin (COHb) level on 
arrival at 18.6 ± 17%.
Neurological changes were the most presenting symptoms including 
headache (n =  652, 98%), dizziness (n =  272, 40%), seizure (n =  15, 
2.3%) and loss of consciousness (n =  81, 12.2%). Digestive disorders 
involving vomiting and nausea were observed in 32.1% (n  =  214). 
One woman without cardiovascular risk factors developed non ST-
segment elevation myocardial infarction complicated by lung edema. 
The majority of patients (n = 601, 90%) received normobaric oxygen 
during 6  h (n =  535) and 12  h (n =  66). Hyperbaric oxygen therapy 
was administered at 2.5 ATA during 1  h to 65 patients for neurologi-
cal changes (n = 24), pregnancy (n = 22) and elevated COHb ≥ 25% 
(n  =  19). Mechanical ventilation was required for 5 patients, and 
admission into intensive care unit in 39 patients (6%). Death occurred 
in 5 cases (0.7%).
Conclusion The carbon monoxide poisoning is a common reason for 
emergency department visits in winter. The physician should be aware 
of the serious neurological and cardiovascular complications, if symp-




Neuro‑respiratory toxicity of baclofen in the rat: study of the 
concentrations/effects relationships and role of GABAergic 
receptors
Salma Tannous1, Lucie Chevillard1, Laurence Labat1, Patricia Risede1, 
Isabelle Malissin2, Bruno Megarbane2 
1Inserm u1144, Paris‑Descartes University, Paris, France; 2Department of 
medical and toxicological critical care, Lariboisière Hospital, Paris, France
Correspondence: Bruno Megarbane ‑ bruno.megarbane@aphp.fr
Annals of Intensive Care 2017, 7(Suppl 1):P222
Introduction Baclofen, a GABA-B receptor agonist is used as muscle 
relaxant agent and recently for the treatment of alcohol dependence. 
The number of poisonings has significantly increased since this new 
indication. Clinical presentation of poisoning mainly includes sedation, 
hypotonia, respiratory depression and seizures. To characterize the 
neurorespiratory toxicity of this molecule at high doses, we aimed at 
investigating alterations in Sprague–Dawley rat ventilation and brain 
electrical activity after baclofen administration and studied their 
reversal by GABA-receptor antagonists.
Materials and methods Rat ventilation was investigated using 
plethysmography and arterial blood gas analysis while brain electrical 
activity was studied using EEG with one implanted frontal electrode. 
Three baclofen doses were used including 43.5  mg/kg (30% lethal 
dose-50%), 72.5  mg/kg (50%) and 116  mg/kg (80%). Baclofen 
concentrations were obtained using HPLC-MSMS assay. We modeled 
baclofen pharmacokinetics and analyzed the doses/effects and 
effects/concentrations relationships.
Results Baclofen induced early-onset and prolonged dose-
dependent sedation (p = 0.0002), hypothermia (p = 0.004), EEG and 
respiratory depression (0.001) characterized by significant increase 
in the inspiratory (p  =  0.0001) and expiratory times (p  =  0.02). 
Significant increase in PaCO2 and decrease in arterial pH and PaO2 
were observed at 116  mg/kg (p  =  0.001), peaking at 240  min. 
EEG showed signal slowing, burst-suppression aspects and spikes 
peaking at 5–6 h post-injection without normalization at the end of 
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the experiment at 24  h. We did reverse baclofen-induced decrease 
in tidal volume with saclofen (a GABA-B receptor antagonist) and 
interestingly no alteration of baclofen-induced respiratory depression 
was observed with flumazenil (a GABA-A receptor antagonist). 
Pharmacokinetic parameters of baclofen were obtained at the 
three doses and were dose-dependent. Significant but non-linear 
relationships were observed between baclofen-induced effects and 
concentrations.
Conclusion Baclofen causes dose-dependent neurorespiratory 
toxicity in rats. However, due to increased poisonings, its safety profile 
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Introduction Baclofen is commonly used as treatment of spasticity, 
and recently prescribed in treatment of alcohol withdrawal. It has 
spasmolytic action resulting from antagonistic activity at presynaptic 
GABA receptors of the spinal cord. Because it’s widely prescription, 
it became one of the principal agents of poisoning. We present a 
retrospective study that aims to report the clinical outcomes and 
management of twenty cases of baclofen poisoning requiring ICU 
admission.
Patients and methods Retrospective review of medical 
observations of patients admitted to our intensive care unit for 
baclofen poisoning.
Results Between January 2013 and June 2016, 20 patients were 
enrolled in this study. Mean age was 28.2 ± 11 years. Sex ratio was 0.53. 
Mean APACHE II scale was 8.7 ±  4. Mean IGSII scale was 22.35 ±  11. 
Poisoning was deliberate in 100% of cases. Mean ingested dose was 
448.5 ± 349 mg. The majority of patients presented to the emergency 
room at 4.8  ±  5  h after ingestion. Digestive decontamination was 
performed in 9.6% (n = 2) of patients.
Clinical presentation was dominated by neurological symptoms; 
including coma (n = 15), hypotonia (n = 5), hyporeflexia (n = 5), agi-
tation (n = 5), seizures (n = 3) and delirium in 1 case. Hemodynamic 
manifestations included bradycardia in 12 patients, three of them 
required atropine infusion. One patient presented with hypotension 
responding to vascular resuscitation.
Sixteen cases required mechanical ventilation. Aspiration pneumonia 
was noted in 6 cases. Mean duration of ventilation was 36.6  h ±  27. 
Mean hospital length of stay was 62 h ± 25. Complications included 
ventilation associated pneumonia in one case and moderate 
rhabdomyolysis in 3 cases. All patients evolved favorably. There is no 
correlation between coma and assumed ingested dose.
Conclusion Baclofen overdose causes mainly neurological effects 
and except for bradycardia cardiovascular effects were uncommon. 
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Introduction The lack of an effective treatment for the maintenance 
of abstinence from alcohol has led physicians to take an interest in 
baclofen. Beyond efficacy, safety of baclofen, prescribed in high doses, 
is a concern, especially in case of drug overdose. Indeed, patients 
with chronic alcohol abuse frequently develop psychiatric disorders, 
and are at risk of voluntary drug intoxications. Thus, we set up a ret-
rospective study to describe morbidity and mortality associated with 
baclofen overdose.
Patients and methods A case was defined as exposure to baclofen 
in self-harm attempt with or without symptoms between January 
2008 and December 2015. This study was based on data collected by 
the Poison Control Center (PCC) of Angers University Hospital during 
telephone responses to toxicological exposure and during patient 
follow-up, supplemented by reports from clinical staff in hospital. The 
mortality rate of baclofen poisoning cases was compared to the 31,859 
non-baclofen voluntary drug poisoning cases declared to the PCC of 
Angers University Hospital over the same period. Baclofen elimination 
half-lives were calculated in patients with multiple samplings.
Results 190 cases (median age: 40 years; gender (female): 46.8%) of 
voluntary intoxications were reported, including two deaths diag-
nosed at first medical assessment. Over years, number of baclofen 
poisoning grew up from 8 cases in 2008 to 91 cases in 2015. 111 
patients (59%) had GCS ≤12 at admission and 77 had GCS >12 (41%). 
Eighty patients required mechanical ventilation (42.6%). Neuro-
logical severity (GCS ≤  12 or >12) was significantly associated with 
higher suspected ingested dose (400 [IQR 190–685 mg] vs 120 [IQR 
80–300  mg], p  <  0.0001) and higher baclofen blood concentra-
tion (3.24  mg/l [min–max  =  0.05–14.82  mg/l] vs. 0.32  mg/l [min–
max =  0–1.66  mg/l], p  <  0.001). Seizures were frequently observed 
in patients with GCS < 12 (n = 24, 22% vs. n = 2, 3%, in patients with 
GCS >12, p  <  0.001). Three patients died in the hospital (hospital 
mortality rate 1.6%, total mortality rate 2.6%). Non-baclofen cases 
had lower rate of endotracheal intubation (n = 1833, 6%, p < 0.001 
for comparison) and mortality rate (n  =  299, 0.1%, p  =  0.02 for 
comparison).
Spontaneous baclofen elimination half-life was calculated in 
six patients with normal serum creatinine and was 5.57  h [min–
max = 3.2–8.3 h]. In the five patients who underwent dialysis for toxi-
cological reason without evidence of renal failure, baclofen half-life 
was 3.46 h [min–max = 2.4–4.43 h]. Comparison between these two 
data showed a significant difference (p = 0.03).
Conclusion Baclofen, prescribed in high doses, may lead to severe 
intoxications: self-poisonings frequently require endotracheal intu-
bation and are associated with an increased risk of death. Dialysis 
decreases baclofen elimination half-time but clinical relevance of this 
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Introduction Baclofen, a GABA-B receptor-agonist with muscle relax-
ant properties established since 1974, has been recently used at 
elevated doses to treat dependence to ethanol. The number of pre-
scriptions has exponentially increased without an exact evaluation of 
its toxicity. We aimed to describe acute baclofen poisoning requiring 
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intensive care unit (ICU) admission and study the relationships between 
the toxic encephalopathy and the plasma baclofen concentration.
Patients and methods We conducted a single-centre retrospective 
study including all baclofen-poisoned patients admitted to the ICU in 
2013–2016. When requested by the clinical situation, repeated electro-
encephalograms and measurements of the plasma baclofen concen-
trations were performed. Toxic EEG encephalopathy on a scale of zero 
to five was graded according to the international rating system (Mar-
kand, 1984). Plasma baclofen concentration was determined using 
liquid chromatography coupled to mass spectrometry in tandem 
developed with a Quantum Ultra apparatus (Thermo Fisher Scientific) 
and electrospray source ionization in positive mode (limit of quantifi-
cation: 5 ng/mL). Linear regression and Chi-2 or Mann–Whitney tests 
were used as requested for subgroup comparisons. Baclofen pharma-
cokinetics and the relationships between the toxic encephalopathy 
and the plasma baclofen concentration were modeled using WinNon-
lin software v.5.3 (Pharsight Corporation, CA).
Results Twenty-eight patients (17  M/11F; age: 41  years [32; 49] 
(median [25th; 75th percentiles]) were included. Poisoning was mainly 
multidrug ingestion (92%) by suicidal attempt (63%) occurring in 
chronic alcoholic patients (71%). The presumed ingested dose of 
baclofen was 210 mg [109; 460] and the initial plasma concentration 
1425 ng/mL [206; 2298]. Poisoning features included coma (Glasgow 
coma score: 3 [3; 11]) with hypotonia (46%), seizures (39%), abnormal 
pupil diameter (75%), sinus bradycardia (39%), aspiration pneumonia 
(21%) and EEG disturbances (43%) including the presence of burst 
suppressions, spikes, spike-waves, background slowing and even 
prolonged isoelectric trace in one severely poisoned patient. 
Management was supportive including mechanical ventilation (54%) 
which duration was related to the plasma concentration of baclofen 
(r2 = 0.67). One patient was dialyzed. No patient died. Baclofen half-
lives of elimination (7  h [4; 9]) were closed to the observed values 
reported at therapeutic doses. The relationship between baclofen-
induced encephalopathy as a function of the baclofen concentrations 
was described using a sigmoidal Emax model.
Conclusion Baclofen poisoning may be life-threatening. Toxic 
encephalopathy is well-described with EEG and its grade correlated to 
the baclofen concentration. Prescribers should be aware of the dangers of 
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Introduction During week 52, 2014, in the northeast of the 
Democratic Republic of Congo, an African area included in the 
“Meningitis belt of Africa” and in which malaria is endemic, patients 
with suspected but atypical meningitis were reported. In January 
2015, Médecins sans Frontières (MSF) Geneva was approached by the 
Ministry of Health to support the outbreak.
Patients and methods At the scene, data were collected on individual 
chart file records. Thereafter, at MoH and MSF case-management sites, 
information for each patient was recorded in a standardized Excel line-
list. Patients’ demographic characteristics, clinical features, and dis-
charge were recorded in an epidemiological study. At per request of 
the attending physician, cerebrospinal fluid was analysed for evidence 
of meningitis and blood for malaria. Owing to the atypical clinical fea-
tures, on the advice of the MSF referent toxicologist, urine and medi-
cine samples were collected in symptomatic patients. Toxicological 
analysis included liquid chromatography-mass spectrometry and high 
performance liquid chromatography/UV spectrometry. The study was 
approved by the Ethical Committee of the Ministery of Health of the 
Republic Democratic du Congo, including treatment of adults and 
children with specific antidote.
Results Initial examination suggested that an illness other than bacte-
rial meningitis was the cause of patients’ complaints. First hypothesis 
was meningitis receiving uncomplete dosage regimen of antibiotics. 
Thereafter owing to apparent loss of consciousness with abnormal 
eyes movements, non-tonico-clonic seizures were considered mean-
while. The ratio of individuals less 5 y-o to those equal to and greater 
was 33/67%. The male to female ratio was 46/53%. The mean duration 
of hospitalisation was 3.4 ±  0.8  days (extremes 1–10  days). Extrapy-
ramidal syndrome predominant on the upper part of the body was 
noted by paediatrician neurologists who suggested considering a 
genetic disease. However, signs and symptoms were present in people 
from different families in different areas at the same time. The defini-
tive diagnosis made on pictures and videos of children and adults and 
was facio-troncular dystonia resulting from drug-induced adverse 
effect. Four urine samples were collected in children and sent to a toxi-
cological laboratory in France. All urine samples were positive for halo-
peridol meanwhile the other causes of facio-troncular dystonia were 
excluded, including other neuroleptics, metoclopramide, antidepres-
sants, amodiaquine, anti-histaminic drugs, anti-epileptics, and cocaine. 
From January to August 2015, 1021 hospitalisations were recorded in 
925 patients. Looking for the source of haloperidol showed that tablets 
sold as ‘diazepam’ and consumed by symptomatic patients contained 
haloperidol as the sole active pharmaceutical ingredient, suggesting 
that this large outbreak was due to haloperidol toxicity from falsified 
diazepam. Initial treatment was diazepam to relieve severe facio-tron-
cular dystonia which was efficient but resulted in long-lasting seda-
tion more especially in children. A dosage regimen using bipéridène 
administered by intravenous and oral route was refined to prevent 
adverse effects related to this anticholinergic agent used in children. 
The complete reversal of the facio-troncular dystonia was the antidotal 
evidence supporting the toxicological diagnostic. The mortality rate 
was less than 5% meanwhile the direct causal relationship with ADR is 
questionable. An epidemiological study, including toxicological analy-
sis in controls in ongoing. Indeed, facio-troncular dystonia induced 
by haloperidol does not result from a drug overdose but is an ADR 
occurring in about 20% of patients treated with haloperidol. WHO is 
involved in the inquiry related to this counterfeature involving differ-
ent countries. The cause of the error is presently under investigation.
Discussion This outbreak emphasizes the need to consider toxicity 
resulting from counterfeatured medicines when facing collective 
atypical signs and symptoms in countries with unrestricted access to 
medication with limited control of qualities of the medicinal drugs.
Conclusion Counterfeatured medicinal drug may result not only in 
poor efficacy but also in onset of unexpected outbreak of unknown 
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Introduction In late 2014-early 2015, Médecins Sans Frontières 
(MSF) had to face an outbreak of severe facio-troncular dystonic 
syndrome (FTDS) in North-East Congo. This outbreak resulted 
from counterfeature of pills sold as diazepam. Toxicological analy-
sis revealed one pill contained about 10  mg of haloperidol. FTDS 
induced by haloperidol does not result from a drug overdose but is 
an adverse drug reaction (ADR) occurring in about 20% of patients 
treated with haloperidol. Nine-hundred and twenty-five individuals 
were admitted in MSF structures for 1021 FTDS. The ratio of indi-
viduals less than 5 y-o and equal to or greater of age was 33/67%, 
including 35 (3.4%) of children less than 1 y-o. Initial treatment was 
based on diazepam which relieved FTDS but resulted in long-lasting 
sedation, preventing given any drug by the oral route. Owing to the 
definitive diagnosis, a shift to the use of a more specific antidote 
was chosen. Biperiden was selected as existing in the intravenous 
and oral form in the Swiss pharmacopea. The study was approved 
by the Ethical Committee of the Ministery of Health of the Republic 
Democratic du Congo.
Patients and methods As a whole, biperiden was used in 223 cases 
(84% of the total). Treated children presented with severe dystonia as 
evidenced by inability to cooperate and to swallow. Verbal informed 
consent was obtained from relatives. The dosage regimen to treat 
drug-induced dystonic syndrome in the Swiss pharmacopea is as fol-
lows: for parenteral use in children, intravenously or intramuscularly: 
0.040  mg/kg or 1.2  mg/m2 BSA every 30, according to response and 
tolerance; a maximum of four doses per day should be used. The inter-
nal MSF recommendations for biperiden use in children were 0.01–
0.05 mg/kg of body weight that might be repeated four times a day. 
Initially, biperiden administration was administered under medical 
supervision by the MSF referent at the scene.
Results There was no pediatric preparation of biperiden. Accordingly, 
the adult preparation was used in children. The preparation contained 
5 mg of biperiden in one milliter of solvent. The initial planned dose 
for children of 1 y-o and less and those up to 5 y-o were 1 and 2 mg, 
respectively. The 5 mg (1 ml) of biperiden was diluted in 4 ml of saline 
resulting in a final dilution of 1  mg/ml. Six children were treated 
according this dosage regimen. However, the one 1  mg dose was 
either of limited efficacy while being associated in others of signs 
suggestive of ADR, including agitation, heart rate greater than 160 b/
min, the upper limit for children aged of 1 y-o and less. Two children 
greater than 1  y-o presented severe abnormal behavior resulting in 
an attempt at escape. Owing to question about safety, the dosage 
regimen was changed, as follows: 5 mg (1 ml) of biperiden was diluted 
with 9 ml of saline resulting in a final dilution of 0.5 mg/ml. An initial 
dose of 0.5  mg was administered intravenously as a bolus dose. The 
effects were looked for over 15  min. In the absence of improvement 
in facial dystonia, a second bolus dose of 0.5  mg was administered, 
a third dose could be considered 15  min later if the FTDS did not 
resume. The cumulative initial dose should not be greater than 2 mg. 
In addition to the reversal of facial dystonia, the therapeutic effect of 
biperiden included the return of swallowing to normal allowing to give 
further doses of biperiden by the oral route for three days. The first oral 
dose was administered no less than 12 h after the last initial dose at a 
dose equal to the efficient initial cumulative dose. The following doses 
were halved every 12  h. No ADR related to biperiden were reported 
using this dosage regimen. The mean duration of hospitalisation was 
3.4 ± 0.8 days.
Discussion The bioavailability of biperiden by the oral route is equal 
to 33%. Accordingly, the corresponding intravenous dose should be 
divided by a factor three. Dosage regimen of anticholinergic drugs in 
children are poorly documented. The dosage regimen recommended 
by the pharmacopea resulted in frequent and severe ADR. Titration of 
biperiden resulted in efficient and safe dosage.
Conclusion When biperiden administration is required by intravenous 
route in children of 5 y-o and less, biperiden should be administered 
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Introduction Severe poisoning by rodenticides is frequent. It 
represents nearly 30% of patients admitted to the new intensive 
care unit (ICU) of the region. That is why we decided to perform this 
study. The aim of this work was to describe the epidemiology, clinical 
features and management of all patients admitted to our unit for 
acute poisoning with rodenticides.
Patients and methods It was a retrospective study performed in the 
year 2013 from January to December. The study included all patients 
admitted in the ICU for rodenticide poisoning.
Results 32 patients were enrolled in the study. Our patients were 
young with a mean age of 30 ± 2 years. Poisoning was more common 
in females (n  =  24; 75%). The mean delay between rodenticide 
poisoning and first medical contact was about 2  ±  2  h in the 
cases where this information. Most of our patients (91%) attended 
the emergency department of Zaghouan with a non-medical 
transportation. It was a suicide attempt in most cases (62%) and an 
accidental poisoning in 32% of patients. The most frequent cause of 
poisoning in our study was organophosphorus pesticide (n  =  24; 
75%). The second cause was alpha-chloralose poisoning with seven 
cases (22%). One patient ingested accidentally an anticoagulant 
rodenticide. Most of patients had ingested (oral route) the rat poison 
(n  =  23; 78%). Clinical examination found normal vital signs in ten 
cases (31%). Nine patients (28%) had a shock, eight patients (25%) 
had an acute metabolic disorder and five patients (16%) had acute 
respiratory failure or were comatose. All patients enrolled in the study 
were admitted in the ICU for a period of clinical observation of 24 h. 
Stomach pumping (gastric lavage) was performed in 30 patients 
(93%). An antidote which was atropine was needed in twelve patients. 
Three patients (9%) who ingested alpha-chloralose needed intubation 
and mechanical ventilation. All patients had a good outcome and 
were discharged from ICU and from hospital. The mean ICU length of 
stay was 2 ± 3 days.
Conclusion This is the first study of acute poisoning with rodenticides 
admitted in the new ICU. The results of our study were similar to 
those published in recent literature. Cases of acute poisoning with 




Hemodynamic correlates of the left ventricular mean ejection 
pressure: a carotid tonometric study
Mathieu Jozwiak1, Sandrine Millasseau2, Jean‑Louis Teboul1, Jean‑Emma‑
nuel Alphonsine1, François Depret1, Nathalie Richard2, Pierre Attal3, 
Christian Richard1, Xavier Monnet1, Denis Chemla4 
1Service de réanimation médicale, inserm umr s_999, université paris‑sud, 
Hôpital de bicêtre, hôpitaux universitaires paris‑sud, Assistance publique 
– Hôpitaux de Paris, Le Kremlin‑Bicêtre, France; 2Alam medical, ALAM 
Medical, Vincennes, France; 3Otolaryngology‑head and neck surgery, 
Shaare‑Zedek Medical Center and Hebrew University Medical School, 
Jerusalem, Israel; 4Service de physiologie, inserm umr s_999, université 
paris‑sud, Hôpital de bicêtre, hôpitaux universitaires paris‑sud, Assistance 
publique – Hôpitaux de Paris, Le Kremlin‑Bicêtre, France
Correspondence: Mathieu Jozwiak ‑ mathieu.jozwiak@aphp.fr
Annals of Intensive Care 2017, 7(Suppl 1):P229
Introduction The systemic arterial load imposed to the left ventricle 
(LV) is a major determinant of normal/abnormal cardiovascular 
function. The LV mean ejection pressure (LVMEP) is the best estimate 
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of load faced by the LV throughout ejection. The contribution of the 
steady and pulsatile blood pressure (BP) component of arterial load to 
LVMEP is debated. We studied the hemodynamic correlates of LVMEP 
using carotid tonometry. Intensive care unit patients equipped with an 
indwelling catheter were studied, thus allowing precise calibration of 
the tonometer.
Patients and methods Carotid tonometry (Complior Analyse® 
ALAM Medical, France) was prospectively performed on 28 
hemodynamically stable, spontaneously breathing patients (12F, 
mean age ± SD = 64 ± 18 years). Carotid waveforms were calibrated 
from diastolic BP and time-averaged mean BP invasively obtained at 
the radial (n = 18) and femoral (n = 10) artery. All patients were free 
of aortic stenosis. LVMEP was the area under the systolic part of the 
carotid pressure waveform divided by ejection time.
Results LVMEP (111  ±  17  mmHg) was strongly related to central 
systolic BP (126 ± 21 mmHg; r2 = 0.97) and was also related to mean 
BP (r2 = 0.82), peripheral systolic BP (r2 = 0.83), peripheral (r2 = 0.35) 
and central (r2 = 0.50) pulse pressure (each P < 0.05). The LVEMP was 
not related to age, heart rate and stroke volume. Systolic pulse wave 
amplification ratio from carotid to periphery was 1.07 ± 0.08.
Conclusion LVMEP was most strongly related to central systolic 
BP, which combines the influences of the steady and pulsatile 
components of central arterial load (r2 = 0.97). LVMEP was less strongly 
related to peripheral systolic BP, which may be less informative given 
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Introduction Myocardial dysfunction is one of the main predictors 
of poor outcome in septic patients, with mortality rates next to 
70%. Many pathological findings were found in the sepsis induced 
cardiomyopathy including myocardial ischemia, alterations in 
microcirculation and proinflammatory cytokines.
The aim of this study was to assess the prognostic value of a recently 
developed highly sensitive cardiac troponin I (hsTnI) assay in patients 
with septic shock.
Patients and methods We performed a prospective observational 
study in septic shock ICU patients within 72 h of admission. Exclusion 
criteria were age >18 years; pregnancy; post-cardiac arrest and brain-
dead. HsTnI was measured soon after admission and 12, 24, 48 and 
72 h after. Patients were subjected to transthoracic echocardiography 
(TTE) at study inclusion and regular biochemical and hemodynamic 
assessments were performed. Pearson’s Chi square and Fisher’s Exact 
tests were used. P < 0.05 was considered significant.
Results Thirty-three patients (M/F  =  25/8) with septic shock were 
included in the study. Significant differences in demographic and 
biochemical (laboratory and metabolic) parameters, severity scores, 
life-support therapies (vasopressors, ventilation), and length of ICU 
stay were compared between survivors and non-survivors at 28 days. 
15 patients (45.45%) showed an elevated HsTnI on admission time. The 
level of HsTnI at 72 h was significantly higher in non-survivors (n = 12) 
than survivors (n  =  21) (median 69.6 [16.7–118.8] vs 9.6 [4.2–21.4] 
ng/L, P  =  0.049). HsTnI level elevation was mainly correlated with 
lactate serum and hemodynamic parameters. Besides, the clearance of 
creatinine was significantly lower in non-survivors patients at 28 days 
(median 48.15 [27.5–121.5] vs 110 [90–135] ml/min, P = 0.022). Right 
heart abnormalities existed in non-survival patients but were not 
associated with elevated hsTnI. Tricuspid Annular Peak Systolic Velocity 
was significantly lower in non survivors than survivors (median 16 [13–
16.1] vs 17 [15.75–24] cm/s, P = 0.042).
Conclusion Circulating hs-cTnI is present in patients with septic shock. 
A rise of HsTnI may be an indicator of poor outcome. Also, right heart 
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Introduction Right distribution Width (RDW) has been recently 
proposed as a pronostic factor in different pathologic situations 
and especially to the septic patients who stay in ICU. Some works 
substantiate the relationship between an alteration of the red blood 
cell rheology during the septic shock and a severe state of the disease. 
No one has studied the RDW between the differents shocks yet.
We are going to determinate the relationship between RDW and 
APACHE II score, mortality rate in the Intensive Care Unit (ICU), at the 
hospital, at the day 30 and 90.
Materials and methods We investigated those parameters near 228 
patients who were admitted at the ICU and needed norepinephrine 
between the first of March and the 31st of December.
They were stratified in différent groups: septic shock n  =  101, 
cardiogenic shock n = 100, hemorragic shock n = 20 and obstructive 
shock n = 7.
Results We did not observe any correlation between the RDW and the 
ICU mortality, hospital mortality and at the day 30 and 90. Only a poor 
significant correlation has been found between the cardiogenic shock 
and the mortality rate: at the hospital (p = 0.01), at day 30 (p = 0.01) 
and at the day 90 (p = 0.05) but not in the ICU (p = 0.89). The Receiver 
Operating Characteristics (ROC) curves do not show significant 
differences between RDW, APACHE II score and ICU mortality rate or 
intra hospital.
The sample of the hemorrhagic shock and obstructive shock was not 
usable for this calculation. Compared to other studies which were 
focused on the septic shock where the mortality was approximately 
20%, we determinated a mortality rate near 50%.
Conclusion The delta of the RDW D3/D1 did not present any 
correlation with the mortality rate. In our study, the RDW in the 
different kind of shocks do not look like to be a good predictive marker 
of the mortality, except for the patients included in the cardiogenic 
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Introduction Prognostic factors in patients admitted to the Intensive 
Care Unit (ICU) with a complicated Acute Myocardial Infarction (AMI) 
have been scarcely described. The aim of our study was to determine 
independent factors of hospital death in this specific population.
Patients and methods This two-center retrospective study included 
all consecutive patients who were admitted to the ICU between 
January 2000 and December 2015 for a complicated AMI. Exclu-
sion criteria were an inaugural cardiac arrest revealing AMI, a 
peri-operative AMI, and patients transferred to the ICU after emer-
gency coronary artery bypass grafting (CABG) for AMI. Patients 
with ventricular arrhythmias responsible for transient circulatory 
arrest during their management, with rapid recovery of normal 
consciousness were studied. In each patient, comorbidities, SAPS2 
score, SOFA score upon ICU admission, and AMI complications includ-
ing cardiogenic shock, transient circulatory arrest, pulmonary edema 
and mechanical complications (i.e., ruptured papillary muscle, ventric-
ular septal defect, tamponade) were recorded. Multivariate regression 
analysis was performed to determine independent factors of hospital 
death.
Results Among 358 patients admitted to the ICU with complicated 
AMI, 91 were excluded for inaugural cardiac arrest with sustained 
coma requiring therapeutic hypothermia (n  =  60), emergency 
CABG for AMI (n  =  17), or AMI after surgery (n  =  43). Finally, 267 
patients (1.4% of all admissions) were studied (180 men; mean age: 
67 ± 12 years; SAPS2: 57 ± 21; SOFA: 8 ± 4), 82% of them being ven-
tilated. AMI complications were: cardiogenic shock (n  =  191), pul-
monary edema (n  =  124), transient circulatory arrest (n  =  60), and 
mechanical complication (n  =  29). Prompt coronary angiography 
was performed in 215 patients (81%) and angioplasty in 167 of them 
(78%). Coronary angiography was not performed in 52 patients for 
hemodynamic instability preventing patient transportation (n  =  40) 
or expired time of potential revascularization (n  =  12). Only two of 
these patients had cardiogenic shock. Hospital mortality reached 46% 
(n = 122). Non survivors were older, had higher severity scores, were 
more frequently under mechanical ventilation and catecholamines, 
had lower ejection fraction (27 ±  13 vs 37 ±  12%: p =  0.0004), and 
exhibited higher lactate (8.1 ± 5.1 vs 4.6 ± 3.3 mmol/l: p = 0.0001) and 
creatinine levels (178 ± 122 µmol/l vs 136 ± 103 µmol/l: p = 0.0027) 
than survivors. Independent prognostic factors were: SAPS2 
score (OR 1.13 per point [95% CI 1.05–1.22; p  =  0.002), serum 
creatinine >150  µmol/l upon admission (OR 1.82; 95% CI 1.0–3.32; 
p  =  0.05), and cardiogenic shock (OR 3.37; 95% CI 1.72–3.32; 
p = 0.0004).
Conclusion Cardiogenic shock was the most frequent complication 
of AMI who led to ICU admission, whereas mechanical complications 
are rare at the era of early coronary reperfusion strategies. In addition 
to severity score, serum creatinine and cardiogenic shock appeared as 
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Introduction Pulmonary embolism (PE) in high-risk is a partial or 
total obliteration of the pulmonary arterial network by a fibrin-clot 
cruoric more than 50%, the management requires a rapid reduction of 
pulmonary arterial resistance and right ventricular post load through 
rapid revascularization by thrombolysis. Our aim is to determine 
the value of thrombolysis in pulmonary embolism and describe the 
clinical, paraclinical and outcome pulmonary embolism at high risk.
Patients and methods This is a descriptive study of 20 cases 
of pulmonary embolism at high risk admitted to the cardiology 
department to CHU Oran between 2008 and 2014. Signs of gravity of 
(PE) comprising: syncope, circulatory collapse, cardiogenic shock or 
acute pulmonary sonographic sign of heart. It was confirmed in chest 
CT. All patients received thrombolysis using the protocol accelerated 
by two types of molecules: streptokinase or actilyse.
Results The sex ratio was 0.11; mean age 44  years, ranging from 20 
to 80  years; Risk factors were dominated by contraception was 35% 
and the postoperative 30% the clinical picture was dominated by 
cardiogenic shock in 75% of cases. 20% cardiovascular collapse and 
syncope in 5%; Doppler echo all patients had signs of dysfunction 
of the right ventricle represented by the dilatation of the right 
cavities and pulmonary hypertension. The CTA found a (PE) bilateral 
in 70% right in 20%. Thrombolysis using actilyse in 12 patients and 
streptokinase in 8 cases.
The outcome was favorable in 16 patients; with two cases that are 
complicated by chronic pulmonary heart and the death of 2 patients 
with cancer.
Discussion The female predominance is explained by the increase 
of risk factors hormonal contraception, whose first generation 
combination hormonal. Our patient had a high probability with 
clinical signs of severity based on the score WELLS [1]. This diagnosis 
was confirmed by chest CT; which shows the vascular bed obstruction 
degree with a very good sensitivity and specificity.
The suspect patients with severe PE and that presented signs 
of acute pulmonary heart ultrasound have effectively (PE). 
The indication of thrombolysis was chosen on hemodynamic 
criteria; success is found in 80% of patients with improved 
hemodynamics dice the early hours. This success is explained by 
the role of thrombolytic in lysis clot to obtain pulmonary arterial 
revascularization; and reduce pulmonary arterial resistance and the 
right ventricular afterload which accelerates the healing of right 
heart failure and improvement of pulmonary capillary volume. 
The 02 cases who developed a chronic pulmonary heart; it was 
done immediately a right ventricular dysfunction with pulmonary 
arterial outset of very high pressures suggestive that the embolism 
occurred on an already pathological right heart. No cases of massive 
bleeding were noted in our series.
Conclusion Severe pulmonary embolism is burdened with high 
mortality; diagnosis is based on the stratification of risk score, was 
facilitated by the non-invasive strategies that articlent around the 
Doppler echocardiography and CT angiography; thrombolysis can 
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Introduction Hypertension is a frequent motif for admission to 
emergencies. The diabetic is increasingly exposed to this risk [1]. 
The objective of this study is to evaluate the proportion of diabetic 
patients presenting to the emergency department with high blood 
pressure (BP) and to identify their epidemiological and clinical 
characteristics.
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Patients and methods Prospective study conducted over a period of 
3-month (1/01/2016–31/03/2016). After measuring vital signs in the 
emergency, patients included had a systolic BP ≥ 140 mmHg and/or 
diastolic BP ≥  90  mmHg with diabetes. A BP control was performed 
30  min after the inclusion. If hypertension persists, patients were 
admitted to cardiology or general medicine department.
Results We included 75 patients. Thirty-eight patients (50.6%) had 
persistent hypertension. The most common background were: dyslipi-
demia, coronary disease and kidney failure associated with diabetes 
and hypertension. The average age of patients was 58 ± 13 years. The 
sex ratio was 2.8. The average duration of diabetes was 8 ± 3.5 years. 
It was a type 2 diabetes in 64% of cases and type 1 in 36% of cases. 
Among the degenerative complications: coronary disease in 14.7%, 
arterial disease of the limbs (10.7%), stroke (5.3%), retinopathy (5.3%) 
and nephropathy (4%). All patients had at least one cardiovascular 
risk factor. Hypertension was classified: grade I (33%), grade II (45%), 
grade III (22%). The IEC was the antihypertensive most prescribed in 
our series with a monotherapy in 56% of cases, 24% in bitherapy and 
20% in triple therapy.
Conclusion Hypertension is a disease frequently associated with 
diabetes. It worsens the prognosis of diabetics from where the need 
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Introduction Sepsis associated liver dysfunction (SLD) is usually 
attributed to systemic and/or microcirculatory disturbance. Hypoxic 
hepatitis, also known as shock liver or ischemic hepatitis, is a life 
threatening event associated with high morbidity and mortality. 
Doppler ultrasonography is a non invasive method to measure 
Doppler hepatic hemodynamic parameters. The primary objective of 
this study was to assess the accuracy of the hepatic hemodynamic 
parameters (portal venous blood flow PVBF and resistance index of 
the hepatic artery HARI) in predicting SLD in septic shock patients. 
The secondary aims were to identify factors associated with SLD, 
investigate the effects of volume expansion (VE) on systemic and 
intrahepatic hemodynamics and to assess the intra- and interoperator 
reproducibility. We also analyzed 28-day mortality.
Patients and methods In a prospective design, we included 30 
consecutive patients with septic shock (24 males; median age: 
36.5  years) admitted to the ICU with septic shock in Charles Nicolle 
Hospital of Tunis from February to July 2015. All patients were 
resuscitated following the Surviving Sepsis Campaign guidelines. We 
measured systemic hemodynamic variables (Mean arterial pressure 
(MAP), and cardiac index (CI)) and performed hepatic Doppler before 
and after volume expansion. We measured PVBF and computed the 
HARI. We recorded the liver function tests (ALT, AST and Bilirubin) for 
48  h. SLD was defined as an increase in serum Bilirubin ≥  20  µmol/l 
(Hepatic SOFA ≥ 1). Accuracy of the hepatic hemodynamic parameters 
to predict SLD was measured by the area under the ROC curve. 
P < 0.05 was taken to indicate statistical significance.
Results The median SOFA score at T0 was 8 points and the median 
IGS2 score was 38 points. The sources of infection were as follows: 
the lungs (n = 19), the abdomen (n = 4) and the urinary tract (n = 3). 
The incidence of SLD in our cohort was 33.3% (n  =  10). There was 
no significant difference between “SLD group” and “No-SLD group” 
in all hepatic hemodynamic parameters especially the PVBF and the 
HARI. Lactate levels were significantly higher in patients with SLD 
(median 3.55 vs. 0.85  mmol/l). Similarly, the platelet count was sig-
nificantly lower in the “SLD group” [mean (± SD) 149.2 ± 103.9 (109/l) 
vs. 242.8 ± 104.1 (109/l); p = 0.039]. There was no difference in dura-
tion of mechanical ventilation, ICU length of stay and 28-day mortality 
between the 2 groups.
The PVBF was significantly lower in patients who died before D28 
(median: 558 vs. 826 l/min in the survivors; p = 0.014).
Volume expansion caused a significant increase in CI, mean hepatic 
artery velocity and the PVBF.
The intra- and interoperator reproducibility was good to excellent 
for the systolic and mean velocities of the hepatic artery, portal vein 
diameter and the PVBF.
Conclusion Our results don’t support the hypothesis that the hepatic 
sonography is predictive of SLD in septic shock. Our pilot study 
showed higher lactate levels and hematologic SOFA in SLD group. The 
PVBF was significantly lower in patients who died before D28. More 
experience will be necessary to define the ultimate role of Doppler 





Postoperative care and risk factors after multiple valve surgery 
for advanced rheumatic heart disease in 150 patients
Youssef Zarrouki1, Amra Ziadi1, Manal Rhezali1, Zahira Zouizra2, Drissi 
Boumzebra2, Mohamed Abdennasser Samkaoui1 
1Anesthesiology and intensive care, caddi ayyad university Mohammed 
VI teaching hospital, Marrakesh, Morocco; 2Cardio vascular surgery, caddi 
ayyad university Mohammed VI teaching hospital, Marrakesh, Morocco
Correspondence: Youssef Zarrouki ‑ zarroukiyoussef@hotmail.fr
Annals of Intensive Care 2017, 7(Suppl 1):P237
Introduction Early surgery is the current trend for management of 
patients with valvular disease. That said many of them, particularly 
from developing countries, are still operated at a very advanced stage 
of disease. Despite improvements in myocardial protection and surgi-
cal techniques, postoperative care after multiple valve surgery (MVS) 
for advanced rheumatic heart disease (RHD) remains to be a clinical 
challenge. We conducted a study to determine postoperative com-
plications and morbidity-mortality risk factors in this subgroup of 
patients.
Patients and methods Through a retrospective study over a period 
of 8  years, from June 2007 to October 2015, patients admitted in 
intensive care after aortic and mitral valve surgery combined with 
tricuspid repair for RHD, were included if at least one the following 
criteria is found. Criteria for selecting patients: exertional dyspnea 
grade III or IV of the NYHA; cardiomegaly; low left ventricular ejection 
fraction (LVEF); severe pulmonary hypertension (PHT) and or right 
ventricular dysfunction; deterioration of more than one vital function. 
Preoperative clinical and ultracardiosonographic features are assessed. 
Surgical difficulties are evaluated, as well as risk factors for occurrence 
of complications and causes of death.
Results 150 patients (out of 1025 admitted during the same 
period) are eligible to be included. Patients clinical profile and 
ultrasonographic data are summarized in Tables 8 and 9.
The surgical procedure consisted mostly in a double mitral and aortic 
valve replacement with tricuspid valve repair. Additional procedures 
are realized in 59 patients (39%).
The average ICU length of stay is 7  days (2–30  days) with a mean 
mechanical ventilation duration of 48 h (1–10 days) and an inotropic 
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support in 100% of patients. Additive therapies like nitric oxyde is used 
in 35 patients and sildenafil in 42.
Early postoperative complications occured in 63 patients: low cardiac 
output Sd in 12 cases and acute right sided heart failure in 7 patients. 
Bleeding with redo in 10 patients. Infections are noted in 19 patients 
with 7 cases of septic shock. Acute kidney failure requiring dialysis 
in 5 patients. Dysarythmias and transient atrioventricular block are 
observed in 23 patients and serious neurologic events in 5 patients.
In hospital mortality is 18.6% (28 patients). Deceased patients profile is 
listed in Table 10.
Causes of death are: severe LV dysfunction (5 patients); severe RV 
dysfunction (15 patients); severe pneumonia (3 patients); septic chock 
(2 patients); stroke (1 patient); intraventricular hemorrhage (1 patient); 
fulminant hepatitis (1 patient).
Discussion In the European Registry of the Euro Heart Survey, patients 
with very advanced heart valvular disease accounted for 8% of all val-
vular heart disease. In our series, they represent 22%.
Conclusion The operative mortality was typically very high, but new 
surgical technologies and intensive care standards should improve 
outcome. Generally the postoperative mortality is very significantly 
lower than spontaneous mortality. Thus the indication of surgery 
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Introduction We aimed to identify factors associated with ICU survival 
among selected patients receiving Extra Corporeal Life Support (ECLS) 
for in-hospital or out-of-hospital refractory cardiac arrest.
Patients and methods All consecutive patients treated with ECLS 
for refractory cardiac arrest in the Caen University Hospital in 
northwestern France over the last decade (2005–2015) were included 
in a retrospective cohort study.
Results Sixty-two patients were included: 25 with out-of-hospital 
refractory cardiac arrest and 37 with in-hospital refractory arrest. 
The initial rhythms was shockable rhythm in 25 (40%) cases. At ECLS 
initiation, the mean no flow was 0.8  ±  3.9  min and mean low flow 
(time between the time of refractory cardiac arrest and time at which 
an ECLS flow was provided) was 71  ±  37  min. The mean ECLS flow 
rate was 4.17  ±  1.31 L/min. Initial blood test results were: arterial 
pH = 7.04 ± 0.20 and plasma lactate = 12.8 ± 5.9 mmol/L.
Eleven (18%) patients survived (4/30 (13%) acute coronary syndrome, 
4/8 (50%) severe poisoning due to drug intoxication, 1/4 (25%) dilated 
cardiomyopathy, and 2/20 (10%) others). Survival was lower for 
patients with out-of-hospital refractory cardiac arrest, 2 of 25 (8%), 
than for patients with in-hospital refractory cardiac arrest, 9 of 37 
(24%), respectively, p =  0.17. As expected, out-of-hospital refractory 
cardiac arrest was associated with a more prolonged low flow 
(89 ± 40 min vs 60 ± 30 min, p < 0.01) and a more profound acidosis 
(pH 6.9 ± 0.2 vs 7.1 ± 0.2, p = 0.01 and arterial lactate 14.7 ± 6.1 vs 
11 ± 5, p = 0.05).
In univariate analysis, survival was lower for patient with refractory 
cardiac arrest unrelated to drug intoxication, 13 vs 50%, respectively, 
p  =  0.03. In addition, mortality was associated with arterial pH 
(7.01  ±  0.2 vs 7.14  ±  0.15, p  =  0.025) and low flow (75  ±  40 vs 
55  ±  12  min, p  =  0.005).In multivariate analysis, two factors was 
associated with survival: drug intoxication as the reason for ECLS 
[Adjusted Odds Ratio, 8.34; 95% CI, 1.25–71; p =  0.01], and low flow 
[Adjusted Odds Ratio, 0.98; 95% CI, 0.95–1; p = 0.14].
Conclusion In a highly selected group of critically ill patients with 
refractory cardiac arrest, the potential beneficial effect of ECLS could 
be due only to its clinical impact on reversible causes of circulatory 
failure (i.e. severe drug intoxication in our cohort). Further studies are 
needed to clarify whether the use of ECLS could be considered as a 
disproportionate tool, specifically in patients with out-of-hospital 
refractory cardiac arrest due to acute coronary syndrome or associated 




Post‑cardiac arrest shock treated with veno‑arterial 
extracorporeal membrane oxygenation: an observational study 
and propensity‑score analysis
Wulfran Bougouin1, Nadia Aissaoui2, Alain Combes3, Nicolas Deye4, Lionel 
Lamhaut5, Daniel Jost6, Carole Maupain7, Frankie Beganton,8, Adrien 
Bouglé(), Florence Dumas9, Eloi Marijon1, Xavier Jouven10, Alain Cariou11, 
Sudden Death Expertise Center 
Table 8 Patients clinical profile
Age 37 years (21–64 years)
Gender F: 81 (54%), M:69 (46%)
Medical 
history
Systemic hypertension: 21 (14%); diabetes: 18 (12%); Stroke: 
17 (11.33%); acute lower limb ischemia: 4%; recurrent 
heart failure: 97 patients(64.6%); Hepatic dysfunction: 15 
(10%); renal insufficiency: 18 (12%); infective endocarditis: 
17 (11.33%); Prior mitral valve surgery: 9 (6%)
Symptoms Exertional dyspnea III–IV: 123 (82%)
chest x‑ray Cardiomégaly with CTR > 0.7: 128 (85%)
ECG Atrial fibrillation: 135 (90%)
Table 9 preoperative ultracardiosonographic data
Cause Exclusively rheumatic advanced multiple 
valvulopathy
Impact of the 
Valvular 
disease
PHT: 70 mmHg (60–120 mmHg);RV dilatation with 
moderate to severe dysfunction: 68 (45.33%) with 
moderate to severe functional tricuspid regurgitation; 
LVEF: 42% (22–65%); Left Atrium dilatation: 
54.6% + thrombus 12%; Ascending aortic aneurysm:2%
Table 10 Deceased patients profile
Age 44 years old (30–64 years)
Symptoms Exertional Dyspnea grade III‑ VI;HF renal 
insufficiency; Liver dysfunction; ascites; acute 




Severe PHT: 9 patients; severe mitral regurgitation 
caused by infective endocarditis with severe LV 
dysfunction: 1 case; Massive Ao regurgitation 
with severe LV dysfunction: 2 cases
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Introduction Post-cardiac arrest (CA) shock is a mixed shock, 
including vasoplegia and myocardial dysfunction. Several authors 
reported the reversibility of post-CA myocardial dysfunction, 
described as a myocardial stunning. This complication often requires 
inotropic support, mostly dobutamine, combined with vasoactive 
drugs. However, these treatments are sometimes insufficient to 
control the circulatory failure. Veno-arterial extracorporeal membrane 
oxygenation (VA-ECMO) has been proposed in the most severe cases 
but the level of evidence is very low. We assessed characteristics, 
outcome and prognostic factors of patients treated with VA-ECMO for 
post-CA shock.
Patients and methods Using a large regional registry, we focused 
on all CA admitted in ICU. Post-CA shock was defined as the need for 
continuous norepinephrine or epinephrine infusion to maintain mean 
arterial pressure above 60 mmHg for more than 6 h following ROSC, 
despite adequate fluid loading. Among patients who developed a 
post-CA shock, prognostic was compared according to VA-ECMO use, 
using logistic regression and propensity score. Specific prognostic 
factors were identified among VA-ECMO patients.
Results Among 2988 patients admitted after CA, 1489 developed a 
post-CA shock, and were included. They were mostly male (68%), with 
mean age 63  years (SD  =  15). 52 patients (3.5%) were treated with 
VA-ECMO, mostly patients with ischemic cause of CA (67%). Among 
patients with post-CA shock, 312 (21%) were discharged alive (25% 
in VA-ECMO group, 21% in control group, P = 0.45). After adjustment 
for pre-hospital and in-hospital factors, survival did not differ among 
patients treated with VA-ECMO (OR for survival = 0.9, 95% CI 0.4–2.3, 
P  =  0.84). Results were consistent after propensity-score matching. 
Among patients treated with VA-ECMO, initial arterial pH (OR 1.7 per 
0.1 increase, 95% CI 1.0–2.8, P = 0.04) and implantation of VA-ECMO 
over 24 h after ROSC (OR 20.0, 95% CI 1.4–277.3, P = 0.03) were associ-
ated with survival (Fig. 10).
Conclusion Post-CA shock is frequent and is associated with a high 
mortality rate. When used in selected patients, we observed that 




Esophageal cooling after cardiac arrest
Antoine Goury1, Florent Poirson1, Ulriikka Chaput2, Pierre Garçon1, 
Thomas Beeken1, Lamia Kerdjana1, Sebastian Voicu1, Isabelle Malissin1, 
Leclerc Maxime1, Oueslati Haikel1, Dominique Vodovar1, Jonathan Chelly1, 
Philippe Marteau2, Bruno Megarbane1, Nicolas Deye3 
1Réanimation médicale et toxicologique, Hôpital Lariboisière 
(AP‑HP), Paris Cedex 10, France; 2Hépato‑gastro‑entérologie, Hôpital 
Saint‑Antoine, Paris, France; 3Réanimation Médicale et Toxicologique, 
Hôpital Lariboisière (AP‑HP), Paris, France
Correspondence: Antoine Goury ‑ gouryantoine@gmail.com
Annals of Intensive Care 2017, 7(Suppl 1):S4
Introduction Targeted temperature management (TTM) between 
32  °C and 36  °C is recommended in comatose patients successfully 
resuscitated after out-of-hospital cardiac arrest (OHCA). Advanced 
cooling methods of TTM seem the most effective. This prospective, 
monocentric, observational, open clinical study aimed to assess the 
feasibility and safety of a new esophageal device to perform TTM in 
such patients.
Patients and methods The Esophageal Cooling Device (ECD®, 
Advanced Cooling Therapy, USA) is a semi-invasive multichambered 
silicone heat exchanger device, placed in the esophagus to provide 
highly efficient heat transfer, replacing the usual standard gastric 
tube. ECD is connected to a heat exchanger console Medi-therm III® 
(Gamida, France) performing the temperature’s automatic feedback 
control. Main inclusion criteria were: OHCA from presumed cardiac 
cause needing TTM, delay between CA and return of spontaneous 
circulation (ROSC) <60  min, delay between ROSC and inclusion 
<240  min. Main exclusion criteria were: known esophageal disease, 
unstable ROSC and hemodynamic condition, severe cardiac 
conductive disorder requiring pacing. After achieving sustained ROSC 
and performing coronarography ± CT-scan, ECD was inserted as soon 
as possible. A target temperature (TT) of 33  °C was maintained for 
at least 24 h followed by a controlled rewarming (rate <0.5 °C/h). No 
cold fluids had to be used during TTM. Normothermia was maintained 
during the first 3  days after CA. Esophagogastroduodenoscopy was 
performed systematically after removal of ECD.
Results 18 patients were enrolled in the study and 17 completed the 
study (median [IQR 25–75], age: 60yo [54–65], SAPSII: 69 [61–75], time 
to ROSC: 20  min [14–30], shockable rhythm 53%). Time to reach the 
TT was 15 h [10–17], with a mean cooling rate to reach TT of 0.26 °C/h 
[0.19–0.36]. The average time spend in the 32–34 °C-target range was 
26 h [21–28]. All patients reached the 32–34 °C-target range (3 patients 
did not reach 33  °C). The temperature deviation out of the 33  °C-TT 
during the maintenance phase was 0.1  °C [0.03–0.20]. Five patients 
(36%) presented an episode of minor deviation (0.5°–1  °C), and one 
patient (6%) a deviation >1  °C versus the TT. Rewarming time was 
16 h [12–20] and the mean rewarming rate was 0.20 °C/h [0.18–0.22]. 
Average time between introduction and removed of the ECD was 50 h 
(42–56). Among the 16 esogastroduodenoscopy performed, 9 (56%) 
were strictly normal. Endoscopy showed minor gastric injuries in 6 
patients (38%). Within these patients, 3 (19%) also presented minor 
esophageal injuries. Esogastric injuries characteristics were mostly 
similar to usual orogastric probe injuries. One patient (6%) experienced 
a serious ulcerous esophagitis mimicking a peptic esophagitis, not 
firmly related to the ECD. No patients necessitated hemostatic local 
procedure and no significant gastrointestinal bleeding was observed. 
Eight patients (47%) were alive at D90, including 5 patients (29%) with 
a Cerebral Performance Category score of 1. This compares favorably 
to outcomes from previous studies.
Conclusion ECD seems an interesting and safe semi-invasive method 
of cooling in OHCA patients treated with 33 °C-TTM. Although it seems 
slower than more invasive devices to reach 33  °C, ECD was able to 
strictly maintained the TT within the maintenance phase of TTM. 
Further studies will be necessary to define the exact place of this new 




Fig. 10 See text for description
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Introduction Since post-cardiac arrest care might influence the 
outcome, characteristics of receiving hospitals should be integrated 
in survival evaluation of patients transported in hospital. We aimed at 
assessing the influence of care level center on survival at discharge in a 
regional registry of out-of-hospital cardiac arrest (OHCA).
Materials and methods We prospectively collected Utstein and 
in-hospital data for all non-traumatic OHCA patients, in whom a 
successful Return of Spontaneous Circulation (ROSC) had been 
obtained, from a large metropolitan area (Great Paris). Receiving 
hospitals were categorized in 3 groups (A, B, C) depending on their 
respective characteristics (annual volumes, 24/7 catheterization 
availability and temperature management use). We compared 
patients’ characteristics in the 3 groups and performed a multivariable 
logistic regression using discharge survival at endpoint.
Results During the study period (May2011–Dec2013), 1476 patients 
were admitted in 48 hospitals (917 in group A, 428 in group B and 91 
in group C). Overall survival rate at discharge was 433/1436 (30%). 
Patients’ baseline characteristics significantly differed, as hospitals 
from group A treated younger patients and more frequent shockable 
rhythms (p  <  0.001). Unadjusted survival rate differed significantly 
among the 3 groups of hospitals (respectively 34, 25 and 15.4% for 
A, B, C, p  <  0.01). However in multivariable analysis, the category of 
hospital was no longer associated with survival.
Conclusion In this population-based study, characteristics of receiving 
hospitals are not associated with survival rate at discharge. This could 
result from the strategy used for triage, which aims in matching 
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Introduction Acute kidney injury (AKI) commonly occurs after cardiac 
arrest and is associated with an increased mortality and a delayed 
awaking. Early recognition of AKI remains challenging, given that 
serum creatinine increases belatedly after aggression. The aim of this 
study was to test the hypothesis that urinary [TIMP-2]*[IGFBP7] can 
predict early AKI after cardiac arrest.
Materials and methods We conducted a monocentric prospective 
study from August 01, 2015 to August 31, 2016. Urinary [TIMP-
2]*[IGFBP7] was measured within the 6 h following the cardiac arrest. 
Were excluded moribund, anuric, early RRT indication, CKD stage 4–5 
and renal transplant recipients. The primary end point was to assess 
the predictive value of urinary [TIMP-2]*[IGFBP7], to identify early AKI 
defined by a KDIGO stage 3 within the first 48 h of observation.
Results Among forty patients analyzed, 17 (42.5%) reached KDIGO 
stage 3. An urinary [TIMP-2]*[IGFBP7] above 1.13 can predict KDIGO 
stage 3 with a sensitivity of 76.5% (50.1–93.2), specificity of 91.3% 
(72.0–98.9) and AUROC at 0.87 (0.73–0.96). Baseline serum creatinine 
above 81 µmol/l and baseline urinary output ≤0.62 ml/kg/h achieved 
respectively AUROC at 0.72 and 0.78. Pairwise comparisons of ROC 
curves were non-significant, between these 3 parameters.
Conclusion Early urinary [TIMP-2]*[IGFBP7] dosage achieved good 
performance to detect patients with high risk of AKI after cardiac 
arrest. However, in the limits of this study, its performances were not 
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Introduction Out-of-hospital cardiac arrests (OHCA) are an absolute 
urgency and have a very poor prognosis. Pediatric guidelines differ 
from adult guidelines for cardiac arrest management. Since 2005, 
adult guidelines apply from the onset of puberty. The main objective 
was to describe the epidemiological characteristics and outcome 
of OHCA victims while taking puberty into account. The secondary 
objective was to determine the prognostic factors for survival at D30.
Materials and methods All patients less than 65 years of age, victims 
of OHCA between July 1, 2011 and September 1, 2015 care by a Mobile 
Emergency and Resuscitation Service (SMUR) participating in French 
National Cardiac Arrest registry (RéAC) were included. Patients were 
split into 3 groups: Prepubescent patients (named “Children”: Girls 
0–9 years, Boys 0–11 years), Pubescent patients (named “Adolescents”: 
Girls from 10 to 17  years and Boys from 12 to 17  years) and “Adults” 
(men and women 18–64  years). The “Adolescents” group was 
consecutively compared to the “Children” group and to the “Adults” 
group.
Results 644 children, 256 adolescents and 16,566 adults under 
the age of 65 have been included. OHCA in Adolescents occurred 
more often on public roads (30%) or in public places (15%) 
and were more often traumatic (46%) than those in children 
and adults. Respiratory causes were more frequent in children 
(27%) than in adolescents (18%) and adults patients (18%). The 
proportion of shockable rhythm increased with age (3, 7 and 10% 
for children, adolescents and adults respectively). Survival at D30 
was greater in adolescents (12%) than in children (7%) and 
adults (8%) (p  =  0.01 and p  =  0.02 respectively). In the 3 studied 
groups, initial shockable rhythm was a survival factor at D30 
(respectively OR 18.97, 95% CI [3.84–93.78], OR 29.51, 95% CI 
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[8.02–108.64] and OR 14.11, 95% CI [11.39–17.48] for children, adoles-
cents and adults). Other risk factors are described in Table 11.
Conclusion Adolescents had better survival at D30 than the 2 others 
groups. Adolescents and adults had shockable rhythm more often 
than children. Moreover, respiratory failure was less frequent in adoles-
cent and adults patients compared to children. Puberty seems to be a 
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Introduction Non-invasive ventilation (NIV) is an effective alternative 
to endotracheal mechanical ventilation (MV) in the management of 
acute respiratory failure (ARF) patients. Nevertheless, it can be still 
difficult to assess its real feasibility, application and outcome in daily 
clinical practice. Therefore, we report our clinical experience with 
routine use of NIV since the last national recommendations (2006). Our 
aims were to evaluate the clinical efficacy and outcome of NIV, and to 
identify predictive factors for NIV failure based on a daily use.
Patients and methods We conducted an observational retrospective 
single-center cohort study by reviewing all medical records from 
January 2006 to December 2013 in our 22-bed medical intensive care 
unit (ICU). Eligible patients were those having received NIV during 
their ICU stay. Two groups were defined according to the indication 
of NIV: NIV for hypoxemic or hypercapnic ARF (ARF-NIV), and NIV used 
in the post-extubation period for weaning, prevention or treatment 
of post-extubation ARF (post-extubation NIV).The main evaluation 
criteria were the incidence of NIV use, success/failure rate of NIV and 
risk factors for NIV failure in each group. NIV failure was defined as the 
need for stopping NIV whatever the reason (intubation, intolerance, 
death) within 3 days after its initiation.
Results Of the 5031 MV performed in 8  years, 979 (19.5%) NIV 
trials were included: 805 (82.2%) for ARF-NIV (399 hypoxemic, 
406 hypercapnic) and 174 (17.8%) for post-extubation NIV. The 
main causes for ARF were pulmonary infections (35.5%) and acute 
cardiogenic pulmonary edema (24.3%). The overall incidence of NIV 
use increased from 25.5% of ARF in 2006–36.4% in 2013 (maximum 
of 59.0% in 2012). The failure rate was 23.6% for the ARF-NIV group 
(27.8% for hypoxemic ARF, 19.5% for hypercapnic) and 14.9% for the 
post-extubation NIV group (p  =  0.0009). Efficacy of NIV was similar 
despite an increased severity of patients (SAPSII) during the study 
period. The median length of ICU stay was 5 days (2; 9), and was longer 
in the post-extubation NIV group (11 days (6; 19)) than in the ARF-NIV 
(5 days (3; 9) for hypoxemic ARF, 4 (2; 6) for hypercapnic) (p < 0.001). 
The overall ICU mortality was 11.0% (15.8% in hypoxemic group, 
8.1% in hypercapnic group, and 6.9% in post-extubation NIV group) 
(p = 0.0005).
In multivariate analysis, the main risk factors for ARF-NIV failure were: 
SAPS II on admission (p  <  0.0001), absence of cardiologic history 
(p = 0.0274) and the cause of ARF (p = 0.0016) with a higher failure 
rate for pulmonary infections than acute cardiogenic pulmonary 
edema (OR 2.94, p  =  0.0004). For post-extubation NIV, the only 
independent risk factor for failure was normocapnia before NIV 
initiation (p = 0.0011).
Conclusion Our large longitudinal study demonstrates the feasibility 
and efficacy of NIV applied in daily clinical practice. Provided it is 
performed in a suitable environment by an experienced team, NIV 
should be considered as a first-line ventilatory treatment in various 
etiologies of ARF and a very useful ventilatory support in the post-
extubation period. Nevertheless, risk factors for NIV failure should be 
known by ICU clinicians, hypoxemic ARF remaining the more difficult 
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Table 11 Risk factors of survival at day 30
Ref. reference
Odds Ratio IC 95% p
Children
Initial rhythm
 No shockable Ref.
 Shockable 18.97 [3.84–93.78] <10–3
Resuscitation duration
 >30 min Ref.
 ≤30 min 16.81 [3.91–72.21] <10–3
Adolescent
Low flow
 >15 min Ref.
 ≤15 min 45.65 [5.77–361.27] <10–3
Initial rhythm
 No shockable Ref.
 Shockable 29.51 [8.02–108.64] <10–3
Adults
No flow
 >10 min Ref.
 <5 min 1.27 [1.03–1.56] 0.03
 5–10 min 1.51 [1.18–1.93] <10–3
Initial rhythm
 No shockable Ref.
 Shockable 14.11 [11.39–17.48] <10–3
Resuscitation duration
 >30 min Ref.
 ≤30 min 3.03 [2.29–4.02] < 10–3
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Introduction Acute respiratory failure (ARF) is the leading cause for 
ICU admission in immunocompromised patients. In these patients, 
oxygenation strategy is of major interest to avoid the need for 
mechanical ventilation (MV), which is associated with high mortality 
rates. In that setting, use of non-invasive ventilation (NIV) and oxygen 
therapy with High Flow Nasal cannula (HFNC) could be interesting 
alone or in association, but data about initial ventilation strategy in 
immunocompromised patients are controversial.
Patients and methods To assess how initial oxygenation strategy 
actually influences the risk of MV on the coming day within the three 
first days of ICU stay. The study end-point was the need for MV on the 
coming day. We restricted analyses to these first three ICU days given, 
based on our own experience, most of MV was expected to occur by 
then.
We performed a post hoc analysis combining three prospective 
studies of critically ill immunocompromised patients (two rand-
omized control trials, the IVNICTUS and the MINIMAX studies and 
one prospective cohort, the TRIAL-OH study). We only considered 
patients with ARF and a delay between ICU admission and study 
inclusion less than 48  h. We excluded patients who required 
invasive MV within the first day, those with an ICU stay less than 
1  day and those with acute pulmonary edema diagnosis at ICU 
admission.
In order to estimate and compare the causal effect of daily respira-
tory management strategy on the probability of intubation in the 
coming day, we computed inverse probability of treatment weights 
(IPTW) using propensity-score, defined as the probability of actual 
treatment selection conditionally on observed covariates. To handle 
confounding in such dynamic regimens, we considered marginal 
structural models (MSM), which have been proposed to estimate the 
causal effect of a time-dependent exposure when time-dependent 
covariates that can be affected by the previous treatment are pre-
sent. Two treatment exposure models were considered: NIV versus 
oxygen therapy regardless the device (model 1) and HFNC alone, 
NIV alone versus NIV + HFNC versus standard oxygen therapy alone 
(model 2).
Results 847 patients were included in the study. In model 1, there 
was no difference between NIV and oxygen groups on MV whatever 
the landmark time. In model 2, while the unweighted OR for 
intubation at day 1 was significantly higher in the NIV group (OR 
2.05, 95%CI 1.29–3.29) and HFNC group (OR 2.85, 95%CI 1.37–5.67) 
than those in the standard oxygen alone group, these differences 
disappeared in the weighted samples. Using MSM, no effect of 
the oxygenation strategy on MV was found, regardless of the 
oxygenation devices but the landmark time was associated with a 
reduced occurrence of MV.
Conclusion We found no evidence of any significant difference from 
several oxygenation strategies on mechanical ventilation probability 
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Introduction The role of noninvasive ventilation (NIV) is debated in 
the management of patients with acute hypoxemic respiratory failure. 
A recent study showed that patients treated with high-flow nasal 
cannulae oxygen therapy (HFNC) had lower intubation and mortality 
rates than those treated by the association of HFNC with NIV (1). 
High tidal volumes (VT) delivewred with NIV may be associated with 
an increased risk of intubation (2). We aimed to identify risk factors 
associated to intubation, in hypoxemic patients with acute respiratory 
failure and especially the role of VT under NIV.
Patients and methods This is an ancillary study from a multicenter, 
randomized, controlled trial including patients with acute 
hypoxemic respiratory failure (FLORALI-study). We focused on 
only patients with moderate or severe hypoxemia (PaO2:FiO2 
ratio ≤200  mmHg) and we excluded those with mild hypoxemia. 
The criteria for intubation were predetermined including worsened 
or persisted respiratory failure, impairment of neurologic status and 
hemodynamic instability.
Results After adjustment on the oxygenation strategy, the two 
factors independently associated with intubation were the presence 
of bilateral pulmonary infiltrates at admission (OR 2.33, 1.10–4.94, 
p = 0.03) and the respiratory rate (OR 1.04, 1.0–1.09, p = 0.05).
In patients treated with NIV, a tidal volume exceeding 9 ml/kg 1 h after 
NIV initiation was the only variable independently associated with 
intubation (OR 2.92, 1.05–8.10, p = 0.04).
In patients treated with HFNC, the respiratory rate was the only 
variable independently associated with intubation (OR 1.1, 1.02–1.18, 
p  =  0.02). Patients with a respiratory rate ≥30 breath/min had a 
significantly increased risk of intubation (OR 3.30, 1.09–9.97, p = 0.03).
Conclusion Bilateral pulmonary infiltrates and a high respiratory 
rate were the two major factors of intubation in patients with acute 
hypoxemic respiratory failure. A high tidal volume (≥9  ml/kg) under 
NIV was associated with an increased risk of intubation.
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Introduction Simulation is a powerful tool for technical skills teaching. 
No data exists on how to improve teaching and evaluating the 
potential impact of stress. Main objective of our study was to validate 
stress measurement parameters during two simulated intubation 
conditions.
Materials and methods 26 physicians were recruited (10 juniors/16 
seniors) and equipped with various biometric sensors. All simulation 
sequences were videorecorded and physicians also weared eye-track-
ing glasses. Salivar cortisol measurements were performed after each 
sequence. Two situations were randomly tested, one in standard and 
easy intubation conditions, one under difficult conditions presumed 
to induce stress (monitoring alarms, mannikin lying on the floor, dif-
ficult intubation). Autoevaluations of video recordings and mental 
workload (MWL) were performed retrospectively.
Results Few differences were depicted in-between junior and sen-
iors. Physiological parameters modifications and a heart rate variabil-
ity decrease were observed under the difficult intubation conditions 
(SDNN for juniors = 41.2 ± 20.9 vs 29.7 ± 12.4 ms; p = 0.015). Stress 
was demonstrated to increase MWL (Nasa-TLX = 39 ± 18 vs. 63 ± 15; 
p = 0.001), frustration being its determinant component (p = 0.033) 
(Fig. 11). Video-recordings depicted significant stress occurence under 
the difficult conditions, whatever the operator’s experience.
Conclusion Stress is an important component of success during 
intubation. Simulation conditions enables to reproduce its occurence, 
using different types of tools, from physiological parameters to heart 
rate variability and psychocognitive tests. Future research is required 
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Introduction In ICU, intubation is a high risk procedure associated 
with high morbidity. Despite procedure’s improvement with 
systematic application of fluid loading, early use of vasopressors and 
checklist use, morbidity remains high. Preoxygenation and intubation 
are the 2 main determinants of complication occurrence. McGrath Mac 
failed to improve first pass laryngoscopy success during intubation in 
ICU as compare to Macintosh laryngoscope. A predefined post hoc 
analysis of the MACMAN study was performed to evaluate quality of 
preoxygenation with 4 devices allowed: bag valve mask, non-invasive 
ventilation (NIV), high flow nasal cannula (HFNC), and non-re-breather 
mask (NRM).
Patients and methods MACMAN was a multicentre, open-label, 
randomized controlled superiority trial. Consecutive patients 
requiring intubation were randomly allocated to either the 
McGRATH MAC videolaryngoscope or the Macintosh laryngoscope, 
with stratification by centre and operator experience. An only 
inclusion criterion was: “Patients must be admitted to an ICU 
and require mechanical ventilation through an endotracheal 
tube”. Patients were excluded if: contraindication to orotracheal 
intubation (e.g., unstable spinal lesion); insufficient time to include 
and randomize the patient (e.g., because of cardiac arrest); age 
<18  years; pregnant or breastfeeding woman; correctional facility 
inmate; patient under guardianship; patient without health 
insurance; refusal of the patient or next of kin to participate in 
the study; previous enrolment in a clinical randomized trial with 
intubation as the primary end point (including previous inclusion 
in the present trial). Post-hoc analysis was performed to assess 
occurrence of SpO2 <90% during intubation procedure between 4 
groups of preoxygenation: BVM (at a minimum flow of 15  L/min, 
NIV (100% FiO2), HFNC (at a minimum flow of 60 L/min, with 100% 
FiO2), and NRM (at a minimum flow of 15  L/min). Between-groups 
difference in desaturation occurrence was adjusted for baseline 
covariates significantly associated with the group membership 
(P  <  0.2). Multivariate analysis of the occurrence of a desaturation 
(<90%) was performed using logistic regression. Bag-valve mask 
was considered reference.
Results Baseline characteristics were showed in Table  12. Groups 
were similar at baseline except for PaO2/FiO2 ratio. In univariate analy-
sis, age (P = 0.08), SAPS2 (P = 0.02), PaO2/FiO2 ratio (P = 0.03),SpO2 
(P = 0.001) and method of preoxygenation (P = 0.08) were associated 
with occurrence of desaturation below 90%. In multivariate analysis, 
SpO2 at randomization and method of preoxygenation were only 
predictors of desaturation below 90%. BVM and HRM were associ-
ated with similar risk of desaturation occurrence whereas NIV (OR 0.10 
[0.01–0.81]) was protective and HFNC (OR 5.75 [1.15–28.75]) was pre-
dictive of desaturation occurrence.
Conclusion All methods of preoxygenation were not equal for 
occurrence of desaturation below 90% during intubation process. 
Ours results suggest than NIV could be first line device during 
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Introduction Intubation procedure is a challenging issue in intensive 
care unit (ICU) [1]. Cardiac arrest related to intubation in critically ill 
adult patients has been poorly studied. The studies were not powered 
to conclude on this rare outcome [2]. The main objective of our study 
was to establish the incidence of cardiac arrest and to assess the risk 
factors of cardiac arrest in a large prospective database of intubation 
procedures performed in ICU.
Patients and methods Five prospective studies were included, with 
similar data collected before, during and after intubation procedures 
using the same methodology. The primary outcome was the incidence 
of cardiac arrest related to intubation. The secondary outcomes were 
the death (cardiac arrest without return of spontaneous circulation 
(ROSC)), the cardiac arrests with ROSC, the complications related to 
intubation, the length of ICU stay and the 28-day mortality. The factors 
associated with cardiac arrest related to intubation procedures were 
assessed by univariate and multivariate analysis based on patient, 
provider and practice characteristics.
Results Among the 1847 intubation procedures included, 49 
cardiac arrests (2.7%) occurred, including 35 with ROSC (71.4%) 
and 14 without ROSC (28.6%). Main patient, provider, procedure 
characteristics and outcomes according to cardiac arrest related to 
intubation are presented in Table  13. In multivariate analysis, the 
independent predictors of cardiac arrest related to intubation were 
low systolic blood pressure prior to intubation, hypoxemia prior 
to intubation, no preoxygenation, overweight or obesity and age 
>75 years. Mortality rate at day 28 was significantly lower in patients 
intubated without cardiac arrest (30.1%, 541 of 1798) than with cardiac 
arrests overall (73.5%, 36 patients of 49, p < 0.001) and cardiac arrest 
with ROSC (63%, 22 patients of 35, p < 0.001).
Conclusion Cardiac arrest related to intubation in adult ICU is not a 
rare event occurring in 2.7% of cases with high immediate mortality 
of 28.6% and at day 28 of 73.5%. We identified five independent risk 
factors to cardiac arrest which 3 of them could be modifiable. Optimal 
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Introduction Naasotracheal intubation (NTI) has been progressively 
given up in favour of the orotracheal intubation (OTI) in intensive 
care unit (ICU). This could be explained by more frequent infectious 
(sinusitis and ventilator associated pneumonia) and non-infectious 
(epistaxis, turbinates bones injury) complications the former being 
thought to be more frequent with NTI. However, whereas infectious 
sinusitis is a risk factor for VAP, no study has yet demonstrated 
that OTI decreases the infectious sinusitis rate compared with NTI. 
Furthermore, nasal route could improve patient comfort and decrease 
auto-extubation. Finally NTI can be performed without laryngoscopy 
with less risk of lips and dental injury. In this prospective study, we 
aimed to compare the complication of NTI and OTI and to assess the 
comfort of the patient.
Patients and methods We performed a prospective observational 
study in a 12-bed medical ICU including patients requiring endotra-
cheal intubation. The intubation route was let at the discretion of the 
physician in care of the patient, however OTI was compulsory in case 
of cardiac arrest, severe hypoxemia (P/F  <  150 when available) and 
clotting perturbation. For each patient, age, sex, SAPSII, mechanical 
ventilation duration. intubation route were recorded as well as com-
plications during the placement of endotracheal tube. Infectious and 
non infectious complications during invasive ventilation period were 
also recorded. In patients who were successfully extubated, pain, 
burning feeling, dryness and the wish of tube removal were assessed 
using visual analogic scales (VAS).Results are expressed as mean ± SD. 
Qualitative data were compared using Chi-2 or Fisher’s exact test while 
quantitative data comparisons used Student t Test or Mann–Whitney 
as appropriate.
Results One hundred and thirty-seven patients were included (60 
women, age: 65 ±  17  years, SAPSII: 49 ±  18, mechanical ventilation 
duration 4.2 ± 3 days). Among them, 90 received OTI and 47 NTI. No 
statistical difference was found between initial characteristics of the 
two groups.
During the placement of endotracheal tube, the NTI group received 
less sedatives (66 vs 91%; p < 0.0006) and less frequently succinyl cho-
line (6 vs 71%; p = 0.0001). NTI was performed without laryngoscopy 
Table 12 See text for description
Bag valve mask  
N = 157





Age 62 ± 16.4 65 ± 12.2 57 ± 17.7 63 ± 17.6 0.29
Gender male (%) 96 (61.1%) 45 (63.4%) 15 (75%) 43 (60.6%) 0.66
SAPS II score 60 ± 22 57 ± 22 51 ± 20 57 ± 21 0.38
PaO2/FiO2 156 ± 178 102 ± 65 107.5 ± 52 170 ± 157 0.01
SpO2 95 ± 6 95 ± 6 96 ± 5 96 ± 4 0.54
Successful first‑pass laryngoscopy 107 (68%) 46 (65%) 16 (80%) 54 (76%) 0.34
At least one SpO2 < 90% 16 (11%) 2 (3%) 4 (20%) 4 (6%) 0.04
At least one mild to moderate complication 12 (8%) 3 (4%) 1 (5%) 2 (3%) 0.51
At least one severe complication 18 (12%) 7 (10%) 5 (25%) 6 (9%) 0.27
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in 77% of patients. Selective intubations and desaturation during the 
procedure were observed with a similar frequency in the two groups 
(13.6% OTI vs 4 NTI p = 0.13).Lips injury were more frequent after OTI 
(7 vs 0%, p =  0.09). Epistaxis occurred in 15% of patients in the NTI 
group vs none in the OTI group (p < 0.05) and one required a blood 
transfusion.
While the endotracheal tube was in place, ulcerations caused by the 
tube or the fastening system were more frequent in the OTI group [lips 
ulcerations, n = 27 (30%) versus nostrils ulcerations in the NTI group, 
n  =  6 (13%) (p  <  0.05)]. Tube repositioning was required in 22% of 
patients in the OTI group versus 11% in the NTI group (p = 0, 1) while 
self extubation was observed in 3 patients in each group (p  =  0.4). 
Ventilator-associated pneumonia occurred in 4% in OTI and 7.5% NTI 
(p = 0.69). Other infectious complications were one sinusitis in the NTI 
group (p = 0.34) and 3 labial herpes in the OTI group (p = 0.55). Gue-
del cannula was used only in the OTI group (9 vs 0%, p = .05).
Among the 58 patients successfully extubated, pain caused by the 
tube was similar (3, 4/10 in the OTI group vs 3/10 in the NTI, p = 0.6). 
Burning feeling was similar (2, 3/10 in the OTI vs) 3, 2/10 in the NTI, 
p = 0.3), while dryness feeling was more important in the OTI (VAS 5.4 
vs 3.8 in the NTI, p = 0.05). The wish of tube removing was greater in 
the OTI group (5/10) and 4/10 in the NTI (p = 0.3).
Discussion In this pilot study, patients in the NTI group required 
less frequently sedative and succinyl-choline use during tracheal 
intubation. During mechanical ventilation, ulcerations were more 
frequent in the OTI group. No difference between the two routes was 
found concerning the infectious complications while the endotracheal 
tube was in place.
Conclusion Despite its small size, and the absence of randomization, 
the present study suggests that nasotracheal intubation improves the 
comfort and the tolerance of tracheal intubation and is not associated 
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Introduction There is a strong biological rationale to support the 
use of low to moderate doses of corticoids for the treatment of 
vasopressor-dependent septic shock. The question of whether 
corticosteroids should be given to septic shock patients by continuous 
or by bolus infusion is still unanswered.
Objective: to evaluate the effect on morbidity and mortality of mode 
of hydrocortisone administration in patients with septic shock.
Patients and methods We conducted a prospective randomized 
and monocentric study in the medical intensive care of the teaching 
Hospital of Taher Sfar in Mahdia between April 2013 and June 2016. 
We assigned patients with septic shock to receive hydrocortisone 
treatment either by bolus or by continuous infusion with equivalent 
dose (200  mg/day). Corticosteroids were continued as long as vaso-
pressors were needed. The primary endpoint was all cause of ICU 
mortality. Secondary endpoints included length of stay, number of 
vasopressor free days, change in SOFA score, leukocyte count, tem-
perature, plasma C-reactive protein, and the occurrence of adverse 
Table 13 Main patient, provider, procedures characteristics and outcomes according to cardiac arrest related to intuba‑
tion
Data expressed as median (25–75% IQR) or proportion (%)
Overall (n = 1847) Cardiac arrest (n = 49) No cardiac arrest (n = 1798) p value
Age >75 years, n (%) 257 (14) 12 (24) 245 (14) 0.03
SOFA score 6 (3–8) 8 (5–10) 5 (3–8) 0.039
BMI (kg/m2) 25 (22–29) 27 (23–29) 25 (21–29) 0.039
Sp02 < 80%, n (%) 411 (22) 22 (45) 389 (22) <0.001
Lowest SBP before intubation 98 (78–120) 87 (65–105) 110 (89–130) <0.001
SBP < 90 mmHg, n (%) 855 (46) 41 (84) 814 (45) <0.001
MACOCHA score ≥3, n (%) 183/1108 10/28 (35) 173/1080 (16) 0.005
Preoxygenation, n (%) 1517 (82) 30/36 (83) 1487/1797 (96) 0.003
Severe complications during intubation procedure 329 (18) 49 (100) 280 (16) <0.001
 Severe hypoxemia 415 (22) 26 (53) 389 (22) <0.001
 Severe collapse 536 (29) 49 (100) 487 (27) 0.002
 Cardiac arrest 49 (2.7) 49 (100) 0 (0) <0.001
 Death 14 (0.7) 14 (29) 0 (0) <0.001
Moderate complications during intubation procedure 346 (19) 24 (49) 322 (18) <0.001
 Cardiac arrhythmia 58 (3) 15 (31) 43 (2) <0.001
 Inhalation 39 (2) 2 (4) 37 (2) 0.331
 Esophageal intubation 86 (5) 4 (8) 82 (5) 0.232
 Dental injury 15 (0.8) 0 (0) 15 (0.8) 0.522
 Difficult intubation 200 (11) 7 (14) 193 (11) 0.430
 Agitation 28 (2) 0 (0) 28 (2) 0.378
Length of ICU stay 15 (7–30) 2 (1–10) 16 (7–30) 0.001
Mortality 28 days 576 (31) 36 (73) 541 (30) <0.001
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events (Secondary sepsis, hyperglycemia, hypokalemia, peripheral 
neuropathy).
Results The trial included 54 patients, of whom 27 were assigned to 
continuous infusion of hydrocortisone and 27 to discontinuous mode. 
The baseline characteristics of patients were similar between the two 
groups. Sepsis was secondary to community-acquired infection in 54% 
of cases. There was no difference in mortality between groups (74% in 
continuous groups and 59% in discontinuous group). SOFA score was 
significantly higher at days 1, 2 and 5 in discontinuous group. Length 
of stay, duration of mechanical ventilation, number of day without 
vasopressors, and the occurrence of adverse events were similar in the 
two groups.
Conclusion The mode of hydrocortisone administration in patients 
with septic shock has no influence on morbidity or mortality. The 
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Introduction Widespread activation of coagulation with platelet 
consumption is a pathophysiological feature of severe sepsis and 
septic shock. Thrombocytopenia, either defined by platelet count 
below 150 G/L or by a significant relative 20–40-percent decrease in 
platelet count is a potent poor prognostic factor in sepsis. Besides 
their role in hemostasis, platelets also carry various immune and 
inflammatory functions that are likely to impact on host defense 
against infections. We aimed to assess whether changes in the platelet 
count induced by sepsis is associated with the development of 
subsequent nosocomial infections.
Patients and methods Patients were obtained from two prospective 
studies about immuno monitoring of dendritic cells and innate-like 
lymphocytes in critically ill septic patients (1, 2). Adult patients with 
severe sepsis and septic shock were included. Exclusion criteria were 
any immunosuppressive condition (hematological malignancy, HIV 
infection at any stage, bone marrow or solid organ transplantation, 
daily corticosteroid therapy >0.5  mg/kg prednisone-equivalent, 
chemotherapy or any other immunosuppressive treatments), 
pregnancy, do-not-resuscitate orders on admission. In addition 
patients who died or who received platelet transfusion during the 
first week after ICU admission were also excluded. Platelet counts 
were collected on the day of sepsis diagnosis (D1) and then on D3, D5 
and D7. The relative variation in platelet count at day n compared to day 
1 was calculated as follows: (count at day n −  count at day 1) ×  100/
(count at day 1). Patients were screened daily for the development of 
ICU-acquired infections diagnosed according to usual guidelines (for 
ventilator acquired pneumonia, urinary tract infection, intravascular 
catheter-related infection).
Results 94 patients were included in the study (65 years old, 68% of 
men, APACHE 2 =  28). The overall in-ICU mortality rate was 15%. 21 
(22%) patients developed ICU-acquired infections after a median 
of 8 [7–13]  days following ICU admission. Patients with nosocomial 
infections were older (68 [62–73] vs. 64 [60–68]  years, p =  0.34, had 
higher severity at admission (APACHEII 31 [28–34] vs. 27 [25–29], 
p = 0.09) and finally had higher mortality rate (29 vs. 10%, p < 0.05).
The average admission platelet count was 239 [210–269] G/L and non 
significantly dropped to 185 [158–212] G/L at 3  days, 182 [159–205] 
G/L at 5 days and 222 [199–246] G/L at 7 days. Platelet counts at D1, 
D3, D5 and D7 appeared similar in patients without and with fur-
ther nosocomial infections. The relative variations in platelet counts 
between between D1 and D3, between D1 and D5 and between D1 
and D7 were also similar between patients with and without ICU-
acquired infections (Fig. 12).
Discussion In this preliminary study from selected cohorts of non-
immunocompromised patients, sepsis resulted in mild alterations 
in platelet counts, making it unlikely to become associated with the 
development of nosocomial infections. It would be relevant to address 
this question in larger cohorts of non-selected patients, as well as the 
impact of platelet transfusions in this setting.
Conclusion Changes in platelet counts were not associated with an 
increased susceptibility towards ICU-acquired infections in non-immu-
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Introduction Sepsis is the leading cause of mortality in the intensive 
care unit (ICU) patients despite the progress regarding their care. 
The immunodeficiency due to sepsis with the consequent profound 
lymphocyte alterations is now well proven. The objective of this work 
was to determine the prognostic impact of lymphocytopenia in septic 
patients in ICU.
Patients and methods Retrospective study including all patients 
hospitalized for sepsis or septic shock between 01/01/2013 and 
31/05/2015. The sepsis and septic shock definitions were adjusted 
with the third international consensus definitions for sepsis and septic 
shock. Were excluded from the study patients of onco-hematology.
Lymphocytopenia was defined as an absolute lymphocyte count 
less than level of 1500/mm3 during the first 24  h of hospitalization. 
The prognostic factors analyzed for the lymphopenic and non 
lymphopenic patients were in hospital mortality, the occurrence of 
nosocomial infections and hospital length of stay.
Results Among the 52 patients, aged 58  ±  17  years, 23 patients 
were with septic shock and 29 patients with sepsis. IGSII score and 
SOFA score were respectively 42  ±  19 and 5  ±  3. Four patients 
were immunocompromised due to HIV infection in one case and 
Fig. 12 Trends in platelets count over time in patients with and 
without ICU acquired infection
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an immunosuppressive therapy in 3 cases. Lymphocytopenia was 
observed in 41 patients (78%). Twenty-eight patients (53%) died 
within an average of 11  ±  13  days. It was noted the occurrence of 
10 nosocomial infections. The median length of stay was 7  days 
with extremes of one and 74  days. The lymphopenic patients were 
comparable to non lymphopenic patients in terms of medical history 
and severity scores. Mortality was comparable between the 2 groups 
with a rate of 51% (n = 21) in lymphopenic patients and 64% (n = 7) 
in non-lymphopenic patients (p  =  0.51). The earliness of death was 
correlated with the duration of lymphopenia (R2 =  0.32, p =  0.007). 
The occurrence of nosocomial infections was not different between 
the two groups: 17% (n = 7) for lymphopenic and 27% (n = 3) for non 
lymphopenic patients. The hospital length of stay was not different 
between the two groups but was correlated with the duration of 
lymphocytopenia (R2 = 0.29, p = 0.000).
Conclusion Lymphocytopenia is frequently found in sepsis. Lympho-
cytopenia was not associated with excess of mortality nor with the 
subsequent occurrence of infectious complications during the ICU 
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Introduction Relative adrenal insufficiency (RAI) is common in ICU 
patients, particularly during septic shock (1). It has been shown that 
the RAI also occurs during cardiogenic shock (2). Septic cardiomyopa-
thy occurs in a significant proportion of septic shock patients. The aim 
of this study was to evaluate the role of RAI on septic cardiomyopathy.
Patients and methods Prospective observational study conducted in 
the intensive care in one university hospital in France. Patients meeting 
the criteria for septic shock without prior corticosteroid therapy and 
without chronic heart disease were included. Total blood cortisol 
levels were assessed immediately before (T0) a short corticotropin 
stimulation test (0.25  mg iv of tetracosactrin) and 30 and 60  min 
afterward. Δmax was defined as the difference between the maximal 
value after the test and T0. RAI was defined as an inappropriate 
adrenal response with Δmax < 9 µg/dl and septic cardiomyopathy as 
the appearance of cardiac systolic dysfunction (left ventricle ejection 
fraction <45%) within the first 3 days of septic shock. We performed a 
multivariable analysis using backward stepwise logistic regression to 
identify independent predictors of septic cardiomyopathy.
Results Of the 52 patients enrolled, 19 (37%) died during ICU stay 
and 22 (42%) during hospitalization. Septic cardiomyopathy was 
revealed in 18 patients (35%). Overall, RAI occurred in 32 patients 
(62%) and this prevalence was significantly higher in patients with 
septic cardiomyopathy as compared to their counterparts (83 vs. 
50%, p = 0.03) and in non-survivors as compared to survivors (82 vs. 
47% p = 0.02). In the multivariable analysis, RAI was an independent 
predictor of septic cardiomyopathy (OR 4.74, p  =  0.03), along with 
SAPS2 (OR 1.06, p  <  0.01). Results were similar when the use of 
etomidate was forced into the model as a potential confounder.
Discussion Although the definition of RAI is not consensual, a 
threshold of Δmax at 9  µg/dl has been widely used in septic shock, 
with or without the use of T0 (1). The usefulness of substitutive doses 
of steroids in septic shock is controversial, but many authors assume 
this treatment has a potential in reversing overt vasoplegia. Our data 
suggest an implication of RAI in septic cardiomyopathy.
Conclusion We found RAI to be an independent predictor of 
septic cardiomyopathy. These findings may suggest a new role for 
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Introduction Regional perfusion parameters, like lactate, pyruvate and 
glycerol, may predict outcome in septic shock patients. Continuous 
venovenous haemofiltration (CVVH) has been considered beneficial in 
septic shock patients. The aim of our study was to investigate whether 
CVVH, in comparison to intermittent haemodialysis (IHD), is able to 
improve regional perfusion in septic shock patients studied by muscle 
microdialysis.
Patients and methods It was a prospective, randomized, clinical 
study, including septic shock patients with acute renal failure, aged 
over 16  years. Patients were randomized to receive either CVVH 
(n =  10) or IHD (n =  10) for renal replacement therapy. Intermittent 
haemodialysis was carried out during the first 4  h of the 24  h study 
period. Systemic haemodynamics and interstitial tissue concentrations 
of lactate, pyruvate, glucose and glycerol were obtained at baseline, 6, 
12, 18 and 24 h after initiation of renal replacement by using muscle 
microdialysis.
Results Regarding systemic haemodynamics parameters, CVVH 
caused a decrease in heart rate in contrast to IHD after 6  h (−4 ±  2 
vs +6  ±  3/mn). There were no changes in vasopressor support 
throughout the 24-h study period and so systolic blood pressure 
remained stable in both groups.
During the 24  h of all renal replacement therapies there was no 
significant change in muscle pyruvate and glucose levels.
During CVVH muscle lactate decreased constantly, as did mus-
cle glycerol levels. This decrease reaches a significant levels at H12 
for muscle lactate and at H24 for muscle glycerol (Fig. 13).
Conclusion Our results suggest that among septic shok patients, 
CVVH may improves regional perfusion in comparison with IHD.
Competing interests
None.
Fig. 13 Muscle biological data measured by microdialysis during 
study period
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Introduction Acquired hypernatremia (H-Na) is an independent risk 
of death among ICU patients (1). In the RCT “Hyper2S” study, we com-
pared normal to 3% hypertonic saline during the first 72 h in patients 
with septic shock with normal serum Na concentration (SNa) at base-
line. The study was prematurely stopped for potential harmful effect 
associated with more frequent H-Na. We assessed the role of H-Na on 
mortality.
Patients and methods Data are a post hoc analysis of the “Hyper2S” 
study database including 434 patients. SNa was measured at H0, every 
12  h for 3  days and then daily until D7. Study fluids were stopped if 
SNa >155 or >12  mmol/l increase over 24  h. Mild, moderate, and 
severe H-Na were defined as SNa >145  mmol/L, >150  mmol/L and 
>155 mmol/L, respectively. SNa profiles were compared between D28 
survivors and non-survivors. Acute kidney injury (AKI) was defined by 
doubling serum creatinine and/or need for dialysis.
Results 431 patients with available data were analysed. 234 (54%) 
developed H-Na (mild: 28%, moderate: 16%, severe: 10%). No matter the 
absence or presence and its severity, H-Na did not affect mortality (43, 
34, 41, and 35%, respectively without, with mild, moderate, and severe 
H-Na, p = 0.41). SNa profiles were similar between survivors and non-sur-
vivors (Table 14). A sensitivity analysis performed among survivors at D3 
did not change the results. Compared to patients without H-Na, AKI 
occurred in 42% of patients with H-N vs 40% (p = 0.58), atelectasis in 
8 versus 10% (p =  0.58) and ICU acquired weakness in 7 versus 10% 
(p = 0.23).
Conclusion Hypernatremia occurrence is not associated with an 
increased risk of morbidity and mortality during hypertonic fluid 
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Introduction Guidelines about the moderate hypokalemia 
treatment (between 2.5 mmol/l and 2.9 mmol/l) are based on experts 
estimations, and non-specific ones for patients in the intensive care 
units (ICU). The aim of this study was to evaluate the correction of the 
hypokalemia in an ICU and the compliance of recommendations.
Materials and methods An observational epidemiological, retro-
spective and monocentric trial has been realized during a period of 
13  months (from January 2015 to February 2016). The study popula-
tion included hospitalized patients in the ICU who have shown a first 
moderate hypokalemia episode, all cause considered. Patients who 
have presented an acute renal failure with a KDIGO (Kidney Disease: 
Improving Global Outcomes) score of three the day of their inclusion 
were excluded. The main primary study endpoint was percent correc-
tion of the serum potassium after 24 h. The secondary study endpoints 
were the incidence rate of moderate hypokalemia and the efficacy 
about the hypokalemia correction in accordance with the achieved 
treatment consistent or not with recommendations.
Results 140 patients had at least one episode of hypokalemia. 
The incidence rate of the hypokalemia first episode was 
1.8%. The study population included 106 patients. IGS2 
score was 47.1 (±  16). 48 patients required mechanical ventilation 
at the inclusion. The serum potassium was greater than or equal to 
3.5 mmol/l after 24 h about 34 patients (32.1%) (corrected group). At 
24  h one patient had a serum potassium higher than 5  mmol/l. The 
average total potassium was respectively 72.3  mmol/L (±57) in the 
corrected group and at 75.4  mmol/l (±53.67) in the non-corrected 
group (p = 0.96). Among 75 patients without contraindication to the 
enteral administration, this one was used in 46.7% (n = 35) of cases. 
47/75 (62.7%) of these patients have received continuous intravenous 
Table 14 Serum Na profile in  D28 survivors and  non‑sur‑






OR 95% CI, p
Hypernatremia, n (%)
 No 113 (43) 84 (50) 1
 Yes 149 (57) 85 (50) 0.77 (0.52–1.13), 0.18
Hypernatremia, n (%)
 No 113 (43) 84 (50) 1
 Mild 80 (31) 41 (24) 0.69 (0.43–1.10), 0.12
 Moderate 41 (16) 29 (17) 0.95 (0.55–1.65), 0.86
 Severe 28 (11) 15 (9) 0.76 (0.34–1.66), 0.49
Max SNa 
(mmol/L)
146 (143–151) 145 (141–149) 0.98 (0.95–1.01), 0.22
Mean SNa 
(mmol/L)




7 (3–13) 6 (1–12) 0.98 (0.95–1.01), 0.15
Max SNa increase 
rate (mmol/
L/h)
0.33 (0.23–0.58) 0.33 (0.17–0.75) 1.31 (0.84–2.07), 0.23
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infusion of potassium and 7 (6.6%) patients have been a management 
compatible with the most common recommendations (input 
potassium chloride of 100 mmol, use of the enteral administration and 
lack of continuous intravenous infusion). The percent correction of the 
hypokalemia after 24 h was respectively of 2/7 (28.6%) in the group in 
which recommendations had been respected and of 32/99 (32.3%) in 
the other one (p = 1.00).
Discussion In our knowledge there are no previous studies that have 
specifically focused on the correction of the moderate hypokalemia 
in critically ill patients. In our study the incidence rate of the moder-
ate hypokalemia was lower than data from the literature because we 
have only considered the first episode of the hypokalemia [1]. Among 
patients without contraindication to the enteral administration, this 
one was used in less than half of the cases. 62% of these patients 
received potassium with a continuous intravenous infusion and only 7 
patients received medical care conform to the guidelines. The medium 
potassium quantity provided was very lower to the guidelines. Only 
32% of the patients have been corrected after 24 h without any differ-
ence in the medium potassium quantity which has been provided in 
relation to the uncorrected group.
Conclusion Only 32.1% of moderate hypokalemia in ICU are corrected 
after 24 h. The intravenous way is considerably used (in 72% of cases) 
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Introduction Acute Kidney Injury (AKI) is frequent in intensive care 
unit (ICU) patients and associated with poor prognosis. Among the 
various contributing factors, administration of nephrotoxic drugs 
is potentially avoidable. A better knowledge of the nephrotoxic 
prescription pattern and its contribution to renal injury in ICU 
patients, may enable to identify opportunities for improvement. The 
objective of this study was to describe the frequency and modality of 
nephrotoxic drug prescription during the first 7 days in the ICU.
Patients and methods Prospective observational study including 
all patients admitted during two 4  weeks periods, between 2013 
and 2015, in 10 ICUs in France. Patients undergoing chronic dialysis, 
patients with renal replacement therapy within the preceding week 
of ICU admission as well as patients admitted for benign psychotropic 
poisoning without organ failure were not included. Nephrotoxic 
drugs received by the patients were collected daily. AKI was defined 
according to the KDIGO (Kidney Disease: Improving Global Outcomes) 
criteria.
Results 1028 patients were included. Mean  ±  SD age was 
65  ±  16  years, 64% were male, mean  ±  SD SAPS II was 47  ±  20. 
ICU length of stay was 7 ±  11  days and ICU mortality rate was 23%. 
During the first 7  days in the ICU, 60% of patients received at least 
one nephrotoxic drug. 31% of patients received one, 18% received 
two, 9% received three and 3% received more than three nephrotoxic 
medications. Diuretics, antibiotics and iodinated contrast media were 
the nephrotoxic drugs most frequently administered to, respectively, 
35, 22 and 15% of patients. AKI (KDIGO stage 1 or higher) occurred 
in 58% of patients during the first 7  days in ICU. The proportion of 
patients with AKI increased with the number of nephrotoxic drugs 
received: 189/410 (46%) of the patients not exposed to nephrotoxic 
drugs developed AKI whereas, respectively, 189/315 (60%), 136/184 
(74%), 62/91 (68%) and 24/28 (85%) of the patients receiving one, 
two, three, and more than three nephrotoxic drugs developed AKI. 
The univariate association between the number of nephrotoxic 
medication and AKI persisted in the multivariate analysis adjusted on 
baseline SAPS II score (p < 0.001).
Conclusion The significant proportion of patients exposed to 
nephrotoxic drugs and the observed association with AKI warrants 
further investigation. Statistical adjustments for multiple potential 
confounders is needed in order to assess a potential causal 
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Introduction Hypocalcemia is a common disorder in ICU, especially 
in septic patients and it is associated with mortality. The mechanisms 
underlying this disorder are unknown. The aim of this study was 
to investigate the relationship between serum ionized calcium 
concentration and its determinants in septic shock patients and 
notably to study the kidney response to hypocalcemia.
Patients and methods This prospective, single-center, observational 
study was conducted in the medical ICU of the University Hospital of 
Angers, from May 2013 to September 2015. Two groups of patients 
were evaluated: a group of septic patients with [Ca2+] <1.10 mmol/L 
(hypocalcemia group) in whom physician in charge considered appro-
priate as routine care to perfuse calcium chloride (CaCl2) to treat 
hypocalcemia and a group of non-septic and normocalcemic patients 
hospitalized for acute respiratory failure (normocalcemia group). 
Exclusion criteria were: age <18  years old, pregnancy and lactation, 
chronic disorder of calcium or phosphate homeostasis, major hemo-
dynamic instability, use of diuretics in the 24 h before inclusion, anuria 
or renal replacement therapy and refusal to participate. In the 24 h fol-
lowing ICU admission, calcium metabolism was compared in the two 
groups of patients (serum [Ca2 +], parathyroid hormone (PTH), 25 OH 
vitamin D, calcitriol, phosphorus, magnesium, creatinine and urinary 
calcium concentration). These assays were repeated in hypocalcemic 
patients after an intravenous infusion of 2 g of CaCl2 over 2 h. Action 
of PTH on the kidney was assessed by evaluating nephrogenous cyclic 
AMP.
Results 32 patients were included in the study, 19 in the hypocalce-
mia group and 13 in the normocalcemia group. Hypocalcemic patients 
had lower [Ca2+] than normocalcemic patients (1.03 [0.95–1.05] vs. 
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1.15 [1.12–1.20] mmol/L, p < 0.0001). In hypocalcemic patients, [Ca2+] 
was significantly increased by the end of the intravenous infusion of 
CaCl2 (1.19 [1.07–1.28]  mmol/L, p  <  0.001 vs. baseline). PTH was sig-
nificantly increased in hypocalcemic in comparison to normocalcemic 
patients (60 [36–130] vs. 43 [25–59] pg/mL, p = 0.02) and significantly 
decreased after CaCl2 infusion (25 [10–60]  pg/mL, p  <  0.01 vs. base-
line). No other calcium determinant (25 OH vitamin D, calcitriol, pH, 
phosphorus, magnesium) significantly differed between the two 
groups. PTH was negatively correlated with [Ca2+] (Rho  =  −0.6, 
p  <  0.001). Urinary calcium excretion by 100  mL of glomerular fil-
trate (GF) was lower in hypocalcemic versus normocalcemic patients 
(0 [0–0] vs. 1.4 [0.15–5.85]  µmol/100  mL GF, p  <  0.001) reflecting an 
effective tubular reabsorption of calcium, but remained unchanged 
after CaCl2 load. Nephrogenous cAMP, although above upper limit 
range of normal values, was not significantly different in hypocal-
cemia group and normocalcemia group (3.09 [0.91–11.48] vs. 2.96 
[1.51–11.54] nmol/100 mL GF, p = 0.63). Nephrogenous cAMP did not 
decrease significantly after CaCl2 load (1.7 [0.14–6.7] nmol/100 mL GF, 
p = 0.15 vs baseline).
Conclusion In septic shock patients with hypocalcemia, we observed 
an adequate PTH response to calcium variation and an efficient tubu-
lar calcium reabsorption. In the absence of increased nephrogenous 
cAMP, persisting tubular calcium reabsorption despite Ca load and 
PTH decrease, may suggest that the usual physiological link between 
PTH, nephrogenous cAMP and tubular reabsorption is altered in ICU 
patients. Thus, non-PTH factors drive tubular Ca reabsorption. Finally, 
our results show that hypocalcemia in septic patients is not explained 
by altered renal tubular calcium transport and a flux of calcium from 
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Introduction Iodinated contrast media is considered to be a frequent 
contributor to acute kidney injury (AKI) in hospitalized patients 
(contrast-associated AKI). Recently, the urinary G1 cell-cycle arrest 
proteins TIMP2 and IGFBP7 have been identified as potential key 
diagnostic markers of AKI. However, the impact of iodinated contrast 
media, frequently administered to intensive care unit (ICU) patients on 
those kidney biomarkers has not been evaluated. The aim of this study 
was to evaluate TIMP-2 and IGFBP-7 urinary concentrations variations 
before and after iodinated contrast media infusion for a computed 
tomographic scan in ICU patients. This setting represents a unique 
situation of a calibrated kidney aggression in a population of patients 
at increased risk of AKI.
Materials and methods We prospectively enrolled patients under-
going their first contrast media-enhanced computed tomographic 
scan during their stay in two ICUs. Measurements of urinary [TIMP-
2]*[IGFBP7] was performed before and 6  h after iodinated contrast 
infusion. Patients were followed 5 days for occurrence of AKI (KDIGO 
classification).
Results We included 77 patients. Before contrast administration, 
42 (54.5%) had no AKI, whereas 20 (26%) had stage 1 and 15 (19%) 
stage 2 or 3 AKI. Median [TIMP-2]*[IGFBP7] before contrast was 
0.07 [interquartile range (IQR) 0.04–0.27] and individual change 6  h 
later was −0.01 [−0.11; 0.11] (ng/ml)2/1000, p  >  0.1. Fourteen (18%) 
patients increased their serum creatinine of more than 26.4  µmol/L 
and 30 (41%) increased their KDIGO classification within 72  h after 
contrast infusion, indicating possible contrast-associated AKI. [TIMP-
2]*[IGFBP7] change over 6  h was not significantly different among 
patients developing or no contrast-associated AKI, whatever the defi-
nition. Sixteen (21%) patients had a significant increase (≥0.2 (ng/
ml)2/1000) in [TIMP-2]*[IGFBP7] 6  h after contrast. Among them, 11 
(69%) increased their KDIGO score within 72 h of contrast administra-
tion, whereas only 26 (43%) of patients with lower values of [TIMP-
2]*[IGFBP7] did so.
Conclusion Changes in urinary concentration of [TIMP-2]*[IGFBP7] 
within 6  h of contrast infusion for a computed tomographic scan 
were modest. Hypotheses advanced for this finding would be (1) 
the minimal kidney aggression by current monomeric nonionic 
low-osmolar contrast media, late serum creatinine increase being 
explained by the occurrence of later (between the 6th and the 
72nd hour) kidney injury due to critical illness or its therapy or (2) 
insufficient sensitivity of early (6 h) measurements of this biomarker to 
detect contrast-associated AKI.
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Introduction Diabetic ketoacidosis, generally resulting from an 
absolute deficiency of insulin, is a frequent cause of hospitalization 
in intensive care unit. Recommendations for diagnosis of diabetic 
ketoacidosis, care and site of admission have been published by the 
English society of diabetology. ICU admission are recommended if one 
of the following criteria is present: GCS < 12, systolic arterial pressure 
(SAP) <90 mmHg, SpO2 < 92%, ketosis >6 mmol/L, HCO3 < 5 mmol/L, 
pH  <  7.1, potassium level  <  3.5  mmol/L or anion gap >16  mmol/L. 
However, it is suspected that adhesion to recommendations remains 
low.
In this study, we aimed at describing patients admitted for 
diabetic ketoacidosis in ICU. We looked at adhesion to published 
recommendations regarding admission and care. We also described 
metabolic complications and looked for an association between 
complications and dose of initial insulin therapy.
Patients and methods We performed a 2-years retrospective analysis 
of patients admitted for diabetic ketoacidosis within five ICU in Paris 
area. Clinical and biological characteristics at admission, treatment 
and complications during ICU stay were recorded. Categorical data 
are presented as % and continuous data as median [IQ25–IQ75]. 
Correlation between hypokalemia and hypoglycemia with insulin 
dosage was performed using a Spearman test.
Results Among the 118 patients admitted in 2013–2014 for diabetic 
ketoacidosis, 111 (94%) were admitted from home. Median age was 
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42 years old. Discontinuation of insulin therapy was the main cause of 
ketoacidosis (37%), whereas this condition revealed diabetes in 30% of 
patients. Sepsis was responsible for 19% of the cases. One death (0.8%) 
was observed over the 2 years study.
Despite convincing data on reliability of venous blood gas for 
ketoacidosis evaluation, arterial blood gas was performed before or at 
ICU admission in 92% of patients without oxygen desaturation.
At admission, 111/118 patients presented at least a criterion for 
ICU admission based on British recommendations. A GCS  <  12 was 
observed in 11% of patients, SAP < 90 mmHg in 13%, SpO2 < 92% in 
9%, HCO3 < 5 mmol/L in 34%, pH < 7.1 in 37%, K + < 3.5 mmol/L in 9% 
and anion gap >16 in 93%. Among the 7 patients that did not meet 
the criteria, four were admitted in ICU for other medical conditions 
such as hematemesis, acute kidney injury or pneumonia. One single 
patient, pregnant and suffering from hyperemesis gravidarum had a 
glycemia below 11 mmol/L at admission.
Treatment At diagnosis of ketoacidosis, 11 patients received sodium 
bicarbonate, in which 7 received hypertonic sodium bicarbonate; 9 
of them had either a pH  <  7.0, EKG signs of hyperkalemia or hyper-
kalemia >5.0. Patients received a median of 3000 mL of NaCl 0.9% in 
the first 24 h. Initial insulin bolus of 10 UI [8–10] has been injected in 
24% of patients. This was slightly correlated to hyperglycemia (Spear-
man test, p = 0.035) but not to pH or kalemia. A continuous infusion 
of intravenous insulin was started in all patients at a median of 7 UI/h 
[6–10].
Complications Hypoglycemia (<3.9 mmol/L) was observed in 48% of 
patients within the first 24 h in which 19% were <2.9 mmol/L. This was 
47 and 15% of patients between 24 and 48 h of ICU stay. Hypokalemia 
below 3.5  mmol/L happened in 44% of patients within the first 24  h 
and in 52% between 24 and 48 h. Neither hypoglycemia nor hypoka-
lemia were correlated with initial insulin bolus or initial dosage of con-
tinuous intravenous insulin. Hypophosphatemia <0.30  mmol/L was 
observed in 15% of patients.
Discussion In this study, admission to ICU was consistent with British 
recommendations since most patients presented at least one clinical 
or biological criterion indicating ICU admission. Arterial blood gas 
were sampled in the large majority of patients despite consistent data 
showing that venous blood gas might be sufficient in non-hypoxemic 
patients. Also, initial insulin bolus and sodium bicarbonate perfusion 
were performed in a significant subset of patients despite absence of 
convincing data or recommendations supporting their use.
Finally, significant hypokalemia and hypoglycemia were frequent in 
these patients. These complications are in theory favored by insulin 
therapy but we did not observe a correlation between administration 
of an insulin bolus or the dose of continuous intravenous insulin 
perfusion.
Conclusion In this retrospective multicentre study, patients admitted 
in ICU for diabetic ketoacidosis were correctly oriented regarding the 
British recommendations. Metabolic complications (hypoglycemia 
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Introduction The appropriate rate for hypernatremia (H-Na) correc-
tion is unknown. Under-correction could be associated with worse 
outcome. Experts recommend a rapid correction of acute (<2  days) 
and sever (>  150  mmol/l) H-Na with a rate of −2  mmol/l/h until 
Na < 146 mmol/l (1). Correction should be, therefore, obtained within 
24 h. In patients with septic shock resuscitated with iso- or hypertonic 
saline and who acquired acute severe H-Na, we assessed if the correc-
tion rate was associated with mortality.
Patients and methods Data are a post hoc analysis of the RCT 
“Hyper2S” database comparing normal to 3% saline for 72 h in septic 
shock. Serum Na (SNa) was measured at H0, every 12 h for 3 days and 
Table 15 Characteristics and  evolution of  H‑Na 
between  D28 survivors and  non‑survivors (results are 





OR 95% CI, p
Characteristics of hypernatremia
3% HT saline gp, 
n (%)
54 (83) 26 (89) 1.77 (0.45–6.88), 0.41
Max SNa, 
mmol/L
155 (152–157) 155 (152–157) 1.04 (0.94–1.15), 0.40
Max SNa gap, 
mmol/L
15 (12–20) 18 (12–22) 0.93 (0.86–1.01), 0.10
Evolution of hypernatremia within 24 h
H‑Na corrected, 
n (%)
10 (15) 7 (24) 1.75 (0.59–5.2), 0.31
Correction rate, 
mmol/L/h









Final evolution of hypernatremia
Finally cor‑
rected, n (%)
57 (88) 20 (69) 0.31 (0.11–0.92), 0.03
Time to SNa 
<146, h
60 (36–84) 36 (24–48) 0.98 (0.96–1.00), 0.05
Over‑corrected, 
n (%)
10 (15) 3 (10) 0.63 (0.16–2.50), 0.52
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then daily until D7. Patients with severe H-Na and available SNa con-
trol within 24 h were included. SNa evolution was compared between 
survivors and non-survivors. Correction and over-correction were 
defined as SNa <146 and <135 respectively.
Results 94 patients were included with a median SNa of 153 (152–156) 
mmol/l. H-Na was corrected within 24  h in 17 (18%) patients with a 
correction rate of −0.17 (−0.29 to 0) mmol/l/h. H-Na corrected within 
24  h was higher in non-survivors (24 vs 15%, p =  0.31) (table). H-Na 
correction rate was more rapid in non-survivors, p = 0.05 (Table 15). 
Over-correction occurred similarly in survivors (15%) and non-survi-
vors (10%). The time to reach SNa normalization was shorter in non-
survivors (p = 0.05). After adjustment for SAPSII and MacCabe scores, 
more rapid correction rate remained significantly associated with mor-
tality: OR 0.16; 95% CI (0.03–0.86), p = 0.048.
Conclusion In the context of acute severe H-Na induced by fluid resus-
citation, a rapid correction rate might be associated with even aggra-
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Introduction Systemic Capillary Leak Syndrome (SLCS) is a rare 
disease characterized by recurrent life-threatening attacks of capillary 
hyper permeability in the presence of a monoclonal gammopathy 
(MG). During acute episodes, the leak of fluid and proteins from the 
intravascular compartment to the interstitium results in clinical signs 
of both acute hypovolemia and interstitial edema. Biological profile 
is pathognomonic with marked hemoconcentration and paradoxal 
hypoproteinemia. Hypovolemic shock is the classical feature of 
severe SCLS attacks. However, beside this typical hemodynamic 
profile, several case report described myocardial dysfunction during 
SCLS attacks. The objectives of this study were to assess frequency, 
characteristics and outcome of myocardial involvement during severe 
SCLS attacks.
Patients and methods Multicenter retrospective analysis of data from 
the European Clarkson registry (EurêClark). Criteria to retain SCLS diag-
nostic were; presence of a MG; ≥1 typical attack with clinical manifes-
tations of hypovolemia and capillary leak; hemoconcentration with 
paradoxal hypo protidemia; exclusion of secondary capillary leak syn-
drome causes. Patients with severe attacks admitted in ICU were iden-
tified in EurêClark registry. Physician were contacted and offered to 
include the attack using a pre-established case report form. Categori-
cal variables are expressed: n (%) and continuous variable: mean ± SD 
or median [IQR].
Results Between May 1992 and February 2016, 64 attacks in 39 
patients have been included. In 11 (28%) patients, and 14 (22%) 
attacks, a myocardial involvement was reported. Sex ratio was 1.2 
with an age of 48.2  ±  13  years. Ten (91%) patients had an IgG MG 
with Kappa light chain in 7 (70%) patients. Eight (57%) patients were 
admitted in ICU for cardiogenic shock. SAPS II score at admission was 
62 [49.2–73] and SOFA score 9.5 [5.7–13]. Admission hemoglobin, 
protidemia and serum creatinine were 19.1 [17.3–21.5] g/dL, 44 [28.7–
52.5] g/L and 228 [120–294] µmol/L, respectively. Echocardiography 
(TTE) was performed in all 14 patients. TTE reveled global hypokinesia 
in 10 (71%) patients, focal hypokinesia or dyskinesia in 3 (21%) 
and ventricular hypertrophy without hypokinesia in 1 (7%). Left 
ventricular myocardial dysfunction was present in 13 (93%) patients 
with median left ventricular ejection fraction (LVEF): 15 [5–40]  %. 
Pericardial effusion was reported in 7 (50%) patients. Transient 
ventricular hypertrophy mimicking hypertrophic cardiomyopathy was 
reported in 3 (21%) patients. LVEF returned to normal in all survivors 
on follow-up TTE. Troponin was elevated in 12/13 (92%) patients (one 
missing data). Twelve patients (85%) required vasopressive amines, 9 
(64%) mechanical ventilation, 6 (43%) renal replacement therapy, 5 
(36%) veno-arterial extracorporeal membrane oxygenation, 1 (9%) 
intra-aortic balloon pump and 1 (9%) an IMPELLA. Compartment 
syndrome occurred in 5 (45%) patients and 4 (36%) died in ICU. We 
then compared the 11 patients with myocardial involvement to the 28 
without Clinical and biological manifestations were similar in between 
groups. However, chest pain (54 vs 11%, p =  0.008), dyspnea (82 vs 
39%, p = 0.03) and respiratory failure (54 vs 18%, p = 0.044) were more 
frequent in patients with myocardial involvement than in others. There 
was no difference between groups regarding treatment received in 
ICU, complication and outcome except for the use of VA-ECMO (36.4 
vs 0%, p = 0.004).
Conclusion Myocardial involvement seems frequent in patients 
with severe SCLS attack, occurring in 22% of the cases. Such patients 
exhibited classical features of SCLS attacks. Myocardial involvement 
was responsible for altered LVEF or transient ventricular hypertrophy. 
Myocardial dysfunction could be severe, even requiring mechanical 
circulatory support. SCLS attacks should be known as a cause of severe 
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Introduction In refractory cardiorespiratory emergencies, ECMO appears 
a good alternative to conventional treatment. Its extracorporeal circuit 
justifies curative anticoagulation explaining haemorrhagic and throm-
botic complications. Activated Clotting Time (ACT) is empirically and 
commonly used to assess anticoagulation but with large inter and intra-
individual variabilities. In practice, antiXa activity dosage is available to 
approach anticoagulant effect of heparin and is less expensive, but data 
during ECMO are missing. We sought to demonstrate the lack of correla-
tion between antiXa and ACT in patients under ECMO support.
Patients and methods We prospectively include patients supported by 
ECMO in CHU Toulouse, France, between 01/2014 and 04/2015 for cir-
culatory/respiratory support. Anticoagulation was achieved by unfrac-
tionated heparin: initial bolus then continuous intravenous infusion 
(800–1200  IU/h), for antiXa target of 0.2–0.4. Concomitant dosing of 
antiXa (laboratory) and ACT (Hemocron®) was conducted two times a day 
on the same sample throughout the ECMO period. Relationship between 
ACT and antiXa was analyzed by Spearman correlation (Rho). After trans-
formation into categorical variables (obtained target = 1; outside the tar-
get = 0), analyzes were completed by a concordance study (Kappa). As 
recognized on literature ACT’s targets were between 180 and 220.
Results 65 patients were included: 46 men (72%), median age 55 yo 
(53–57). Indications were veno-arterial (n  =  42) and veno-venous 
ECMO (n = 23). ECMO median duration was 5 days (hours to 30 days). 
Spearman correlation test found low and inconsistent correlation 
between antiXa and ACT (Rho Spearman  <  0.4). This correlation lack 
present from the day one, worsens over time. Analyzed Kappa showed 
no discrepancy between the areas “targets” of ACT and AntiXa con-
firming the results (Table 16).
Conclusion Use of ACT for ECMO anticoagulation monitoring doesn’t 
seem appropriate and high price probably justifies preferential use of 
antiXa in clinical practice. Analyzes of relationships between antiXa 
and bleeding/thrombotic events are needed to confirm the antiXa 
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Introduction Postcardiotomy cardiogenic shock (CS) has an incidence 
of 2% to 6% after routine adult cardiac surgery. In 0.5–1.5% of cases, 
an venoarterial extracorporeal life support (VA-ECLS) is requested. The 
6-month survival rate is 17.6% (1). Survivors may suffer of physical and 
psychological impairments as well as an alteration of quality of life. 
This study was designed to assess the outcomes, long-term health-
related quality-of-life (HRQL) and occurrence of anxiety, depression 
and post-traumatic disorder symptoms in patients treated by VA-ECLS 
in postcardiotomy refractory shock.
Patients and methods All patients treated with VA-ECLS in postcar-
diotomy refractory CS between June 2014 and December 2015 are 
included in this study. Baseline patient characteristics and ICU events 
were retrospectively analyzed based on patient’s medical records. 
Long-term outcomes were assessed prospectively by the mean of a 
telephone-based questionnaire including French SF-36 quality-of-
life assessment, Post-Traumatic Stress Scale 10, Hospital Anxiety and 
Depression Scale and assessment of function, morbidity, resource use, 
return to work and usual activities.
Results At all, 78 patients were included. At all, 35 patients (45%) 
survived to hospital discharge., 5 died after hospital discharge and 
26 answered the telephone-based questionnaire between July and 
September 2016 (median follow-up: 512  days). SF-36 evaluation 
revealed impaired HRQL compared to the French general population 
tested by Leplège (2) especially concerning items related to physi-
cal health and social functioning. Patients had significantly lower 
mean scores for Physical functioning (p  =  0.0004), Role physical 
(p = 0.0005), General Health (p = 0.02) and Social functioning (0.01) 
items. Mean physical and mental scores were at 57 ± 27 and 64 ± 23 
respectively. Anxiety, depression and/or post-traumatic stress disor-
der symptoms occur in 30, 15 and 19% of the patients, respectively. 
Since ICU discharge, 65% of patients reported physical sequelae., 
ECLS-related limb pain occurs in 38% of patients while paresthesia 
occurs in 23% and chronic-tiredness in 69%. Mean Karnofsky score 
was 68% (Table 17).
Conclusion After VA-ECLS for postcardiotomy cardiogenic shock long-
term physical and psychological sequelae are frequent in survivor 
Table 16 ACT—AntiXa concordance analysis by Kappa coefficient study for the first 5 days of ECMO
Morning J1 J2 J3 J4 J5
ACT 192 196 194 196 194
Median [IC95%] [181 to 200] [191 to 204] [186 to 201] [183 to 210] [187 to 207]
Anti Xa 0.21 0.25 0.18 0.21 0.21
Median [IC95%] [0.17 to 0.34] [0.20 to 0.32] [0.14 to 0.23] [0.17 to 0.25] [0.16 to 0.24]
Kappa 0.085 0.082 0.069 −0.238 0.115
[IC95%] [−0.149 to 0.320] [−0.150 to 0.315] [0.172 to 0.310] [−0.530 to 0.054] [−0.189 to 0.419]
Evening
ACT 195 193 195 196 195
Median [IC95%] [190 to 205] [188 to 200] [189 to 197] [185 to 204] [180 to 199]
Anti Xa 0.23 0.19 0.17 0.22 0.19
Median [IC95%] [0.21 to 0.30] [0.13 to 0.26] [0.13 to 0.21] [0.19 to 0.26] [0.14 to 0.25]
Kappa 0.034 0.093 0.154 0.208 0.062
[IC95%] [−0.198 to 0.267] [−0.113 to 0.301] [−0.075 to 0.383] [−0.093 to 0.509] [−0.283 to 0.408]
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patients, impacting their long term quality-of-life. These results sup-
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Introduction Datas concerning extracorporeal life support (ECLS) 
weaning are scarce. Nevertheless, early weaning or unjustified main-
tenance of such support can lead to own morbidity and mortality. 
This study would like to determine clinical, biological and echocardio-
graphic predictive criteria for weaning success.
Patients and methods The pump flow of patients, considered as sta-
bilized, was decreased to less than 2 L/min during 60 min. A transtho-
racic echocardiography and a biological test were made before and 
after the weaning test. Weaning decision was under the responsibility 
of the intensivist in charge of the patient. Objective of the study was to 
determine echocardiographic, biological and clinical prognostic value 
compare to clinical decision.
Results 39 tests have been performed on 31 patients between 05.2014 
and 07.2016. Patients were essentially men (n = 21, 68%), median age 
of 46 years old (35–57) with classical cardiovascular risk factors. Indica-
tions of ECLS were shared between cardiogenic shock (n = 22, 71%) 
and cardiac arrest (n = 9, 29%). Five parameters allowed to distinguish 
patients able to be weaned or not (see Table 18 below): age (threshold: 
51  years old), BMI (threshold: 28.6), lactate clearance between ECLS 
cannulation and test (threshold: 77%), inotrope time perfusion dur-
ing weaning (threshold: 7 days) and LVEF stability or slightly rising for 
patients able to support weaning (threshold −2%).
Furthermore, we developed a clinical and biological model for 
weaning. Patients with less than 7  days inotrope perfusion during 
weaning and with LVEF stabilized during test had 88.2% probability to 
be weaned of ECMO after the test.
Conclusion A simple multi-parametric result of the weaning trial 
could help the difficult ECLS weaning decision. To confirm these data, 
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Table 17 See text for description
Scores: mean ± SD Survivors Control (2) p
SF‑36: Physical score 57.5 ± 27.5
PF (Physical Functioning) 61.3 ± 31.3 86.5 ± 19.7 <0.0004
RP (Role‑Physical) 42.3 ± 48.8 80.6 ± 33.6 <0.0005
BP (Bodily Pain) 69.1 ± 19.7 74.3 ± 25.2 0.1926
GH (General Health) 58.7 ± 20.6 69 ± 20.9 <0.0178
SF‑36: Mental score 64.4 ± 22.7
VT (Vitality) 51.9 ± 21.5 61.4 ± 20.3 <0.0333
SF (Social Functioning) 68.8 ± 23.3 80.7 ± 22.5 <0.0153
RE (Role‑Emotional) 66.6 ± 47.1 80.9 ± 34.1 0.1368
MH (Mental Health) 70.2 ± 13.2 67.8 ± 19.7 0.3627
PTSS‑10 (N < 35) 22 ± 9
HAD‑Anxiety Score (N < 7) 6 ± 3
HAD‑Depression Score (N < 7) 4 ± 3
Table 18 Area under the curve of continuous variables distinguished patients able to be weaned or not
AUC area under the curve, CI 95% confidence interval 95%, Se sensitivity, Sp specificity, PPV positive predictive value (probability of death at 1 month when the test is 
positive), NPV negative predictive value (probability of survival at 1 month when the test is negative)
AUC CI 95% p Threshold Se Sp PPV NPV
Age (years) 0.738 0.57–0.87 0.0037 ≤51 66.67 86.7 88.9 61.9
BMI 0.855 0.7–0.95 <0.0001 ≤28.6 80.9 85 89.5 75
Inotrope time perfusion during weaning (days) 0.896 0.75–0.97 <0.0001 ≤7 82.6 80 86.4 75
Lactate clearance between ECLS cannulation and test (%) 0.857 0.67–0.96 <0.0001 >76.9 73.7 88.9 93.3 61.5
LVEF after test–LVEF before test (%) 0.753 0.55–0.89 0.0086 >−2 83.33 55.56 78.9 62.5
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Introduction Veno-Arterial Extra Corporeal Membrane Oxygenation 
(VA ECMO) is a mechanical circulatory support used for critical 
patients with cardiogenic shock refractory to conventional therapies. 
Nevertheless, mortality observed for these patients remains very 
high. Contrary to others critical situations, such as sepsis or ARDS, the 
impact of fluid balance is little studied, whereas these patients also 
present and intense inflammatory stress and often required large 
amount of fluid resuscitation. The purpose of this study was to identify 
fluid balance as a predictor for mortality in patients under VA ECMO.
Patients and methods We conducted a single-center, retrospective 
and observational investigation in the cardiac surgical ICU of Rouen 
University Hospital. Patients requiring VA ECMO between March 
2013 and May 2016 were included. Pregnant women, patient under 
16  years old, patients deceased before 24  h of admission in ICU 
and ECMO for ARDS were excluded. The primary outcome was the 
relationship between 1-day fluid balance and 28-day mortality. 
Secondary outcomes were the association between 28-day mortality 
and other biological and clinical characteristics after 1, 3 and 7  days 
in ICU: fluid balance, weight gain, RIFLE (Risk, Injury, Failure, Loss of 
kidney function, and End-stage kidney disease) score, use of Renal 
Replacement Therapy (RRT), troponins, bilirubin and transminases 
values. Univariate analysis was performed through a Chi-2 or fisher 
exact test for qualitative values and a Student t test for continuous 
variables. Statistically significant data were then included for 
multivariate time to death analysis (Cox model). P < 0.05 was consider 
as significant.
Results 88 patients were included (52 ± 14 years, 70% male). Overall 
28-day mortality was 53%. Univariate analysis indicated that fluid bal-
ance and weight gain at 1-day were significantly higher for deceased 
patients (1099 ± 2608 vs 3419 ± 3216 mL, p < 0.0001 and 0.07 ± 2.21 
vs 1.78  ±  2.85  kg, p  =  0.0033, respectively). Troponins at admis-
sion were five fold higher in deceased patients (11,469 vs 2098 ng/L, 
p = 0.002). IGS-2 score was higher in deceased patients (79.1 ± 15.2 
vs 60.5 ± 15.1, p < 0.0001). Deceased patients presented worse renal 
function with higher rifle score (93% of failure or injury status vs 73%, 
p = 0.009), lower MDRD score at day 1 (38 ± 20.8 vs 50 ± 25 mL/min/
m2, p = 0.019) but no difference regarding need for RRT. Multivariate 
analysis wit Cox regression only identified IGS-2 score as an independ-
ent factor associated with 28-days mortality (HR 1.04 [1.017–1.063]).
Discussion Interest for fluid management is growing in critical 
patients. Nevertheless, no study has yet investigated its impact in 
selected patients with cardiogenic shock treated with VA ECMO. Our 
study suggested a possible association between fluid overload and 
mortality but lack the power to confirm these results with multivariate 
analysis.
Conclusion Fluid management is a key therapy during VA ECMO but 
fluid overload could be associated with worsen outcomes. Further 
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Introduction Extracorporeal life support (ECLS) has taken an impor-
tant place in the treatment of cardiogenic shock (CS) or refractory 
cardiac arrest (CA). However, ECLS deplore a high mortality rate in the 
first days raising important ethic and economic consequences. In this 
context, continuation of support should be reassessed precociously. 
The aim of this study was the research of prognostic factors of 30-days 
mortality, 24 h after ECLS implantation for CS or CA.
Materials and methods All patients undergoing ECLS in our tertiary 
center during a 2-year period were prospectively included. The ECLS 
were managed with a multidisciplinary protocol based on consen-
sus. Clinico-biological data were collected just before and 24  h after 
ECLS implantation. These data were compared between survivors and 
deceased at 1 month.
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Results 94 patients were included with a males’ predominance (66%) 
and a median age of 53 years. ECLS was implanted for CA under resus-
citation (29.8%), acute CS (37.2%), CS after CA (22.3%) and CS due to 
end-stage heart failure (10.6%). 30-days mortality was 56.4%. Signifi-
cant data were selected in univariate analysis. Thanks to a Cox model 
(survival model at 30  days), multivariate analysis showed the influ-
ence of bilateral mydriasis before ECLS (RR = 2.87, IC95% [1.34–6.07]; 
p = 0.006), arterial lactate rate >6.2 mmol/l 24 h after ECLS (RR = 4.04, 
IC95% [1.96–8.32]; p  <  0.001) as well as acute pulmonary edema 
occurrence in the first 24 h after ECLS (RR = 2.37, IC95% [1.20–4.70]; 
p =  0.013). CHAID’s segmentation method represented the patients’ 
survival using these covariables with a prevision of 75.3% and may 
help to stop or maintain ECLS after 24 h of support (Fig. 14).
Conclusion Simple biological and clinical markers as initial mydria-
sis, lactate level at H24 and the occurrence of an acute pulmonary 
edema during the first 24 h could serve to predict 1-month mortality 
for patients under ECLS for CA or CS. At 24 h, simple parameters could 
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Introduction Patients surviving a self-attempted hanging present an 
anoxic encephalopathy which is recognized as an optional indication 
for hyperbaric oxygen (HBOT). Previous studies have shown a total 
neurological recovery in 57–77% of patients. Mortality risk factors of 
post-hanging patients have been identified, but long term morbid-
ity prognostic factors have not. A follow-up study with neurological 
evaluation at 6 and 12 months have been undertaken to determinate 
those factors.
Patients and methods In this observational study, all patients 
hospitalized for post-hanging in ICU in a 5-year period were 
included. Prehospital and ICU data were collected. Neurological 
evaluation at 6 and 12  months was performed according to 
CPC scores. Factors associated with neurological recovery were 
determined by comparing CPC 2  +  3+4 (bad recovery) versus 
CPC 1 (good recovery). Qualitative variables were compared by X2 
tests, and quantitative ones by Mann–Whitney. A p value less than 0.05 
was considered as statistically significant.
Results 231 patients with a median age of 40.3  years [IQR 30–50.2] 
were included. 104 patients (47%) were found in cardiac arrest (CA). 
HBOT was performed in 95% of patients, with a median delay of 
120  min [IQR 90–180]. 95 patients died in ICU (41%), 93 (89%) in CA 
group and 2 (1.6%) in the group without CA. Neurological evaluation 
at 6 and 12  months was obtained in 97 of the 136 alive patients. At 
6  months, in the CA group (n =  9), CPC score was respectively 1 for 
6 patients, 2 for 2, 4 for 1. At 12 months, CPC score changed only for 
the 2 patients with a CPC score at 2 (one died after another suicide 
attempt, one changed his CPC score to 3). In the group without CA 
(n  =  88), 79 had normal neurological status at 6  months and 78 at 
12  months (one patient died because of a cancer). Among these 
patients, 96% returned at home and 77% returned to work. 16 (18%) 
patients re-attempted suicide in the year. The major risk factor of mor-
tality is the presence of a cardiac arrest on hanging site. All the other 
factors found to be related to mortality are well known risk factors 
in cardiac arrest of other origin. In univariate analysis, risk factors of 
neurological sequelae at 6  months were a cardiac arrest on hanging 
site (p = 0.045) an elevated diastolic blood pressure (87 vs 70 mmHg; 
p = 0.04), a lower initial Glasgow score (4 vs 5; p = 0.04), and an ele-
vated blood glucose (1.39 vs 1.13 g/L p < 0.001) at admission in ICU.
Discussion Our cohort of self-hanging patients can be divided in 
two parts: a) patients with CA in the pre-hospital period with a high 
mortality and a good neurological recovery in 2/3 surviving patient, 
but with a small group; b) patients without CA with a very low 
mortality and a very good neurological recovery. These results seem to 
be better than in the most important cohort [1] published until now in 
self-hanging patients without CA and not treated by HBOT (mortality 
at 9.5% and 3.5% of poor neurological recovery).
Conclusion Patients surviving a self-attempted hanging who have not 
presented CA and treated by HBOT have mainly a good neurological 
outcome. Randomized control study should be undertaken to confirm 
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Fig. 14 Representation of 30‑days patients’ survival by the CHAID’s 
segmentation method using the variables of interest
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Introduction Venoarterial extracorporeal membrane oxygenation 
(VA-ECMO) is increasingly used to treat refractory cardiogenic shock 
or cardiac arrest. Acute brain injury (i.e. ischemic stroke, haemorrhage 
and/or failure to awaken because of diffuse brain injury) may occur in 
up to 15% of patients on VA-ECMO and is associated with increased 
mortality and poor functional outcome in survivors. However, early 
indicators of neurological outcome are lacking in this population. We 
aimed to assess the prognostic value of early electroencephalography 
(EEG) alterations during VA-ECMO.
Patients and methods We conducted a prospective single-center 
study in the medical ICU of a university hospital on consecutive 
patients cannulated to VA-ECMO. A standardized clinical neurological 
evaluation including the RASS score, the GCS score, the Full Outline 
of UnResponsiveness (FOUR) score and brainstem reflexes was 
coupled to an intermittent EEG. EEG was recorded as soon as possible 
within the first 72  h after VA-ECMO cannulation. EEG characteristics 
were analyzed by a neurophysiologist who was blinded to the 
patient’s condition. A severely altered EEG pattern was defined as a 
predominant delta frequency, discontinuous, unreactive and/or an 
isoelectric background. The primary endpoint was poor neurological 
outcome, defined as the composite of death or acute brain injury 
on neuroimaging within 28  days. Data are presented as median 
(interquartile range) or number (percentage). False-positive rates 
(FPRs, corresponding to 1-specificity) of poor neurological outcome 
were calculated for each significant predictor, using an exact binomial 
95% confidence interval (CI).
Results Sixty-nine (age 58 (50–67)  years) patients with a SOFA score 
of 14 (13–17) were included. Main indications for ECMO were: post 
cardiac surgery (n  =  25, 36%), terminal dilated cardiomyopathy 
(n = 12, 17%), and acute myocardial infarction (n = 11, 16%). Cardiac 
arrest before ECMO cannulation was noted in 20 (29%) patients. 
EEG was recorded 1 (1–2)  days after VA-ECMO cannulation and 62 
(90%) patients were sedated at time of EEG. At day 28, 46 (67%) had 
a poor outcome (n =  37 deaths and n =  9 patients alive with acute 
brain injury). In univariate analysis, a lower RASS score (p = 0.003), a 
lower FOUR score (p = 0.001), a lower score on the motor component 
of the Glasgow coma scale (p  =  0.001), and a lack of cough reflex 
(p  =  0.033) at the time of EEG were significantly associated with 
a poor outcome. A severely impaired EEG pattern or presence of 
a discontinuous background activity were also associated with a 
poor outcome (p =  0.015 and p =  0.002, respectively). Indicators of 
poor neurologic outcome are presented in the Table  19. Among all 
parameters, a discontinuous background activity was the only variable 
that constantly predicted poor outcome (false-positive poor outcome 
prediction rate of 0%, 95% CI 0–15%).
Conclusion Early intermittent EEG has a strong prognostic value for 
sedated patients on VA-ECMO. Presence of a discontinuous EEG back-
ground activity seems to be more accurate than clinical alterations to 
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Introduction Hepatic encephalopathy (HE) may occur after 
transjugular intrahepatic porto systemic shunt (TIPS) placement. 
Multimodal MRI, combining morphologic sequences, diffusion tensor 
imaging (DTI), and H proton magnetic resonance spectroscopy (MRS), 
is modified in cirrhotic patients even in the absence of patent HE. Our 
aims were: (1) To assess if TIPS induces changes in multimodal MRI; (2) 
To correlate changes to the development of HE after TIPS.
Patients and methods All consecutive patients with cirrhosis and 
an indication for TIPS were prospectively screened. Exclusion criteria 
were: common counter-indication to MRI, active drinking, overt HE. 
Neurocognitive evaluation using Psychometric HE test score (PHES), 
were assessed at baseline at inclusion, at the day of MRI, and 3 months 
after TIPS placement. MRI combined morphologic sequences, DTI, 
and MRS. DTI data were processed with standard tools of FSL5 
including eddy current correction and the tensor metrics (Fractional 
Anisotropy, FA and Mean Diffusivity, MD) computation. Averaged 
measures of FA and MD were calculated within the 48 regions of the 
ICBM-DTI-81 white-matter labels atlas.
Results 25 consecutive patients were prospectively analysed (age 
57  ±  8, male gender 68%, Child-Pugh score 7.8  ±  1.6, MELD score 
12 ± 4, cause of cirrhosis: OH/virus/others 16/4/5, indication for TIPS 
placement: Ascites/Varices secondary prophylaxis/other 20/3/2), HE 
status: no HE/minimal HE (MHE)/patent HE: 20/5/0. 8/25 patients 
developed HE after TIPS (1 MHE, 7 patent HE). Baseline metabolites 
were significantly different in patients with or without MHE before 
TIPS: decrease in myoinositol, choline and increase in glutamate/
glutamine. MD and FA were similar according to the presence of 
MHE or not before TIPS. TIPS induced significant changes in MRS 
metabolites as compared to baseline: decrease in myoinositol, 
glycerophosphocholine, N-acetylasparte, increase in glutamate/
glutamine. TIPS did neither modify FA nor MD. Baseline metabolites 
were not predictive of the development of HE after TIPS. However, 
baseline FA was significantly lower in patients who developed HE: in 
cingulate gyrus, in external capsule and in fronto-occipital regions.
Conclusion TIPS induced significant changes in cerebral metabolites, 
even in the absence of the development of HE. DTI findings before 
TIPS could help predicting the development of HE after TIPS. This find-
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Introduction Cerebral thrombophlebitis (CTP) is a dramatic and 
potentially lethal disease. It occurs mostly in children and young 
Table 19 Indicators of  poor neurologic outcome 
for patients cannulated to VA‑ECMO
Variable False positive poor outcome 
prediction rate (%)
95% CI
Motor component of the 
GCS < 4
19 9–34
Absence of cough reflex 16 5–36
FOUR score < 6 12 4–26
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adults. Septic thrombosis of the dural venous sinuses is a rare account-
ing for 0.5–1% of all strokes but often catastrophic complication of a 
variety of infectious processes. Bacterial meningitis and paranasal 
sinusitis may be complicated by superior sagittal sinus thrombosis, an 
entity associated with a mortality rate of nearly 80%. Although there 
is often no direct evidence that the thrombus itself is infected, cases 
of cerebral sinus thrombosis are presumed to be “septic” when the pri-
mary process is an infection.
Here in we are interested in bacterial meningitis with or without 
locoregional infection complicated by CTP. Our objectives were to 
determine the risk factors predisposing to the occurrence of CTP in 
case of bacterial meningitis.
Patients and methods A retrospective case/control study performed 
in 2 units (intensive care and infectious diseases) over 44 months. Were 
recorded all patients who suffered from bacterial meningitis. Exclusion 
criteria were tuberculosis meningitis and meningitis on immunocom-
promised. We performed a multivariate logistic regression analysis to 
determine firstly the association between risk factors and occurrence 
of CTP and secondly between CTP and mortality. Analyse risk factors 
were: demographic factors, locoregional infection, craniofacial trauma, 
pregnancy, co morbidities (Thrombophilia, vascularitis, and cancer), 
clinical features (coma, seizures, cephalalgia), scannographic data, 
cytobacteriological and biochemical data of cerebro-spinal fluid (CSF) 
analysis, delayed diagnosis and/or management.
Results 100 patients were hospitalized with meningitis between 
Jan 2013 and Aug 2016. CTP occurred in 13 cases (13%). Age, sex-
ratio, SAPS II and SOFA scores did not differ between patients with 
meningitis complicated by CTP versus those with meningitis not 
complicated by CTP: (39 vs 45 years, p = 0.22), (2.25 vs 1.71, p = 0.76), 
(28 vs 23, p  =  0.25) and (4.3 vs 2.7, p  =  0.08) respectively. Coma, 
cerebral oedema, cerebral commitment and positive cerebral spinal 
fluid (CSF) culture were significantly associated with the occurrence 
of TPC. SOFA >3 and contraception were near to significance (joined 
Table 20). It was not found a significant association of CTP to mortality 
(46% in the case group and 30% in control group, p  =  0.08). Other 
factors that increased mortality were coma, seizures, shock, oedema, 
cellularity in CSF >1200 units/mm3. Otherwise, the ventilation length 
was prolonged with CTP group (8.7 vs 3.4  days, p  =  0.034) and 
neurological sequels namely the epilepsy was more frequent with the 
group CTP: (23 vs 5%, p = 0.028).
Conclusion The occurrence of CTP on bacterial meningitis was 
significantly associated with CT scan lesions which seems to be 
an association be in both directions. Also, the positive culture 
predisposed more to the CTP. Mortality was higher with the presence 
of CTP but without real significance. The CTP was a factor that extends 
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Introduction Acute bacterial meningitis requires rapid triage and 
therapeutic decision-making. The aim of this study was to assess the 
overall ability of a point-of-care glucometer to determine bacterial 
infection in cerebrospinal fluid (CSF).
Materials and methods We performed a prospective, observational 
study. We included patients for whom an analysis of CSF was indicated 
by the physician in charge with blood sampling performed for glucose 
concentration measurement within 1 h. We simultaneously measured 
the glucose concentrations in CSF and blood using a central labora-
tory and point-of-care glucometer. The diagnosis of bacterial menin-
gitis was determined by two physicians after reviewing the complete 
medical chart. We compared CSF and blood glucose concentrations 
and CSF/blood glucose ratios obtained at the bed-side with a glucom-
eter versus those obtained by the central laboratory. We determined 
the performance characteristics of the CSF/blood glucose ratio pro-
vided by a glucometer to detect bacterial infection in the CSF immedi-
ately after CSF sampling.
Results We screened 201 CSF collection procedures during the 
study period and included 172 samples for analysis. Acute bacterial 
meningitis was diagnosed in 17/172 (9.9%) of CSF samples. The 
median turnaround time for glucose concentration analysis with a 
point-of-care glucometer was shorter than for the central laboratory: 5 
[IQR 2–10] min versus 112 [IQR 86–154] min (p < 0.0001), respectively. 
The optimal cut off for the CSF/blood glucose ratio from central 
laboratory measurements to identify bacterial meningitis was 0.44 
with a sensitivity of 94.1% [95% CI 71.3–99.9%], a specificity of 92.3% 
[95% CI 86.9–95.9%], and a positive likelihood ratio of 12.
The optimal cut off of CSF/blood glucose ratio calculated from a 
bed-side glucometer was 0.46 with a sensibility of 94.1% [95% CI 
71.3–99.9%], a specificity of 91% [95% CI 85.3–95%] and a positive 
likelihood ratio of 10.
Conclusion We demonstrated that the CSF/blood glucose ratio 
measured by a glucometer can serve as a clinical decision support 
tool for the early detection of CSF with a high probability of bacterial 
infection. This costless point-of-care method has the potential to 
expedite medical decision-making for the triage of adult patients with 
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Table 20 Factors associated with CTP complicating menin‑
gitis by stepwise logistic regression
variables OR (95% CI) P value
Coma 3.73 (1.33–10.48) 0.019
Cerebral oedema 1.82 (1.07–3.39) 0.003
CEREBRAL commitment 1.45 (1.14–1.97) 0.018
Positive CSF culture 1.27 (0.99–1.64) 0.017
SOFA > 3 1.12 (0.95–1.33) 0.11
Oral contraception 1.32 (0.75–2.34) 0.17
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Introduction An emergence of Zika virus (ZIKV) infections occured 
in Martinique, an 400,000 people island of the French West Indies, 
with more than 35,000 estimated cases between December 2015 
and September 2016. The disease is usually benign and self-limiting 
if symptomatic (fever, headache, retro-orbital pain, non-purulent 
conjunctivitis, maculopapular rash, arthralgia, and myalgia). ZIKV is 
strongly suspected to be a cause of Guillain–Barré syndrome (GBS) 
based on case–control study describing French Polynesia outbreak in 
2014 (1). Virological investigations were essentially both microsphere 
immunofluorescent and seroneutralisation assays for Zika virus and 
Dengue virus because of cross reactivity. Since then, numerous publica-
tions help to understand time of detection of ZIKV in biological human 
samples as blood or urine by Reverse-Transcriptase Polymerase-Chain-
Reaction (RT-PCR) to diagnose ZIKV infection unambiguously. We 
aimed to asses the role of ZIKV in GBS outbreak in Martinique.
Patients and methods In this prospective cohort study, cases were 
patients with GBS at the French university hospital of Martinique dur-
ing the outbreak period. Demographic, clinical, biological and electro-
physiologic data, times of endotracheal intubation, and mechanical 
ventilation (MV) weaning were collected for all patients. At least 4 
early predictors for MV were reached before endotracheal intubation 
(2). Weaning was usually decided when maximal minute ventilation 
was twice the minute ventilation after a 3–6 h trial of T-tube ventila-
tion. Virological investigations included RT-PCR in blood and urine, 
and serological tests for ZIKV. Certainty ZIKV infection diagnosis was 
definite by RNA Zika detection by RT-PCR in blood or urine and by a 
negative screening for the others common etiologies of GBS (Cyto-
megalovirus, Epstein-Barr Virus, Human Immunodeficiency Virus and 
Human T-cell Lymphotropic Virus 1).
Results 30 patients were diagnosed for SGB during the study period. 
21 had a certainty diagnosis for ZIKV infection. 13 patients were male. 
Median age was 65.4 years (range 56.7–71.2). 14 patients had clinical 
manifestations for ZIKV in a median preceding days of 5 (range 2–7). 
Immune therapy using immunoglobulins was realized in most of cases 
except for two patients who received plasma exchange. The median 
time before plateau phase was 8 days (range 6–12). 13 patients were 
hospitalized in ICU, 10 requiring MV for a median duration of 11.5 days 
(range 6–27). 19 patients underwent an electromyography in a 
median delay of 14 days (range 10–22). Acute inflammatory demyeli-
nating polyradiculoneuropathy was diagnosed in 18 cases. 3 of them 
had axonal involvement.
Discussion Half of the patients had a need for MV. Temporality of 
events, certainty of ZIKV infection diagnosis by RT-PCR and exclusion 
of alternative explanations provide evidence for ZIKV causability 
in SGB. Annual incidence of SGB had already double comparing 10 
previous years. SGB incidence backward have to be observe after the 
ZIKV outbreak.
Conclusion This study provides evidence for Zika virus infection 
causing Guillain–Barré syndrome. Consistency (same association 
found in different studies and populations) is strengthened by our 
study. At risk countries need to prepare for adequate intensive care 
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Introduction Cardiac arrest remains a frequent cause of admission in 
intensive care unit. A majority of patients will die during their hospital 
stay mainly from consequences of hypoxic-ischemic brain injury after 
a decision of withdrawal of life sustaining therapy support by a predic-
tion of poor outcome. The reliability of prognostication is crucial, but is 
still a difficult and uncertain exercise. EEG is the most widely used prog-
nostic tool to support a clinical examination and is accessible in most 
hospitals. It is recommended for both prognostication and ruling out 
subclinical seizures. There is no high-level evidence for predicting poor 
prognosis using EEG because of the wide variety of classification sys-
tems used and the interrater variability. Our objective is to assess the 
prognostic value of simple EEG features based on the recent American 
Clinical Neurophysiology Society (ACNS) standardized classification 
and to study the interrater variability.
Patients and methods We conducted a retrospective monocentric 
observational study in a 12 bed medical intensive care unit of the uni-
versity Hospital la Timone, Marseille, France. All patients aged of more 
than 18  year-old admitted for a resuscitated cardiac arrest between 
November 2012 and July 2014 who underwent therapeutic hypo-
thermia and a full multimodal prognostic evaluation including a EEG 
were included in the study. Outcome was classified according to the 
Cerebral Performance Category Score measured at day 28. Unfavora-
ble outcome was defined as death (CPC 5), persistent vegetative state 
(CPC 4), or severe neurological disability (CPC 3). Favorable outcome 
was defined as moderate neurological disability (CPC 2), or no dis-
ability (CPC 1). EEG was performed in all patients still comatose after 
rewarming between 48 and 72 h after admission and after discontinu-
ation of sedation. EEG interpretation was made by 2 independent sen-
ior neurophysiologists, blind to the outcome. EEG features are based 
on the latest ACNS classification. For each EEG feature, sensitivity, 
specificity, positive predictive value (PPV), negative predictive value 
(NPV) for predicting an unfavorable outcome were calculated.
Results During the study period, 122 cardiac arrest were admitted 
of which 48 patients went through a full neurologic evaluation 
and were finally included in the study. According to neurological 
outcome, 19% had a favorable evolution, and 81% had an unfavorable 
outcome. The presence of burst suppression, and epileptiform 
activity was constantly associated with an unfavorable prognostic 
with a 100% specificity and 0% false positive. A non-reactive EEG 
is strongly associated with an unfavorable evolution with a 89% 
specificity and 3% false positive. Other features including periodic or 
rhythmic patterns and low voltage were inconstantly associated with 
unfavorable outcome. Kappa score for all EEG feature was slight or fair 
and always under 0.4.
Discussion This study allowed us to identify a homogenous cohort 
of comatose patient after cardiac arrest who underwent therapeutic 
hypothermia. We identified simple EEG features based on the new 
classification of the ACNS constantly associated with unfavorable 
outcome. These features must be known by intensivists to better 
integrate EEG in the multimodal evaluation of neurological prognostic. 
There is important interrater variability that must lead to caution and 
to always use multimodal approach to prognostic an unfavorable 
outcome.
Conclusion Bedside EEG is an excellent tool for predicting outcome 
of post-anoxic coma through simple EEG features. Burst suppression, 
epileptiform activity and non-reactive EEG are strongly associated to 
neurological outcome after cardiac arrest. However, the interrater vari-
ability emphasize the need of being well trained for the standardized 




1. Westhall E. Neurology. 2016;86(16):1482–90.
2. Ben‑Hamouda N. Chest. 2014;146(5):1375–86.
Page 166 of 207  Ann. Intensive Care 2017, 7(Suppl 1):7
S41 
The air‑leak test revisited in childhood: a prospective 
observational study of feasibility in a PICU
Géraldine Poncelet1, Fleur Le Bourgeois2, Levy Michael2, Guillot Camille2, 
Jérôme Naudin3, Anna Deho4, Stéphane Dauger3 
1Pédiatrie, Hôpital Robert‑Debré (AP‑HP), Paris, France; 2Réanimation et 
surveillance continue pédiatriques, Hôpital Robert Debré, Paris, France; 
3Réanimation et surveillance continue pédiatriques, CHU Robert Debré, 
Paris, France; 4Réanimation et surveillance continue pédiatriques, CHU 
Robert Debré, Paris, France, France
Correspondence: Géraldine Poncelet ‑ gege.ponce@orange.fr
Annals of Intensive Care 2017, 7(Suppl 1):S41
Introduction Emergent reintubation is a well-known risk of laryngo-
tracheal trauma and of ventilatory acquired pneumonia. To precisely 
define its risk before extubation for each patient is a part of qual-
ity of care in intensive care units. The air-leak test (ALT) around the 
endotracheal tube (ETT) has been validated in adults to predict post-
extubation adverse events such as stridor, upper airway obstruction 
or reintubation. Although the only six studies performed in childhood 
have shown highly variable results, this test is often used in pediatric 
intensive care units (PICU) where cuffed ETTs are now strongly recom-
mended even in young infants. We report here the feasibility of differ-
ent kinds of ALT in critically ill pediatric patients.
Patients and methods We designed a prospective, monocentric, 
observational study in our 12 beds-PICU of a University Hospital. 
From May 2016 to September 2016, we included all patients 
aged from 2  days to 18  years and intubated with cuffed ETT. 
We excluded patients intubated with uncuffed ETT, who were 
transferred still intubated to another PICU or who died during 
their stay in PICU. ALT was performed in all patients as soon as they 
were considered weanable from the ventilator by the intensivist in 
charge of the PICU. Thirty minutes before extubation, the intensivist 
successively tested two methods, before and after cuff deflation, 
with patients ventilated under CPAP (+5  cms H2O) with the FiO2 
needed to obtain a saturation above 94%: (i) a qualitative test based 
on detection of an audible air-leak around the ETT with and without 
the use of a stethoscope placed on the larynx, (ii) a quantitative test 
known as the percent of cuff leak either calculated with expiratory 
tidal volume (VtE) or inspiratory tidal volume (VtI) (PCL: VtE inflated 
cuff - VtE deflated cuff/VtE inflated cuff × 100 or VtI inflated cuff - VtI 
deflated cuff/VtI inflated × 100). ALT was considered positive when no 
air-leak was audible and/or the PCL is less than 10%. Data are reported 
as medians [first-third quartiles].
Results During 4  months, 65 patients were mechanically venti-
lated in the PICU. 21 patients were excluded (11 deaths, 3 trans-
ferred still intubated and 7 intubations with uncuffed ETT). Of 44 
patients with inclusion criteria, 43 (98%) were included (male/female: 
30/13; age: 42 [6; 146]  months; weight: 16.6 [5.6; 37.1]  kg; PIM2 
score: 3 [1.4; 5.6]; PELOD score at Day#1: 10 [1; 11]; medical/surgical: 
28/15; duration of mechanical ventilation: 3 [2; 5] days; length of stay 
in PICU: 4.5 [3; 7] days). Numbers of cuffed ETT of each diameter were 
as follow: 1 × 2.5 cm, 8 × 3.0 cm, 7 × 3.5 cm, 5 × 4.0 cm, 7 × 4.5 cm, 
3 × 5.0 cm, 3 × 5.5 cm, 3 × 6.0 cm, 4 × 6.5 cm, and 2 × 7.0 cm.
Every 10 senior pediatric intensivists working day or night in the PICU 
reported that performing all forms of ALT before extubation was easy, 
fast and safe. Clinical detection of an audible air-leak with or without 
a stethoscope was in agreement in 84% of cases. During the study 
period, no patients have been reintubated because of untractable 
inspiratory distress resisting to anti-inflammatory treatment (aerosol 
of epinephrine and systemic steroids) and non-invasive ventilation. 
29 (67%) ALT were negative (presence of air-leak around ETT) and 
14 (33%) were positive (absence of air-leak), with 67% concordance 
between qualitative and quantitative test. This concordance may 
depend on age (56% if <1 year, 76% if 1–7 years, and 78% if >7 years). 
With a cut-off of 10%, the result of the PCL calculation was identical 
using VtE or VtI.
Discussion Quite all patients have been included during the study 
period. ALT is fast and easy to safely perform at the bedside in PICU. 
It doesn’t take too much time for the intensivist. Audible ALT could 
be done without the use of a stethoscope which is difficult to place 
in front of the larynx on the anterior part of the neck in small infants. 
Comparing VtE, a usual parameter systematically measured by all PICU 
ventilators, before and after cuff ETT deflation, was the simplest ALT to 
use in this population. An average of six consecutive measurements, 
as performed in adults, could maybe enhance the test’s specificity. 
None of these 43 consecutive children representative of PICU activ-
ity has been reintubated. The coming prospective muticentric study 
which aims to validate ALT in childhood must precisely define this cri-
teria of evaluation.
Conclusion The different methods of ALT are feasible in real clinical 
conditions in PICU. Because of the increasing use of cuffed ETTs in a 
wide variation of patients with different body weight, the best ALT to 
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Introduction Prolonged mechanical ventilation (PMV) and chronic 
mechanical ventilation (CMV) in neonates is associated with a high 
morbidity and mortality. The objective of the study is to identify, 
among the patients with PMV, those that evolved to CMV, as well as 
the adverse respiratory, neurological and feeding sequelae.
Patients and methods We conducted a retrospective study of the 
last 10  years at the CHU Sainte-Justine (Montreal, Canada). Chart 
review included patients with PMV (≥21  days) using the paediatric 
definition adapted from the 2005 NAMDRC consensus conference 
(1). Demographic and clinical data, including follow-up at 6 and 
18 months corrected age, was collected for each included patient. The 
evolution of PMV neonates with CMV (≥125  days) and without (21–
125 days) was compared.
Results We identified 174 neonates that met criteria for PMV. 
Patients born between 2004 and 2011 (n =  110, 63% of the cohort) 
were analyzed. Around half of the patients (5–10 patients a year) are 
transferred from the neonatal unit to the paediatric intensive care 
unit. In our center, they represent around 1% of total admissions, but 
their length of stay is among the longest. Among these 110 newborns, 
79% were preterm (n = 87) with 45% (n = 50) born before 29 weeks 
gestation. Of all patients with a malformation (52%, n =  57), 21 had 
a thoracoabdominal anomaly and 24 had congenital heart disease. 
Thirty-six patients had CMV with mean ventilation time of 239  days 
(range 125–753  days). Survival at 18  months corrected age was 66% 
(49/74) in the PMV group and 72% (26/36) in the CMV group. At 
18 months corrected age, 30% of patients were dependent on artificial 
enteral feeding (nasogastric tube or gastrostomy), with 18% in the 
PMV group and 54% in the CMV group. Nine percent of patients had 
oxygen supplementation (2 patients in the PMV group and 4 in the 
CMV group), and 7% were mechanically ventilated. Ten percent of 
patients had a tracheostomy (5 patients in the PMV group and 2 in the 
CMV group).
Discussion Neonates with CMV have more sequelae. Their rapid 
identification (at 21  days of ventilation) is essential to implement 
multidisciplinary development care in order to minimize 
neurodevelopment impairment.
Conclusion Most newborns in our PMV cohort have a congenital mal-
formation. Survival at 18 months corrected age appears equivalent in 
both PMV and CMV group. Artificial enteral feeding is more frequent 
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Introduction The value of pressures and volumes in assessing the fluid 
responsiveness depend on the systolic cardiac function in adult (1). We 
have studied the relative value of static filling volume and pressure to 
predict the fluid responsiveness, according to systolic cardiac function 
in children during acute circulatory failure.
Patients and methods Patients under 8  years old with an acute 
circulatory failure of two intensive care units during a 1  year period 
of inclusion were analyzed. An exhaustive cardiac echography was 
performed initially (indexed End-diastolic volume (EDVi) and E/e’ from 
transmitral and tissue Doppler were recorded), and the stroke volume 
index (SVI) was measured before and after a fluid challenge (a 10 ml/
kg of crystalloid over 10 min). SVI was computed as the left ventricular 
outflow tract velocity time integer multiplied by the left ventricular 
outflow tract surface. Patients were responders to fluid loading if their 
SVI increased of at least 15%. Patients were considered to have a low 
systolic function if their Left Ventricular Ejection Fraction (LVEF) was 
under 50% or normal if it was over 50%. R software with pROC package 
was used to performed descriptive and analytic statistic. Receiver 
operative characteristic curves were built. Bootstrap technic was 
used to compute the confidence intervals. p  <  0.05 was considered 
significant. Local institutional review boards approved this study (CPP 
Lyon Sud Est II). Written informed consent was obtained from parents.
Results Twenty-five children with acute circulatory failure were 
included. Fluid responsiveness occurred in 6 of the 13 fluid loading 
events with low LVEF, and in 6 of the 12 fluid loading events with 
normal LVEF. Pressure approach: For low and normal LVEF, the AUC-
ROC for fluid responsiveness was respectively 0.83 (CI 0.56–1)/0.73 
(0.39–1) for a E/e’.The best thresholds of E/e’ in low LVEF was 7.9 with a 
sensitivity of 87 (CI 62–100) % and a specificity of 67 (CI 33–100) %. For 
low and normal LVEF AUC ROC was respectively 0.6 (CI 0.21–0.99)/0.52 
(CI 0.14–0.9) for the PVC.
Volume approach: For low and normal LVEF, the AUC-ROC for fluid 
responsiveness was respectively 0.69 (CI 37–1) and 0.74 (0.4–1). The 
best thresholds in normal LVEF was an EDVi below 29  ml/m2 wit a 
Specificity of 83 (CI 50–100) and a sensitivity of 71 (CI 42–100) %.
Discussion Our study shows a variation of the diagnostic value of E/e’ 
and EDVi according to the left ventricular systolic function. Therefore, 
the systolic function should be taken into account to analysed the 
E/e’ and EDVi value. Few preload dependency markers are validated 
in Children and none for children in spontaneous ventilation (2). Our 
study suffers from a lack of power that calls into question the validity 
of our results. Another limitation is that both approaches with volume 
and pressure are not very discriminant as it is known for static value in 
adults. Our study illustrates that, on a pressure–volume curve, when 
the cardiac inotropism is reduced, the filling of the Left ventricle is 
moved to the up and right of the curvilinear diastolic function curve. 
Therefore, pressure variations are larger than volume variations. These 
values should be monitored on a larger scale to define their exact 
diagnostic value.
Conclusion Static PVC value is a low preload-dependency surrogate. 
When LVEF is low a pressure evaluation based approach seems more 
accurate. When LVEF is normal a volume evaluation based approach 
seems informative as predicted by the slope of the end diastolic pres-
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Introduction Acute viral bronchiolitis is a primary cause of respiratory 
distress in paediatric intensive care unit (ICU). Prone position (PP) is 
commonly used in neonates to improve respiratory mechanics and 
has been found beneficial to adult patients with acute respiratory 
distress syndrome. We aimed to evaluate the effect of PP on work of 
breathing as compared to supine position (SP) in children with severe 
bronchiolitis requiring non-invasive ventilation.
Patients and methods The protocol was approved by our IRB (2015- 
A01200–49). Fourteen infants (9 boys) with median age 33 days [first-
third quartiles 25–58] with severe bronchiolitis requiring CPAP were 
included after written informed consent. Children were investigated 
in PP and SP each applied for 1 h in a random order with a washout 
period of 10  min between them. Level of CPAP was set at 7  cmH2O 
in both conditions. Oesophageal pressure probe was inserted orally 
(CTO-2 pressure transducer, Gaeltec, Scotland) to measure oesopha-
geal pressure. Flow and airway pressure (Pmo in Fig.  15) were simul-
tanuously recorded using a Neurovent data acquisition system 
(Neurovent Inc, Toronto, Canada). One hundred breaths were ana-
lyzed in each condition, in which work of breathing was estimated 
from oesophageal pressure–time product (PTPes) and oesophageal 
swings (Fig. 15). Data were expressed as median (first-third quartiles) 
and compared by using the Wilcoxon two-sample paired sign test. A 
p-value below 0.05 was considered significant.
Results Respiratory rate was not different in PP and SP position (66 
[46–78] vs 59 [52–77] breaths/minute, p  =  0.40). Between PP and 
Fig. 15 Example of recording and main analysis (PTP pressure time 
product)
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SP, the oesophageal PTP per breath was 3.5 [2.9–4.2] vs 4.6 [3.4–
5.1]  cmH2O  s, respectively, p  =  0.048 and the swings of oesopha-
geal pressure amounted to 9.3 [8.3–12.8] vs 14.9 [11.0–16.2]  cmH2O, 
respectively, p = 0.035.
Discussion Work of breathing estimated by using the oesophageal 
PTP and oesophageal swing was lower in PP than in SP in children who 
required non-invasive ventilation for severe bronchiolitis. This physi-
ologic study suggests that PP may improve respiratory condition in 
children with severe bronchiolitis.
Conclusion In children with severe bronchiolitis, the prone position 
decreased significantly the work of breathing compared to the supine 
position during non-invasive ventilation.
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Introduction Abusive head trauma assigned a frequency to high mor-
bidity and mortality and it is not uncommon in pediatric intensive care 
unit. The aim of this study was to describe the frequency and the char-
acteristics of abusive head trauma from all head trauma in children 
under 2 years hospitalized in a pediatric intensive care unit and define 
initial prognostic factors of mortality.
Patients and methods We performed a retrospective observational 
cohort study, including all patients under 2 years, admitted in pediatric 
intensive care unit of Lille, France for head trauma from January 
2004 to December 2014. Outcome for initial prognostic factors was 
mortality.
Results One hundred forty patients were included, 64% were abusive 
head trauma and 36% were accidental head trauma. The main differ-
ences between the 2 groups were respectively age (3 vs 12 months), 
retinal hemorrhages (81 vs 8%), subdural hematoma (94 vs 40%), loca-
tion of fractures (long bones: 61 vs 0%; ribs: 46 vs 3%) and location of 
ecchymosis (face: 84 vs 8%; skull: 32 vs 96%) (all p  <  10–4). Seizures 
were more common in abusive head trauma (74%) versus accidental 
head trauma (24%) (p < 10–4). Patients with abusive head trauma were 
mostly boys (sex ratio: 1.4). Mortality rate was higher in abusive head 
trauma (26%) versus accidental head trauma (8%). Prognostic factors 
of mortality were younger age (p =  0.03), a threshold probability of 
death PIM 2 of 8% (Se 92%, Sp 77%) and 12% for the PRISM III score 
(Se 89% Sp 77%), Glasgow score ≤8 (OR [CI95%]: 7 [53; 424]), lactate 
level greater than 2  mmol/l and initial hypoxic-ischemic injuries in 
cerebral tomodensitometry (CT) (p < 10–4). Only subdural-peritoneal 
shunt placement was a protective factor (OR 0.007 [95% CI 0.2, 0.6]; 
p = 0.003).
Conclusion In our study, abusive head trauma is a fre-
quent cause of head trauma in children under 2  years (68%) 
and is more lethal than other head injuries. Young age, PIM2 
or PRISM III score, Glasgow score, lactatemia and hypoxic-ischemic 
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Introduction Since May 2015, we have been able to collect several 
physiological and therapeutic data in an electronic database (eDTB) 
implemented in our paediatric intensive care unit (PICU) of CHU Sainte 
Justine using all medical devices at bedside and informatics network 
of the hospital. The purpose of this abstract is to present the data after 
1 year of exploitation.
Materials and methods The eDTB was implemented after the CHU 
Sainte Justine ethical committee approval. Data are collected from 
admission to discharge, every 5 s from monitors and every 30 s from 
mechanical ventilator and infusion pumps. All these data are linked to 
medical information retrieved from electronic medical chart.
Results Between May 21th 2015 and July 31st 2016, 993 patients 
were hospitalised in our PICU, among them 43 weren’t included in 
the eDTB for technical and age (over 18 years old) reasons. Eventually, 
after 20 exclusions, 930 patients remained in the eDTB. Mortality was 
4.3% (n =  40). The eDTB contained 1063 PICU stays (1048 complete 
and 15 partial).The median age was 2 years old [0–17], median weight 
was 12.9  kg [2.3–104.0]. The median ICU stay was 53  h [3–11,720] or 
2  days [0–488]. The first motive for admission was respiratory causes 
(308, 28.9%) Other principal motives were post-surgery (186, 17.5%) 
post cardiac surgery procedures (160, 15.1%), neurologic causes 
(116, 10.9%). Other motives were under 10% (hemodynamic causes, 
traumatic injuries, infectious diseases, intoxications, metabolic causes, 
cancer, organ transplant, cardiac arrest). The eDTB contains data 
from ventilated patients (invasively and non-invasively) and details 
concerning ionotropic and sedative treatment during PICU courses.
Discussion As far as we know, this eDTB is currently the only one 
as exhaustive available in PICU worldwide. After almost 3  years of 
multidisciplinary collaboration, we are able to collect many useful 
physiological, therapeutic and medical data in an ongoing eDTB. 
Although many concerns remain concerning data validation, 
organisation and exploitation, this eDTB already contribute to the 
development of clinical decision support systems and virtual patient 
validation and we create international collaborations to further 
develop these tools. Three research protocols using the database 
are ongoing including: validation of a neuromonitoring clinical 
decision support system, validation of a cardio-respiratory simulator, 
developement and validation of the automatic diagnosis of pediatric 
acute respiratory distress syndrome and development of SpO2 
forecast using artificial neuronal network.
Conclusion Thanks to informatics and electronic devices 
improvement, data gathering in intensive care units has empowered. 
We hope that our work in PICU will encourage other teams on the way 
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Introduction Severe trauma is rare in the pediatric setting (15% of all 
trauma in France). However, its morbidity and mortality remain high, 
in relation to brain injury. Pediatric traumatic brain injury (TBI) pre-
hospital care is challenging for non-pediatric retrieval teams. Though, 
we disseminated pediatric TBI pre-hospital care regional guidelines 
and thereafter intended to assess severe pediatric trauma pre-hospital 
care and secondary cerebral insults control.
Materials and methods We conducted a retrospective study in a single 
pediatric trauma center. Children admitted in emergency room with 
severe trauma and moderate to severe TBI (Glasgow coma scale ≤12) 
from June 2014 to March 2016 were included. Pre-hospital and hospital 
data regarding primary care, equipment, medications and secondary 
cerebral insults control (i.e. blood pressure, oxygenation, CO2 
level, temperature, glycemia) were collected from medical files. Two 
pediatric transport team experts assessed the quality of pre-hospital 
care, based on two major endpoints.
Results Twenty-nine files were analyzed. Median ISS was 34 [9–75]. 
All the children had been referred directly from the trauma scene 
to the pediatric trauma center. They were all intubated in the pre-
hospital setting, 4 (13.7%) presented with SpO2  <  90% before or at 
emergency room admission, and 17 (58.6%) presented with a pCO2 
>45  mmHg at admission. At least one peripheral catheter was 
inserted in all the children. Mean total fluid bolus was 26.9  mL/kg 
(± 14). Nor-epinephrine was administered in 16 (55%) children. Mean 
blood pressure was below age threshold in 18 (62%) children during 
transport or at admission. An intracranial hypertension treatment 
(apart from sedation) was delivered in 17 (55%) children before 
admission. Body temperature was monitored in 10 patients and 17 
were hypothermic at emergency room admission. Experts concluded 
on sub-optimal care in 17 children: major endpoint was “respiratory 
care”, “hemodynamic care” and “neurologic care” in 13, 12 and 9 
patients respectively.
Discussion On this small series, we showed pre-hospital sub-optimal 
care regarding secondary cerebral insults control, especially regarding 
CO2 level, blood pressure and body temperature. Our results will help 
to design new care improvement strategies (e.g. sedation, fluid bolus 
and ventilation optimization, early use of vasoactive drugs, systematic 
body temperature monitoring…).
Conclusion Data on pre-hospital secondary cerebral insults care are 
rare in the pediatric setting. Based on our results, we aim to improve 
quality of care of children presenting with traumatic brain injury, and 
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Introduction Unsuccessful extubation from mechanical ventilation 
increases mortality and morbidity. To reduce the extubation failures 
in our Intensive Care Unit we used a mechanical ventilator weaning 
protocol, based on published data. During the first part of the study, 
risk factors and incidence of extubation failure were first described. 
Afterwards in the second part, our mechanical ventilator weaning 
protocol was tested to determined its efficiency regarding the 
extubation failure.
Patients and methods A monocentric and observational study, was 
first conducted. We included 245 children aged from birth to 18 old, 
during a period of 15  months and collected for each patient their 
medical history, intubation and extubation parameters, and existing 
events of extubation failure or extubation complication. The second 
part of the study was prospective, we include 70 patients extubated 
by applying our mechanical ventilator weaning protocol.
Results Average duration of mechanical ventilation was 51.6  h in 
the first part of the study. Using a univariate analysis, duration of 
mechanical ventilation was a risk factor of extubation failure with an 
average duration of 131.6  h in the group with an extubation failure 
versus 40.8  h in the group without failure (p  =  0.000005). Chronic 
respiratory affection (OR 2.46 [1.04; 5.57] p  =  0.049), and history of 
previous intubation (OR 2.46 [1.26; 7.41] p = 0.005) were found to be 
failure extubation failure risk factors. SaO2 was statistically lower for 
a higher FiO2 in the group with failure extubation. Use of sedation 
did not change the risk of extubation failure except for midazolam. 
Administration of benzodiazepine at the time of extubation 
significantly increased extubation failure (OR 3.06 [1.07; 8.33]; 
p = 0.02).
In children intubated for respiratory or neurologic distress we 
observed more extubation failures compared to children intubated for 
hemodynamic distress or surgical reasons (p = 0.02).
Using a multivariate analysis, each mechanical ventilation additional 
hour increased of 1.004 the risk of failure extubation [1.001; 1.0081] 
(p  =  0.02). Extubation complications increase by 10.86 the failure 
extubation risk [3.947; 29.907] p = 0.000004.
The mechanical ventilator weaning protocol in ICU strongly reduced 
the risk of extubation failure (OR 4.55 [1.10; 40.35] p  =  0.026). The 
number needed to treat with the protocol to avoid one extubation 
failure is 12 patients. Our protocol did not change the average 
duration of mechanical ventilation. (51.6 vs 48 h p = 0.07) neither the 
incidence of extubation complications (17.1 vs 10% p = 0.19).
Discussion Our study confirms published data about extubation 
failure risk factor like duration of intubation, chronic respiratory 
affection, history of previous intubation, and the administration of 
benzodiazepine. It is the first pediatric study that shows a reduction 
of extubation failure by using a specific mechanical ventilator weaning 
protocol. The mean bias of our its retrospective and prospective 
character.
Conclusion Our study shows the interest of a mechanical ventilator 
weaning protocol to reduce the incidence of extubation failure. We 
currently continue the apply our protocol to include more patients in 
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Introduction Stroke of the child is formidable though it is ten times 
rarer than in adults, but this scarcity can have adverse consequences 
on the speed and quality of the management and the consequences 
on later psychomotor development. Our goal is to describe the clinical 
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and therapeutic aspects of these pediatric stroke while bringing our 
experience.
Patients and methods Retrospective study of cases of children 
hospitalized in general intensive care unit to the pediatric hospital 
Canastel Oran for stroke during the period from January 2014 to 
January 2016. The clinical, etiological, para clinical, and scalable were 
studied and transcribed on a standard electronic form.All patients 
had a brain CT. Magnetic resonance imaging(MRI) was possible in 02 
patients for lack of availability of the technical facilities during the 
study.
Results Ten cases were selected. The mean age was 64  months 
(1 month to 15 years), 66% are male, 2 patients had a history of CHD 
like tetralogy of Fallot and complicated bronchiolitis myocarditis, 
one patient had a history of petechial purpura, 1 other was a factor 7 
deficiency, headache history was noted in 02 patients, and 04 patients 
with no particular antecedent was found.
All patients arrived comatose 11/15 score on the scale of glasgow, iso-
chores reactive pupils with a motor deficit of hémicorps, 03 patients 
have degraded their neurological score with onset of clinical signs of 
hypertension intra cranial namely anisocoria and hypertension requir-
ing osmotherapy, sedation and mechanical ventilation with an aver-
age duration of 2–7 day. O1child arrived brain dead, 03 patients had 
generalized tonic–clonic seizures which yielded after taking a ben-
zodiazepine (Diazepam) and phenobarbital (like gardenal). Cerebral 
CT was performed in all cases and could we revealed the nature of 
the stroke hemorrhagic in 07 cases and ischemic stroke in 03 cases. 
Two patients have benefited from an MRI that found a thrombosis of 
the artery internal carotid right Sylvian. Besides symptomatic treat-
ment, treatment was initiated based on the type of stroke, 03 patients 
received low molecular weight heparin (LMWH) at 0.1 ml/kg in addi-
tion to symptomatic treatment, 02 patients received vitamin K. Four 
patients died in an array of autonomic disorders and evolved favorably 
and six patients were transferred to a pediatric unit.
The average length of stay in ICU was 5.5 days (2–10 days).
Discussion The mortality rate is important since no specialized center 
for children, and difficulty especially in the diagnostic imaging field 
while Suspected stroke should be confirmed by imaging and the 
diagnostic delay. Which is due to a poor assessment of the initial 
situation in half of the cases by the parents, the other half by the 
Swiss magazine consulté.une doctor showed that in a study in 42% 
of children with stroke, this diagnosis was not primarily discussed 
and that in 11% of cases the cause of the stroke was poorly evaluated 
[1]. Heart disease certainly represent the second most important risk 
factor. A collaboration of a team must be multidisciplinary, death 
has affected mostly older children whose age is between 11 and 
15 years, who have a hemorrhagic stroke against by infants who have 
an ischemic stroke have evolved and oriented they exceed the acute 
phase to pediatric services for further investigation and monitoring.
Conclusion The child may also be having a stroke, which usually 
reaches the elderly. This justifies a good knowledge of this disease, 
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Introduction Nosocomial infections are a main problem for public 
health for their cost as well as for the morbidity and mortality they 
generate. They are particularly common in intensive care units due to 
patient’s lower defenses and of invasive procedures proliferation.
Work’s purpose:
  • Determine the epidemiology of bacterial noso-Comiales infections 
(IBN) in the medico-surgical pediatric intensive care department 
of Children’s University Hospital of Casablanca.
 • To identify factors associated with these infections.
Patients and methods We led a retrospective study of hospitalized 
patients, spending more than 48  h in medical-surgical pediatric 
intensive care department, at the University Hospital Ibn Rochd of 
Casablanca, over a period of 12  months from 1 January 2015 to 31 
December 2015.
Results During the studied period, 420 patients were admitted at 
intensive care with a stay of more than 48 h.
Thirty episodes of INB were recorded. The incidence rate was 7.1% and 
the incidence density was 20.6% per 1000 hospitalization’s days.
The admission average age was 4.6 ± 22-month starting from 1 month 
to 12 years with a male predominance (60%).
Most of admissions (80%) was related to medical background, 50.3% 
received from other hospital department.
Furthermore, 40% of the patients received prior antibiotics, usually 
prescribed before ICU admission.
Invasive procedures (intubation, central catheterization) were used in 
93.3% of patients, VVP only in 6.66%, tracheotomy in 33.3 and 6.66% 
had received surgery.
Gram-negative bacilli (BGN) were isolated for a lot of patients, 
dominated by Acinetobacter baumannii. These bacteria were isolated 
throughout the study year. Risk factors Analysis underlined that 
the presence of invasive procedures enhances IN risk, that is central 
venous catheter and the need for mechanical ventilation.
Conclusion Nosocomial bacterial infections are dominated by pneu-
monia and central catheter infections, and are mainly due to BGN. The 
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Introduction The Guillain–Barré syndrome (GBS) is the most common 
cause of acute flaccid paralysis in children since the acute anterior 
poliomyelitis eradication.
Few studies have been held on the topic and knowledge of GBS in 
children, although it is recognized that the etiologic mechanisms, 
and clinicobiological background, are the same as in adults, prognosis 
remains different.
Our work’s aim is to study this disease’s mortality factors of children 
hospitalized in pediatric intensive care.
Patients and methods It is a retrospective, descriptive, mono cen-
tric study to review 35 patients with GBS between January 2009 and 
December 2015 and hospitalized at pediatric intensive care depart-
ment of AbderrahimHarouchi hospital of Casablanca.
The used software is SPSS 16.0 to compare the bivariate variables, we 
used the khi2 test, and to compare quantitative variables, the ANOVA 
to 1 factor test was used. The level of significance was fixed at 5% with 
95% confidence interval.
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Results The disease was predominant in male with a sex ratio of 1.7 
men/women. After a prodromal event, usually infectious (95.7%) and a 
free interval of 15 days on average to start motor disorders.
These are of two types: either a hypo or areflectic flaccid paralysis of 
the lower limbs (25.7%) of ascending evolution in 91.4% of the cases. 
Either flaccid tetraplegia or hypo areflectic, (74.3%).
Ventilation was required in 65.7% of the cases, and specific treatments 
based on immunoglobulins were administered in 88.6% of the cases.
Death’s rate is still high (22.9%) and mainly due to hospitalization 
complications.
In our study respiratory disease was noted in 65.7% of the cases, also 
other signs of serious illness such as swallowing disorders (71.4%) and 
autonomic disorders (14.3%) also noted what led to management in 
intensive care for all our patients.
These patients study allowed to identify some mortality prognosis 
factors of the disease in intensive care units (such as male gender, 
Ig administration duration, the occurrence of autonomic disorders 
like blood pressure instability), the most discriminating remains the 
occurrence of nosocomial infections.
Conclusion It must be underlined, that in view of our strict inclusion 
criteria, focusing only on patients admitted at intensive care and of 
the relatively small sample size (35 cases), our results must be qualified 
and must be enhanced by additional and more varied studies to better 
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Introduction Early surgical treatment is recommended for refractory 
intracranial hypertension (HTIC) in children to improve vital and 
functional prognoses, whether traumatic or vascular cause. The main 
objective of this study was to compare the mortality and morbidity 
of children with severe intracranial hypertension after severe head 
trauma (TC) or due to vascular cause after decompressive craniectomy 
(DC) or medical therapy alone. The secondary objective was to identify 
the initial severity factors associated with higher mortality.
Patients and methods A retrospective study was performed with 
data collected from patients aged under 18  years-old admitted to 
our pediatric intensive care unit for severe intracranial hypertension 
of traumatic or vascular cause, between January 2000 and January 
2016. They were divided into 2 groups: patients who received medical 
therapy alone and those treated with decompressive craniectomy 
after optimal medical management.
Results A total of 83 children were included. Among them, 17 were 
treated with DC (6 HTIC of vascular cause and 11 HTIC of traumatic 
cause), and 66 were supported by medical means only (6 HTIC of 
vascular cause and 60 HTIC of traumatic cause).
In the population “traumatic intracranial hypertension”, we note that 
children in the “DC” subgroup are more often in mydriasis upon arrival 
(p = 0.017) than in the subgroup treated medically. In this same popu-
lation, children in the “DC” subgroup received higher doses of MIDA-
ZOLAM (p =  0.015), of MANNITOL (p =  0.0041) and hypertonic saline 
(p  =  0.0006) than in the other subgroup. In the population “vascular 
intracranial hypertension” the two subgroups were comparable.
In the case of traumatic intracranial hypertension, mortality rate in the 
“DC” subgroup was 54.5% against 13.34% for children treated medi-
cally (p  =  0.0015); “DC” children had more metabolic complications 
such as hypernatremia than “not DC” children, p  =  0.043. Mortality 
rate in the «vascular intracranial hypertension» group was 0% for chil-
dren treated with decompressive craniectomy, and 83.3% for children 
treated medically alone (p = 0.015). Patients treated surgically in the 
«vascular intracranial hypertension» group had longer overall stays 
(p  =  0.009) and longer ICU stays (p  =  0.016). POPC Score (Pediat-
ric Overall Performance Category) upon discharge for children with 
intracranial hypertension of traumatic cause treated with decompres-
sive craniectomy was 4.91 ± 1.37 against 3.75 ± 1.31 among children 
treated medically, p = 0.08. In “DC” children with intracranial hyperten-
sion of vascular cause, POPC upon hospital discharge was 3.66 ± 0.51 
against 5.66  ±  0.81 among non-operated children, p  =  0.007. The 
schooling rate was higher among children treated medically for 
intracranial hypertension of traumatic cause, p  =  0.012. The sever-
ity factors related with higher mortality identified in the population 
“traumatic intracranial hypertension” were mydriasis upon admis-
sion, a PIM 2 score higher and a lower temperature (<35.5°); the latter 
being the only factor identified for HTIC of vascular cause. In the case 
of traumatic intracranial hypertension, ICP monitoring in survivors was 
40.35% against 28.6% in children died, with no significant difference. 
In the population “vascular intracranial hypertension”, all the patients 
who died had not been monitoring PIC.
Discussion The severity factors related with higher mortality identified 
in the population “traumatic intracranial hypertension” were mydriasis 
upon admission, a PIM 2 score higher and a lower temperature 
(<35.5°); the latter being the only factor identified for HTIC of vascular 
cause. Other studies have related other severity factors as initial 
Glasgow scale, tardive decompressive craniectomy.
Conclusion Decompressive craniectomy doesn’t seem to improve 
the mortality rate or the outcome in patients with hypertension 
of traumatic cause in our study but the DC traumatic subgroup was 
more serious than the subgroup treated medically. In children with 
refractory intracranial hypertension of vascular cause DC significantly 
improves survival and outcome. Further studies are needed to clarify 
the role of decompressive craniectomy and its timing in the therapeu-
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Introduction Shortage of heart grafts is a major problem, leading to 
a significant mortality rate in the national waiting list, essentially for 
young children with low weight. The potential paediatric brain-dead 
donors often have myocardial dysfunction (MD), which seems to be 
reversible.
The aim of this study is to assess prevalence, causes and consequences 
of MD when the potential paediatric donors are taken over, up to 
multi-organ retrieval, and the evolution after cardiac transplantation.
Materials and methods This observational, monocentric, 
retrospective study included all brain-dead children aged 0–18 years 
old, who had their myocardial function assessed through a cardiac 
ultrasound performed by a cardiologist and identified from 2004 
to 2016. All adult patients and those who didn’t undergo a cardiac 
ultrasound were excluded.
MD was defined as an LVEF ≤50% with or without abnormal seg-
mented cinetic parameters.
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The main evaluation criteria was the prevalence of MD in potential 
identified donors. The secondary evaluation criteria were the causes 
and consequences of MD on heart retrieval and the origin of this MD.
Results Out of 40 included patients, 11 had MD. Prevalence of MD was 
of 30%.
There was no significant difference between 2 groups regarding 
aetiology of brain death nor administration of catecholamines. 
Having a cardiopulmonary arrest during intensive care unit stay was 
associated with a significant risk of presenting a MD (p  =  0.034). 
Having a MD had no consequences on organ retrieval in general 
(p =  0.25), but was significantly associated with a decrease in heart 
retrieval opportunities (p  =  0.036). The cause of heart grafts refusal 
was a poor ventricular function in 50% of cases (3 cases out of 6). 
The cause for non-retrieval was parental refusal in one-third of cases. 
Evolution of the cardiac grafts was favorable in 16 cases on 18, one 
transplanted patient died (from a non-cardiac cause) and 1 patient 
was lost to follow up.
Conclusion MD in paediatric brain-dead patients has direct 
consequences on heart retrieval and transplantation, and otherwise, 
organ shortage is a major ongoing problem. A better transplant 
management regarding hemodynamics (with the use of a protocol) 
could increase the number of heart transplants, especially in small 
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Introduction The prone positioning (PP) is a strategy widely used in 
the treatment of severe forms of acute respiratory distress syndrome 
(ARDS) in adults. Its early use significantly reduces mortality (1). 
However, the studies do not strongly demonstrate its prognostic 
impact in pediatric ARDS. The aim of this study was to describe the 
prone positioning practices in the French-speaking pediatric intensive 
care units (PICU).
Patients and methods This survey was conducted by email 
questionnaire to pediatric intensivists belonging to the French Society 
of Intensive Care Medicine and the French-speaking Group of Pediatric 
Intensive Care and Emergency Medicine. It was conducted From 
February to May 2016. The survey was addressed to doctors, nurses, 
physiotherapists practicing in PICU. It included 29 questions about 
indications, contraindications, techniques and medical devices used, 
and complications.
Results One hundred and three persons answered (69 doctors and 
33 nurses) which work in 28 french hospitals and 1 canadian hospital. 
Sixty-eight percent of interviewed persons have more than 5  years 
experience and 57% of them treat each year more than 10 children 
ARDS. Only 10% of the PICU have a PP medical protocol. Fifty percent 
of interviewed persons frequently use PP for the medical care of ARDS 
and 30% systematically use it. Thirty-six percent begin PP at the early 
phase of ARDS during conventional ventilation, while 42% before 
the introduction of unconventional ventilatory strategies (OHF); only 
12% use it after the respiratory failure unless unconventional venti-
latory strategies. Seventy-three percent report that PP is used with 
prolonged periods (>12  h/day), 22% with short periods (<12  h/day) 
and 14% with very long periods (>20 h/day). Regarding the weaning 
criteria, most of interviewed persons seem to use multiple and com-
binated criteria: 51% use hypoxemia severity parameters (PaO2/FiO2, 
PaO2, SaO2), 39% use the oxygen level (FiO2) and 38% use the mechan-
ical ventilation parameters (PEEP, P max, P plate). Finally, despite a 
low level of scientific evidence in children, 87% of the persons gave 
a strong recommendation for PP as standard care in severe pediatric 
ARDS. See Fig. 16.
Discussion The survey confirmed the widely use of PP in pediatric 
ARDS. However, no specific protocol is avalaible in most of the PICU. 
The timing of the PP beginning can be different according to children, 
early and prior to use of the conventional ventilation strategy in most 
cases. The duration of PP seems more consensual. Most of the centers 
use extended periods longer than 12 h/day. These results are close to 
Guérin et al. advocating a duration >16 h/day. Finally, the weaning is 
a great issue and depends on multiple criteria. In Guerin et al. (2) PP 
was interrupted if one of the following criteria were present: PaO2/
FiO2 ≥ 150 mmHg, with PEEP of ≤10 cm of water and a FiO2 of ≤0.6; 
decreased PaO2/FiO2 than 20%, compared to compared to the supine 
position, or the occurrence of complications. No study has validated 
PP weaning criteria during pediatric ARDS.
Conclusion The prone positioning is a strategy commonly used in 
pediatric intensive care units for the severe pediatric ARDS. The crite-
rias of implementation and timing are variable, as well as the weaning 
criterias. More pediatric multicenter randomized studies will be neces-
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Introduction Allogeneic Hematopoietic Stem Cell Transplantation 
(HSCT) recipients have profound defects in every immunity 
compartments that can lead to severe opportunistic infections (OI). 
20% of HSCT patients require admission to the ICU because of diverse 
infectious or non-infectious complications with dismal outcomes. OI 
specific course in this population has not been described previously 
Fig. 16 Criteria used to stop Prone positionin in the French‑speaking 
Pediatric Intensive Care Units
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and the management of these infections may be a concern. The aim of 
this study was to investigate risk factors, management and outcomes 
of IO in HSCT recipients admitted to the ICU.
Patients and methods This was a retrospective (2007–2016) single 
center study of patients admitted to ICU after an allogeneic HSCT. 
Patients provided written informed consent according to Helsinki dec-
laration. Data regarding the transplant, infections and life sustaining 
therapy use were analyzed. OI were considered if present at the time 
or during ICU admission.
Results Hundred and ninety-four patients (Pt) were included. 
Median age was 43 [28; 58]  years, 63.2% were males. Reason for 
transplantation was acute leukemia in 84 (42%) Pt and the hema-
tological condition was still in complete remission at ICU admission 
in 83% of patients. 78 (41%) and 53 (28%) had received a myeloab-
lative conditioning regimen and anti-thymoglobulin serum respec-
tively. 40% had acute graft versus host disease over grade 2 at ICU 
admission. OI was documented in 38 patients (20%). An invasive 
fungal infection (IFI) was found in 19 Pt owing to 3 mucormuco-
sis, 1 trichosporon septicemia and 15 invasive aspergillosis (5 pos-
sible, 9 probable and 1 proven according to EORTC criteria). Serum 
Galactomannane antigen was positive in 10 (67%). Median time 
from transplantation and ICU admission to IFI diagnosis was respec-
tively 86 [18; 529] and −3 [−8; 0]  days. Lung was involved in 90% 
and patients with aspergillosis were admitted to the ICU for acute 
respiratory failure in 71% (vs. 33% for others p = 0.2). They did not 
required invasive ventilation more frequently (36 vs. 31% p =  0.8). 
32 and 10% required vasopressors and renal replacement therapy 
with no difference as compared to others. Median ICU length was 
3 [2; 6]  days. Demographic, stem cell source, and donor type were 
not associated with IFI occurrence in this population. However 
15/19 had received a total body irradiation (78 vs. 47% p =  0.01). 
IFI occurrence was not associated with ICU or Day 90 mortality (33 
vs. 26% p = 0.7 and 53 vs. 41% p = 0.3 respectively). A viral infec-
tion was found in 17 Pt owing to 11 CMV, 1 adenovirus, 1 HSV and 1 
VRS infections. Analyses were focused on CMV reactivation. Median 
time from transplantation and ICU admission to CMV reactivation 
was respectively 111 [50; 151] and −23 [−38; −10]  days. Reacti-
vation was mainly positive blood PCR but 1 pt had CMV colitis. A 
preemptive treatment was started on the same day in median and 
lasts 34 [21; 71] days. Patients with CMV reactivation had more fre-
quently multiple organ failure (50 vs. 22% p = 0.06) and higher ICU 
admission SOFA score (7 [5; 12] vs. 6 [3–8] p = 0.05). They trend to 
have higher admission creatinine serum level (132 [72; 157] vs. 81 
[60; 120] umol/L, p = 0.2) and more frequently required emergency 
renal replacement therapy (36 vs. 7% p = 0.01) mechanical ventila-
tion (64 vs. 30% p =  0.04) and vasopressors (73 vs. 37% p =  0.02). 
Median ICU length was 4 [2; 11]  days and comparable to others. 
Demographic, stem cell source, conditioning regimen and donor 
type were not associated with CMV occurrence. CMV reactivation 
was not significantly associated with ICU or Day 90 mortality (36 vs. 
26% p = 0.5 and 60 vs. 41% p = 0.3 respectively).
Conclusion OI was found in 20% of allogeneic HSCT recipients admit-
ted to the ICU. IFI were mainly responsible for respiratory distress and 
CMV associated to multiple organ failure. Non-invasive diagnostic 
tests were positives in a majority of these patients. In this cohort, IO 
treatment was started quickly after the diagnostic and we did not find 
an association with mortality. Intensivists should always consider OI in 
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Introduction Over the last two decades, targeted therapies in patients 
with solid tumors have both increased their length of survival and sig-
nificantly altered their immune functions. However, data on opportun-
istic infections in this setting remain scarce. In this systematic review, 
we sought to identify published cases of opportunistic infections in 
patients with solid tumors, with a special interest on clinical findings, 
trends over time and outcomes.
Materials and methods We performed a search of Medical Subject 
Headings (MeSH) on PubMed using the words pneumonia pneumo-
cystis (PCP), invasive aspergillosis (IA), histoplasma, mucor, geotri-
chum, cryptococcus, coccidioidomycosis combined with the MeSH 
term neoplasms (breast, lung, ovarian, urologic gastrointestinal, 
digestive system, abdominal, brain, carcinoid tumor, sarcoma, testicu-
lar, seminoma). We identify published cases of opportunistic infec-
tions in non HIV patients with solid tumors between 01/01/1966 and 
05/01/2016 included.
Results Regarding Pneumocystis jirovecii pneumonia, 94 cases 
could be identified. There were 32 men and 62 women, aged of 57.5 
(19–80)  years. Underlying tumors were chiefly brain neoplasms 
(n =  31, 33%), lung neoplasms (n =  24, 26%) and breast neoplasms 
(n  =  16, 17%). At the time of Pneumocystis pneumonia onset, 52 
patients (55%) had a history of chemotherapy, 58 (62%) had received 
long term or high dose steroids, and 21 (22%) had an history of 
biotherapy targeting the malignancy. Of note, 18 patients (19%) 
had received only chemotherapy, 17 (18%) had received steroids 
alone, 4 (4%) everolimus therapy alone and 3 (3%) received none of 
these treatments. Regarding invasive aspergillosis 64 cases could 
be identified. Mean age was 66.7 (37–82) and 46 (72%) were men. 
Solid tumors associated with invasive aspergillosis were primarily 
lung neoplasms (n = 31, 48%) and brain neoplasms (n = 24, 38%). At 
aspergillosis onset, 38 (59%) patients had a history of chemotherapy, 
29 (45%) were receiving long term or high dose steroids and 3 (5%) 
had received targeted therapy. Fourteen (22%) patients had received 
only chemotherapy, 2 (3%) only steroids, and 1 (1.5%) had received 
targeted therapy alone.
For both infection, there was a trend for a higher number of reported 
cases throughout the studied period.
Conclusion This systematic review provides objective data showing 
that an increased proportion of patients with solid tumors present 
with opportunistic infections. We are convinced that it is a clinically 
relevant but still neglected problem. Selected oncologic population 
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Introduction Characteristics and outcomes of adult patients with 
invasive aspergillosis in intensive care unit have rarely been described.
Materials and methods We performed a retrospective study on 
consecutive adult patients with invasive aspergillosis who were 
admitted form January 2010 through January 2016 to the intensive 
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care unit of Strasbourg in France. Patients were included only if 
they are non-immunocompromised according to the European 
Organisation for Research and Treatment of Cancer (EORTC). Invasive 
aspergillosis was defined as an association of microbiological 
evidence, a radiological imaging and a clinical context.
Results Eighteen patients (13 males) were identified during the 
study period. The median of IGS II was 60.5 (interquartile range (IRQ), 
49.25–78.75). Ninety-four percent was under mechanical ventilation. 
Fourteen (78%) patients were suffering from liver failure. Among 
liver failure, twelve (86%) were beforehand suffering from cirrhosis. 
The median MELD score was 42 (interquartile range (IRQ), 30–53). 
Sixty-four percent of aspergillosis were due to Aspergillosis fumigatus. 
Hundred percent were pulmonary aspergillosis. Fifty-six percent of 
aspergillosis were associated with bacterial pneumonia. The mortality 
rate at the date of the latest news (an average of 2 years) was seventy-
two percent.
Discussion Invasive aspergillosis is not exceptional in the non-immu-
nocompromised patient especially in patient developing liver failure. 
An active research of colonization/infection with aspergillus in these 
patients remain to be discussed.
Conclusion Invasive aspergillosis in ICU has a poor prognosis. The liver 
failure seems to be the most important risk factor in non-immuno-
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Introduction Liver transplant recipients have high rate of Invasive 
Fungal Disease (IFD) with high morbidity and mortality, in part due 
to its delayed diagnosis. The fungal cell wall component (1,3)-beta-
d-glucan (BG) is a biomarker for fungal infection but its utility remains 
uncertain. This prospective study was designed to review our experi-
ence in IFD and to evaluate the impact of BG in the diagnosis of IFD.
Patients and methods From January 2013 to May 2016, 271 liver 
transplantation were performed in our institution. Serum samples 
were tested for BG (Fungitell; Cape Cod Inc., USA) least weekly 
between liver transplantation and their discharge from hospital. IFD 
was defined as proposed by the European Organization for research 
and treatment of Cancer/mycoses study group.
Results Nineteen patients (7%) were diagnosed with IFD including 
13 cases of Candidiasis infection (CI) in eleven out of 271 patients, 
8 invasive pulmonary aspergillosis (including one who had previ-
ously CI) and one case of septic arthritis of the hip caused by Sce-
dosporium spp. IFD was associated with significantly high mortality 
(log-rank p = 0.003). The area under the ROC curves, for BG to pre-
dict IFD, was 0.78 (95% CI 0.73–0.83). Using a cutoff of 139 pg/ml, 
the most discriminative cut-off point from the ROC curve, The sen-
sitivity, specificity, Positive Predictive Value (PPV) and Negative Pre-
dictive Value (NPV) values of BG for overall IFD was 68% (95% CI, 
59–77), 79% (95% CI, 76–78), 24% (95% CI, 19–30) and 96% (95% 
CI, 95–97).
Conclusion Based on its high NPV, BG value appears to be a good 
biomarker to rule out the diagnosis of IFD when the value is below 
139  pg/ml. A single point BG may guide the investigation and the 
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Introduction Chest wall elastance (Ecw) has been found to increase 
in prone (PP) as compared to supine position (SP) in ARDS patients 
[1]. This makes respiratory system elastance (Ers) not reflecting lung 
elastance (El). Little is known about the changes of Ecw, El and lung 
resistance (Rl) when moving the patient from the SP to the PP via the 
lateral position (LP). The goal of present study was to measure Ecw, El 
and Rl in ARDS patients in SP, LP and PP during the proning procedure.
Patients and methods It was a prospective, single-center, controlled 
study. ARDS patients intubated, sedated and paralyzed with PaO2/FiO2 
ratio  <  150  mmHg, PEEP  ≥  5  cmH20 and an indication of PP were 
included. Mechanical ventilation was delivered in volume controlled 
mode with constant flow inflation and end-inspiratory pause 0.100  s 
included into the inspiratory time. Ventilator settings were unaltered 
during the procedure. An esophageal balloon catheter (Nutrivent 
device) was used for esophageal pressure (Pes) measurement. Pres-
sure at the airway opening (Pao) and airflow were measured by Fleish 
2 pneumotachograph proximal to endotracheal tube and upstream 
Heat and Moisture exchanger. Pao, Pes and airflow were continuously 
measured during 30 min in SP, then during 1 min in LP and 30 min in 
PP. The side for the lateralization was that selected by routine practice 
(in the opposite side from central venous line). Ers and resistance of the 
respiratory system (Rrs) were obtained by fitting flow and Pao signals 
breath by breath to the first order equation. Ecw and resistance of the 
chest wall (Rcw) were similarly obtained by fitting flow and Pes signals 
breath by breath to the first order equation pertaining to the chest wall. 
El and lung resistance (Rl) were obtained by subtracting Ers and Rrs from 
Ecw and Rcw, respectively. Our ethical committee approved the proto-
col. Data are shown as median (first and third quartiles). Comparisons 
between positions were made by using paired-t-test.
Results Twenty-nine patients, 19 males, of 68 (62–74)  years, SAPS 
2 45 (34–55) and SOFA score 7 (3–9) were included 1 (0–2)  days 
after ARDS criteria were met. The ARDS severity was moderate in 
25 cases (86%) and severe in 4 (14%). Tidal volume averaged 5.9 
(5.6–6) ml/kg predicted body weight, PEEP 10 (10–10)  cmH2O, FiO2 
60 (50–70) %, PaO2/FiO2 122 (108–139) mmHg. The cause of ARDS 
was pulmonary in 21 cases (72%), extra pulmonary in 3 (10%) and 
undetermined in 6 (18%). Lateral positioning was on the right side in 
14 (48.3%) and on the left side in 15 patients (51.7%). The results are 
shown in the Table 21.
Conclusion During prone positioning in ARDS patients, as compared 
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Introduction Neuromuscular Blocking Agents (NMBA) could exert 
beneficial effects in Acute Respiratory Distress Syndrome (ARDS) 
through properties on respiratory mechanics and particularly in 
modifying transpulmonary pressures (PL).
Patients and methods Prospective randomized control study in 
moderate to severe ARDS patients within the first 48  h of the onset 
of ARDS. All patients were monitored by an esophageal catheter and 
followed during 48  h. Moderate ARDS patients were randomized 
in two groups according to the systematic administration of a 48  h 
continuous infusion of cisatracurium besylate or not (control group). 
The severe ARDS patients group received a 48 h continuous infusion 
of cisatracurium besylate. The evolution during the 48 h of the study of 
the oxygenation and the respiratory mechanics including inspiratory 
and expiratory transpulmonary pressures and driving pressure were 
assessed and compared. Delta transpulmonary pressure (∆PL) was 
defined as inspiratory PL minus expiratory PL.
Results Thirty patients were included, 24 in the moderate ARDS group 
and 6 in the severe ARDS group. NMBA infusion was associated with an 
improvement in oxygenation both the moderate and the severe ARDS 
patients group accompanied by a decrease in both the plateau pres-
sure and the total positive end expiratory pressure. The mean inspira-
tory and expiratory PL were higher in the moderate ARDS patients 
group receiving NMBA as compared with the control group (Fig. 17). 
In contrast, there was no modification of both the driving pressure and 
the ∆PL related to NMBA administration.
Conclusion NMBA could exert beneficial effects in moderate ARDS 
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Introduction Prone position (PP) is a major treatment in management 
of acute respiratory distress syndrome (ARDS). The use of PP in 
patients with severe ARDS associated with brain injury is at high risk of 
intracranial hypertension.
The aim of this study is to analyze the effect of PP on intracranial pres-
sure (ICP) and cerebral perfusion pressure (CPP) in patients with ARDS 
and acute neurological condition requiring monitoring of ICP.
Patients and methods It is a retrospective descriptive study includ-
ing sixteen patients with acute brain injury (subarachnoid hemor-
rhage, severe head trauma, and hemorrhagic stroke) and continuous 
monitoring of ICP who developed a severe ARDS during ICU stay from 
January 2012 to December 2015 and for which PP was performed. 29 
PP sessions were analyzed. Hemodynamic and respiratory parameters, 
blood oxygenation, PIC and PPC were studied in supine, before PP and 
after PP. The study was approved by FICS ethic comity.
Results A significant increase in PaO2/FiO2 ratio was observed in PP, 
from 112  ±  34 to 200  ±  84 (p  <  0.01). In PP, the ICP was increased 
11 ± 1.1–17 ± 1.3 mmHg (p < 0.05) while the CPP was stable 74 ± 2 
versus 76 ±  2  mmHg (NS). Median duration of PP session was 16  h 
(12–20). Increasing of ICP during PP required medical treatment in 
8 sessions (27%). PP session was interrupted in 6 sessions (20%). In 
subgroup of patients who respond to PP in terms of oxygenation, 
the increase of ICP was lower than in non-responders (43 vs 118%) 
(p < 0.05). CPP was not modified whatever the nature of the response 
to PP (76  ±  15–77  ±  11 in non-responders and from 73  ±  10 to 
76 ± 10 in responders (NS)) (Fig. 18).
Discussion Our study shows an improvement of oxygenation during 
PP in severe ARDS patient with acute brain injury. We observe a 
constant increment of PIC during PP sessions. The increment of ICP is 
less in responders to PP.
Significant increased ICP requiring an enhancement in the medical 
treatment was observed in 30% of the cases, and lead in most cases 
to a discontinuation of the session. Our data underlined the absolute 
necessity to monitor ICP during PP session in patients with acute brain 
injury and ARDS, even if ICP is controlled previously in supine.
Only 3 prospective (1, 2) and one retrospective studies evaluate the 
effects of PP on ICP in patients with acute brain injury and acute 
respiratory failure (ARF). They results are similar to ours. In all these 
studies, the severity of ARF was often not well specified. Roth and al. 
(2) had included only 10% of ARDS in a population of patient with ICP 
not controlled. In others studies, monitoring of ICP during PP was not 
systematic.




Ecw (cmH2O/L) 9.6 (6.5–12.5) 10.5 (6.9–13.3) 11.3 (7.3–13.3)**
El (cmH2O/L) 27.7 (21.7–43.9) 30.8 (23.5–44.5) 31.3 (23.0–47.0)
Rl (cmH2O/L/s) 13.6 (11.2–16.0) 14.2 (12.2–17.5)** 14.7 (13.2–17.0)
Fig. 17 Mean pooled values of Pplat, PEEP tot, ∆P, PL insp, PL exp 
in moderate ARDS, excluding baseline values, shown as mean and 
standard deviation
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Despite the retrospective nature of the study and the small number 
of patients, it is the only work studying the effects of PP on intracra-
nial pressure in patients with acute brain injury at risk for intracranial 
hypertension and severe ARDS according to the Berlin’s definition.
Conclusion Our work suggest that PP is a quite secure technique 
for use for the treatment of severe ARDS even patients at risk of 
intracranial hypertension with a benefit in terms of oxygenation 
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Introduction Influenza-associated acute respiratory distress syn-
drome (ARDS) requiring extracorporeal membrane oxygenation 
(ECMO) support is known to have a good prognosis (1). However, the 
incidence and impact of co-infection in this setting remain unknown.
Patients and methods We conducted a retrospective, observational 
analysis of data prospectively collected from all patients admitted to 
our medical ICU who received ECMO support for influenza-associated 
ARDS between 2009 and 2016. Co-infection was defined as isolation of 
a pathogen in the lower respiratory tract at a significant level or in the 
blood during the 48 h following hospital admission. When no patho-
gen was identified in a patient receiving antibiotics prior to bacterio-
logical sampling, an independent adjudication committee reviewed all 
charts to assess if the patient had a “high probability” or “low probabil-
ity” for bacterial co-infection, based on clinical, radiological and bio-
logical results available. Results are presented as median [IQR].
Results Among the 116 patients hospitalized for an influenza-
associated infection in our ICU, 77 had an ARDS requiring support 
by either veno-venous- (VV, n  =  58), venoarterial (VA, n  =  15) or 
venoarterio-venous- (VAV; n  =  4) ECMO. Co-infection occurred in 
39 (51%) patients, Staphylococcus aureus (18 patients [46%]) being 
the most prevalent pathogen. Panton-Valentin leucocidin (PVL) was 
present in 10 (56%) of S. aureus co-infection, representing 26% of all 
co-infections. Compared to primary viral pneumonia, co-infected 
patients had a lower BMI (26 [24–30] vs 31 [8–38] kg/m2; p < 0.0001), 
a higher Sequential Organ Failure Assessment (SOFA) score before 
ECMO start (16 [14–18] vs 12 [10–16]; p  =  0.001), and received less 
antibiotics before hospital admission (26 vs 51%; p  =  0.03). No 
differences were observed in age, comorbidities, ARDS management 
before and after ECMO, influenza characteristics (genotype, sub-type, 
neuraminidase inhibitors use, delay between symptoms onset and 
hospital or ICU admission), ECMO management (timing of initiation, 
VV-, VA or VAV- configuration). Co-infection was associated with 
increased ICU mortality (62 vs 29%; OR 3.93; 95% CI [1.51–10.18], 
p =  0.0059), lower ECMO free days at day 60 (0 [0–23] vs 23 [0–46]; 
p  =  0.006) and lower mechanical ventilation free days at 60  days 
(0 [0–0] vs 6 [0–35]; p  =  0.003). Multivariable analysis retained age 
>49  years (OR 8.2; 95% CI 2.3–29.9), pre-ECMO SOFA score >14 (OR 
6.2; 95% CI 1.9–19.8) as independent predictors of hospital mortality, 
but not co-infection (OR 2.5, 95% CI 0.8–7.9). In a second analysis, 
patients with proven co-infection and high probability of co-infection 
were grouped and compared to patients with no co-infection and 
low probability of co-infection; and results were similar. As compared 
to others co-infected patients, those co-infected with a PVL-positive 
S. aureus had same characteristics and similar mortality rate, but all 
received a treatment active against PVL production.
Conclusion Co-infection is frequent in patients with influenza-
associated ARDS supported by ECMO, occurring in roughly 50% of 
the cases. Mortality of patients with co-infection is higher than those 
without, but seems mainly due to the severity of the disease. S. aureus 
was the most frequently identified pathogen, with a high prevalence 
of PVL-positive S. aureus, Infection with a PVL-positive strain was not 
associated with a poorer outcome as compared to other co-infections. 
Whether a treatment active against PVL production should be given in 
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Fig. 18 Evolution from ICP and CPP during the first PP session, 
according to the response
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Introduction Systemic rheumatic diseases (SRD) are autoimmune dis-
eases that are rare but cause substantial morbidity and mortality. SRDs 
chiefly affect the lungs, however, data on critically ill patients with SRD 
admitted for ARF are scarce.
Patients and methods Retrospective cohort conducted in 10 French 
ICUs (2009–2013) and prospectively completed in the coordinating 
center until June 2016. Demographic, clinical and therapeutic data 
were collected. Predictors of hospital mortality were identified by 
multivariable logistic regression.
Results 226 patients totalizing 237 ICU admissions were included 
(median age 61 [47–71]  years, female gender 62%). SRDs were 
connective tissue diseases in 63% of cases (Systemic sclerosis 19.5%, 
Systemic lupus erythematous 18%) and systemic vasculitis in 31% of 
cases. Nearly 5% of patients had antiphospholipid syndrome. Time 
since SRD onset was 7.5 [2.0–15.8] years with median involvement of 
two organs [1.0–4.0]. The major comorbidities were cardiovascular 
(49%), tobacco exposure (25%), chronic kidney disease (18%) 
and neoplasia (15%). Two-thirds of patients were on systemic 
corticosteroids at admission, the median dose of 10 (IQR) mg per day. 
SRD diagnosis was made in the ICU in 11.5% of patients.
Clinically or microbiologically documented bacterial pneumonia 
was the leading ARF etiology (40.9%). In 32% of cases, ARF was 
related to an opportunistic infection (mainly Aspergillus (n =  8) and 
Pneumocystis (n  =  7)). Others ARF etiologies included specific lung 
involvement (23.2%) and cardiac pulmonary edema (20.7%).
SOFA on day one was 5 [3–9]. Associated organ dysfunctions were 
mainly hemodynamic (42%) and renal (45%). Mechanical ventilation 
was needed in 68% of patients (non invasive only in 17.3% or invasive 
in 82.7%), 40% needed vasopressors, and 30% renal replacement ther-
apy. Systemic corticosteroids were started in 20% of patients and 23% 
of patients received pulse steroids. Cyclophosphamide and plasma 
exchange were required in 10 and 11% of patients, respectively.
Length of ICU stay was 7 [4–14]  days. ICU-acquired infection occurs 
in 25% of cases. In total, 59 patients (24.9%) died throughout the ICU 
stay. ARF etiology was not associated with mortality. By multivariate 
analysis, shock on admission (OR 6.25 [2.71–14.40], p < 0.001) and the 
use of invasive mechanical ventilation (OR 5.06 [1.84–13.94], p = 0.02) 
were independently associated with mortality, whereas non-invasive 
ventilation was associated with decreased mortality (OR 0.31 [0.12–
0.81], p = 0.02). By considering among the connective tissue diseases, 
the groups of myositis and scleroderma (n = 61), these diseases were 
associated with a trend for a higher mortality (OR 2.08 [0.95–4.55], 
p = 0.06).
Conclusion In patients with SRD, ARF is associated with a high case 
fatality, primarily when mechanical ventilation is needed. Particular 
attention must be given to specific SRD-sub groups for which pulmo-
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Introduction Infections are among the main causes of non-obstetric 
morbidity and mortality during pregnancy and the postpartum 
period, and the second causes of intensive care unit (ICU) admissions 
for non-obstetric reasons. Among those, pneumonia is of particular 
interest, as pregnancy impairs the ventilatory function, and blunts the 
immune response. In addition, pneumonia might increase fetal morbi-
mortality. We, therefore, sought to investigate the epidemiology of 
community-acquired pneumonia (CAP) occurring during pregnancy or 
postpartum (until 6 weeks postpartum) requiring ICU or intermediate 
care unit admission.
Patients and methods We conducted a retrospective multicenter 
observational study in 41 Paris and suburban area ICUs participating in 
the CUBREA database (January 2005–December 2014). Women were 
identified through the ICD-10 database with an obstetric code (O00–
O99 or Z35–Z39) and an acute respiratory failure (J96) or pneumonia 
code (J10–J22). Charts were reviewed. The primary outcome was to 
determine the rate of CAP diagnoses within this population admitted 
for acute respiratory failure. The secondary outcomes were to compare 
CAP and non-CAP women, regarding comorbid conditions, ICU course, 
therapies and fetal outcome; and finally to describe the etiologies of 
CAP episodes.
Results Our search retrieved 367 women pregnant or during the 
postpartum period. Seventy-one of those (22.5%) had a CAP, and had 
been admitted in the intermediate (11; 15.5%) or intensive (60; 84.5%) 
care units. CAP women had a median age of 32 years [28–37] (vs. 32 
[27–36] for non-CAP), and a median SAPSII score of 21 [13–29] (vs. 
23 [16–41] for non-CAP). Thirty-four harbored at least one comorbid 
condition (47.9 vs. 36.9%; p =  0.10), and they were more frequently 
active smokers (14.7 vs. 7%; p =  0.044) than non-CAP women. Fifty-
one CAP women were admitted during prepartum (71.8 vs. 36.21% 
for non-CAP; p < 0.0001), 7 in intermediate care unit, and 44 in ICU, at 
31 weeks [26–33] of gestational age, while 20 (4 in intermediate care 
unit, and 16 in ICU) were admitted during the postpartum period (28.2 
vs. 63.8% for non-CAP). Thirty (42.3 vs. 54.3% for non-CAP; p = 0.08) 
underwent mechanical ventilation, 12 (16.9 vs. 11.5% for non-CAP; 
p  =  0.23) non-invasive ventilation and 7 (9.9 vs. 2.9% for non-CAP; 
p  =  0.001) high-flow nasal cannula oxygen therapy. Compared to 
non-CAP, CAP women had longer duration of mechanical ventilation 
(7  days [4–13] vs. 2 [1–5]; p  <  0.0001). Acute respiratory distress 
syndrome occurred in 20 CAP women (28.2 vs. 3.7% for non-CAP; 
p  <  0.0001), and 6 required extra-corporeal membrane oxygenation 
(8.4 vs. 4.5% for non-CAP; p  =  0.23). Preterm extraction occurred 
for maternal reasons in 15 CAP women (21.1 vs. 7.8% for non-CAP; 
p = 0.004), and more frequently by cesarean section (84.2 vs. 53% for 
non-CAP; p = 0.0003). Fetal survival did not differ significantly, as live 
births occurred in 85 vs. 77.4% for non-CAP (p = 0.39). Length of ICU 
and hospital stays were significantly longer in CAP compared to non-
CAP women (respectively 4 [2–8] vs. 3 [1–5] days; p = 0.001), and 12 
[7–22] vs. 9 [4–15]  days; p =  0.001). ICU and hospital mortality were 
null for CAP versus 5.8 and 6.6% for non-CAP (respectively p = 0.045 
and p  =  0.027). Regarding CAP microbial etiologies, no causative 
pathogen was found in 25 CAP subjects (39.7%); Influenza was 
identified alone in 18 (25.7%), Streptococcus pneumoniae in 6 (8.6%), 
Haemophilus sp. in 3 (4.3%), methicilin-resistant Staphylococcus aureus 
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in 2 (2.3%) and methicillin-susceptible S. aureus in one (1.4%). Finally, 
another respiratory virus was diagnosed in 3 patients (4.3%).
Discussion In this series, CAP was the cause of nearly a quarter of 
pregnancy or postpartum respiratory failure requiring intermediate or 
intensive care unit admission. Despite a longer ICU and hospital stay, 
no woman died. As in the non-pregnant population, the absence of 
any causative pathogen is frequent. Influenza was the most frequent 
pathogen identified.
Conclusion Pneumonia during pregnancy and postpartum requiring 
intermediate or intensive care unit has important maternal and 
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Introduction The pancreaticoduodenectomy (PD) is major surgery in 
visceral surgery. This technique performed for the first time in 1935 by 
Whipple has seen much progress and development over the years that 
have enabled a significant reduction in mortality, while the morbidity 
remains high. The aim of this study was to analyze postoperative 
morbidity pancreaticoduodenectomies.
Patients and methods We retrospectively studied 34 cases of cephalic 
duodenopancreatectomy at the department of surgical emergencies 
resuscitation (wing 33) spanning 6 years, between January 2010 and 
December 2015.
Results The average age of patients was 58.2  years with 43% of 
females and 57% of males, the frequence of pancreatic resections was 
5 years.
The indications of cephalic duodenopancreatectomy were: tumors of 
pancreatic head (65%), Ampulla Vater (23%), duodenum tumors (12%).
The restoration of continuity after cephalic duodenopancreatectomy 
was realized with a rate of 41% for pancreaticogastrostomy and 59% 
for pancreaticojejunostomy.
The average hospital stay was 11, 7  days, with extreme lengths of 
6–27 days.
The postoperative course was marked by the occurrence of 8 deaths 
(24%), the morbidity rate was 29, 25% after PJ and 28% after PG; the 
most frequent complications were the pancreatic fistula (40%), the 
postoperative peritonitis (40%), the digestive bleeding (20%), the 
gastroparesis (20%).
Conclusion Advances in the overall care of patients by surgical teams, 
anesthesiologists and intensivists, the DPC mortality is currently low in 
experienced centers. The multidisciplinary, involving surgeons, radi-
ologists and especially intensive care, to manage more effectively the 
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Introduction Severe Acute Pancreatitis (SAP) is a common but poten-
tially lethal pathology due to the multiplicity and severity of compli-
cations that can occur at all stages of evolution. In the last decade, 
mini-invasive interventional treatments of infected pancreatic necrosis 
(IPN) have been developed. The aim of the present study was to assess 
the management and outcomes of SAP patients, as well as to identify 
the role of IPN.
Materials and methods This was a retrospective study of prospec-
tively collected data from all consecutive patients admitted in Inten-
sive Care Unit (ICU) in a single French center (Hospital of Nantes) 
from 2012 to 2015. Using logistic regression, we evaluated the asso-
ciation between IPN and patients characteristics at baseline and the 
outcomes.
Results In total, 148 patients were included in this study. Overall mor-
tality was 17% and was significantly associated in multivariate analysis 
with BMI, Computed Tomography Severity Index (CTSI) and the need 
for life sustaining support. 16 patients (11%) died during the early 
phase ≤8 days. During the late phase of the onset of SAP (>8 days), IPN 
was present in 62 patients, all requiring an intervention (i.e. radiologic, 
endoscopic, and surgical). In contrast, 70 patients with no suspicion 
or confirmed IPN were managed conservatively. The flow chart of the 
study and details from mortality during the early and the late phase 
are details Fig. 19. Complications such as haemorrhage, perforation of 
visceral organ, ischemia of enteric tube or colon and portosplenomes-
enteric venous thrombosis (PSMVT) occurred more frequently in the 
IPN group. The late phase mortality and hospitalisation length of stay 
were significantly higher in the IPN group (14.3 vs 3.6%, p = 0.01 and 
65.5 vs 15 days, p < 0.001, respectively). In multivariate analysis, factors 
associated with IPN were PSMVT (OR 6.0 [2.42–14.90], p < 0.001), and 
life sustaining support (OR 5.72 [1.06–30.9], p = 0.04).
Discussion This retrospective cohort reports an overall mortality 
slightly lower than previously reported. This may be related to the 
development of novel life support techniques and mini-invasive 
interventional treatments of IPN. The outcomes in term of late 
phase mortality, length of stay and complications (i.e. haemorrhage, 
perforation of visceral organ and mesenteric ischemia) are all strongly 
associated with IPN. Therefore, to determine predictive factors of IPN 
may help identify patients with a high morbidity and mortality. In 
multivariate analysis, organ failure during the first week and PSMVT 
were strongly associated with IPN. The radiological findings in term 
of PSMVT could be important to assess the degree of severity of 
patients with AP. Further prospective studies are needed to confirm 
the association between these factors and IPN.
Conclusion Our study is the first to focus on mortality and outcomes 
of IPN in real life since the development of mini-invasive interventional 
treatments. 43% of patients admitted with severe SAP in ICU devel-
oped IPN and required intervention. IPN was managed with different 
drainage and necrosectomy’s modalities. The late phase mortality, 
length of stays and complications such as PSMVT were all significantly 
higher in the IPN group.
Fig. 19 Flow chart of the study and details from mortality during the 
early phase and details from mortality of the two groups: infected 
pancreatic necrosis (IPN) and non‑IPN patients during the late phase 
of the onset of severe acute pancreatitis
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Introduction The acute pancreatitis appears as a pathology that 
we can define with difficulty because of its clinical presentation or 
prognosis.
Patients and methods In our study, we analysed 102 cases of acute 
necrotic and hemorrhagic acute pancreatitis, hospitalized at the 
department of resuscitation of the surgical emergencies (P33) of the 
UHC Ibn Rochd Casablanca during the period (2009–2015).
The purpose of this study is to do a descriptive analysis of the epidemi-
ologic, clinic, radiological, therapeutic and evolutive data of the acute 
necrotic pancreatitits, we included in our study 102 patients with epi-
demiologic, clinic, radiologic, biologic criteria of acute necrotic pancre-
atitits diagnosis whatever is the biliary or alcoholic etiology.
The valuation gravity of the pancreatitis has been based on:
  • Ranson bioclinical score >3/APACHE II >8;
  • Visceral failure.
 • Spreading of the necrosis.
Results The analysis of the results shows that: About the 
epidemiologic aspect: mean age (52  year old), the biliary etiology 
predominates (81%).
About the clinical aspect: pain (95%) vomiting (77%), stop of the 
transit (18%), the visceral distresses are: the shock (34%), respiratory 
distress (40%), and neurological distress (28%).
About the radiological aspect: pleural effusion (42%), abdominal ech-
ography: vesicular lithiasis (60%), dilated principal biliary duct (13%), 
abdominal computerized tomography: stage E (49%).
About the biological aspect: hyperglycemia (80%), hyper-amylasemia 
(68%).
The indexes of gravity that have been appreciated in this study are: 
Ranson score >3 (58%), Imrie score >3 (66%), IGS score ≥6 (47%), OSF 
score ≥1 (70%).
The treatment of the ANHP has been symptomatic in particular and 
the evolution has been characterized by mortality about 38%, the 
cause was particularly infectious.
The prognostic factors predetermined in this study are:
  • Female type (p = 0.0004).
  • Hemodynamic distress (p = 0.00005).
  • Respiratory distress (p = 0.0000001).
  • Scores of gravity:
  • Ranson >3 (p = 0.0000001).
  • Imrie >3 (p = 0.02).
  • OSF ≥ 1 (p = 00001).
  • Infection (p = 0.0000001).
  • Duration of the hospitalization (p = 0.02).
 • Rate of C-reagent protein (p = 0.001).
Conclusion In conclusion, the mortality is still high in the ANHP, con-
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Introduction Cirrhotic patients undergoing an initial liver 
transplantation (LT) have a 1-year survival exceeding 85%. Some 
cirrhotic patients present organ failures at the time of LT defining 
Acute-On-Chronic Liver Failure (ACLF). The aim of this study was 
to build a decision-tree algorithm for predicting 90-day mortality 
in transplanted patients, by assessing the independent prognostic 
contribution of ACLF.
Patients and methods All patients transplanted between 2008 and 
2014 (N  =  4789) were included as part of the OPTIMATCH study, 
yielding 4010 patients with complete data for the present analysis. 
Data collected comprised clinical and biological features at the time of 
LT for recipients and their donors, assessing ACLF status according to 
ACLF/CANONIC criteria to categorize patients. A survival Classification 
and Regression Analysis (CART) algorithm was applied to build the 
prognostic model for 90-day mortality.
Results 1657 patients (41%) met the CANONIC criteria of ACLF with at 
least one organ failure (1: 20.3%; 2: 12.6%; 3 and more: 8.4%). Over-
all 90-day mortality rate was 7.6%, with corresponding rates of 5.4, 
7.2, 10.2 and 20.1% in patients with 0, 1, 2, 3 and more organ failures, 
respectively. Decision-tree modelling identified 12 subgroups further 
classified in 4 increasing risk classes (Fig.  20), highlighting the prog-
nostic importance of respiratory failure and acute renal failure at the 
time of LT, as well as complex interactions between donor and recipi-
ent features.
Discussion
Conclusion Ventilator support and/or acute renal failure at the time 
of LT are major predictors of mortality but complex recipients/donors 




Fig. 20 Decision tree freom CART survival analysis (a) and corre‑
sponding Kaplan–Meier curves (b)
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Introduction Evaluation of morbidity and mortality in ICU is crucial to 
determine risk factors and improve clinical outcome. The aim of our 
study was to identify risk factors of postoperative morbidity and mor-
tality of gastrectomy for cancer.
Patients and methods We conducted a retrospective monocentric 
study in surgical ICU of UH Ibn Rochd of Casablanca. Were included all 
patients admitted for gastrectomy for cancer between January 2014 
and December 2015. Clinical, radiological and biological data was col-
lected. Patients were categorized into 2 groups: Group A including 
patients who developed postoperative complications and Group B 
including patients who didn’t. The qualitative data were expressed as 
absolute value and percentage. Quantitative data were expressed as 
mean. Categorical variables were compared by a Chi2 test or Fischer 
test. Comparing the quantitative variables was performed by a Stu-
dent’s t test. Odds ratios were calculated with 95% confidence inter-
val and a difference was considered significant if p < 0.05. Multivariate 
analysis was performed by a test logistic regression. Statistical analysis 
was performed using the Epi-Info software 3.5.4.
Results Sixty patients were enrolled. The sex-ratio was 1.7. The mean 
age was 59.8 ±  11.7  years. The mean ASA score was 2 (±  0.7). Eight 
patients (13.3%) had a medical history of diabetes. Nineteen patients 
(31.7%) had cardiovascular diseases (high blood pressure, arythmia, 
heart failure). Seven patients (11.7%) had at least one family history of 
gastrointestinal cancer in a related. The postoperative body mass index 
(BMI) was 23.2 ± 3.2 kg/m2. The mean albumin level was 31 +/9.3 g/l. 
Twenty-two patients (35%) suffered from malnutrition and had 
received preoperative nutritional rehabilitation. The most frequently 
reported tumor location was the gastric antrum (40%). Five patients 
(8.3%) had a pan-gastric extension. Preoperative chemotherapy was 
performed in 18.3% of patients. Total gastrectomy was performed in 
28 patients (46.7%). Twenty-three had partial gastrectomy (2/3), and 9 
subtotal gastrectomy (4/5). Enlarged gastrectomy was performed in 3 
patients (5%). The mean operative time was 244.3 ± 58 min. Per-opera-
tive transfusion was required in 14 patients (23.3%). The average length 
of stay in ICU was 8.2 ±  5  days. Postoperative mortality was 6.7%. In 
our series, 13 patients (21.7%) had at least one postoperative com-
plication: An anastomotic fistula diagnosed in 7 patients (11.7%), 12 
patients (11.3%) had postoperative peritonitis and 6 patients had venti-
lator associated pneumonia. Reoperation was necessary for 13 patients 
(21.7%), it was performed after 7.2  days (2–18  days). In univariate 
analysis, risk factors for postoperative morbidity after gastrectomy was 
hypoalbuminemia (p = 0.0145), anemia (p = 0.0001), BMI (p = 0.001) 
and malnutrition (p  =  0.007). Age, sex, neoadjuvant chemotherapy, 
extended lymphadenectomy, splenectomy or pancreatosplenectomy, 
total gastrectomy and operative time were not significantly associated 
with higher postoperative morbidity. In multivariate analysis, malnutri-
tion (p = 0.01) and BMI (p = 0.001) were significantly associated with 
the occurrence of postoperative complications.
Conclusion The results of our study are similar to those reported in 
medical literature. Preoperative evaluation and nutritional rehabilita-
tion are crucial to improve patient’s outcome and reduce morbidity 
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Introduction The mesenteric ischemia is a condition relatively rarely. 
It is marked by high mortality. Mortality is primarily related to the land 
on which ischemia occurs and especially the time taken to diagnose. 
This delay is due to the low specificity of clinical signs and the absence 
of diagnostic laboratory test. The mesenteric ischemia remains a diag-
nostic and therapeutic challenge.
Patients and methods Twenty cases of acute mesenteric ischemia 
have been collected at the surgical resuscitation (resuscitation 33) at 
the hospital center IBN ROCHD of Casablanca from January 2010 to 
December 2015.
Results The mean age of our patients is 50 year old. It is about a dis-
ease that the incidence increases these last years, particularly because 
of the waxing number of old patients and/or suffers from advanced 
cardiovascular diseases.
The cardiovascular risk factor has been present in 35% of our patients.
The abdominal pain has been present in all the patients. It is a sudden, 
intensive pain localized the most often at the level of the epigastria, 
becomes diffuse in few hours or even few days. Other clinical signs 
have been described as the bilious vomiting that becomes fecaloid 
after few days. The digestive hemorrhages as the moelena and the 
hematemeses. A stop of the matter and the gazes was noticed in 25% 
of our patients.
The absence of specificity of the clinical signs forced the realization of 
complementary examinations.
The scanner becomes the reference imaging. It permits a differential 
diagnosis, the search of direct signs of vascular obstruction and the 
emphasis of intestinal pain.
Four etiologies are noticed: The arterial occlusion by emboli (40%), the 
arterial thrombosis (20%), the venous thrombosis (25%) and the “non 
occlusive” form (15%).
The strategy of management of the acute mesenteric ischemia is mul-
tidisciplinary, based on the equips of radiology, vascular surgery and/
or visceral surgery and resuscitation.
The treatment consists in measures of general resuscitation, the 
techniques of endoluminal vascular disobstruction and techniques of 
surgical revascularization.
In spite of the improvements in the diagnosis and the therapeutic 
procedure of the IMA, the disease still know a rate of mortality 
between 60 and 97% according the studies.
In our study, we noticed 8 cases of death (40%), 9 cases of good 
recovery (45%), 3 cases are unknown evolution (15%).
Conclusion It is a vital emergency that the evolution still knows great 
mortality. It is very important to remind the acute mesenteric ischemia 
in the case of any acute abdominal symptom in order to anticipate 
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Introduction Extracorporeal Membrane Oxygenation (ECMO) is 
responsible for hemostatic disorders, increasing the risk of bleeding 
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during invasive procedures. Particularly, outcome of patients 
undergoing digestive surgery while on ECMO has been poorly 
reported to date. This study aimed to describe the outcome of 
critically ill ECMO patients undergoing emergent digestive surgery, 
in comparison to a population of non-ECMO patients operated in the 
same unit.
Materials and methods Retrospective single-center study.
Results Data are expressed as % or median (IQR).
Between 2006 and 2014, 35 patients with ECMO and 42 patients 
without ECMO underwent emergency digestive surgery. The main 
indications were intestinal ischemia (43% ECMO vs. 41% non-ECMO, 
ns) and cholecystectomy (23 vs. 26%, ns). Patients on ECMO were 
younger [59 (43–64) vs. 64 (54–74) years; p = 0.02] but had a higher 
preoperative SAPS II score [79 (70–90) vs. 71 (44–83); p = 0.03]. There 
were significantly more reinterventions for bleeding in the ECMO 
group (20 vs. 2%, p = 0.02) and a greater need for blood transfusion 
within 72  h after surgery (13 packed red blood cells (6–22) vs. 3 
(0–5); p  <  0.0001). In multivariate analysis, ECMO remained strongly 
associated with the occurrence of bleeding (OR 5.6; CI [0.2–15.4]; 
p  =  0.001). ICU mortality was significantly higher in patients under 
ECMO (69 vs. 33%; p  =  0.003) but perioperative mortality remains 
comparable between groups (14 vs. 12%, ns). These results were 
confirmed in a sensitivity analysis in 36 ECMO and non-ECMO patients 
matched on the pre-operative SAPS-II score, age, and type of digestive 
surgery.
Conclusion In critically ill patients undergoing emergent digestive 
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Introduction Emergency Departments staff are frequently exposed 
to many complex stressful situations and consequently burnout 
syndrome. Our study aimed to describe epidemiological particularities 
and determine the risk factors of burnout syndrome in different 
categories of emergency.
Patients and methods We studied five academics and four regional 
hospitals. The level of burnout was assessed using the “Maslach 
Burn Out Inventory” score and the degree of depression with Major 
Depression Inventory (MDI) test.
Results One hundred and forty-three correctly completed ques-
tionnaires were collected. The mean age of study population was 
32 ± 7 years. Sex-ratio was at 0.63. Fifty-one per cent of the care staff 
were married. Physicians represented 40% and paramedical 60%. The 
general frequency of Burnout syndrome was 85% (n = 127). Low level 
Burnout was present in 32%, moderate level in 45% and high level in 
23%. The depression frequency was 52%.
A statistically significant correlation was found between burnout and 
depression firstly (p = 0.006) and between burnout and lack of equip-
ment (p = 0.04). Their relative risk was 4.7 [1.5, 15] and 9.14 [2.2, 37.6] 
respectively).
Main risk factors associated with high level burnout are detailed in 
Table 22.
Conclusion Burnout syndrome frequency in our emergency depart-
ments is alarming. Helping to resolve social and psychological prob-
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Introduction The healthcare activity is recognized as a major pollut-
ing activity. In France, it generates 800,000  tons of waste cremated 
each year, and represents 12% of the tertiary energy consumptions. In 
the United States, it generates 7000 tons of waste per day and 7% of 
total CO2 emissions in 2007 were attributed to him. Ultimately, such 
waste production is associated with adverse environmental and health 
effects. Nevertheless, near half of the hospital waste would be recycla-
ble, particularly in our intensive care units (ICU) [1]. Furthermore, sus-
tainable development solutions generate profits.
The aim of this study is to make an overview of waste produced in a 
ICU and offer solutions to conserve natural resources and reduce the 
carbon footprint bound to the healthcare activity.
Materials and methods Experimental study, single-center, 
concerning a period of 6  months in an ICU—high surveillance unit 
compound of 16 beds. We have identified all waste generated. Our 
packaging were given to the recycling company in connection with 
the hospital. Then we have studied the impact of the implementation 
of sustainable development solutions.
Results Firstly, we have studied the non-recycled waste and the 
quantity produced over a period of 1  month. Approximately 8  kg of 
waste is produced per patient per day with 45% of infectious waste 
and 55% of general waste. These results were linked with a bad 
distribution of garbage bags in the rooms (130  L of infectious waste 
versus 50 L of general waste).
Secondly, we have improved our way to sort and consume and we 
have created recycling dies without compromising patient safety. All 
these measures have not increased workload.
Changing bags in the rooms (20  L of infectious waste and 2 bags of 
50 L of general waste) allowed to reach the normal goals of 2 sectors 
with a net benefit estimated at 4500 euros per year.
The medical broken glass containing drugs was thrown into plastic 
containers of 5  L for infectious waste to prevent the risk of cuts. 
By creating a specific die intended to the general waste, we could 
quantify the production of this glass to 10 kg per week and to spare 
the use and the incineration of 350 containers of 5 L per year (global 
economy of 1000 euros).
Table 22 Factors associated with high level burnout







P RR 95% CI
Conflictual 
situations
29 (100%) 85 (74%) 0.19 – –
Civil state: 
married




20 (68%) 44 (38%) 0.06 9.708 [1.326, 5.530]
Medical staff 8 (27%) 51 (44%) 0.8 – –
Heavy work‑
load




9 (31%) 72 (63%) 0.14 – –
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Plastic packaging represented an important proportion of the cre-
mated waste. We have created 3 sectors of recycling including the 
polypropylene (80–200 kg per month), the polyethylene colorless and 
colored polyethylene. This plastic is sold to be recycled without addi-
tional cost for the hospital.
The linerboards was cremated. We have created a recycling die 
(50  kg per month). This sector was subsequently extended to the 
entire hospital structure, particularly the pharmacy that produces 12 
containers of 400 L per month. They are now sold without additional 
cost.
Many unnecessary plastic waste is generated daily. We have removed 
using mild soap plastic bottles of 30 ml by using the same mild soap 
in pump of 500 ml (economy of 1000 euros). The use of 100 L plastic 
bags for the transitional deposit of linen has been deleted (economy 
of 450 euros).
Concerning the paper: 100% of the impressions were made in sim-
plex. Printers were parametrized on both sides by default allowing the 
economy of 60 reams per year (30,000 sheets), several thousand liters 
of water and the reduction of CO2 emissions.
Discussion Recycling is only one component of the sustainable devel-
opment in health. Other avenues that could be considered to improve 
ICU sustainability would include examining water use (for linen), 
electricity use (reducing non-essential use at night…). Beyond these 
actions, we need to encourage our suppliers to turn to sustainable and 
recyclable packages to reduce the use of polluting and depletable fos-
sil fuels such as oil. But also to develop with them circular economies 
where waste is returned to them to be reused.
Conclusion We must ask the question also resuscitate our tons of 
waste. Our ICU produce large quantities of waste (over 2  tons per 
year per bed). However, a significant proportion, especially plastic, 
is recyclable with a significant environmental and financial benefit. 
Waste management also requires an optimal and rational use of 
supplies because “the best waste is that which is not produced” and 
that excess is not a guarantee of quality.
As already said St Exupéry in 1939: “We do not inherit the Earth 
from our parents, we borrow it from our children.” So do not expect 
tomorrow to reduce major adverse ecological impact paradoxically 
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Introduction Point of care ultrasonography (US) is more are more 
used in Intensive Care Unit. It should be performed to answer ques-
tions with a dichotomous response (yes or no or I don’t know). 
Whereas hand held US (HHUS) devices are well fitted to this practice, 
the place of new available pocket size US (PSUS) devices has still to 
be delineated. The aim of the present study was to compare quality 
of portable and pocket size US devices and to assess the agreement 
between the two modalities.
Patients and methods During a 8-month period every cardiac, pul-
monary or abdominal point of care US exam deemed to be performed 
between 08.30 am and 07.00 PM with a HHUS device was eligible. Vas-
cular exam were excluded. Every US exam was performed twice, with 
our regular HHUS device (MTurbo®, Sonosite, Bothwell, MA, USA) and 
with a PSUS (Vscan®; GEHealthcare, Wauwatosa, WI, USA) equipped 
with a phased-array probe 1—5  MHz and 1.7—3.8  MHz respectively. 
HHUS and PSUS were performed at random by intensivists skilled in 
general ultrasonography and mastering at least a basic level of echo-
cardiography. Exam duration as soon as US device was working, imag-
ing quality assessed using a semi quantitative scale (0 nothing is seen 
to 4 excellent) were recorded. Several items were assessed: left ven-
tricular ejection fraction (normal, moderately or severely depressed), 
right ventricular dilation (RV < 0.6LV, RV = LV, RV > LV), IVC variation 
(present or not), Pleural effusion (present or not, centesis feasible), 
B-lines (less than 3 or coalescent), lung condensation (present or not), 
diphragmatic excursion ascites (present or not, centesis feasible), kid-
ney visualization (yes or no), obstructive uropathy (present or not), 
intrabiliary duct dilation (present or not). Demographic and descrip-
tive data are expressed as mean ± 1 SD or median IC25%–75%. Pro-
cedure duration ultrasonographic were compared using the Student 
t test. Answers to the questions were yes, no, or do not know. Agree-
ment between the answers to clinical questions was assessed using 
the Kappa Cohen coefficient.
Results During the study period, 71 US exams were performed in 38 
patients (71 years [51–82], 28 male, SAPSII:45 (30–55), height 172 cm 
[168–177], weight 74 kgs [65–90], 50% of them receiving mechanical 
ventilation). Duration of exams were shorter with (PSUS (181 ± 97 vs 
225 ±  146, p =  .006). Global imaging quality was better with HHUS 
(2.95  ±  0.87 vs 2.73  ±  0.84, p  =  .004) and was better for cardiac, 
abdominal and lung exams even difference did not reach significancy. 
Simultaneous visualisation of both ventricles on an apical view was 
more frequently impaired with PSUS (27 vs 4.5%, p =  0.04). Among 
the 690 items assessed by both US devices, inability to answer to a 
question was more frequently observed with PSUS than HHUS (6.7 vs 
4.2%, p = 0.05).
Agreement between the two devices for some of the items assessed 
are depicted in the Table 23.
Conclusion Despite a weaker imaging quality and greater 
unconclusive exam rate, this study suggests that pocket size US device 
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Introduction There is a growing interest in long-term outcomes of 
patients aged 80 and over. Survival rate ranges from 20 to 30% 1 to 
2 years after intensive care unit (ICU) admission according to different 
publications. A better knowledge of patient’s short-term prognosis 
Table 23 Agreement between  HHUS and  PSUS for  some 
of the items tested
Question Case Discrepant results K coefficient
Pleural effusion (38) 19 5 0.71 [0.56–0.87]
B‑lines (38) 29 5 0.69 [0.55–0.83]
Lung consolidation (38) 12 3 0.71 [0.52–0.90)
Obstructive uropathy (25) 3 0 1
LVEF (23) 7 3 0.7 [0.51–0.89]
VD (23) 1 3 0.61 [0.42–0.79]
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and the inherent risks of ICU care impeding recovery would provide 
intensivists with management guidelines for ICU admissions and pro-
cedures for clinical practices. Physicians could adapt medical care to 
outcomes which could be expected rather than limiting to age. This 
study aims to analyse 6-month mortality in patients aged 80 and over 
following admission to an ICU, to investigate withholding/withdraw-
ing (Wh/Wd) life sustaining treatment decisions and to identify predic-
tors of 6-month mortality.
Patients and methods We conducted a retrospective, observational, 
cohort study including all elderly patients (≥80 years) admitted from 
1st January 2012 to 31st December 2013 in a medical-surgical ICU in a 
French district general hospital.
Results 109 patients (13%) who were at least 80  years old were 
selected for the study out of the 814 patients admitted to the ICU dur-
ing the study. 76 (70%) had medical conditions and 29 (27%) required 
unscheduled surgery. The mean SAPS II score was 57  ±  21 and the 
mean APACHE II score was 19  ±  8. During the ICU stay, 85 (78%) 
required mechanical ventilation, 74 (68%) catecholamines, 32 (30%) 
blood transfusions, 22 (20%) needed additional renal support and 15 
(14%) neuromuscular blockade. More than 80% needed antibiotics.
Six-month mortality was 58% (63/109), with no significative difference 
between age, sex or reasons for admission. Two-thirds (41/63) of 
deaths occurred in ICU with a mean length of ICU stay of 9 ± 9 days. 
ICU-mortality of our study population was significatively higher than 
ICU-mortality of the 705 younger patients (<80 years) admitted during 
the same period (38 vs 22%, OR 2.1, 95% CI [1.4–3.2], p = 0.001). This 
was particularly significant for male mortality (41 vs 20%, OR 2.8, 95% 
CI [1.7–4.8], p < 0.0001), but not female (32 vs 26%, p = 0.453). Two-
thirds of patients were alive 6-month after their ICU visit, although 
19% were to die during their hospital stay. Less than 6% of patients 
followed up with a specific geriatric care after discharge the ICU.
The SAPS II score, the APACHE II score, severe sepsis and Wh/Wd 
decisions were independently associated with 6-month mortality 
(SAPS II  ≥  60, OR 3, CI95% [1.1–8.5], p  =  0.034; APACHE II ≥19, OR 
3, CI95% [1.1–8], p  =  0.029; severe sepsis, OR 6.2, CI95% [1.1–33], 
p =  0.034; Wh/Wd decisions, OR 14.7, CI95% [4.5–47.8], p  <  0.0001). 
75% (31/41) of patients died in ICU were identified for Wh/Wd 
treatment, this represented 63% of 6-month deaths. More than 
88% (40/45) of patients who had Wh/Wd decisions during ICU stay 
died within 6  months. In contrast, 89% of survivors had no Wh/Wd 
treatment during their ICU stay.
Conclusion This study confirms that physicians should not reject ICU 
admission simply on the basis of 80  years old or over. Initial clinical 
severity measured by usual prognostic scores, severe sepsis, as well 
as withholding/withdrawing decisions made during the ICU stay, are 
independent risk factors of 6-month mortality. Six-month survival 
in these patients is far from negligible. Future research on patient’s 
prognosis after an ICU stay should clearly concentrate on the existence 
of a comprehensive geriatric system of care and on Wh/Wd treatment 
decisions. Special attention should be paid to the Wh/Wd decision-
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Introduction In-ICU admission of critically ill patients depends partly 
on benefits expected. Then, some patients are not admitted in ICU 
because of a high risk of mortality and/or a poor expected quality of 
life after ICU hospitalization. While ICU readmissions increase mor-
bidity and mortality, decisions of “non-readmissions” are taken for 
patients who had underwent very difficult ICU hospitalizations. But 
«non-admission» and «non-readmission» decisions lead to limit initia-
tion of life-sustaining therapy for (potential) life-threatening patients. 
Then, these are decisions to forgo life-sustaining treatment as defined 
by the French law enacted in April 2005 (the so-called Leonetti’s law). 
The aim of this study is to evaluate practices concerning ICU «non-
readmission» decisions.
Materials and methods We performed a survey among French inten-
sive care physicians by electronic questionnaire between December 
2015 and January 2016 to evaluate «non-readmission» practices. The 
questionnaire consisted of 27 items relating to various aspects of the 
decision process. We also recorded responders’ socio-demographic 
data (age, sex, length of practice, type of ICU in which they practiced). 
Qualitative variables were expressed in percentages and were com-
pared according socio-demographic data using the Chi-2 test or Fisher 
exact test.
Results Among 653 physicians contacted, 165 (25.3%) completed 
the questionnaire. Responders were mostly male (sex ratio 3:1), aged 
between 35 and 50 years and were experienced for years in intensive 
care. «Non-readmission» decisions are mainly taken at the end of 
ICU hospitalization (87%) following a collegial discussion (89%). 
However, patients, relatives and/or family, external consultant or 
general practitioner are marginally involved in the decision process 
(respectively 10, 34, 14 and 29% cases). If 73% of the relatives are 
informed of the «non-readmission» decision, less than a third of 
patients receive this information. Once decision made, the latter 
is notified in the patient’s medical record in 93% cases. However, 
96% of responders consider having the right not into account this 
decision as appropriate. In addition, 92% of doctors consider clearly 
a difference between readmission’s request for a new acute episode 
and the same request for a worsening of a chronic disease. Otherwise, 
palliative care program is decided jointly to the «non-readmission» 
decision in only 41% of cases. Finally, 91% of responders consider the 
«non-readmission» decisions as fully parts of the law of April 2005. 
Secondary analyzes have not identified any difference according to 
socio-demographic groups.
Conclusion Evaluation of «non-readmission» decisions shows 
a defective process regarding French legal and ethical aspects. 
Particularly, patients themselves are insufficiently involved in 
discussion and/or informed of decisions about their own health. 
Moreover, an external consultant is rarely applied and palliative cares 
are insufficiently developed after «non-readmission» decisions. For 
providing corrective measures, this study lead to propose a «non-
readmission» process by integrating the discussion for a real «patient’s 
care project» at the end of the ICU hospitalization. This process would 
lead to collect patient’s opinion through advance directives, to ensure 
a collegial discussion including an external consultant and to allow 
reevaluation of global patient’s clinical status and one or more organ 
failure(s). Then, «non-readmission» decisions would be integrated in a 
therapeutic project which would promote the initiation of a palliative 
care program if necessary. The purpose of this process is well to 
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Introduction The proportion of elderly patients is steadily increas-
ing. Due to the growth of this part of the population who suffer from 
multiple pathologies, the need for hospitalization in intensive care 
increases. According to the simulations, the proportion of octoge-
narian patients in ICU will increase reaching the third of ICU patients. 
While chronological age is not a significant factor of poor prognosis 
in the ICU (1), many factors should be taken into account to evalu-
ate the relevance of ICU admission in the senior population and 
withholding such intensification should be consensually discussed 
between clinicians and obviously as often as possible with the 
patient himself (2).
The aim of the study was to assess the role of stakeholders (ward phy-
sicians, intensivists, family doctor and patient himself ) in the decision 
of withholding ICU admission for elderly patients in our internal medi-
cine department.
Patients and methods We made a prospective observational mono-
centric study, including all the elderly patients (defined as older than 
75) admitted in the internal medicine department from January 2012 
to June 2012. The only non-inclusion criterion was patient’s refusal to 
participate to the survey.
Collected data involve physiological (cognitive, autonomy, nutritional 
status), morbidities (acute and chronic diseases) and social parameters 
(marital status, relatives). And evaluation of quality of life by the 
patient himself using an analog visual scale was also obtained.
Internal medicine physicians were asked to report any ICU withholds 
decision for their patients. In absence of notification, every physician 
was questioned again the day of the concerned patient’s discharge.
Results One hundred ninety-one patients were included between 
January and June 2012. The average age of the study population was 
85.7 ±  6.01  years. A decision of therapeutic intensity limitations was 
made for 96 patients (50.2%). Lack of decision concerning potential 
ICU transfer was noted for 7 patients (3.6% of cases).
In 60.4% (58 of 96 patients) of cases withholding ICU decision was 
taken by the attending physician, alone. Family physicians was 
involved in limitation decision in only 77 (40.3%) of cases. During the 
period of the study, ICU physician were involved in only 3 decisions 
about potential intensification of therapeutic interventions in patients. 
Concerning patient for whom a therapeutic limitation was taken, 46% 
did not want to take an active part in decision affecting their potential 
intensity of care. On the other hand, patient’s opinion was not sought 
in 30.5% of cases.
Factors associated with an ICU withholding decision were the 
presence of advanced cognitive impairment (26% of limitation 
decisions), dependency (Katz scale ≤4; 22.9%), high comorbidities and 
age (86.9 vs 82.8 years; p = 0.002).
Discussion The absence information regarding refusal decision 
actually made by intensivist can be considered as a weakness of the 
study. Nevertheless, systematic prospective information of limitation 
decisions before potential ICU proposal of critical patients show the 
weak involvement of intensivist about intensification decisions in our 
hospital.
Conclusion ICU withholding is relatively frequent in internal medicine 
department, notably due to the importance of elderly and comorbid 
admitted patients. Despite medical societies and law recommenda-
tions, lonesome limitation decision remains surprisingly frequent. 
Patients’ participation in this reflection is made difficult both because 
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Introduction The French law and recent expert opinions have empha-
sized the need for a multidisciplinary approach in decisions to forgo life 
sustaining therapies for the critically ill. We sought to assess how ICU 
nurses actually rank their involvement and perceive this process.
Materials and methods We conducted a cross sectional survey using 
a web-based questionnaire between June and September 2016.
Results Of the 38 ICUs invited to participate, 22 (58%) agreed. A 
total of 541 ICU participants completed the survey of whom 73% 
were nurses and 26% assistant nurses. Median age was 31 (Inter 
Quartile Range 27–38)  years and 84% were female. Median work 
experience was 7 (4–12) years and time in the ICU was 5 (3–8) years. 
Eighty-five percent of the participants have been involved at least 
once in a multidisciplinary end-of-life discussion. Less than half of the 
participants reported a good (4%) or partial (44%) knowledge of the 
current end-of-life legal framework.
The decision to start a discussion about Withdraw Life-Sustaining 
Therapy (WLST) was initiated by a senior intensivist in 83% of the 
cases, by a nurse in 5% and an assistant nurse in 0.6%. This decision 
was approved by 97% of the participants. The decision-making 
process was considered to be initiated at the right time for 49% of 
the participants, too late for 48%, and too early for 3%. The discussion 
occurred mostly in the afternoon (38%) or during the medical staff 
(22%), in a dedicated place in 63% of the cases. A median of 7 (5–10) 
health-care professionals attended the WLST discussion.
Half the respondents reported being reluctant to talk during the 
discussions and 11% never expressed their own opinion. Indeed, 
although the length of the discussion was 30 (15–45)  minutes, par-
ticipants estimated to talk during only 3 (1–5) minutes. The following 
reasons were mentioned by the participants to explain these facts: 
having cared for the patient for too short time (62%), lack of medical 
knowledge (35%), decision of WLST already taken by the medical staff 
(31%), their opinion not really taken into account (19%), reluctant to 
talk during meetings in general (18%), consider that the discussion is 
limited to a medical expertise (15%), limited professional experience 
(14%), and fear to express a different opinion (12%).
Nevertheless, 84% of the participants were partially (76%) or totally 
(8%) satisfied by the way the decision making process was conducted, 
81% considered that collegiality was applied, and 93% agreed with the 
final decisions.
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Conclusion ICU nurses rank favorably multidisciplinary WLST discus-
sions. Nevertheless their involvement in the discussion remains lim-
ited. Beyond factors related to work organization and professional 
experience, efforts should be made to recognize their role and value, 
and to encourage them to share their own opinions with the other 
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Introduction The aim of this study was to assess determinants and 
the prognostic value of high-sensitivity cardiac Troponin T (hsTnT) 
elevation in intensive care unit (ICU) patients with vasodilatatory 
shock (VS).
Materials and methods A prospective observational cohort 
study conducted in an ICU. Patients hospitalized for VS were 
consecutively included between October 2014 and December 2015. 
This observational study was approved by the Ethics Committee 
of Félix Guyon University Hospital (R14008). Clinical, laboratory, 
electrocardiography and echocardiography data were collected within 
24 h of admission. Established criteria for the diagnosis of VS were as 
follows: (1) vasopressors required despite adequate fluid loading to 
achieve a mean blood pressure >65  mmHg; (2) absence of elevated 
left-ventricular filling pressures at transthoracic echocardiography; 
(3) signs of impaired organ perfusion and (4) absence of positive 
inotropes.
Values of hs-cTnT with exponential distribution were log10 
transformed for linear analyses. Univariate (t-test and Pearson 
correlation test) and multivariate analysis were used to examine 
correlations of variables with log10(hs  −  cTnT). Predictive factors of 
in-hospital mortality in bivariate analysis with P  <  0.05 were entered 
into a multivariate logistic regression analysis using backward 
selection with P  <  0.05. Results are expressed as median [25th–75th 
percentiles], mean ± standard deviation or number (%) as appropriate.
Results During the study period 206 patients were hospitalized 
in ICU for VS (71.8% with septic shock) with a mean simplified 
acute physiology score 2 of 58 ±  17. Among them 185 (89.8%) had 
hsTnT > 14 pg/mL and the median peak of hsTnT was 55.1 [24.5–136] 
pg/mL.
Combining all variables following multivariate analysis, high body 
mass index (t =  2.52, P =  0.01), low left ventricular systolic function 
(t  =  −2.73, p  =  0.007), high white blood cell count (t  =  3.72, 
P  =  0.0001), low creatinine clearance (t  =  −2.84, P  =  0.0005), high 
lactate level (t = 2.62, P = 0.01) and ST-segment depression (t = 3.98, 
P  =  0.0001) best correlated with elevated log10 transformed hsTnT 
concentration. Left ventricular diastolic dysfunction defined by the 
presence of a lateral E′ maximal velocity <10 cm/s did not significantly 
correlate with log10 (hsTnT) (T = 1.41, P = 0.16).
Seventy-seven patients (37.4%) died in-hospital. Following univari-
ate analysis peak of hsTnT was higher in non-survivors (67.4 [32.5–
167]  pgmL) than in survivors (50.1 [20.9–121.3], P  =  0.027). After 
multivariate analysis, peak of hsTnT was not associated with a signifi-
cant reduction of in hospital mortality (aOR 0.99 [95% CI 0.93–1.02]). 
Factors associated with a significant reduction of in hospital mortality 
were higher age (P = 0.002), higher lactate level (P = 0.004), chronic 
obstructive pulmonary disease (P = 0.04), diabetes mellitus (P = 0.03), 
immunodepression (P = 0.05) and respiratory failure (P = 0.02).
Conclusion In patients hospitalized for VS high body mass index, 
low left ventricular systolic function, high white blood cell count, low 
creatinine clearance, high lactate level and ST-segment depression are 
the variables correlating significantly with high-sensitivity troponin-T 
concentrations. Peak of hsTnT was not significantly associated with 
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Introduction Mitochondria are evolutionary endosymbionts that are 
derived from ancestral aerobic bacteria and so might bear and release 
bacterial molecular motifs supporting the role of mitochondria in 
danger signal regulations. Free circulating mitochondrial DNA (mtDNA) 
is elevated in a wild range of critical illness observed in intensive 
care units, and is associated with bad outcomes and mortality. The 
mtDNA is a molecular pattern that belongs to mitochondrial damage 
associated molecular patterns (mtDAMPs), and can interact with 
pattern recognition receptors (PRR) to induce self defense reaction. 
Free mtDNA activates inflammatory signaling pathways through 
Toll-like endosomal receptor 9 (TLR9) interactions. Nevertheless, new 
evidence advocates a role of the receptor for advanced glycation 
end-products (RAGE) in mtDNA signaling. Experimental data suggest 
a role of mtDNA-PRR interaction in systemic inflammation and organ 
dysfunctions as septic acute kidney injury or pulmonary inflammation. 
Impact of free circulating mtDNA on endothelial cell is not known.
The main purpose of this study was to test whether mtDAMPs and 
mtDNA can induce endothelial dysfunction. We also evaluated the role 
of mtDNA-RAGE axis in mtDAMPs induced endothelial dysfunction.
Materials and methods Mitochondria 
were isolated from livers of wild type C57B6 
mice. Isolated mitochondria were sonicated on ice to obtain mtDAMP 
preparations. Semi quantitative evaluation of mtDAMP content was 
tested by qPCR, with specific markers of mtDNA (cytochrome B (cytb), 
NADPH oxidase (ND4)). Intraperitoneal injection of 1 mg of mtDAMPs 
was used as experimental model in wild type and RAGE KO mice, as 
previously described [1]. The mtDAMPs were also administrated after 
ex vivo DNAse preparation. Endothelial function was assessed with a 
Mulvany-Halpern style myograph, 4  h after mtDAMP administrations 
on aorta (conductive vessel) and on 2d division of mesenteric artery 
(resistive vessel). Endothelial-dependent relaxation was studied 
by cumulative expositions of the vessels to acetylcholine (1.10-10–
1.10-5 M). Endothelial-independent relaxation was studied by sodium 
nitroprussiate exposition.
Results The mtDAMPs preparation contains a high quantity of 
mtDNA with a 1/cycle threshold (Ct) ratio of 0.062 for cytb expres-
sion. Intraperitoneal administrations of mtDAMPs induced a decrease 
of endothelial-dependent relaxation mainly on conductive vessel 
(p = 0.0079, n = 5 per group) and to a lesser extent on resistive ves-
sel (p =  0.22, n =  5 per group). RAGE-KO mice were protected from 
mtDAMPs-induced aorta dysfunction (p = 0.53, n = 5 per group). The 
ex  vivo exposition of mtDAMPs to a DNAse preparation decreased 
mtDNA content in mtDAMPs solution with a 1/Ct ratio of 0.038 for cytb 
expression. Eventually, the pretreatment of mtDAMPs with a DNAse 
preparation prevented the mtDAMPs-induced aorta dysfunction 
(p = 0.85, n = 5).
Discussion More than prognostic markers, mtDAMPs particularly 
mtDNA seems implicated in endothelial dysfunction in critically ill 
patient. New evidence suggest RAGE interaction in endosomal TLR9 
pro-inflammatory and pro-oxidant response to mtDNA [2]. Also in 
sepsis, physiological clearance of circulating DNA might be impaired, 
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this results comfort the possibility of therapeutic regulation of free 
circulating mtDNA to prevent septic organ dysfunction related to 
mtDAMPs accumulations.
Conclusion Exogenous mtDAMPs can induce endothelial dysfunction 
in mice. The mtDNA-RAGE axis is a key component of the signaling 
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Introduction The use of dynamic parameters to assess fluid 
responsiveness was supported by cyclic changes in stroke volume 
induced by mechanical ventilation. However, these parameters have 
several limits. Venous to arterial carbon dioxide difference inversely 
related to cardiac index. Consequently, fluid administration would be 
beneficial if carbon dioxide gap increases.
Objective To investigate whether carbon dioxide gap predicts fluid 
responsiveness in patients with acute circulatory failure.
Patients and methods We conducted a prospective study in 
the medical intensive care unit of Hospital Taher Sfar at Mahdia, 
between March 2013 and April 2016. Patients with circulatory 
failure and who required mechanical ventilation were included. 
We measured the variation of cardiac index between baseline 
and after volume expansion of 500  ml of saline fluid. The PiCCO2 
was used to measure cardiac index. Response to fluid challenge 
was defined as a 15% increase in cardiac index. Before and after 
fluid administration, we recorded carbon dioxide difference and 
hemodynamic parameters.
Results Among 68 included patients, 33 (49%) were responders. 
The causes of acute circulatory failure were septic shock (n  =  45), 
cardiogenic shock (n  =  11), and Hypovolemia (n  =  12). Carbone 
dioxide gap was significantly higher in responders group (8  ±  7 vs 
4 ±  4  mmHg, p =  0.019). The area under the ROC curve for carbon 
dioxide gap was 0. 68 (95% CI 0.55–0.80). The best cutoff value was 
6  mmHg (Sensibility  =  46%, specificity  =  80%, positive predictive 
value = 52% and negative predictive value = 60%). The area under the 
ROC curve for delta carbon dioxide was 0.54 (95% CI 0.4–0.68).
Conclusion In this study, baseline carbon dioxide gap was not 
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Introduction Supraventricular arrhythmia (SVA) is commun in 
intensive care unit (ICU). Its incidence seems to be higher in patients 
with sepstic shock. Sepsis-associated myocardial dysfunction promote 
the occurrence of SVA by constituting an arrythmogenic substrate or 
under the effect of inotropic drugs.
The aim of this study is to assess the incidence and prognostic impact 
of SVA in patients with septic shock.
Patients and methods We retrospectively studied all patients with 
new onset SVA suffering from septic shock in non cardiac surgical ICU. 
Myocardial dysfunction was evaluated by transthoracic echography 
(TTE) after an adequate cardiac resuscitation using intravenous fluids 
expansion and adjunctive vasoactive agents. SVA was detected by the 
electrocardiogram scope. During the study period clinical and biologic 
characteristics, hemodynamic tolerance (vasopressors doses, arterial 
pressure changes), current treatment (such as corticoid), duration of 
mechanical ventilation, duration of vasopressor requirement and hos-
pital mortality were collected.
Results Sixty patients were included in the study. The SVA occurred 
in 28 patients, with an incidence of 46%. The median time to onset 
was 2  days. Cardioversion was performed for 15 patients with an 
effectiveness of 80%. Clinical and biological characteristics were similar 
between the groups with and without SVA: SAPS 2 and SOFA score 
at the beginning of septic shock, the existence of ARDS and cardiac 
biomarkers (NT-proBNP, troponin). However, renal failure and the use of 
corticoid in septic shock were more frequent in the group with SVA. The 
maximum doses of vasopressor agent were not significantly different 
between the groups with or without SVA. Myocardial dysfunction in 
sepsis defined by the left ventricle ejection fraction (LVEF) less than 
45% (or the need for inotropic drug for LVEF > 45%) was not associated 
with the occurrence of SVA (+SVA group: n =  8; −SVA group: n =  6; 
p: 0.57). SVA was poorly-tolerated, observed by a significant decrease 
in mean arterial pressure and a significant increase in norepinephrine 
doses within 1  h of the start of SVA. The occurrence of SVA was 
associated with longer duration of use of vasopressor agent and a 
longer duration stay in ICU (+SVA group: 21 days, −SVA group: 14 days; 
p = 0.03). There was no difference in duration of mechanical ventilation 
and hospital mortality between the two groups.
Conclusion The occurrence of SVA is common in septic shock, poorly 
tolerated hemodynamically and associated with longer duration stay 
in the ICU and vasopressor need. Sepsis myocardial dysfunction isn’t 
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Introduction A short term beneficial effect of prone position on 
cardiac index has been shown in 50% of 18 ARDS patients, and was 
related to an increase in cardiac preload in preload responsive patients 
(1). The aim of this study was to evaluate the long term hemodynamic 
response to prone position in a larger series of ARDS patients.
Patients and methods Single center retrospective observational 
study performed on ARDS patients hospitalized in a medical ICU 
between July 2012 and March 2016. Patients included were adults 
fulfilling the Berlin definition for ARDS, undergoing at least one prone 
position session, under hemodynamic monitoring by the Picco® 
device, with availability of hemodynamic measurements performed 
before (T1), at the end (T2), and after the prone position session 
(T3). Prone position sessions were excluded if they were performed 
>7  days after ARDS onset. The following variables were recorded: 
demographic, SAPSII, ARDS severity and risk factor, SOFA score and 
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cumulative fluid balance at PP onset, delay between ARDS session and 
PP session, hemodynamic, arterial blood gas, ventilatory settings, pla-
teau pressure, catecholamine dose and additional treatments. Statisti-
cal analyses were performed using prone position session as statistical 
unit and mixed models taking into account both multiple prone posi-
tion sessions by patient and multiple measurements during a prone 
position session. p < 0.05 was chosen for statistical significance. Data 
are expressed as mean ± standard deviation.
Results 85 patients fulfilled the inclusion criteria over the study 
period, totalizing 149 prone position sessions (2  ±  1 sessions per 
patient). Patients’ age was 65  ±  11 y, 67% were male, 75% fulfilled 
the criteria for severe ARDS, and SAPSII at ICU admission was 64 ± 17. 
ARDS risk factors were pneumonia in 63 (74%), aspiration pneumonia 
in 26 (31%), and sepsis in 7 (8%) patients. Duration of prone position 
sessions was 16 ± 3 h. Hemodynamic measurements were performed 
in PP 13 ± 3 h after PP session onset. At session onset, SOFA score was 
15 ± 4, and cumulated fluid balance was 2.5 ± 7.1 L. Vasopressor were 
used in 87%, inhaled nitric oxide in 22%, and neuromuscular blocking 
agents in 91% of the sessions. Hemodynamic and respiratory param-
eters before, during and after the prone position sessions are reported 
in Table 24.
Cardiac index increased by at least 15%, decreased by at least 15% or 
remained stable in 35 (24%), 36 (34%), and 78 (52%) of the sessions, 
respectively. As compared to both other groups, PP sessions with sig-
nificant increase in cardiac index had the following significant differ-
ences at T1 by univariate analysis: lower cardiac index, lower global 
end-diastolic volume, lower cardiac function index, and lower vaso-
pressor dose. Multivariate analysis is under investigation.
Conclusion Prone position is associated with an increase in global 
end-diastolic volume, reversible after return in supine position that 
may explain the positive effect of PP on cardiac index observed in ¼ 
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Introduction Make sure that our patient have a good circulatory 
condition is a daily challenge for the intensivist. One of the 
therapeutics is fluid and one of his purpose is to increase venous 
return and then cardiac output. In order to examine that, There are 
several tools as the transthoracic echocardiogram wich allows the 
visualisation and the study of the respiratory variability from the 
inferior vena cava (IVC). Unfortunately there are some situations where 
the IVC visualisation is difficult (obesity, gut surgery, emphysema). 
The IVC is easily seen by a transhepatic ultrasound in her retrohepatic 
section. We make the hypothesis that the shape of the IVC could be 
predictive of fluid responsiveness.
Patients and methods We have performed fluid challenge in 
patients under mechanical ventilation. The need for fluid therapy is 
the intensivist in charge decision. We performed a echocardiogram 
and we take two measures of the ICV: major axis and minor axis, 
the ICV is measured avec the sus hepatic vena. A elastometry index 
(EI) is determined which is the ratio of minor axis to minor axis. The 
fluid challenge is 250  ml of isotonic saline then we perform a new 
echocardiogram. A Tag is written on the patient to take the same 
ultrasound slice. We retain one increase of 15% of the cardiac index 
(IC) as a success of the filling. We exclude the presenting patients A 
right cardiac insufficiency, an arrhythmia and/or a HTAP. The statistical 
analysis is realized with the software R.
Results Between August, 2015 and January, 2016 we included 
49 patients. The average age is of 59  years (24–81), IGS2 
of 48 (20–84), Ejectionnal Fraction of 48% 35–75) and the S wave tri-
cuspid is 14 (9–21). The causes of the filling were an oliguria (31%), a 
low blood pressure (20%), a low cardiac output (30%), a hyperlacta-
témia (9%) and an other cause in 10% of the cases. We find a positive 
correlation between the EI and the increase of the IC, also for the area 
of the VCI and the respiratory variations of the VCI (p0.05) the other 
variables are not predictive (BP, E/e’, E/A). The data are summarized in 
the picture 1. ROC curves has been established (Table 25; Fig. 21).
Conclusion It is an alternative and simple technique once acquired. 
The limits are essentially established by technical conditions such as 
Table 24 Hemodynamic and  respiratory measurements 
at T1, T2 and T3
† p < 0.05 versus before PP; ‡ p < 0.05 versus end of PP; * p < 0.05 versus after PP
Before PP (T1) End of PP (T2) After PP (T3)
Cardiac index 
(L min−1 m−2)
3.4 ± 1.2 3.4 ± 1.0 3.2 ± 1.0†,‡
Extravascular lung 
water (mL kg−1 PBW)
13.9 ± 4.7 13.5 ± 4.5 13.1 ± 4.0†
Pulmonary vascular 
permeability index
2.6 ± 1.1 2.3 ± 0.8† 2.4 ± 0.8†
Global end‑diastolic 
volume (mL m−2)
729 ± 204 757 ± 203†,* 723 ± 208
dPmax (mmHg s−1) 1207 ± 496 1177 ± 478 1132 ± 458
Global ejection frac‑
tion (%)
21 ± 7 21 ± 7 20 ± 7
Cardiac function index 
(min−1)
4.9 ± 1.5 4.7 ± 1.5 4.6 ± 1.6†
Vasopressor dose 
(µg kg−1 min−1)
0.94 ± 1.53 0.90 ± 1.82† 0.97 ± 1.94†
Dobutamine dose 
(µg kg−1 min−1)
3 ± 5 3 ± 6 3 ± 6
Lactates (mmol L−1) 3.7 ± 3.3 3.3 ± 2.9† 3.2 ± 2.9†
PEEP (cmH2O) 9 ± 3 8 ± 2† 9 ± 3†
Plateau pressure 
(cmH2O)
22 ± 4 21 ± 4† 21 ± 4†
VT (ml kg−1 PBW) 6 ± 1 6 ± 1 6 ± 1
PaO2/FiO2 
(mmHg)
110 ± 25 176 ± 58†,* 150 ± 56†
Table 25 Relevant parameters
R IC Value
EI 0.64 0.38–0.77 0.83 (0.69–093)
ICV Area 0.21 0.15–0.89 12 (9–17)
ICV respiratory variation (%) 0.61 0.34–0.85 12 (8–17)
ACS (IC95) Se/Sp Threshold
Courbes ROC
EI 0.81 (0.67–0.91) 85.7–75 0.85
ICV Area 0.70 (0.55–0.83 90–45 16.37
ICV respiratory variation
(%) 0.79 (0.65–0.87) 80–77 16
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the necessity of being very perpendicular at the risk of falsifying the 
EI. For now it is just a static index but an ovoïd vena cava (EI: 0.85) may 
be predicative of fluid responsiveness. The strangely big size of the VCI 
can be attributed to a deformation of the in-depth image because of 
the probe but this should not modify in theory the report of EI. It is 
a question in the future of testing this parameter at the spontaneous 
breathing patient, study his variability with respiration and strength-
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Introduction The Standards for the Reporting of Diagnostic Accuracy 
Studies (STARD) statement was developed in 2003 to improve the 
quality of reporting of diagnosis studies (1). STARD is a list of 25 essen-
tial items, it was updated in 2015 (2). Fluid responsiveness evaluation 
is a cornerstone of hemodynamic management of patient with circula-
tory failure. Numerous studies have evaluated tools for assessing fluid 
responsiveness. The purpose of this work was to evaluate the quality 
of reporting of studies assessing fluid responsiveness, using the STARD 
criteria.
Materials and methods We used MEDLINE via PubMed to search 
all publication of studies assessing the ability to predict or diagnose 
fluid responsiveness in a perioperative or circulatory failure context 
between the 1st of January 2004 and the 1st of January 2014. We have 
presented herein the last 5 years (2010–2014). Paediatric studies, pub-
lication with no abstract available or in another language than English, 
review, meta-analysis, and journals with impact factor less than 2 were 
excluded. We have checked these studies for all the 25 STARD crite-
ria. The rating methodology of each item was discussed and double 
checked (GI and MJL). The 2003 and 2015 STARD quality score (SQS) 
was the integer of the present item. Univariate and multivariate anal-
ysis were conducted to find out if some characteristic of the studies 
were linked with a better SQS. Following items were studied: year of 
publication, positive or negative study, location of study, expert team, 
funding source, conflict of interest, the use of a new device, instruction 
to the author including STARD statement, impact factor of the journal. 
Every covariate associated with a p-value lower than 0.20 in the univar-
iate analysis were used in the multivariate analysis. Statistical analysis 
was performed with R software. All the test were two-sided, p < 0.05 
was considered statistically significant.
Results After a double screening (GI, MJL) of 430 articles (2010–2014), 
97 were selected, then 46 were excluded because of an IF < 2. Fifty-one 
studies were selected and reviewed. The mean 2003 overall quality 
score was 11.85 on a scale of 0–25, whereas the mean 2015 overall 
quality score was 15.34 on a scale of 0–30. The 2003 SQS remained 
stable between 2010 and 2014 (p = 0.173). Correlation between 2003 
and 2015 SQS was good (r = 0.83; p < 0.001). Some items are insuffi-
ciently reported, especially: participant sampling (adequately reported 
in 19.6% of studies), executing and reading the tests (11.7%), blind-
ness (11.8%) and, the description of test reproducibility (19.1%). Some 
items are better reported: technical specifications and/or references to 
tests (65.1%), methods for calculating or comparing (90.2%), clinical 
and demographic characteristics (82.3%), diagnostic accuracy (90.2%). 
Only 16% of the journals studied required authors to use STARD. A 
high Impact factor and the year of the study were the items associated 
with a better SQS the presence of a conflict of interest was associated 
with a lower SQS in univariate analysis. A higher impact factor (>  5), 
was the only independent factors statistically significantly (p = 0.037) 
associated with higher SQS in a multivariate regression model.
Discussion Our study showed that the SQS were very low. Assessment 
of a study depends on quality of reporting. Blindness and participant 
sampling are the cornerstone to evaluate such bias as spectrum, veri-
fication, review and selection bias of a study, and were unfortunately 
scarcely reported compared to existing data in diagnosis accuracy 
reporting. One of the limitation is the 5 years sample of the study. We 
have planned to continue the analysis for a 10-year review starting just 
after the 2003 STARD publication.
Conclusion Our study showed that several items remain poorly 
reported. We recommend systematic use of STARD criteria in the 
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Introduction Neurological impairment, i.e. encephalopathy, is 
commonly observed in patients with decompensated cirrhosis 
and/or portosystemic shunts admitted in ICU. Often ascribed to 
high plasmatic levels of ammonia, encephalopathy could also be 
induced by drugs or infection, due to altered blood–brain barrier 
(BBB) permeability. This latter setting is often underdiagnosed and 
encephalopathy related to hyperammonemia (so called hepatic 
encephalopathy-HE) being pointed out as the culpit of all neurological 
symptoms in cirrhotic patients. Quinolones and betalactamins were 
recently found in the cerebrospinal fluid of HE patients and it has 
been shown that the expression of efflux pumps, responsible for 
drugs passing through the BBB, was altered in animal models of HE. 
The purpose of this study was to assess the incidence of neurological 
impairment, i.e. encephalopathy, in cirrhotic patients hospitalized in 
Fig. 21 See text for description
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ICU and to analyse its promoting factors, especially ammonia levels, 
infection and drug intake.
Patients and methods Between February 2015 and September 2016, 
all cirrhotic patients admitted in ICU were prospectively included. 
We collected patient’s clinical and biological parameters, especially 
ammonia levels, all the ongoing treatments, and seeked for the 
presence of evolutive infection defined as an infection considered 
as clinically relevant. Cirrhotic patients having encephalopathy and 
ammonia levels above 75  μmol/L were considered as having HE. 
We performed univariate and multivariate analysis to estimate the 
association between ammonia level, infection or drugs intake and the 
presence of encephalopathy.
Results 202 cirrhotic patients were included, they were 58 ± 11 years-
old, 71% were men. Etiology of cirrhosis was as followed: alcohol 
110 (54%), virus 27 (13%), NASH 19 (10%), mixed 30 (15%), others 
16 (8%). 122 patients (60%) displayed neurological impairment, i.e. 
encephalopathy at admission, 84 (42%) had ammonia levels above 
75 μmol/L, 80 (40%) had evolutive infection and the following drugs 
were found: furosemide, hydrochlorothiazide, betablockers, lactulose, 
rifaximine, betalactamins, proton pump inhibitors (PPIs), quinolones, 
benzodiazepines, morphine derivatives, insulin, anti-epileptic drugs, 
corticosteroids and immunosuppressants. In univariate analysis, 
patients with encephalopathy had significantly higher Child and 
MELD scores, higher ammonia, bilirubin and leukocytes levels, more 
evolutive infections, and received more frequently PPIs, lactulose 
and quinolones as compared to those who had no encephalopathy. 
Patients with encephalopathy took also more frequently an association 
of agonist of efflux pumps (e.g. PPIs, betalactamins or quinolones) 
(p = 0.0005). In the group of patients displaying low ammonia levels 
(less than 75  μmol/L), encephalopathy was significantly increased in 
patients having infection (p < 0.0001), taking quinolones (p = 0.0086), 
PPIs (p  =  0.0196), and betalactamins (p  =  0.0438) whereas 
ursodeoxycholic acid treatment had a protective effect (p =  0.0299). 
Multivariate analysis showed that high ammonia levels (p  <  0.0001), 
presence of infection (p < 0.0001), and taking quinolones (p = 0.0403) 
were independently associated with the presence of encephalopathy.
Conclusion These results highlight the involvement of drugs in the 
physiopathology of neurological impairment in cirrhotic patients. 
Several drugs that were implicated can modify the activity of efflux 
pumps expressed on the BBB. Besides HE, cirrhotic patients are 
susceptible to develop drugs-induced encephalopathy regardless 
of ammonia level, underlying the necessity to carefully assess every 
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Introduction Little is known about the causes, clinical course and long-
term outcome of prolonged hypoglycemic encephalopathy. We investi-
gated functional long-term prognosis and identify prognosis factors of 
patients admitted in an Intensive Care Unit (ICU) with prolonged neuro-
logical manifestations related to obvious hypoglycemia.
Patients and methods This was a retrospective study conducted in 
patients hospitalized from July 1, 2004, to July 1, 2014, in 9 polyvalent 
intensive care units in French university and general hospitals. 
Participants were adults admitted to the ICU with a Glasgow Coma 
Score <8 due to hypoglycemia <0.5  g/l and persistent consciousness 
disorders after normalizing blood glucose levels. Patients with possible 
other causes of consciousness disorders, previous cognitive disorders, 
hypothermia <35 °C or circulatory arrest within 24 h after ICU admission, 
were excluded. Follow-up phone call was used to determine the 
functional outcome using modified Rankin Scale at 1-year minimum 
(mRS) with mRS 0–3 defining good and mRS 4–6 poor outcomes.
Results Forty-nine patients were included. Median age was 55 years. 
Causes of hypoglycemia were various, mainly including insulin or 
oral antidiabetic drugs abuse (65%) and neuroendocrine carcinoma 
(16%). Twenty (41%) patients died in the ICU, and a total of thirty-one 
(63%) patients had a poor outcome at 1-year follow-up. Twenty-two 
(45%) patients underwent therapeutic limitation, primarily due to no 
hope expected for improvement (86%). Among survivors with poor 
outcome at ICU discharge (n = 15), one died 10 months later and six 
improved their outcome at 1-year follow-up with a median decrease 
in mRS of −2 [IQR −2.5 to −1.75], including five patients who finally 
reached the good outcome group. Among the patients with good 
outcome on ICU discharge, one died, seven further improved their 
outcome at 1  year with a median decrease in mRS of −2 [IQR −2.0 
to −1.0], whereas one patient deteriorated while remaining in the 
good outcome group (from mRS 1–2). On multivariate analysis, only 
low mRS prior to ICU admission (OR 2.6; 95% CI =  1.1–6.3; P =  .03) 
and normal brain imaging (OR 7.1; 95% CI 1.1–44; P  =  .03) were 
significantly predictive of outcome. All patients (n =  15) who stayed 
hypoglycemic 480 min or more evolved poorly.
Conclusion Poor outcome was observed in about 60% of this popula-
tion of prolonged hypoglycemic encephalopathy. Some patients can 
recover satisfactorily over time though we did not identify any robust 
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Introduction The lumbar puncture is an important tool of the 
etiologic investigations during status epilepticus. Scarce data 
are available regarding cerebrospinal fluid pleocytosis directly 
induced by seizures. We aimed to describe the cerebrospinal fluid 
characteristics of the patients admitted to the intensive care unit 
for status epilepticus, and to report the clinical, biological and 
radiological data of these patients. Furthermore, to determine 
whether status epilepticus per se increases the cerebrospinal fluid 
pleocytosis, we specifically studied cerebrospinal fluid parameters 
after status epilepticus in adult patients after exclusion of the cases 
of status epilepticus induced by acute infection or neoplastic disease 
of the central nervous system.
Patients and methods This monocentric retrospective study (2005–
2012) included patients of more than 18  years old admitted to the 
intensive care unit for status epilepticus and who had a lumbar punc-
ture. Status epilepticus was defined by a single seizure lasting more 
Page 190 of 207  Ann. Intensive Care 2017, 7(Suppl 1):7
than 5  min or multiple seizures without neurological recovery in 
between. A cerebrospinal fluid pleocytosis was defined by a cerebro-
spinal fluid cell count of more than 4/mm3. We analyzed demographic, 
medical, biological data and outcomes at 3  months and 1  year. The 
groups were compared using univariate and multivariate analysis. Cer-
ebrospinal fluid pleocytosis was considered directly linked to seizures 
when etiologic investigations identified causes of status epilepticus 
which were not known to induce cerebrospinal fluid pleocytosis.
Results Among 191 patients admitted to the intensive care unit 
for status epilepticus, 124 (65%) had a lumbar puncture and were 
included. Eight of them had a cerebrospinal fluid pleocytosis of 
infectious or neoplastic origin. Among the 116 remaining patients, 
97 (84%  =  group B2) had normal cerebrospinal fluid parameters, 
and 19 (16%  =  group B1) had a cerebrospinal fluid pleocytosis 
considered as directly linked to seizures, with a median [Q1–Q3] 
cerebrospinal fluid cell count of 8/mm3 [7–20]. No other cerebrospinal 
fluid parameters changes were observed in the two groups, unless a 
slight increase in the cerebrospinal fluid lactate (mmol/l), but without 
significant difference between the two groups (3.1 [2.7–3.4] group B1 
vs 2.9 [2.5–3.5] group B2). In the multivariate analysis, only myoclonic 
status epilepticus (OR 55.1; CI 95% 6.02–1103.88; p  =  0.001) and 
leukocytosis at the admission (OR 1.1 per 103/mm3 increment; CI95% 
1.01–1.21; p = 0.01) were associated to pleocytosis directly linked to 
status epilepticus. The intensive care unit mortality was significantly 
increased in patients with pleocytosis directly linked to status 
epilepticus (5 (26%) vs 7 (7%), p = 0.02), but hospital mortality was not 
significantly different between the 2 groups.
Discussion Overall, we reported a higher rate of lumbar puncture 
than those reporting in others studies concerning status epilepticus. 
Furthermore the rate of 16% of pleocytosis directly linked to status 
epilepticus is slightly higher than in most studies. Unfortunately we 
didn’t realize a second lumbar puncture to assess the pleocytosis 
normalization during the days following the first lumbar puncture. 
The pathophysiological hypothesis of this phenomenon may be that 
prolonged/repeated seizures during status epilepticus would induce 
a blood–brain barrier dysfunction thereby favoring a cerebrospinal 
pleocytosis.
Conclusion In our study, 16% of status epilepticus without infectious 
or neoplastic origin had a cerebrospinal pleocytosis directly linked 
to status epilepticus. This pleocytosis was significantly associated 
with myoclonic seizures and blood leukocytosis. These data may 





1. Chatzikonstantinou A, Ebert AD, Hennerici MG. Cerebrospinal fluid 
findings after epileptic seizures. Epileptic Disord. 2015;17(4):453–9.
2. Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S. 
Effect of epileptic seizures on the cerebrospinal fluid—a systematic 
retrospective analysis. Epilepsy Res. 2015;114:23–31.
S92 
Synek score and NSE to predict poor neurological outcome 
after cerebral anoxia and therapeutic hypothermia
Dimitri Titeca Beauport1, Magalie Joris1, Philippe Merle2, Loay Kontar1, 
Antoine Riviere1, Bertand De Cagny1, Thierry Soupison1, Michel Slama1, 
Julien Maizel1 
1Réanimation médicale, Centre Hospitalier Universitaire, Amiens, France; 
2Explorations fonctionelles du système nerveux adulte, Centre Hospitalier 
Universitaire, Amiens, France
Correspondence: Dimitri Titeca Beauport ‑ titeca.dimitri@chu‑amiens.fr
Annals of Intensive Care 2017, 7(Suppl 1):S92
Introduction Neurological prognostication from cardiac arrest survi-
vor is a current concern. EEG patterns and NSE dosage are two impor-
tant prognostic factors. NSE threshold for prediction of poor outcome 
appear controversial, in part, because of variability in dosage timing 
and measurement techniques. Synek Score is routinely used in our 
center to classify comatose patients in post cardiac arrest. The aim of 
this study was to assess the prognostic value of NSE and Synek clas-
sification to predict poor neurological outcome.
Materials and methods We conducted a retrospective monocentric 
study in our medical intensive care unit between November 01, 2013 
and August 31, 2016. All patient having at least one EEG and H48-72 
NSE dosage available were included. Patients dead from post cardiac 
arrest shock, stroke, moribund, spontaneous awaking, or missing data 
were excluded. Electroencephalograms were prospectively classified 
by electrophysiologist according to the Synek score and NSE were 
performed within H48-72 post cardiac arrest.
Results Among 162 cardiac arrest survivors, 70 were retrospectively 
analyzed. All patients received sedation with midazolam and sufenta-
nil and mild therapeutic hypothermia for 24 h. Forty-eight were clas-
sified as poor outcome (CPC ≥ 3) and 22 as good outcome (CPC 1–2). 
Serum NSE levels above 46 µg/l was associated with a poor neurologi-
cal outcome with sensitivity of 75%, specificity of 100% and AUROC at 
0.95. The Synek score ≥3 was also strongly associated with poor neu-
rological outcome with sensitivity of 91.5%, specificity of 90.9% and 
AUROC at 0.95.
Conclusion In the limits of this study, Synek score ≥3 on first EEG and 
H48-72 NSE  >  46  µg/l are two strong predictor of poor neurologic 
outcome. The prognostic value of the association of the NSE and the 
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Introduction Traumatic Brain Injury (TBI) is a major public health 
problem. It is the leading cause of death and disability in young 
subjects. One of the principles of the TBI management is prevention 
of secondary cerebral insults including maintaining perfusion and 
cerebral oxygenation, control of intracranial pressure (ICP). An increase 
in ICP above 20  mmHg is associated with poor outcome. Cerebral 
hypoxia can occur with normal level of ICP and cerebral perfusion 
pressure (CPP).Monitoring of regional partial pressure of brain tissue 
oxygen (PbtO2) is a safe and reliable method for measuring cerebral 
oxygenation.
Patients and methods A retrospective single-center 
observational study was conducted between January 2012 
and December 2013, aimed to study the influence of PbtO2 
with severe TBI patients outcome at 6  months through 
Glasgow Outcome Scale (GOS). The hourly values of ICP, PbtO2 
and CPP were recovered on daily monitoring sheets. We compared 
two groups according to their GOS. During the study period, 66 
patients underwent a monitoring ICP and PbtO2.
Results The mean age was 33.7  ±  14.1  years. 78.8% were men. 
The initial Glasgow score was 6.6  ±  3.7. The mean Simplified Acute 
Physiology Score (SAPS II) was 43.4  ±  11.2 and Injury Severity 
Score (ISS) 30.5  ±  9.7. At 6  months, 7 patients had died (GOS1). 
Forty patients had a good outcome: GOS 4–5 (Group 1). Sixteen 
patients had poor outcome: GOS 2–3 (Group 2). In Group 2, there 
are significantly more PbtO2 hourly values below 10  mmHg at Day0 
(5.5  ±  6.4 vs 2.3  ±  3, 2 in Group 1, p  =  0.025); and more PbtO2 
hourly values greater than 20 mmHg at Day0 (8.4 ± 7.0 vs 4.8 ± 4.9, 
p = 0.045).
Conclusion PbtO2 less than 10  mmHg or greater than 20  mmHg at 
Day0 is associated with poor outcome at 6 months in the severe TBI. 
The PbtO2 allows a more individual approach of monitored TBI.
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Introduction Organ donation in patients after a decision to withdraw 
life-supportive therapies (WLST) (Maastricht 3 condition: M3) have 
been performed in our hospital since May 2015. We report here main 
characteristics of donors, data on M3 procedure and results on renal 
transplant recipients.
Patients and methods All potential donors were included in a sur-
vey from May 2015 to June 2016, according to the French national M3 
protocol defined by the French Organ Procurement Agency (Agence 
de la Biomédecine:ABM) [1].The demographical, clinical and biological 
characteristics of the donors, the different deadlines and times of the 
protocol and data of renal transplantation were collected and analyzed.
Results 28 patients had inclusion criteria. Patients were admitted in 
intensive care unit for cardiac arrest (68%), strokes (14%), traumatic 
brain injury (14%), ARDS (4%). Of them, 15 procedures (54%) were 
stopped (6 refusals of organ donation, 4 medical contra-indications 
discovered with additional exams, 1 failure of vessel cannulation, 4 
deaths more than 3  h after extubation). 28 kidneys were harvested 
and 26 transplantations performed (1 renal cancer discovered during 
procurement surgery).The characteristics of the donors, deadlines of 
the protocol and transplant recipients are reported in the Table 26.
Conclusion The French programm Maastricht 3 offered a new possibil-
ity of organ donation in our hospital. Thanks to these donors, the num-
ber of renal grafts increases and the preliminary results on transplant 
recipients are encouraging in line with the preliminary report of the 
ABM. Nevertheless, it is necessary to follow the transplant recipients 
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Introduction Microaspiration of gastric and oropharyngeal contami-
nated secretions occurs frequently in intubated critically-ill patients, 
and plays a major role in the pathogenesis of ventilator-associated 
pneumonia (VAP). At basic state, patients with chronic obstructive 
pulmonary disease (COPD) have an increased risk of microaspiration 
(due to gastro-esophageal reflux disease, pharyngo-laryngeal dys-
function…), this risk may even be more important under mechanical 
ventilation. The main purpose of this study is to determine if COPD is 
a risk factor for global abundant microaspiration (GAM) in intubated 
critically-ill patients.
Materials and methods We gathered data about two prospective 
multicentric randomized trials focused on microaspiration in intubated 
patients. Data about COPD were retrospectively collected in order to 
complete previous data. Microaspiration of gastric and oropharyngeal 
secretions was respectively determined by quantitative measurements 
of pepsin and salivary amylase in all tracheal aspirates during the first 
48 h after intubation. GAM was defined as the presence at significant 
level of pepsin (>200 ng/ml) and/or salivary amylase (>1685 UI/L) in at 
least 30% of the tracheal aspirates. In order to find GAM independent 
risk factors, we realized an univariate and multivariate analysis of the 
variables collected.
Results Out of 448 patients included in the studies, 415 were ana-
lyzed among which 95 patients with COPD. 360 patients (87%) had 
GAM. Neither COPD diagnosis, nor spirometric severity nor specific 
therapeutics were associated with GAM. Risk factors for GAM in uni-
variate analysis were the age, diabetes, low score in Glasgow Coma 
Scale (GCS), and no recourse to paralytic agents or vasopressors. After 
multivariate analysis, age was identified as independant risk factor for 
GAM (OR [IC 95%] = 1.03 [1.01–1.05], p < 0.001); whereas high score 
in GCS (OR [IC 95%] = 0.93 [0.86–0.99], p = 0.03) and use of paralytic 
agents (OR [IC95%] = 0.46 [0.23–0.90], p = 0.02) were associated with 
less occurrence in GAM. GAM was not associated with any increase of 
length of mechanical ventilation, length of ICU stay, VAP incidence or 
surmortailty.
Table 26 Characteristics of  the donors, deadlines of  the 
protocol and transplant recipients
Characteristics of potential donors (n = 28)
Age in years, mean [range] 47.9 [21–59]
Sexe, male (%) 24 (86%)
Serum creatinine, mean (μmol/L) [range] 68.96 [31–154]
CrCl by Cockroft‑Gault, mean (ml/mn) [range] 139.27 [53–255]
Length of stay in ICU, mean (day) [range] 7.85 [2–23]
Deadlines of the protocol (n = 13)
Time from extubation to death, mean (min) [range] 37.2 [7–160]
Warm ischemia time, mean ‘min) [range] 36.8 [21–51]
Duration of vessel cannulation, mean (min) [range] 27.2 [12–45]
Duration of normothermic regional perfusion, mean 
(min) [range]
171.2 [94–222]
Duration of cold storage, mean (min) 591
Characteristics of transplant recipients (n = 26)
Age in years, mean [range] 56.4 [35–71]
Sexe, male, n (%) 16 (61.5%)
Length of stay in transplant unit, mean (day) [range] 12.8 [6–41]
Duration before creatinine <250 μmol/L after 
transplantation, mean (day) [range]
7.8 [1–34]
Serum creatinine (μmol/L) at the hospital discharge, 
mean [range]
157.5 [52–276]
Delayed Graft Function, n (%) 4 (15.3%)
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Discussion In this study, we found some relevant risk factors for 
microaspiration (age, low score at GCS) consistent with literature on 
the subject. Patients with paralytic agents had less GAM which may 
be due to higher PEEP, higher cuff pressure and less enteral nutrition 
because of the severity of the underlying diseases.
Conclusion This study did not show any increased risk of microaspira-
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Introduction Protected specimen brush (PSB) is considered to be one 
of the standard methods for the diagnosis of ventilator-associated 
pneumonia (VAP). To our knowledge, there is no study assessing effect 
of prior antibiotherapy on direct examination, bacteriological culture 
and concordance of direct microscopy and culture.
Patients and methods All consecutive episodes of suspected VAP 
were retrospectively evaluated between January 2014 and December 
2014 in a 20-bed intensive care unit. Patient’s characteristics and 
preexisting conditions were abstracted from the medical charts. 
After assessment of VAP probability using the clinical pulmonary 
infection score (CPIS), PSB were performed in patients with a 
CPIS of 6 or more. Based on antibiotic treatment in patients when 
bacteriological specimens were obtained, two groups were defined: 
no antibiotic group and antibiotic treatment started before PSB group. 
Two independent bacteriologists retrospectively reviewed direct 
examination and culture of PSB to assess bacteriological concordance, 
defined as non-concordant when direct examination and culture 
were different, concordant when direct examination and culture were 
similar and partially concordant when either direct examination or 
culture were comparable but with other microorganisms lacking in 
one or the other method.
Results During this 12-months period, among 73 mechanically ven-
tilated patients, 116 episodes of suspected VAP with PSB were evalu-
ated. We found 60% of PSB (n  =  70) performed without antibiotic 
treatment and 40% of PSB (n = 46) performed under antibiotherapy. 
We found no significant differences in patient’s demographics, charac-
teristics, and severity between both groups. Patients received antibiot-
ics for the following reasons: aspiration pneumonia (n = 12), peritonitis 
(n = 8), VAP (n = 7), community-acquired pneumonia (n = 4), septic 
shock of unknown origin (n =  4), pyelonephritis (n =  3), meningitis 
(n = 2), acute pancreatitis (n = 2) and others (n = 4). The median dura-
tion of mechanical ventilation in the antibiotic receiving group and in 
the group without antibiotics was 7.5 days (IQR; 5–12 days) and 9 days 
(IQR: 5–22), respectively. When PSB was performed under antibiotic 
treatment, direct examination was positive in 26% (n  =  12), culture 
was positive in 28% (n = 13) and those methods were concordant, non 
concordant and partially concordant in 93% (n = 43), 4% (n = 2) and 
3% (n = 1), respectively. On the other hand, when PSB was performed 
without antibiotics, direct examination was positive in 65% (n = 46), 
culture was positive in 62% (n = 43) and those methods were concord-
ant, non concordant and partially concordant in 71% (n  =  50), 18% 
(n = 12) and 11% (n = 8), respectively. In univariate analysis, we found 
a significantly higher proportion of negative direct examination and 
negative culture in the antibiotic group (p  >  0.001). Moreover, these 
methods were significantly more frequently concordant (p  =  0.01), 
with a higher rate of both negative microscopic exam and culture 
when compared to the no antibiotic group (76%, n  =  33 vs 38%, 
n =  18). Surprisingly, among the 13 patients previously treated with 
antibiotics with positive culture, 38% (n =  5) of the microorganisms 
showed antibiotics sensitivity.
Discussion Whether prior antibiotic treatment may induce false nega-
tive of false positive treatment is a well-recognized phenomenon, the 
precise effect of antibiotics on direct examination and quantitative 
culture is not well assessed in VAP. Moreover, despite recent develop-
ment of clinico-radiological score, diagnosis of VAP remains difficult, 
with no gold-standard. Therefore, bacteriological guided therapy is of 
particular importance. We found PSB realization under antibiotic treat-
ment is associated with a lower rate of positive direct examination and 
culture and suggest performing these bacteriological samples without 
antibiotherapy. Some authors have suggested lowering the diagnostic 
threshold point of this bacteriological technique in order to preserve 
its accuracy. However, we can postulate that microorganisms respon-
sible of superinfection in mechanically ventilated patients treated with 
antibiotics may be resistant and therefore the PSB could be positive.
Conclusion In patients with a high pre-test probability of ventilator-
acquired pneumonia, recent introduction of antibiotics significantly 
reduced the diagnostic accuracy of protected brush specimen by 
reducing rates of positive direct examination and culture. Further stud-
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Introduction In 2005, an international consensus conference took 
stock of the various measures to be implemented for the prevention 
of ventilator acquired pneumonia (VAP) [1]. These measures are often 
gathered in groups of 3 or 5 under the term of “ventilator-bundle.” 
The effectiveness of these “bundles” was poorly evaluated in African 
environment.
Objective To establish a VAP prevention program and assess its 
impact on morbidity and mortality of patients under mechanical ven-
tilation in our service.
Patients and methods Prospective, mono centric, quasi-experimental 
before-after study. It took place in the intensive care unit of the Uni-
versity Clinics of Kinshasa in the Democratic Republic of Congo (DRC). 
This service is equipped with 8 beds and a respirator for two beds. 
The observational period (phase1) was carried out from February 1st 
to December 31st, 2014 and the intervention period (phase2) from 
February 15st, 2015 to February 15st, 2016. All consecutive patients 
intubated and mechanically ventilated for more than 48  h were 
included. Five preventive measures were held: hand hygiene, the ele-
vation of the head of the bed at 30°–45°, the daily lifting of sedation, 
oral decontamination with chlorhexidine and control cuff pressure of 
the endotracheal tube. Compliance with this bundle was assessed by 
direct observation without the knowledge of caregivers. The diagno-
sis of “VAP” was held before a clinically modified sore (m CPIS) >6. The 
main outcomes were the incidence of VAP and mortality. The protocol 
for this study was approved by the Ethics Committee of the School of 
Public Health of the University of Kinshasa, under the approval num-
ber: ESP/EC/015/2015.
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Results We included 44 patients in the phase1 and 58 patients 
in the phase2. Baseline characteristics of patients were similar in 
both groups. Compliance with all the measures has been improved 
between the two period from 0 to 32.75%. The incidence density 
decreased from 33.74 to 18.05 VAP per 1000 ventilator days between 
observational and interventional period, but the all-cause mortality 
was almost equal in the 2 groups (88.6 vs. 86%).
Discussion With the implementation of our bundle, observance of 
the team were improved in the second group, compared to the first 
and the incidence density decreased from 33.74 to 18.05 VAP per 1000 
ventilator days between both period. This result is consistent with the 
littérature. Sure enough, many studies show the same effect of VAP 
prevention with a decrease of nearly 50% of the incidence density of 
VAP, after implementation of a «ventilator –bundle [2].
Conclusion The implementation of a “ventilator bundle,” has signifi-
cantly reduced the incidence of VAP in our service. In the contrary, our 
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Introduction With an increasing incidence and high mortality rates, 
sepsis is a public health issue. There is growing evidence that sepsis 
induces long lasting alterations of transcriptional programs through 
epigenetic mechanisms that may lead to protracted inflammation, 
organ failure, sepsis-induced immune suppression (SIIS), secondary 
infections and death. We hypothesized that epigenetic changes 
contribute to the pathophysiology of SIIS. To test this hypothesis, 
we studied the effects of histone deacetylases (HDAC) inhibition 
with trichostatin A (TSA) in a double-hit murine model of SIIS and 
secondary pneumonia.
Materials and methods C57BL/6 mice were treated with TSA (2 mg/
kg ip) or saline serum (CTL) 30 min before induction of sepsis by cecal 
ligation and puncture (CLP). Surviving mice underwent intratracheal 
instillation of 1.5 ×  106  CFU of Pseudomonas aeruginosa 8  days after 
CLP. We evaluated the effect of TSA on survival and cellular responses 
to the primary and secondary infections. Cellular responses in 
the blood, spleen and BAL were assessed by flow cytometry after 
CLP (Days 1, 3 & 8) and after pneumonia (4 & 12  h). We also studied 
lymphocyte apoptosis and dendritic cells (DC) expression of CD40, 
CD86, and MHCII. Bacterial clearance was assessed in the BAL and 
in the blood 4 and 12  h after pneumonia. Continuous variables 
represented as mean  ±  SD were compared using Student t test. 
Kaplan–Meier curves were compared by the log rank test. P  <  0.05 
indicated statistically significant differences.
Results Whereas treatment with TSA did not change survival after 
CLP, TSA improved survival after tracheal instillation of P. aeruginosa 
(P = 0.009, Fig. 22).
TSA-treated mice had significantly higher absolute DC, T and 
B-lymphocytes counts with reduced lymphocyte apoptosis after 
CLP. Four hours after secondary pneumonia, TSA-treated mice had 
significantly higher DC counts and improved bacterial clearance in the 
BAL, with reduced systemic dissemination of P. aeruginosa.
Conclusion HDAC inhibition with TSA improves survival in our murine 
model of secondary pneumonia, improves bacterial clearance and 
attenuate cellular features of SIIS. These results suggest that sepsis-
induced epigenetic changes contribute to the advent of SIIS. Com-
prehensive characterization of epigenetic changes associated with 
SIIS might allow us to identify new therapeutic targets to reprogram 
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Introduction Nosocomial infections (NI) are common in burn patients 
due to the loss of the first line of defense against microbial invasion, 
immunocompromising effects of burn injury, and invasive diagnostic 
and therapeutic procedures. The objective of this study was to identify 
the incidence of nosocomial infection (NI), the pathogens and their 
antibacterial patterns, and prognosis of these burn patients.
Patients and methods A retrospective study was conducted in a 20 
bed intensive burn care unit during 6  months. Patients were eligible 
for the study, if they met the following criteria: total burn surface area 
(TBSA)  >  10%, length of ICU stay ≥48  h, and infected in accordance 
with the criteria of the National Nosocomial Infections Surveillance 
(NNIS) and the criteria of the SFETB [1–2]. In this study, NIs were classi-
fied into four main groups: pneumonias, bloodstream infections (BSI), 
catheter related infections (CRI), and urinary tract infections (UTI). For 
included patients, skin levy, blood cultures, urine and sputum cultures 
were drawn during fever or clinical features of sepsis.
Results During the 6-month study period, 190 patients were admit-
ted to the ICU, 47 patients were included (24.7%). 32 were male and 15 
female. The mean age was 41 ± 19 yr. The mean TBSA was 41 ± 24%. 
63% were admitted from another hospital. Burn injuries were due to 
domestic accidents in 53% and self immolation in 25%. The mean 
Fig. 22 See text for description
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length of ICU stay was 16  ±  14  days. 47 patients acquired 58 NIs 
(36.2% BSI, 20.5% pneumonia, 10.3% CRI and 10.3% UTI. There was 
no bacteriological documentation of NI in 22.5% of cases. NIs occured 
4 days post burns. The most three isolated pathogens were: Acineto-
bacter spp. (31%), P. aeruginosa (22.5%) and extended spectrum beta-
lactamase-producing Enterobacteriaceae (17%). The most frequently 
administered antibiotics were polymyxin/carbapenem/teicoplanin 
combination (21%), polymyxin/carbapenem combination (15%) and 
carbapenem/tigecycline combination (15%). In our study, mortality 
rate was 50%.
Conclusion Nosocomial infection occured in 24.7% of cases in 
burn patients, caused by Acinetobacter spp, P. aeruginosa and 
Enterobacteriaceae BLSE. So, eradication of infection in burn patients 
require effective surveillance and infection control in order to reduce 
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Introduction Infection of the lower respiratory tract is the most com-
mon cause of infection in intensive care unit (ICU) (1). Although the 
attributable mortality of ventilator associated pneumonia remains 
debated, the recurrence of these infections is always associated with 
a significant morbidity (2). Staphylococcus aureus methicillin-sensitive 
(SAMS) is one of the most frequently germs involved in ICU pneumo-
nia especially in trauma patients. The aim of the study was to establish 
the risk factors associated with microbiological treatment failure of 
pneumonia, caused by SAMS.
Materials and methods we retrospectively identified 185 patients 
who developed a first episode of ventilator associated pneumonia 
caused by SAMS during a 6 years-period (2009–2014). The primary end 
point was the microbiological treatment failure defined as a second 
episode of pneumonia caused by SAMS corresponding to either a per-
sistent or a recurrence of the pneumonia (Fig. 23). The primary aim of 
the study was to identify factors associated with a treatment failure, the 
secondary objective was to identify factors associated with the occur-
rence of second episode (i.e. persistent, recurrence, superinfection 
and/or relapse of pneumonia caused by any bacteria) during or after 
treatment of the first episode caused by SAMS. Definition of outcomes 
was based after analysis of current concepts available in the literature. 
Factors associated with primary and secondary objectives in univari-
ate analysis (p-value  <  0.20), or clinically relevant ones, were entered 
in a multivariate logistic regression. The final selection was performed 
using the stepwise selection based on the Akaike criterion.
Results Fifty-nine patients (33.3%) developed a second episode of 
pneumonia and among them, 30 (16.6%) were considered as a micro-
biological failure. In a multivariate analysis, the association of oro-
pharyngeal flora (FOP) with the SAMS (OR, 3.86; 95% CI, 1.33–11.11; 
p = 0.011) and the need of emergency surgery (OR, 5.26; 95% CI, 1.39–
35.2; p = 0.035) were predictive of a microbiological failure. Empirical 
antibiotic therapy with amoxicillin-clavulanic acid (OR, 2.28; 95% CI, 
1.15–4.51; p  =  0.017) and performing emergency surgery (OR, 3.60; 
95% CI, 1.34–9.65; p =  .011) were predictors of a second episode of 
pneumonia caused by any bacteria.
Conclusion In this retrospective, monocentric study, the co presence 
of orophryngeal flora and the need of emergency surgery were 
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Introduction Ventilator-associated pneumonia is a major iatrogenic 
problem since it is a cause of hospital morbidity, mortality and 
increase of health care costs. It has been studied many times, but 
data’s revision is always necessary. Our study aimed to describe 
epidemiology of ventilator-associated pneumonia and identify local 
causative pathogens.
Materials and methods We carried out a prospective study in an inten-
sive care unit. Were included patients intubated for more than 48 h, from 
April 2015 to May 2016, and presenting signs of ventilator-associated 
pneumonia (fever, abundant and purulent secretion, increase of FiO2 
greater than 0.2, signs on chest-X ray) with positive culture of endotra-
cheal aspirate. Were excluded patients with germ colonization.
Results A total of 268 patients were ventilated for more than 48  h. 
Among them thirty-four patients aged of 39 ±  18.5  years presented 
54 episodes of ventilator-associated pneumonia (that is 1.58  ±  0.85 
episodes per patient). The mean SOFA score was 5.2  ±  1.8. The 
main reasons of mechanical ventilation were loss of consciousness 
secondary to poisoning (20%), respiratory distress (20%) and status 
epilepticus (12%). The mean duration of stay was 62.5  days with 
extremes at 7 and 180 days. The average time between hospitalization 
and suspicion of ventilator-associated pneumonia was 5.9 ± 2.7 days. 
The average value of the Clinical Pulmonary Infection Score at 
suspicion was 5  ±  1.26. The average time between recurrences was 
16.8 days with extremes at 4 and 39 days. The culture of endotracheal 
aspirate identified two pathogens in 11%. It reveled Acinetobacter 
baumanii in 35% in which 63% were imipenem resistant, Pseudomonas 
aeroginosa in 33%, Klebsielle pneumoniae in 22%, Staphylococcus 
Fig. 23 See text for description
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aureus methicillin resistant in 7%. Extended spectrum β-lactamases 
bacteria were found in 10% and carbapenemases producers in 12%. 
Empirical antibiotherapy was always association of imipenem and 
colistin. It was necessary to adapt it to antibiograms in 33/54.
Ventilator-associated pneumonia was complicated by septic shock in 
28% and acute respiratory distress syndrome in 24%. Patients evolved 
to healing in 63% of episodes (n  =  34), to superinfection in 26% 
(n = 14) and to death in 9% (n = 5). Pseudomonas aeruginosa was the 
most frequent germ in superinfection (7/14), Acinétobacter baumanii 
was the most pathogen associated to death (3/5).
Conclusion Ventilator-associated pneumonia is an iatrogenic disease 
that threatens lives. It’s in part avoidable. Preventive measures have to 
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Introduction Mechanical ventilation (MV) weaning is a crucial step in 
critically ill patients. MV duration is associated with an increased risk 
of ventilator associated events, even though its specific impact on 
mortality has never been clearly demonstrated (1). Automated closed 
loop systems might help the weaning process. A recently published 
meta-analysis has reported a reduction in MV duration when using an 
automated weaning mode as compared to non-automated mode (2). 
However, the different automated modes have not been compared 
to each other. The objective of this network meta-analysis was to 
compare the performance of the three major automated weaning 
modes, i.e. the Automode°, the Smartcare° and the Adaptative 
Support Ventilation (ASV°) for MV weaning in critically ill and post-
operative adult patients.
Materials and methods We included all randomised control trials 
that compared automated closed loop weaning applications either 
to another automated application or standard care, including wean-
ing according to a written weaning protocol or nurse driven proto-
cols. The three modes of automated modes included in the study 
were ASV°, Smartcare° and Automode°. The primary outcome was the 
duration of MV weaning, defined as the time between randomization 
and a successful extubation. We also planned subgroup analyses in 
the ICU and the post-operative populations. The quality of the stud-
ies was assessed independently by two blinded investigators, using 
the evaluation recommended by the Cochrane Collaboration. A net-
work Bayesian meta-analysis using random effect models and based 
on aggregate data from the included studies was performed using 
the gemtc package (R project, Vienna). This trial was declared in PROS-
PERO in August 2015 (CRD42015024742).
Results Search of databased identified 776 articles; 233 were screened 
for eligibility after removal of duplicates. Abstract analysis led to the 
exclusion of 191 articles with a final full text analysis of 42 randomised 
control trials. Ultimately, 15 trials were included in the analysis, repre-
senting 1424 ventilated patients. Nine studies included patients in the 
post-operative period while six were conducted in ICU. The automated 
mode was ASV° (A) in 9 studies, Smartcare° (C) in 4 studies and Auto-
mode° (B) in 2 studies. All studies reported the duration of MV wean-
ing as defined in our protocol. In all studies, the control group was 
standard care with a weaning process driven either by nurses or physi-
cians. In 12 studies (75%) a written weaning protocol was used in the 
control group. All ICU studies used sedation protocols based on seda-
tion scores, none of them including systematic daily sedation inter-
ruption. Each one of the automated application was associated with a 
significant reduction in the duration of MV as compared to the control. 
When comparing all different modes using the network meta-analysis 
framework, ASV° appeared to be the best automated mode when it 
pertains to reducing the duration of mechanical ventilation weaning 
(Fig. 24). Subgroup analysis showed similar results in the post-opera-
tive and the ICU populations.
Conclusion Compared to standard weaning practice, the 3 major 
automated weaning modes significantly reduced the duration of MV 
weaning in critically ill and post-operative adult patients. ASV° was 
associated with the most significant effect when compared to the 
two other automated modes (Smartcare°, Automode°). Further physi-
ological respiratory studies would help to understand the underlying 
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Introduction During mechanical ventilation, mismatch between res-
piratory muscles activity and the assistance delivered by the ventila-
tor results in dyspnea and asynchrony and is commonly observed in 
intensive care unit (ICU) patients. Proportional Assisted Ventilation 
(PAV) is a ventilatory mode that adjusts the level of ventilator assis-
tance to the activity of respiratory muscles estimated by an algorithm. 
To date, PAV has been mostly studied in patients without severe dysp-
nea or asynchrony. We hypothesized that, compared to pressure sup-
port ventilation (PSV), PAV will prevent severe dyspnea or asynchrony.
Patients and methods Were included ICU mechanically ventilated 
patient exhibiting severe dyspnea or asynchrony with PSV. Three 
conditions were successively studied: 1) PSV on inclusion (Baseline), 
2) PSV after optimisation of ventilator settings in order to minimize 
dyspnoea and asynchrony (Optimisation), and 3) PAV. Ten-minutes 
recording were performed with each condition. The intensity of dysp-
nea was assessed by the Visual Analogic State (VAS, only in patients 
able to communicate) and by the Intensive Care Respiratory Distress 
Operating Scale (IC-RDOS) for all the patients. The electrical activity 
(EMG) of extradiaphragmatic inspiratory muscles was measured. The Fig. 24 Bayesian NMA with random effect
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prevalence of asynchrony was quantified by the visual inspection of 
the airway flow and pressure traces.
Results 34 patients were included, 74% male, aged 66 [58–78] years, 
SAPS2 57 [39–66], mechanically ventilated for 6 [4–9]  days. The tidal 
volume (Tv) was higher in the Optimisation and PAV than in the Basal 
condition (Table 27). The respiratory rate(RR) was lower with PAV than 
in the other conditions. The dyspnea-VAS was lower with Optimisation 
and PAV than with the Basal conditions. The IC-RDOS was lower with 
PAV than with the two other conditions. The asynchrony index was 
lower with PAV than with the two other conditions. Parasternal EMG 
activity was lower with PAV and Optimisation (Fig. 25).
Conclusion In ICU patients receiving mechanical ventilation with PSV 
and exhibiting severe dyspnea or asynchrony, the optimisation of 
ventilator settings with PSV and the PAV mode decrease in the simiar 
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Introduction In intensive care unit (ICU) patients, diaphragm dysfunc-
tion is associated with adverse clinical outcomes. Ultrasound measure-
ments of diaphragm thickness (Tdi), excursion (EXdi) and thickening 
fraction (TFdi) have been proposed as estimators of diaphragm func-
tion, but have never been compared to phrenic nerve stimulation.
Our aim was to describe the relationship between Tdi, EXdi, TFdi and 
diaphragm function evaluated using the change in endotracheal pres-
sure after phrenic nerve stimulation (Ptr,stim), and to compare their 
prognostic value.
Patients and methods Ptr,stim and ultrasound variables were meas-
ured in mechanically ventilated (MV) patients <24  h after intubation 
(“initiation of MV”, under assist-control ventilation, ACV) and at the 
time of switch to pressure-support ventilation (“switch to PSV”). Dia-
phragm dysfunction was defined as Ptr,stim <11 cmH2O.
Results 112 patients were included. At initiation of MV, Ptr,stim 
was not correlated to Tdi (rho = −0·13, p =  0·28), EXdi (rho =  0·10, 
p = 0·66) or TFdi (rho = −0·03, p = 0·80). At switch to PSV, TFdi and 
EXdi were correlated to Ptr,stim, (rho  =  0·87, p  <  0.001 and 0·45, 
p = 0·001, respectively), but Tdi was not (rho = −0·09, p = 0·45). At 
switch to PSV, a TFdi <29% could reliably identify diaphragm dysfunc-
tion (sensitivity and specificity of 85 and 88%, respectively), but Tdi 
and EXdi could not. This value was associated with increased duration 
of ICU stay and MV, and mortality.
Conclusion Under ACV, neither Tdi, EXdi nor TFdi were related to 
Ptr,stim. Under PSV, TFdi was strongly correlated to diaphragm 
strength and, when decreased, was associated with poorer outcome.
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Introduction In spite of recent research and progress in weaning 
protocols, extubation failure still occurs in 10–20% of patients and 
is associated with poor outcomes, with a mortality rate of 25–50%. 
Many risk factors for planned extubation failure have been suggested, 
including hypercapnia at end of spontaneous breathing trial (SBT). 
However, performing arterial blood gases at the end of SBT is not 
routinely recommended whereas EtCO2may be routinely monitored 
during a low pressure support SBT. The aim of this prospective 
observational study was to determine the clinical usefulness of EtCO2 
to predict extubation failure.
Patients and methods We recorded clinical data and EtCO2 
during a successful 1  h low level pressure support SBT (at the 
beginning, after 5 min and at the end of the trial). Patients ventilated 
through tracheostomy and unplanned extubations were excluded. 
Extubation failure was defined as death or the need for reintubation 
within 72  h (1) after extubation; this delay was prolonged to 7  days 
(2) in case of noninvasive ventilation after extubation, which was 
systematic in older patients or those with cardiorespiratory disease, 
as per our weaning protocol. Multivariable logistic regression analysis 
was performed to identify independent variables associated with 
extubation failure.
Results One hundred and fifteen ventilated patients were enrolled 
in our study from July 2015 to June 2016. The median age of these 
patients was 63 [52–75]  years, their median Simplified Acute 
Physiology Score (SAPS) II was 48 [38–61] points and 42.5% (n = 49) 
were female. Seventeen (15%) patients had chronic obstructive 
pulmonary disease. Reintubation rate was 15% (n  =  18). EtCO2 
Table 27 Breathing pattern, dyspnea score and  preva‑
lence of asynchrony according to condition
* p < 0. 05 compared to basal condition; § p < 0. 05 compared to optimisation 
condition
Variables Basal Optimisation PAV p
RR (min−1) 27 [22–32] 24 [20–30] * 21 [17–28] *,§ <0.0001
Tidal volume 
(ml)







62 [28–76] 37 [20–55] * 31 [14–45] * <0.001
IC‑RDOS 4.6 [4.1–6.5] 4.3 [2.3–4.8] 4.2 [2.4–4.7] * 0.002
Asynchrony 
index (%)
0.68 [0–2.28] 0.6 [0.31–1.4] 0 [0–0.55] *,§ 0.005
Fig. 25 Electromyographic of activity parasternal muscles. *p < 0. 05 
compared to basal condition
Page 197 of 207  Ann. Intensive Care 2017, 7(Suppl 1):7
at the end of SBT was similar between patients with failed and 
successful extubation: 38 [29–41] vs. 35 [30–40] mmHg, p = 0.9. EtCO2 
at other time points as well as its changes during the SBT were also 
similar between groups. The three variables predicting extubation fail-
ure in the multivariable logistic regression model were a past medical 
history of cirrhosis, acute respiratory distress syndrome before wean-
ing and lower minute ventilation at the end of SBT.
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Introduction Airway management in intensive care unit (ICU) 
patients is challenging [1]. “Airway failure”, defined as the inability to 
breathe without endotracheal tube, differs from “weaning failure”, 
defined as the inability to breathe without an invasive mechanical 
ventilation. However, most of the studies assessing predictive factors 
of extubation failure did not separate airway from weaning failure. 
We aimed to describe incidence of extubation failure in critically ill 
patients, separating for the first time airway from weaning failure, in a 
prospective multicenter observational study.
Patients and methods A prospective, observational, multicenter study 
was conducted in 26 French ICUs. All adult patients consecutively extu-
bated in ICU were included. An ethics committee approved the study 
design (code UF: 9242, register: 2013-A01402-43). The study was regis-
tered on clinicaltrials.gov (identifier no.NCT 02450669). Clinical param-
eters were prospectively assessed before, during and after extubation 
procedure. Extubation failure was defined as the need to reintubate 
less than 48 h after extubation. Extubation failure could be due to air-
way failure, weaning failure or mixed airway and weaning failure.
Results From December 2013 to May 2015, 1514 intubation-proce-
dures were studied in 1465 patients from 26 centers. 49 patients (3.2%) 
were intubated twice. The median number of intubation-procedures 
included by center was 27 (11–72). The flow chart of the study is 
shown in Fig.  26. Incidence of extubation failure was 10.4% (157 of 
1514 intubation-procedures). Incidence of airway failure, weaning fail-
ure and mixed failure were respectively 4.6% (70 of 1514), 5.2% (78 of 
1514) and 0.6% (9 of 1514).
Conclusion Extubation failure at 48 h occurred in 10.4% of the 1514 
extubation procedures recorded, 44% due to airway failure, 50% to 
weaning failure and 6% to mixed airway and weaning failure. Specific 
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Introduction Acute on chronic liver failure (ACLF) have been recently 
defined by an acute decompensation of a chronic liver disease 
associated to organ failure and a high mortality rate. Few authors 
reported on the use of total plasma exchange (TPE) in patients 
with the current definition of ACLF. The aim of this pilot study was 
to evaluate the efficiency and safety of TPE in critically ill cirrhotic 
patients admitted with ACLF in the ICU.
Patients and methods A prospective cohort of cirrhotic patients 
admitted to the ICU between February 2015 and February 2016. TPE 
was performed using a plasma filter (TPE2000, Hospal®) on a CVVHDF 
machine (Prismaflex®, Baxter®) connected to the patient with a femo-
ral double lumen 13F catheter. The plasma volume exchanged per 
session was 1.3–1.5 of the total plasma volume. Ratio and type of fluid 
replacement were 50% with 5% albumin solution followed by 50% 
with fresh frozen plasma. Clinical and biological parameters, and the 
following scores MELD, SOFA, CLIF-SOFA, CLIF-OF and Child Pugh were 
evaluated prior, after TPE session and 7 days distant of treatment.
Results Seven male patients with a mean age of 50.6  ±  7.7  years 
comprised the study and had a total of 20 TPE sessions. The etiology 
of cirrhosis was alcoholic (n = 6) or post-HCV (n = 1). The reasons of 
ACLF were acute alcoholic hepatitis (n = 2), variceal bleeding (n = 2) 
and sepsis (n = 3). Prior to TPE, the mean scores of SOFA, CLIF-SOFA, 
CLIF-OF, MELD and Child-Pugh were respectively 9.4, 12, 11.7, 37.6 
and C12.5. Mean total bilirubin prior and after TPE sessions was 
reduced from 392.3  ±  117.8  µmol/l to 244.9  ±  93.2  µmol/l (reduc-
tion of 37.5%; p  =  3.81E−6); at day 7, mean total bilirubin was still 
lower at 333  ±  132  µmol/l (p  =  0.1). Mean INR prior and after TPE 
improved from 5.54 ± 3.38 to 2.32 ± 0.80 (reduction of INR of 58.1%, 
p = 4.76E−5) and at day 7 of treatment at 4 ± 1.64 (reduction of 43%, 
p = 0.125). Mean GGT levels reduced by 28.5% (p = 0.01). Mean plate-
let counts (50.8  ±  19.5 G/L) reduced by 10.2% (p  =  NS). The prob-
ability of survival at 10, 28 and 90 days was 42.8, 28.6 and 14.3%. One 
patient was transplanted and still alive. Tolerance during sessions was 
good similar to CVVHDF. Two side effects related to the femoral cath-
eter were observed (bacteremia and hemorrhagic shock post catheter 
ablation).
Conclusion This preliminary study of TPE in ACLF showed a marked 
reduction of liver enzymes and improvement in coagulation param-
eters with a relative good safety. A specific caution should be under-
taken regarding catheter related complications. TPE worth to be Fig. 26 Flow chart of the FREE‑REA study
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evaluated in large trials in ACLF’ patients, with a liver transplant pro-
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Introduction Extubation is a key moment for the patient on his way 
to recovery. Extubation failure concerns 10–20% of ICU patients and 
is closely linked to nosocomial pneumonia. The practice concerning 
enteral feeding interruption at time of extubation has not been 
investigated. Fasting before extubation may prevent aspiration and 
development of nosocomial pneumonia. Thus, fasting and gastric 
content suctioning before extubation may be reasonably considered 
as a mean to reduce this burden. Fasting before extubation may 
prevent aspiration and development of nosocomial pneumonia. 
Thus, fasting and gastric content suctioning before extubation may 
be reasonably considered as a mean to reduce this burden. However, 
fasting, as recommended before elective general anesthesia is likely to 
be ineffective in the setting of extubation in the ICU, due to patients’ 
gastroparesis and prolonged gastric stasis. Beyond the potentially 
unnecessary burden in terms of paramedical workload, fasting 
may have some side effects such as caloric deficit, hypoglycemia, 
or delayed extubation. Given the current lack of objective data 
concerning the clinical practice of feeding/fasting and gastric tube 
suctioning before extubation in the ICU, we undertook this descriptive 
study to assess current practice.
Materials and methods We conducted a retrospective, multicenter 
study in eleven intensive care units in the west of France over a 
1  month timespan. All patients extubated were included and data 
about enteral feeding during the peri-extubation period as well as 
extubation failure and nosocomial that pneumonia occured within 
7  days were recorded. Data observed in the eleven participating 
centers were completed with a short email survey concerning 
declarative practice performed among 43 intensive care units.
Results During the study period, 162 patients were included. Overall, 
25 patients (15%) failed extubation and needed reintubation within 
the 7  days following planned extubation. Pneumonia was signifi-
cantly more frequent reintubated patients than the other (36 vs. 4%, 
p < 0.01). Hundred patients (62%) received enteral feeding at the time 
of extubation. Compared to patients who did not receive enteral feed-
ing, those patients had a higher disease severity (SAPSII score 50, [41; 
63] vs. 45 [35; 52], p < 0.01; longer duration of mechanical ventilation 
7 [4; 13] vs. 1.5 [1; 3] days, p < 0.01). Accordingly, those patients had a 
higher rate of extubation failure (21 vs. 7%, p = 0.01) and pneumonia 
(13 vs. 3%, p = 0.05). Among the 100 patients receiving enteral feed-
ing, fasting was implemented before extubation for 64 patients (64%). 
Median fasting duration before extubation was 6 h [2; 13]. Despite a 
higher severity of disease of patients undergoing fasting before extu-
bation (SAPS II of 50 [42; 66] vs. 48 [31; 60], p = 0.05). The rate of extu-
bation failure was similar between the fasting patients and the others: 
15 of 64 patients (23%) versus 6 of 36 (17%) of the patient (p = 0.60). 
Similarly, the incidence of pneumonia was not different between 
groups (n = 9 (14%) vs. n = 4 (11%), p = 0.76). After extubation, the 
fasting patients experienced a longer delay until feeding resumption 
as compared to non-fasting patients (21 h [6; 42] vs. 8 [5; 22]), but this 
difference did not reach statistical significance. Overall gastric content 
suctioning before extubation was not commonly performed; before 
extubation: 30% of the fasting patients and 26% of the non fasting 
patients.
Among the 11 participating centers, while some centers imposed 
a fasting period before extubation to all their patients, some did it 
infrequently. However, no center never imposed fasting, illustrating 
between and within center heterogeneity.
This heterogeneity was confirmed on the larger scale declarative email 
survey (88% response rate amont 43 units) which showed that only 
44% of the units had a written standardized operational procedure for 
extubation. Survey respondents reported to practice fasting before 
extubation “Always”, “Frequently” and “Never or Rarely” in respectively 
71, 21 and 8% of cases.
Conclusion Both practices, fasting as well as pursued nutrition until 
extubation are commonly performed in ICUs, with little standardiza-
tion of practice. Safety seems equivalent, as no clinically significant dif-
ference in terms of reintubation rate and pneumonia were observed. 
Thus, the equipoise condition appears met to undertake a trial evalu-
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Introduction Noninvasive ventilation (NIV) has become a cornerstone 
for the supportive therapy of acute respiratory failure (ARF). Survival 
benefits in chronic obstructive pulmonary disease (COPD) and cardiac 
patients have been demonstrated. Although ARF and COPD patients 
are at risk of malnutrition that adversely affects patient outcomes, few 
data are available regarding the management of nutritional support in 
non-invasively ventilated patients. We sought to describe nutritional 
management in patients receiving NIV as the first line therapy for ARF. 
Secondary objectives were to assess the impact of early nutrition use 
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on the need for invasive mechanical ventilation, occurrence of ICU-
acquired pneumonia, length of stay, and death.
Patients and methods We conducted an observational study from 
the multicenter French database fed by 20 French ICUs. Our institu-
tional review board approved this study. Adult medical patients admit-
ted to the ICU and receiving NIV for more than 2 days were included. 
Exclusion criteria were patients admitted after surgery, readmitted in 
ICU, patients with neuromuscular disease and treatment-limitation 
decisions on admission. Four groups of patients were defined accord-
ing to nutrition received during the first 2 days of NIV: (1) No nutrition; 
(2) Enteral nutrition: patients who received enteral nutrition with or 
without parenteral nutrition; (3) Parenteral nutrition only (3) Oral nutri-
tion only.
The impact of nutrition on day-28 mortality was assessed through 
the use of a Cox model adjusted on clinically relevant covariates. The 
impact of nutrition on other secondary end-point i.e. ICU-acquired 
pneumonia occurrence, need for invasive mechanical ventilation were 
assessed using a Fine & Gray models. Patients were censored after 
28 days of follow-up. Choice among collinear variables was performed 
considering clinical relevance, rate of missing variables and reproduc-
ibility of definitions. Results were given as hazard ratio (HR) for Cox 
models and subdistribution hazard ratios (sHR) and 95% confidence 
intervals (CI). The impact on duration of stay was estimated by a multi-
variate Poisson regression. P values less than 0.05 were considered as 
significant. Statistical analysis was performed using SAS 9.4 (Cary, NC).
Results During the study period, 16,734 patients were included in 
the database and 1075 met inclusion criteria. Among them, 622 
received no nutrition; 28 received enteral nutrition, 74 received par-
enteral nutrition only, and 351 received oral nutrition only. Overall, 86 
patients developed ICU-acquired pneumonia (8%), 158 required inva-
sive mechanical ventilation (14.7%) and 161 died before day-28 (15%). 
Median length of stay was 6 days [4; 9].
After adjustment for confounders, type of nutrition support was asso-
ciated with an increase day-28 mortality (P = 0.02). Compared to oral 
nutrition, enteral nutrition was associated with an increase day-28 
mortality [sHR 2.91, 95% CI 1.44–5.89; P = 0.003] whereas parenteral 
nutrition and no nutrition did not influence this outcome. The type 
of nutrition was not associated with the occurrence of ICU-acquired 
pneumonia (P  =  0.18). However, patients who received enteral 
nutrition experienced more frequently ICU-acquired pneumonia 
[sHR = 3.00, 95% CI 1.08–8.37; P = 0.036] as compared to oral nutri-
tion patients. Ventilator free days within the 28 days were negatively 
associated with the type of nutrition (P  <  0.0001). Compared to oral 
nutrition, parenteral and enteral nutrition were negatively associ-
ated with ventilator free days within the 28 days [RR per day = 1.48, 
95% CI 1.22–1.78; P < 0.0001 and RR per day = 1.77, 95% CI 1.37–2.30; 
P < 0.0001]. Delta PaCO2 measured between the first 2 days was not 
associated with any type of nutrition.
Conclusion More than half the patients receiving NIV were fasting 
within the first two NIV days. Oral nutrition was prescribed for one-
third of them and was well tolerated. Lack of feeding or underfeed-
ing had no impact on mortality and ventilator free days within the 
28 days. However, enteral nutrition was associated with an increased 
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Introduction The optimal nutritional intake in patients receiving tem-
porary extracorporeal life support (ECLS), including extracorporeal 
membrane oxygenation (ECMO) venovenous (VV) or venoarterial (VA), 
remains controversial. Enteral nutrition (EN) is suspect to increase risk 
of gastrointestinal (GI) intolerance and intestinal ischemia. So, total 
parenteral nutrition (TPN) is often preferred. The purpose of this study 
is to describe the nutrition practices for critically ill patients receiving 
ECLS and identify opportunities for improving nutrition therapy in this 
population.
Patients and methods Retrospective analysis of patients requiring 
ECMO-VA or ECMO-VV between 2010 and 2014 in the cardiac surgery 
intensive care unit of the University Hospital of Nantes. Nutritional 
support was daily monitored with parenteral intake (glucose, lipid 
and propofol, protein and albumin, parenteral nutrition) and enteral 
nutrition until ECLS weaning. Two groups were compared during ECLS 
period: no enteral nutrition delivered (none or TPN) (ANEC, n  =  73) 
and at least once enteral nutrition delivered (NEC, n =  50) including 
EN alone and supplemental parenteral nutrition (SPN). Primary out-
come was incidence of GI intolerance and risk factors. Secondary out-
comes were nutritional adequacy (calculated as overall of calories and 
protein delivered divided by the theoretical amount requirements: 
20 kcal/kg/d and 1.2 g/kg/d) and clinical outcome. Data are reported 
as median (25th and 75th percentiles) or number (%), and analyzed 
with student’s t test for continuous variables and χ2 test for categorical 
variables. P < 0.05 was considered as significant.
Results 123 patients were enrolled [age 49  years (38–59), IGS-II 51 
(35–67), IMC 24 (22–29)], represented 1009 nutrition days [ANEC = 428 
(42), NEC = 581 (58)] with duration of 7 days (5–10) [ANEC = 6 (5–8), 
NEC  =  9 (6–13); P  <  0.001] including 96 ECMO-VA and 27 ECMO-
VV. None nutrition support and TPN were respectively received 
on 42% (n  =  428) and 32% (n  =  321) of patient days (NEC  =  105, 
SPN = 155). Patients received median intake of 1188 kcal (751–1784) 
[NEC = 1458 kcal (952–2016), ANEC = 990 kcal (605–1389); P = 0.001]. 
The median ratio of prescribed/required calories per day was 83% 
(50–127) [NEC =  105% (61–144), ANEC =  70% (42–101); P =  0.001]. 
Evolution of daily energy balance is reported in Fig.  27. Digestive 
intolerance was reported in 27 patients (54%) including gastric resid-
ual volume considered high for physician in 15 cases (30%). Motility 
agents were used in 18 patients(36%). No serious GI complications 
or clinical signs of mesenteric ischemia were reported. Risk factors 
for GI intolerance were low weight [66 kg (56–75) vs. 80 kg (68.5–86); 
P = 0.034] and long duration of circulatory support [8 days (5–9.5) vs. 
11  days (6.5–14.5); P =  0.018]. Clinical outcome was similar between 
the groups (NEC vs. ANEC; ECMO-VA vs. ECMO-VV).
Discussion TPN was preferably used in this specific cohort of critically 
ill patients. Although, the number of patients receiving no nutrition 
Fig. 27 Daily proportion of target energy delivered on first 8 days
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was high, caloric debt during temporary ECLS was low in comparison 
with previous results [1]. Overnutrition was frequent in the NEC group 
and would justify implementation of nutrition protocol. Incidence of 
GI intolerance remains frequent and could justify systematic used of 
motility agents with introduction of EN.
Conclusion Enteral nutrition in patients treated with temporary extra-
corporeal life support is feasible and may be improve with systematic 
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Introduction Refeeding syndrome (RS) is a potentially lethal 
condition that remains underdiagnosed. It is characterized by severe 
electrolyte and fluid shifts associated with metabolic abnormalities 
in malnourished patients undergoing refeeding orally, enterally, or 
parenterally. Clinical criteria have been proposed for determination 
of its risk and reported in the National Institute for Clinical Excellence 
(NICE) Clinical Guidelines. Hypophosphoremia (hP) is a prominent 
feature of the RS and seems to be the earliest abnormality. Phosphorus 
is a vital component of nucleic acids, enzyme systems, and various 
metabolic pathways.
Objective To determine the incidence of refeeding hypophospho-
remia (RH)  <  0.9  mmol/L, and severe RH  <  0.6  mmol/L in a medical 
critical care unit.
Patients and methods Monocentric, retrospective and observational 
study with patients from FRench-speAking icu Nutritional Survey 
study FRANS. Critically ill adults (more than 18 yo) were enrolled if they 
were hospitalized for more than 3 days during a 3-month period and 
had an artificial nutritional support. Refeeding hypophosphoremia is 
defined by the occurrence of hypophosphoremia after refeeding. We 
studied the incidence of HR, risk factors, and prognosis.
Results 34 patients were enrolled between 03/01/2015 and 
05/31/2015. RH appears in 73.5% and severe RH < 0.6 mmol/L in 35.3% 
(Fig. 28). There is no correlation between RS risk factors and RH in our 
study. Logistic regression did not permit to identify neither risk factor 
nor prognostic modification. There is a lack in phosphoremia measur-
ing (27.6%), and overfeeding during the first 3 days occurs in 29.4%.
Discussion We define that an hypophosphoremia appearing after 
refeeding is a refeeding hypophosphoremia, and we do not consider oth-
ers etiologies, such as mechanical ventilation, alkalosis, sepsis, alcohol-
ism, malabsorptive states, poor intake, some medication. Our cohort is 
too small to find some possible correlations with risk factors or prognosis.
Conclusion Refeeding hypophosphoremia is common in our popu-
lation. Hypophosphoremia is not an independent predictor of ICU or 
in-hospital mortality in critically ill patients. The knowledge of the SRI 
requires the follow-up of the phosphoremia during nutrition after criti-




1. Marik PE. Refeeding hypophosphatemia in critically ill patients in an 
intensive care unit. A prospective study. Arch Surg 1996;131:1043–1047.
2. Crook MA. Refeeding syndrome: problems with definition and manage‑
ment. Nutrition 2014;30:1448–55.
S115 
Impact of the cumulated proteins and energy deficits on ICU 
patient’s outcome
Isaline Page1, Stéphanie Warnier1, Monique Nys1, Anne‑Françoise Rous‑
seau1, Pierre Damas1 
1Intensive care, CHU Sart‑Tilman, Liège, Belgium
Correspondence: Pierre Damas ‑ pdamas@chu.ulg.ac.be
Annals of Intensive Care 2017, 7(Suppl 1):S115
Introduction To determine the possible relationship between 10 days 
cumulated proteins (10  days CPD) and energy deficits (10  days CED) 
observed in ventilated patients and ICU length of stay, duration of ven-
tilator support, incidence of infections and 28 days mortality.
Patients and methods Mixed medical or surgical ventilated for at least 
2 days adult patients from 5 ICUs from CHU Liège Belgium were enrolled 
into the study. They were fed by enteral route with a target of 25 kcal and 
1.25 g of proteins by corrected kg of bodyweight and by day. If 50% of 
the target was not reached on day seven, parenteral nutrition was added 
with the same target. CED and CPD were calculated for 10 days, taking 
into account all the sources of nutrition, and was defined as the difference 
between the amount of energy or protein intake and the target.
Results From 10/12/2014 till 30/5/2015, 99 patients were followed. 
Data from 62 patients could be cumulated on the first 10 days. There 
were 45 males, mean BMI was 26.9 ± 6.3; SAPS II score on day 1 was 
51.3 ± 15.8, SOFA score at day 1 was 9.1 ± 3.5. They were ventilated 
for a median of 18  days (IQR 13–26), median ICU length of stay was 
27  days (IQR 19–35). Mean SOFA max calculated for the first 10  days 
was 12.1 ±  4.2 and the 28  day mortality was 32.3%. On day 5, only 
42% reached the target of 25 kcal/kg and 27% the target of 1.25 g of 
protein/kg. Mean 10 days CED was −5555.2 ± 4639.9 kcal and mean 
10 days CPD was −350.8 ± 252.3 g. There was a significant negative 
relationship between both deficits and the SOFA max (p  =  0.0064 
for CED and p  =  0.0053 for CPD). However, there were no correla-
tions between any of the deficits and ICU length of stay, duration of 
mechanical ventilation, occurrence of infections and 28 days mortality.
Discussion Saps II level, SOFA max level, ICU length of stay, all these 
parameters emphasize the high severity of this cohort of patients. 
It could indeed been thought that it is in this group of critically ill 
patients that the impact of nutrition could be easily demonstrated. 
Clear relationships between SOFAmax on day 10 and the 10 days CED 
and CPD could be seen. However, both the deficit and the level of 
organ dysfunctions could be cause or consequence. Unlike previous 
studies, usually performed in less severely ill patients, we did not find 
any relationship between CED or CPD and patient’s outcome.
Conclusion Contrary to some recent studies, we found no relation-
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Fig. 28 Incidence of hypophosphoremia at admission, the first day, 
and refeeding hypophosphoremia
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Introduction Cardiac surgery with cardiopulmonary bypass (CPB) 
is associated with a generalized inflammatory response with con-
comitant immune paresis which predisposes to the development of 
postoperative infections and sepsis (1). Lymphocytes are essential 
agents of innate and adaptive immune responses during infections 
or inflammation processes. Lymphopenia has been associated with 
immune dysfunction during septic shock, and it has been shown 
that low absolute lymphocyte count was predictive of postopera-
tive sepsis (2). Furthermore, impaired lymphocyte function probably 
occurs after CPB. Thus, we investigated mechanisms involved in post-
operative lymphopenia and impaired lymphocyte function after CPB. 
The aims of this study were: 1) To describe a potential relationship 
between lymphopenia and occurrence of postoperative infections. 2) 
To demonstrate that CPB induces lymphocytes apoptosis. 3) To dem-
onstrate that CPB impaired lymphocyte function (ability to prolifer-
ate). 4) To demonstrate that IL-10, PD-L1 (programmed cell death 1 
ligand 1) and Indoleamine 2,3-dioxygenase (IDO) could be interesting 
targets to restore lymphocyte ability to proliferate after CPB.
Patients and methods Blood cell counts with differentials obtained 
within the first postoperative week were analyzed in 828 patients 
undergoing cardiac surgery in 2015. Postoperative lymphopenia was 
defined as a lymphocyte count <1.3  ×  109  cells  L−1. Postoperative 
infections were defined following CDC criteria.
Study procedures: The following analysis were performed before (T0) 
and 24  h after (T1) cardiac surgery with CPB: Lymphocyte apoptosis; 
T-cell proliferation ability following polyclonal stimulation; HLA-DR 
and PD-L1 expression on monocytes; plasma IDO activity and IL-10 
levels; and the ability of lymphocytes to undergo a clonal proliferation 
when stimulated using specific inhibitors of IL-10 and IDO.
The study was approved by our local ethics committee. Patients were 
informed of the observational nature of the study and gave their consent.
Results
1. Early lymphopenia after CPB was associated with the occurrence of 
postoperative infection: Postoperative infections occured with a median 
delay of 6 days. Patients who developed postoperative infections had 
a significantly lower lymphocyte count at Day 4, Day 5 and Day 6 than 
patients without postoperative infections.
2. CPB induced lymphocyte apoptosis and decreased T‑cell proliferation ability.
3. CPB during cardiac surgery decreased mHLA‑DR expression.
4. CPB increased IDO activity, PD‑L1 expression and IL‑10 plasma levels.
5. IL‑10 or PD‑L1 inhibition of inhibition could restore ability of lymphocytes 
to proliferate, although IDO inhibitors did not show any effect.
Conclusion We provided new evidences that CPB induces immu-
nosuppression. We also demonstrated that IL-10 and PD-L1 
could be interesting targets to restore ability of lymphocytes to pro-
liferate. As maintaining MV during CPB decreased plasmatic levels of 
IL-10, our study brings new evidences that ventilator strategies could 
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Introduction The prognostic impact of neutropenia in critically-
ill cancer patients remains controversial. Hence, several studies 
in critically ill cancer patients failed to demonstrate the impact of 
neutropenia on outcome [1]. This lack of statistical association might 
however, reflect a lack of statistical power.
A previous meta-analysis of aggregated data suggested 11% (95% CI 
9–14%) raw increase in mortality in neutropenic patients. The available 
data were, however insufficient to allow adjustment with confounders 
[2].
The aim of this study was to assess the influence of neutropenia on 
mortality of critically ill cancer patients using individual data obtained 
from studies identified by our systematic review. Secondary objectives 
were to assess the influence of neutropenia on mortality of critically 
ill patients while taking into account underlying malignancy, use of 
G-CSF or changes related to period of admission.
Patients and methods This systematic review and meta-analysis 
was performed according to the PRISMA statements. Public-domain 
databases including PubMed and the Cochrane database were 
searched by using predefined keywords. The research was restricted to 
articles published in English and studies focusing on critically ill adult 
patients from May 2005 to May 2015.
The methods and objectives of this systematic review were reported in 
the PROSPERO database (CRD42015026347).
Selected manuscripts’ authors were then contacted to obtained part 
of their dataset.
Mortality was defined as either hospital or day-28 mortality.
This preliminary analysis reports results from the whole dataset before 
and after adjustment using logistic regression. Period of admission 
and use of G-CSF were then assessed and were a pre-planned analysis.
Results Our initial search yielded 1528 citations and 131 studies were 
retained for further analysis. Overall, 9 studies were excluded for 
redundancy with other included studies, 5 as containing only neutro-
penic patients, and two as containing only palliative patients. Finally 
30 datasets (26%) containing sufficient data to allow comparison were 
obtained from authors.
Overall, 7356 patients were included in this study, including 1666 
patients with neutropenia at ICU admission. Median age was of 
60  years (IQR 49–69). Median SAPSII score at ICU admission was 
42 (IQR 28–57). Respectively 4101 and 3255 patients had underly-
ing haematological malignancy and solid tumours, and 438 patients 
underwent allogeneic stem cell transplantation. Mechanical ventila-
tion, vasopressors, and renal replacement therapy were required in 
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respectively 50.7% (n = 3729), 41.1% (n = 3024) and 16.1% (n = 1174) 
of the included patients.
Mortality was of 47.4% in the overall population (n = 3483) and was 
higher in neutropenic patients (60.3 vs. 43.6% in non-neutropenic 
patients; P < 0.001). Neutropenia was independently associated with 
poor outcome when adjusted for underlying malignancy, allogeneic 
stem cell transplantation and severity as assessed by organ support 
(OR 1.45; 95% CI 1.27–1.65).
Mortality decreased progressively over time in both non-neutropenic 
(from 54 to 44%; P < 0.0001) and in neutropenic patients (from 72 to 
57%; P  <  0.0001). When adjusted for confounders, admission during 
a more recent period was independently associated with favourable 
outcome and did not change the final model.
Conclusion This preliminary analysis suggests a meaningful survival 
in neutropenic critically ill cancer patients despite an independent 
association between neutropenia and mortality.
Additional analyses are on-going in order to adjust for study weight, 
heterogeneity across studies, assess the influence of neutropenia 
duration or G-CSF use, and confirm the influence of neutropenia in a 
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Introduction Candida bloodstream infections (CBI) are frequent and 
increasing in hospitalized patients, especially in intensive care units. 
Considering the results of some experimental in vitro and animal stud-
ies, it seems that yeasts belonging to Candida genus are able, so as 
to survive, to modulate the immune response of the host by guiding 
T cells polarization to Th2 profile. Th1 and Th17 cytokines are known 
to be involved in host defense against CBI. However, these data are 
mainly experimental or collected after candidemia. The aim of this 
study is to precise kinetic of cytokines network during human CBI.
Patients and methods This was an ancillary study of an institutional 
project dedicated to pathophysiology of candidiasis. We have included 
32 patients with candidemia and 54 controls (27 matched hospitalized 
controls and 27 healthy subjects). The sera of cases were gathered 
before (almost 5 days before), during and after the isolation of yeasts 
from blood culture, defined as day 0 (D0). Quantitative analysis of 
28 cytokines by Luminex® technology and of (1,3)-β-d-glucans by 
Fungitell® test were performed on 132 samples. The amplitude 
of Th profile response was expressed by summing the amount of 
the most relevant cytokines for Th1, Th2 and Th17 profiles, in pg/
mL. For each patient, the highest level of response was considered 
as 100%. Results are expressed for the population by means of 
the results. We then performed univariate analysis (Fischer exact 
test for qualitative variables, Mann–Whitney and Wilcoxon test for 
quantitative variables, Spearman for correlation; GraphPad Prism V6 
software) and a multidimensional analysis by principal component 
analysis (PCA; IgorPro software).
Results Patients with candidemia exhibited an increase in pro-
inflammatory cytokines (IFNγ, TNFα and IL-12), in comparison with the 
anti-inflammatory cytokines (IL-4 and IL-10) before D0 (p =  0.034) in 
univariate analysis. The ratio between mean values reverses at D2 and 
D3 (p =  0.02) and the increase of Th2 response level from D0 to D4 
is correlated to the decrease of Th1 response (r = −0.885; p = 0.033) 
in univariate analysis and PCA. A pro-inflammatory response (Th1) is 
associated with a reduced mortality (RR = 0.58 [0.34; 0.98]) and with a 
lower β-D-glucans levels (p < 0.0001).
Discussion We describe here a dynamic cytokine profiles in response 
to candidemia. Pro-inflammatory response predominates before D0 
and reverses after. This is contradictory to the postulate that an anti-
inflammatory background could predispose to invasive candidiasis 
in ICU patients and exhibiting a “Post-infectious immune suppression 
conditions”. But the relative deficiency in Th1 response compared 
to simultaneous anti-inflammatory cytokines secretion observed 
after CBI is in accordance with experimental data, suggesting the 
modulation of the immune response by Candida. The link between 
cytokinic profile and mortality can also raise the hypothesis of an 
influence by genetic factors on the regulation and direction of the 
immune response and so, the existence of a high-risk population.
Conclusion These data suggest a relation between Candida and the 
orientation of the immune response towards a pattern deleterious 
for the infected host. This could allow to determine the most relevant 
cytokines varying during CBI. They could be used as biomarkers 
to identify the patients who could benefit from an early treatment 
in a preemptive targeted therapeutic strategy. These data will be 
paralleled to genetic background and to circulating Candida derived 
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Introduction Prognosis of cirrhotic patients hospitalized in inten-
sive care unit (ICU) remains poor. Many studies suggested a negative 
impact of systemic inflammation on organ failure and outcome in cir-
rhosis(1). In ICUs, cirrhotic patients are widely admitted and revalued 
after receiving optimal treatments for 3 days. However, little is known 
about how manage these patients after day 3 according to their 
prognosis. The blood neutrophil-to-lymphocyte ratio (NLR) as a novel 
inflammation index biomarker has been reported to be a predictor of 
clinical outcomes in various malignancies and in unselected critically 
ill patients(2). NLR has also been identified as a predictor of mortality 
in patients with stable liver cirrhosis. To our knowledge, the ability of 
NLR to predict outcome in critically ill cirrhotic patients has never been 
studied. The aim of this study was to evaluate the usefulness of inflam-
matory marker such as NLR for diagnosis of infection and predicting 
the outcome in hospitalized critically ill cirrhotic patients.
Patients and methods We performed a retrospective monocentric 
study including consecutively cirrhotic patients hospitalized in a medi-
cal ICU from 2010 to 2014. For each patient, clinical and biological data 
at admission and day 3 were collected. NLR at admission (“NLRD0”), at 
day 3 (“NLRD3”) and the variation of NLR between admission and D3 
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(“delta NLR”) were calculated. Statistical analysis used appropriate non 
parametric tests and Cox regression for survival analysis. The ability of 
the variables to discriminate survivors from non-survivors was deter-
mined using ROC curves. Results are expressed as median (IQR).
Results During the study period, 149 cirrhotic patients were admit-
ted in ICU. The etiologies of liver cirrhosis were alcoholic in 87% 
of cases with severe score: median Child-Pugh score  =  9 [7–11], 
median MELD score  =  25 [18.3–30.8]. Main reasons for ICU admis-
sion were sepsis (40.9%), gastrointestinal bleeding (23.5%) and renal 
failure (19.5%). NLRD0 was higher for patients hospitalized for septic 
shock (p  <  0.001). Patients were followed up for 23  days [5.5–289.5]. 
90 (59.6%) patients died including 57 (37.7%) deaths in ICU and 18 
(12.1%) deaths after ICU discharge during the same hospitalization. 
NLR decreased for survivors between D0 and D3 (−4.5 [−9.8 to 0.0]) 
whereas it increased for non-survivors (+1.2 [−3.1 to +10.1]). In uni-
variate analysis, for predicting survival, higher values of NLRD3, delta 
NLR, MELD score at admission, SOFA score at admission and at day 3 
and delta SOFAD0-D3 were significant factors. Predictors of death in 
multivariate analysis are shown in Fig. 29. Area under delta NLR ROC 
curve was 0.72 (CI = 0.61–0.83).
Conclusion The blood NLR is a novel inflammation index that has 
been shown to independently predict poor clinical outcomes. We have 
demonstrated that delta NLR is an independent predictor of mortal-
ity in critically ill cirrhotic patients. Delta NLR could help to identify cir-
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Introduction Diagnosis of infection in immunocompromised patients 
can be difficult. However, diagnosing infection is very important, 
particularly in critically ill. This study aims to evaluate the benefit of 
procalcitonin (PCT) blood level as a diagnostic marker for bacterial 
infection in patients with hematological malignancies admitted to the 
Intensive Care Unit (ICU).
Patients and methods This retrospective single-center study 
included all consecutive patients with acute myeloid leukemia or 
high grade lymphoid malignancy admitted to the ICU. Patients were 
sorted into three subgroups, according to clinical and microbiological 
data: «Infectious disease», «no infectious disease» and «Unknown». Ini-
tial serum PCT and when available at day 3 and day 5 were recorded. 
Receiver Operating Characteristic (ROC) curve, sensitivity and specific-
ity were calculated. Serum PCT was considered as decreasing when 
the decrease was ≥25% at day 3 and/or ≥50% at day 5. Mortality rates 
in the ICU and at day-90 were also studied.
Results Fifty-four patients were included in the study. At diagnosis, 
PCT levels were significantly different between the “Infection dis-
ease” group and the “No infection disease” group (p =  0.002). There 
was no difference between the “Infection disease” group and the 
“Unknown” group (p  =  0.052). For the diagnosis of bacterial infec-
tion, best initial serum PCT threshold was 0.65  ng per milliliter. For 
that threshold, sensitivity was 94.6% and specificity was 78.6%. PCT 
area under the ROC curve was 0.93 [CI 95%  =  0.855–1]. Youden’s  J 
statistic was 0.73. PCT levels weren’t different between groups 
according to the presence of neutropenia or in case of inaugural 
disease. There was a significant difference in PCT values between 
groups according to the SOFA score (p =  0.027), but not the SAPS2 
score. Mortality rate in the ICU and at day-90 were significantly lower 
for the patients with decreasing PCT (p < 0.001 and p < 0.001, respec-
tively). When comparing serum PCT and CRP predictive values, PCT 
was significantly a better marker of bacterial infection (Fig. 30).
Discussion We found that serum PCT, with a threshold of 0.66  ng/
mL, is a reliable marker of bacterial infection disease in patients 
with aggressive hematological malignancy admitted to the ICU. 
Our study confirms the results of a previous study in unselected 
immunocompromised patients admitted to the ICU, showing a 100% 
sensitivity, a 63% specificity and an area under ROC curve of 0.851 
[0.78–0.92] for a threshold of 0.5 ng/mL (1).
The main limitations of our study are its retrospective design and the 
small number of included patients.
Conclusion PCT is a reliable marker of bacterial infection in patients 
with hematological malignancies admitted to the ICU. PCT kinetic 
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Fig. 29 Multivariate analysis of factors associated with mortality
Fig. 30 ROC Curve of initial blood level of PCT and CRP as markers of 
bacterial infection
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Introduction Endocan is a proteogycan secreted by pulmonary and 
renal endothelial cells (Lassalle et  al.). Its synthesis is increased in 
sepsis and is regulated by Lipopolysaccharide (LPS) and cytokines.
Toll Like Receptors (TLRs) are receptors of innate immunity and 
recognize diverse exogenous and endogenous patterns.
In this study, we have compared the effect of 2 TLRs agonists on 
regulation of secretion and expression of Endocan by Human 
Umbilical Veinous Endothelial Cells (HUVECs).
Materials and methods The stimulation of HUVECs was performed by 
2 TLRs agonists: LPS and PolyInossinic Polycytidylic acid (Poly (I:C)).
The secretion of Endocan was evaluated by Enzyme Linked Immuno 
Sorbant Assay (ELISA) in the supernatant of stimulated HUVECs.
Real Time Polymerase Chain Reaction (qPCR) study compared the 
expression of Endocan in the two groups.
Results The secretion of Endocan by HUVECs is upregulated by LPS 
and poly (I:C).
Kinetics of secretion of Endocan was faster with LPS than Poly (I:C).
q PCR study confirmed that Endocan is overexpressed in HUVECs 
stimulated with LPS than Poly (I:C).
Discussion TLR 4 is involved in the recognition of LPS (Kawai et  al.), 
a component of the outer membrane of Gram Negative Bacteria, 
respiratory syncytial virus fusion proteins, Steptococcus pneumoniae 
pneumolysin.
TLR 3 was originally identified as recognizing a synthetic analog of 
double stranded Ribonucleic Acid (dsRNA), poly(I:c) which mimics viral 
infections.
In this study, we have found that kinetics of secretion and expression 
of Endocan is faster with HUVECs stimlated by TLR 4 agonist than TLR 
3 agonist.
This results could suggest that Endocan may be not only a marker 
of septic shock but could be also a specific marker to recognize the 
nature of pathogenic microorganisms in septic shock.
Furthermore, other studies with more TLR agonists could be useful to 
confirm these results.
Conclusion Studying the effects of diverse TLRs agonists could make 
the plasmatic dosage of Endocan more specific and helpful to recog-
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Introduction Lung ultrasound is widely used in intensive care, 
ermergency and pneumology medicine, for assessing acute 
respiratory pathologies. It is noninvasive, radiation free and rapidly 
available at the patient’s bedside and provides an excellent accuracy. 
So, lung ultrasound may be an interesting tool for the physiotherapist 
as it allows to assess with more accuracy the patient improving the 
chest physiotherapy indication and monitoring (1).
As far as we are aware, no study has evaluated the impact of lung 
ultrasound on clinical-decision making by physiotherapists in the use 
of chest physiotherapy.
This case report highlights the lung ultrasound interest in chest 
physiotherapy in patient with lung consolidation.
Patients and methods This was a case report written following the 
recommendations of the CARE guideline (2).
The case was a 68-years-old female patient, non intubated, hospital-
ized in a respiratory ICU. She was hypoxemic (PaO2 = 59 mmHg and 
SaO2  =  89%), with dyspnoea at rest and an increasing radiological 
opacity at the right lung base. Hypoxemia was the indication for physi-
otherapist referral.
At the clinical examination, the physiotherapist’s findings were: 
decreased mobility, dullness and abolished vesicular sound at the 
base of right hemithorax.
This clinical examination and chest x-rays analysis allowed the physi-
otherapist to propose several clinical hypotheses: pleural effusion, 
obstructive atelectasis or pneumonia.
The chest physiotherapy treatment differs according to the type of 
lung deficiencies. For example, the physiotherapist must to refer 
the patient to the medical staff in case of pleural effusion or may 
implement hyperinflation technique in case of obstructive atelectasis. 
Determining the nature of lung deficiencies is essential to provide the 
more suitable therapeutic strategy. So, the physiotherapist decided 
to perform a lung ultrasound examination to retain the more likely 
hypothesis.
Results Ultrasound examination performed by the physiotherapist 
highlighted the presence of a lung consolidation at the infero-lateral 
and posterior parts of the right lung with a pneumonia pattern: 
presence of tissue-like sign, shred sign, dynamic air bronchogram and 
fluid bronchogram.
The medical staff implemented antibiotic treatment. The ultrasound 
findings guided the physiotherapist to choose chest physiotherapy 
technique improving the alveolar recruitment: nearly prone position 
(left side down) and continuous positive airway pressure during 45 min.
The patient response to the treatment was monitored by ultrasound 
and showed a decrease of the lung consolidation size and apparition 
of B lines, meaning a gain of lung aeration. These findings were associ-
ated with SpO2 improvement but without decrease of dyspnoea.
Discussion Lung ultrasound allowed the physiotherapist to precise 
the nature of the radiological lung opacity. As it is more accurate 
than clinical examination or chest x-ray, this suggests a more suitable 
choice of chest physiotherapy techniques than conventional clinical 
decision-making process.
Ultrasound findings suggested a positive response to the chest 
physiotherapy treatment. The apparition of re-aeration signs (B lines, 
decreased consolidation size) showed a short-term efficacy of the chest 
physiotherapy treatment. This allowed the physiotherapist to continue the 
treatment during 1 week and obtain a substantial clinical improvement.
Conclusion The use of lung ultrasound in the clinical decision-making 
process may help the physiotherapist to choose with more accuracy 
the therapeutic strategy. Moreover, it allows to monitor the treatment 
in real-time and assess the patient’s response. The use of this tool 
may allow the physiotherapist to determine the optimal indications 
for chest physiotherapy and thus avoid unnecessary or inappropriate 
treatments.
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Introduction Chronic Critical Illness (CCI) syndrome is a new condi-
tion affecting an increasing number of patients, who survived an acute 
critical illness but have persistent severe organ dysfunction, requiring 
prolonged specialized care. CCI is a iatrogenic process, reflecting the 
efficacy of modern life support technologies(1), and encompasses 
multiple organ failure, need for prolonged mechanical ventilation 
(MV), organ support, and palsy due to polineuromyopathy. The transi-
tion from acute to CCI is gradual: definitions are based on duration of 
MV, with cut-offs of 7, 14 or 21 consecutive days of MV for ≥6 h/day. 
CCI patients may come from either medical or surgical ICU; their health 
status fluctuates between improvements and deteriorations implying 
recurrent transitions between different levels of care (1).The risk of 
death is reported to be as high as 50%. Despite a relatively young age 
(65  years on average), functional status of CCI patients discharged is 
seriously impaired, thus CCI patients require long-term rehabilitation.
AIM: To estimate the frequency of CCI Syndrome in Careggi, a large 
academic, tertiary care hospital; to describe the clinical course of CCI 
patients through discharge, and their functional status at discharge.
Patients and methods Administrative data on admission, transfer, 
death and discharge of all CCI patients, consecutively admitted in one 
of the 56 ICU beds at Careggi Hospital from January 1 to December 
31, 2014, were collected. CCI was defined with the cut off of ≥21 days 
of ICU stay, representing the index event (IE) without contribution of 
previous or subsequent hospitalization in other hospitals. Reasons 
for admission were grouped into the 4 broad categories of medical 
causes, surgery, major trauma and cardio-respiratory arrest. Patients 
discharged were evaluated in daily living, cognitive status, and 
mobility using Barthel Index.
Results We identified 123 subjects who developed CCI (71 males; age 
61.7  ±  1.5  years, mean  ±  SEM); 36 of them came from an external 
ICU, 87 began their CCI course within Careggi hospital (60 from the 
Emergency Room, 27 from a regular ward). Average duration of 
the IE was 36.1  ±  2.1  days. These sample developed accumulative 
length of ICU stay of 4440  days, corresponding to a 22% ICU bed 
occupation over the theoretical total of 20,440. When days of sub-
intensive care and regular ward were separately added, 5500 days of 
highly specialized care and 6266 days of total acute hospital stay were 
reached. Surgical patients had longer hospitalizations (p = 0.009).CCI 
patients confirmed to be highly erratic: a total of 302 transitions across 
different services were recorded in the 123 patients, with a maximum 
of 9 in 6 of them. Mean age was comparable between the 27 
patients who died (22%) and the remaining 95 who were discharged 
alive (66.9  ±  2.5 vs. 60.3  ±  1.7  years; p  =  0.058).Fourteen subjects 
continued their ICU stay out of hospital. Only 6, whose age was lower 
(37.7  ±  3.7  years), were discharged home; half of the participants 
(n =  68, 55.2%) were admitted to a residential rehabilitation facility. 
Younger subjects scored better in the domains of self care (p = 0.018) 
and cognitive status (p  =  0.008) but not in the domain of mobility, 
including walking ability: 45 patients required maximal assistance in 
performing activities of daily living and transfers, other 12 required 
medium/maximal assistance, with no statistical difference between 
DG group.
Conclusion CCI is a relevant clinical condition that need to be assessed 
and possibly prevented, as it causes severe morbidity, long-term func-
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Introduction Critical illness together with immobilization have delete-
rious effects on patients outcome, especially in the presence of sep-
sis. Increased muscle catabolism and membrane inexcitability reduce 
muscular mass and impair function within the first days after sepsis 
onset (1). Early mobilization could potentially limit muscle wasting and 
functional impairment in this population. The purpose of this study 
was to test whether exercise during the early phase of sepsis is safe 
and beneficial and to which extent it can limit skeletal muscle protein 
catabolism and preserve function.
Patients and methods Adult patients admitted with the diagnosis of 
severe sepsis were included and randomly allocated to two groups; 
1) Control group (Ctrl-G): manual passive/active manual mobilization 
twice a day or 2) Experimental group (Exp-G): additional two times 
30  min of passive/active cycling exercise. Both groups benefited 
from a reduced sedation, adjusted nutritional intake and bed to chair 
transfer as soon as possible.
Skeletal muscle biopsy and electrophysiological testing were realized 
at day-1 and day-7. Muscle histology, biochemical and molecular anal-
yses of anabolic/catabolic and inflammatory signalling pathways were 
performed. A group of four healthy subjects was used to obtain non 
pathological values.
Hemodynamic parameters and patients perception were collected 
during each session.
Results Twenty-one patients were included, however 3 died before 
the second muscle biopsy. Ten patients in Ctrl-G and nine in Exp-G 
were finally analysed. Muscle fibre cross sectional area (µm2) was 
significantly preserved by exercise (relative changes were Ctrl-G: 
−45 ± 41% vs Exp-G:12 ± 19%, p = 0.001). Markers of catabolic sys-
tems were highly increased during sepsis compared to healthy sub-
jects and reduced in both groups 7 days after admission. However the 
reduction in mRNA (relative change) tended to be more important in 
Exp-G: MURF-1 (Ctrl-G: −31 ± 67% vs Exp-G: −63 ± 45%, p = 0.15), 
MAFbx (Ctrl-G: −7  ±  138% vs Exp-G: −56  ±  37%, p  =  0.23), LC3b 
(Ctrl-G: 5 ±  47% vs Exp-G: −21 ±  18%, p =  0.18) and Bnip3 (Ctrl-G: 
27 ± 198% vs Exp-G: −59 ± 23%, p = 0.02). Anabolic and inflamma-
tory markers were not affected by exercise.
Electrophysiological testing, including direct muscular stimulation, 
was abnormal on Day-1 in 10 of 13 evaluated patients. Since only a 
limited number of patients could be reassessed a second time, com-
parison between groups was not possible.
In general, all activities were well tolerated by patients with no adverse 
events.
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Conclusion Early mobilization during the first week of the sepsis onset 
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Introduction The pulmonary auscultation is used by respiratory thera-
pist (RT) to evaluate the efficiency of a treatment. Listen to the noises 
coming from the primary bronchi (PB) is important because it is the 
place where secretions can be accumulated. Therefore, it is crucial 
to know exactly where to place the stethoscope’s chestpiece on the 
chest. Few studies have analyzed the chest area where the PB were 
located. Our hypothesis is that PB are localized on a line that joins 
axillary fossa (Bi-Axillary line: BAL). The aim of our study is to evalu-
ate the probability to find the primary bronchi by analysis of chest 
radiography.
Patients and methods A retrospective study was performed by 
analysis of chest X-Ray using the software: TM reception®, which 
allows precise measures to the tenth of millimeter. All the X-Rays were 
made on confined to bed patients hospitalized within intensive care 
unit, internal medicine and abdominal surgery rooms.
The following measures (in mm) were made between:
a) Lowered perpendicular (LP) of:
• Bi‑Axillary Line (BAL) and the sternal carina (SC)
• BAL’s and the position of right and left PB
• Middle of the body‑sternum (BS) and the perpendicular middle of 
right and left PB.
b) Hyoid bone and the SC
The exclusion criteria were: BMI < 18.5 kg/m2 and BMI > 30 kg/m2, sco-
liosis, minor patient, lack of visibility of one of the axillary fossa, lack of 
visibility of PB, clavicular asymmetry, kyphosis, lack of symmetry in the 
shot, atelectasis and pneumothorax.
Statistics: Normality test: KS. Mean values are expressed with their SD 
and 95% CI.
Results
Discussion In this study, we performed analysis of chest x-Rays of 
bedridden patients and we demonstrated that it is possible to localize 
easily, on either side of the BS, the right and left PB at  ±  25  mm 
distance (LP) above a line joining axillary fossa. This study constitutes 
a new tool for the RT who, by using stethoscope with a chestpiece of 
10 cm2 surface area, will be able to listen to noise coming from PB.
Conclusion The data presented herein (Fig.  31) show that right and 
left PB are located at a mean distance of 25 (±5) mm and 27 (±6) 
mm above the BAL, on both sides of the BS. The BAL represents thus 
an easy and precise mode to detect right and left PB by bedridden. 
Finally, the distance between the hyoid bone and the SC is about 
12 cm. As the PB are located after the bifurcation, this information con-





Study of efficacy on ICU acquired weakness of early standing 
with the assistance of a tilt table in critically ill patients
Celine Sarfati1, Alex Moore1, Paula Mendialdua1, Emilie Rodet1, Catherine 
Pilorge2, Francois Stephan2, Saida Rezaiguia‑Delclaux2 
1Physiotherapy department, Surgical Center Marie Lannelongue, Le 
Plessis‑Robinson, France; 2Réanimation adulte, Surgical Center Marie Lan‑
nelongue, Le Plessis‑Robinson, France
Correspondence: Celine Sarfati ‑ celine.sarfati@yahoo.com
Annals of Intensive Care 2017, 7(Suppl 1):O83
Introduction Critically ill patients frequently develop muscle weak-
ness, which is associated with prolonged intensive care unit and 
hospital stay (1). This randomized controlled trial (Clinical Trials 
NCT02047617) was designed to investigate whether a daily training 
session using a tilt table, started early in stable critically ill patients 
with an expected prolonged ICU stay, could improve strength at 
ICU and hospital discharge compared to a standard physiotherapy 
program.
Patients and methods The study protocol was approved by an eth-
ics committee and informed consent was obtained from all patients. 
Patients admitted in adult ICU of Marie Lannelongue hospital, France, 
who were mechanically ventilated for at least 3  days were included. 
Exclusion criteria were cerebral or spinal injury, pelvic or lower limb 
fracture. Patients were assessed each day for temporary contrain-
dications for mobilization out of bed (RASS score <−2 or >1; hemo-
dynamic instability; a continuous intravenous dose of epinephrine/
Fig. 31 50 X‑Rays (Men = 26, women = 24) have been analyzed. 
Normality test passed. LP lower perpendicular, BAL bi‑axillary line Fig. 32 See text for description
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norepinephrine >2 mg/h; continuous renal replacement; ECMO). Inter-
ventions for patients assigned to the standard physiotherapy group 
(Std) included sitting in armchair for at least 2 h per day. In addition to 
the standard physiotherapy mobilization protocol, patients assigned 
to the Tilt table physiotherapy group (Tilt) were positioned on a tilt 
table for 1 h per day. The primary outcome was the muscles strength 
evaluated using the Medical Research Council (MRC) score (range 
0 = no muscle contraction, to 5 = normal strength), scoring 3 muscle 
groups in each limb, at ICU and hospital discharge, compared to MRC 
score evaluated in ICU before the implementation of the physiother-
apy program. Secondary outcome variables included ICU and hospital 
length of stay.
Results The flow chart of the study, conducted between October 2013 
and October 2014, is presented in the Fig. 32.
Both groups (Std vs Tilt) are comparable for age (63 ± 16 vs 60 ± 15, 
p = 0.37), gender (21 Females vs 26 F and 52 Males vs 46 M, p = 0.34) 
and the SAPSII (43 ±  13 vs 42 ±  12, p =  0.65). No significant differ-
ence was observed in terms of MRC score or in terms of pts with or 
without weakness (MRC > 48) at ICU or hospital discharge. However, 
the number of pts with weakness was significantly higher in the group 
before Tilt mobilization, suggesting a more rapid improvement in 
the tilt group. The ICU and hospital lengths of stay were not different 
between groups.
Discussion The prevalence of muscle weakness in our population is 
high before mobilization (90.6%, 95% CI 85.2–95.6), is still 48.6% at ICU 
discharge but represents only ~ 1% at hospital discharge. This low hos-
pital discharge prevalence is probably related to the early and intense 
physiotherapy in both groups, which may explain our inability to dem-
onstrate superiority of the addition of tilt table positioning, although a 
faster recovery is suggested.
Conclusion Training sessions using a tilt table, in addition to early and 
intense physiotherapy did not improve muscle strength evaluated 
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Introduction Patients with high flow nasal cannula may benefit from 
combined aerosol therapy. Clinical efficacy depends on pulmonary 
deposition which is related to the type of nebulizer. All new nebulizers 
or delivery methods require rigorous evaluation. The aim of this study 
was to compare lung deposition between two nebulizers (jet nebu-
lizer vs vibrating-mesh nebulizer) through high flow nasal cannula in 
healthy subjects.
Patients and methods Aerosol delivery of diethylenetriamine-
pentaacetic acid labelled with technetium-99m (99mTc-DTPA, 
4  mCi/4  mL) to the lungs using a vibrating-mesh nebulizer (Aerogen 
Solo®, Aerogen Ltd., Galway, Ireland) and a constant-output jet nebu-
lizer (Opti-Mist Plus Nebulizer®, ConvaTec, Bridgewater, NJ) through 
high flow nasal cannula (Optiflow®, Fisher & Paykel, New Zealand) was 
compared in 6 healthy subjects. Flow rate was set at 30 L/min through 
the heated humidified circuit. Pulmonary and extrapulmonary depo-
sition were measured by single photon emission computed tomog-
raphy combined with a low dose CT-scan (SPECT-CT) and by planar 
scintigraphy.
Results Lung deposition was only 3.3  ±  1.3 and 1.2  ±  0.8% of the 
nominal dose with the vibrating-mesh nebulizer and the jet nebulizer, 
respectively (p  <  0.05). Dose lost in the high flow circuit, humidifica-
tion chamber and nasal cannula was higher with the vibrating-mesh 
nebulizer as compared to the jet nebulizer (75.2 ± 8.2 vs 45.0 ± 6.2% 
of the nominal dose, p = 0.001). Expressed as percentage of emitted 
dose, lung deposition was similar with both nebulizers.
Conclusion This study demonstrated that aerosol delivery through 
HFNC is poor in the specific conditions of the study despite the 
higher efficiency of the vibrating-mesh nebulizer as compared to the 
jet nebulizer. Placing the nebulizer on the HFNC circuit at 30 L/min 
induces high aerosol loss on the circuit and the oropharynx.
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